data_2l72_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l72 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . . . . . . 0 CA--C 1.517 0.205 0 N-CA-C 112.99 -0.044 . . . . 75.3 112.99 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.414 ' HE2' ' HB2' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -82.55 152.55 25.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 75.2 111.37 -178.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.96 132.77 7.75 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.716 -0.954 . . . . 71.33 110.716 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.26 132.83 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.947 0.403 . . . . 75.55 111.247 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.19 139.25 33.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.757 -0.46 . . . . 62.02 109.757 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -13.83 62.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.2 0.444 . . . . 72.14 112.2 -173.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.8 -32.99 74.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.933 0.397 . . . . 65.14 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.6 m -64.41 -35.32 80.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.901 -0.59 . . . . 73.33 110.453 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.25 -31.55 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.847 -0.615 . . . . 74.42 110.23 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.55 -26.61 68.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.66 -0.7 . . . . 72.03 111.948 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -64.15 -20.11 65.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.945 -0.302 . . . . 73.32 111.525 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 40.7 m-85 -75.5 -18.24 59.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.29 0.478 . . . . 74.32 112.29 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -82.0 -23.41 36.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.017 -0.673 . . . . 73.15 110.35 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -84.1 -21.09 31.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.27 -1.011 . . . . 72.12 108.27 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.652 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 27.4 tp -84.17 -59.79 2.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.683 -1.144 . . . . 73.3 111.594 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -76.25 -43.94 39.64 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.375 -0.375 . . . . 73.5 111.82 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.1 mm -66.51 -44.21 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.431 . . . . 74.53 111.662 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -80.51 -10.36 59.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.282 -0.417 . . . . 73.51 110.515 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.2 tttt 56.57 24.3 8.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.46 -0.791 . . . . 74.03 111.14 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -99.82 125.61 45.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.807 -0.812 . . . . 74.44 108.807 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 m -83.83 138.24 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.113 0.482 . . . . 75.1 110.051 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HZ3' ' HA ' ' A' ' 18' ' ' LEU . 30.5 mtmm -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.477 0.656 . . . . 74.14 112.115 -172.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.725 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.9 t90 -142.54 123.76 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.427 -1.323 . . . . 71.14 107.427 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 41' ' ' ASP . 27.1 pt -119.22 138.98 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.427 -0.583 . . . . 73.04 109.427 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 5.9 p -115.83 120.29 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.839 0.828 . . . . 73.31 111.237 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.826 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -114.94 163.38 15.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.908 -1.042 . . . . 64.12 110.672 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -112.09 127.55 55.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.72 -0.673 . . . . 75.13 109.653 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 86' ' ' THR . 68.8 mt -113.04 100.29 10.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.214 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 86' ' ' THR . 8.8 tp10 -162.55 165.48 25.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.95 -1.13 . . . . 72.54 107.95 171.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 t30 60.6 29.38 18.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.739 0.781 . . . . 71.34 109.936 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 4' ' ' GLY . 50.0 p 57.52 26.97 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.446 -1.252 . . . . 74.41 112.9 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -125.55 136.75 53.65 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.213 -0.304 . . . . 72.24 110.613 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.597 HG23 HD12 ' A' ' 94' ' ' LEU . 9.8 mm -106.34 107.14 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.353 -0.61 . . . . 74.31 109.353 172.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.56 142.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 -0.275 . . . . 74.32 110.467 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 1.8 m -79.91 146.39 7.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.794 0.331 . . . . 75.41 110.478 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 59' ' ' ARG . 50.2 mt-10 -107.03 -18.54 13.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.327 -0.62 . . . . 75.53 109.327 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.54 145.62 14.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.531 -0.758 . . . . 70.22 110.812 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.718 ' HB2' HG21 ' A' ' 27' ' ' ILE . 3.4 p30 -152.08 133.35 14.44 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.807 -0.812 . . . . 71.21 108.807 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.38 159.27 25.69 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.038 -1.077 . . . . 75.21 113.344 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 43' ' ' LYS . 1.6 ptpp? -114.31 121.54 43.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.513 0.673 . . . . 74.04 109.71 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 29.44 1.4 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 108.238 -1.945 . . . . 64.25 108.238 -168.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -44.42 -53.4 6.91 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 115.492 1.664 . . . . 74.44 115.492 -160.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -69.5 -34.75 74.76 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.91 0.337 . . . . 74.51 111.91 -171.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.35 -43.81 11.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.583 0.706 . . . . 63.21 109.932 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.11 -53.52 56.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.485 -1.234 . . . . 63.11 111.518 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' HD1' ' HG ' ' A' ' 53' ' ' LEU . 13.8 m-85 -68.06 -19.05 64.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.871 . . . . 74.32 113.35 -172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.624 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 55.8 mtm-85 -66.33 -30.9 71.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.412 -0.515 . . . . 74.32 110.8 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.0 -20.13 9.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.821 . . . . 73.42 112.498 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.45 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.86 0.319 . . . . 74.11 111.86 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.705 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 35.8 mt -111.99 92.12 17.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.978 0.732 . . . . 75.22 112.978 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -101.04 44.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.875 3.05 . . . . 64.3 108.902 162.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -51.47 -37.95 51.41 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 114.456 1.28 . . . . 75.01 114.456 -163.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 16.6 t-20 68.82 -46.36 0.55 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.473 0.483 . . . . 53.41 111.448 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 55' ' ' ALA . 33.4 t70 -98.74 172.33 7.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.128 -0.487 . . . . 64.44 109.754 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.536 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 9.5 p -84.11 136.08 34.14 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.093 -0.643 . . . . 71.44 109.99 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.532 ' HD2' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mmt85 -135.75 170.5 15.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.059 -1.089 . . . . 75.04 108.059 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.731 ' CE2' ' HB3' ' A' ' 71' ' ' PHE . 2.2 t80 -117.3 119.07 34.01 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.335 -0.546 . . . . 72.14 110.996 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.725 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.07 135.3 10.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 73.2 112.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 2.8 p -106.02 123.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 74.32 110.385 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.58 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 2.4 t80 -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.232 -0.895 . . . . 73.24 109.323 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.53 141.79 31.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 75.4 111.505 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 60.7 m -131.08 169.55 15.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.421 -0.809 . . . . 65.44 109.44 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.9 66.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 33.52 112.478 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -72.45 -34.27 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 73.52 111.374 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -170.53 168.48 7.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 73.31 110.35 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.414 ' HB ' ' HB1' ' A' ' 101' ' ' ALA . 13.2 mt -122.33 118.16 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.271 -0.64 . . . . 73.24 109.271 170.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -112.92 129.14 56.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.321 0.581 . . . . 75.32 110.509 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.731 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.8 m-85 -78.57 114.06 17.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.314 -0.857 . . . . 74.53 109.471 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.36 127.04 43.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.315 0.578 . . . . 62.25 111.511 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 58.4 tp -131.14 107.1 8.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.094 -0.957 . . . . 73.25 110.029 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -85.62 130.29 34.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.871 -0.789 . . . . 72.34 108.871 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -78.14 148.27 74.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.82 0.343 . . . . 74.41 110.624 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.781 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 96.7 Cg_endo -89.43 115.54 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.584 2.189 . . . . 70.13 111.88 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.71 -19.34 41.69 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.48 0.657 . . . . 74.22 109.662 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -102.41 9.88 39.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.379 -0.828 . . . . 74.44 110.639 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.781 ' HB2' ' HB2' ' A' ' 76' ' ' PRO . . . -139.14 152.48 69.88 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 121.962 -0.461 . . . . 72.52 111.013 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 16.7 Cg_exo -68.7 -178.86 2.12 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.177 2.584 . . . . 75.14 113.232 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 85' ' ' MET . 9.1 p -84.64 -8.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 73.5 111.515 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 48.6 mtpt -68.25 -49.73 32.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.393 0.516 . . . . 75.34 112.393 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 26.9 Cg_endo -65.18 -31.54 53.79 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.4 1.4 . . . . 74.51 111.1 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.56 -39.09 92.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.158 -0.928 . . . . 75.11 110.698 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 22.1 mmt -61.34 -39.17 89.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.778 -0.647 . . . . 75.13 111.487 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.738 HG21 HG21 ' A' ' 31' ' ' ILE . 8.2 m -58.08 -43.85 87.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.811 0.339 . . . . 73.32 111.286 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.713 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 90.4 m-85 -66.43 -54.11 27.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 73.51 111.783 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.62 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 73.33 111.808 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -86.48 -45.16 11.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.358 -0.383 . . . . 72.55 111.382 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 31' ' ' ILE . 8.1 m -79.94 -11.18 59.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.41 -0.359 . . . . 70.12 111.691 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.09 -21.76 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 74.45 111.363 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.73 -37.01 81.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.348 -0.387 . . . . 71.52 110.55 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 5' ' ' MET . . . -64.77 -30.74 71.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 72.54 110.683 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.71 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.0 mm? -73.54 -57.6 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 73.53 109.389 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 103' ' ' ALA . 25.1 tp -54.63 -43.51 72.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.676 -1.147 . . . . 73.02 112.282 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -64.66 -25.17 67.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.979 -0.555 . . . . 74.11 111.585 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.27 -36.8 7.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.379 0.881 . . . . 64.31 113.379 -168.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 1.6 pp -87.11 -37.59 17.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.906 1.076 . . . . 75.1 113.906 -164.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.579 ' N ' HD11 ' A' ' 98' ' ' LEU . 9.1 t70 -151.38 168.47 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.779 -0.769 . . . . 72.04 111.421 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.39 14.11 30.65 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.572 -0.74 . . . . 24.04 111.435 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.414 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.52 179.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.005 0.922 . . . . 71.5 112.645 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -83.4 140.28 32.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.594 -0.73 . . . . 74.24 110.333 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.812 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -78.23 -0.29 27.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 64.13 111.521 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.82 147.96 5.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.12 0.486 . . . . 64.02 109.728 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.97 157.77 30.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.99 -0.55 . . . . 75.23 109.581 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.82 116.54 32.19 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.675 -0.491 . . . . 73.12 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.67 127.58 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.971 -0.381 . . . . 74.02 109.971 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.21 119.04 32.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.96 0.409 . . . . 72.34 110.851 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -111.87 -11.23 13.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.139 -0.689 . . . . 73.21 109.139 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -93.14 -161.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.171 -0.922 . . . . 74.55 108.73 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.6 mtp -86.56 18.36 3.37 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.389 -0.194 . . . . 72.34 110.842 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.18 -33.36 74.67 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 114.416 0.526 . . . . 73.43 114.416 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.65 -51.66 68.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.099 0.476 . . . . 71.45 111.356 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 pp -96.49 12.42 31.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 75.14 111.397 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.582 ' O ' HD11 ' A' ' 117' ' ' LEU . . . -87.73 165.35 30.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 71.23 109.98 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.624 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . 37.0 Cg_endo -67.38 89.56 0.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 121.937 1.758 . . . . 73.12 112.793 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.582 HD11 ' O ' ' A' ' 115' ' ' ALA . 5.6 mp -68.53 -39.7 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.219 -0.66 . . . . 74.44 109.219 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.419 -0.809 . . . . 63.45 109.186 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.193 0 CA-C-O 120.938 0.188 . . . . 71.22 112.726 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 174.28 7.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.256 0.55 . . . . 73.32 111.213 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.35 118.59 3.57 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.749 -0.941 . . . . 71.15 110.749 171.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.06 124.59 37.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.668 -0.493 . . . . 75.54 109.668 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.9 147.18 24.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.901 0.382 . . . . 74.35 110.378 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -13.06 60.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 72.24 112.431 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -54.9 -27.75 45.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.935 0.398 . . . . 75.24 111.024 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.96 -56.21 14.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 70.53 110.797 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.96 -27.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.517 -0.31 . . . . 74.42 111.558 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -30.82 71.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.259 0.552 . . . . 73.04 110.434 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.425 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -72.32 -38.56 68.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.808 -0.633 . . . . 75.35 110.652 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 82.5 m-85 -60.75 -28.84 69.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.572 -0.285 . . . . 74.24 111.252 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -62.63 -47.22 84.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 65.42 110.375 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 31.8 mt-10 -67.25 -37.19 83.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 71.1 110.035 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.64 HD11 ' H ' ' A' ' 25' ' ' LYS . 21.5 tp -57.61 -47.93 80.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.996 -1.002 . . . . 73.2 111.052 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -83.43 -58.9 2.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.347 0.499 . . . . 72.54 112.347 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.81 -47.55 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.452 0.538 . . . . 74.14 112.452 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 82.7 mtp180 -72.53 -11.52 60.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.507 0.194 . . . . 75.54 111.193 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 39.7 ttmt 58.95 24.15 12.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.093 0.949 . . . . 72.41 110.136 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -105.76 122.44 46.08 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.104 -0.953 . . . . 72.14 108.544 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.39 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.758 -0.777 . . . . 70.54 110.608 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.64 ' H ' HD11 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -137.94 147.44 44.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 75.51 110.314 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.949 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 4.0 t90 -109.5 124.99 52.0 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.75 -1.574 . . . . 71.53 106.75 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.489 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 29.3 pt -108.43 122.16 62.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.614 -0.834 . . . . 73.42 110.668 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.87 114.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.265 -0.643 . . . . 72.34 109.265 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -112.99 160.2 18.35 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.544 -0.753 . . . . 74.14 111.038 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 3.2 tppp? -113.46 124.47 52.49 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.092 -0.958 . . . . 74.24 108.518 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 94' ' ' LEU . 70.3 mt -109.12 101.53 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.027 0.442 . . . . 74.32 110.576 -175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.21 162.09 31.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.554 -0.748 . . . . 72.22 109.323 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.88 40.06 23.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.038 0.447 . . . . 75.21 111.282 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.6 p 56.54 19.31 4.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.802 0.841 . . . . 74.55 113.168 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -127.98 128.54 45.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 74.02 111.07 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mm -93.42 107.99 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 72.21 108.685 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.13 134.37 66.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.709 -0.223 . . . . 72.44 110.477 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 29' ' ' PHE . 21.3 t -91.56 134.14 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.139 -0.689 . . . . 75.14 109.139 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.08 -18.02 12.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.184 -0.672 . . . . 74.42 109.184 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 10.0 mtpt -144.64 142.78 30.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.565 0.698 . . . . 73.31 112.723 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.465 ' CB ' HG23 ' A' ' 27' ' ' ILE . 3.2 p-10 -131.78 131.69 43.15 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.515 -1.661 . . . . 74.02 106.515 161.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . -107.37 144.68 16.0 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.747 -1.216 . . . . 73.22 113.524 -167.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 3.7 ptpp? -109.21 121.37 45.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.328 -0.989 . . . . 73.24 108.328 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.48 49.67 7.15 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.596 -2.202 . . . . 44.04 107.596 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.949 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 26.8 p-10 -45.09 -51.48 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.469 1.285 . . . . 71.4 114.469 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.13 -23.51 51.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.701 0.286 . . . . 74.34 111.768 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.35 -43.08 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.57 -0.286 . . . . 65.23 111.189 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.83 -53.92 52.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 72.04 110.867 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 33.3 m-85 -68.56 -10.36 55.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.974 0.731 . . . . 74.24 112.974 -172.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -68.02 -15.81 63.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.178 0.513 . . . . 74.42 109.838 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.18 9.19 1.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.929 -0.653 . . . . 61.02 112.339 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 49' ' ' PHE . . . -76.85 -54.43 6.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 74.21 111.073 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.03 78.37 12.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.859 -0.336 . . . . 74.21 111.802 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.69 77.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.165 2.577 . . . . 72.32 110.387 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.49 -14.11 57.37 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.99 0.737 . . . . 64.22 112.99 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 14.4 m120 68.25 8.92 6.9 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.278 0.561 . . . . 65.33 110.737 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -117.26 163.52 16.2 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.034 -0.728 . . . . 73.05 109.034 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 4.9 p -79.37 135.43 36.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 122.295 1.045 . . . . 72.53 110.414 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.91 32.85 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.873 -1.512 . . . . 73.51 108.938 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.0 t80 -102.24 122.22 43.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.927 0.394 . . . . 73.13 110.644 -173.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -122.31 135.95 10.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.16 -0.543 . . . . 75.15 112.161 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.272 0.536 . . . . 71.54 110.74 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.618 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -146.24 148.74 32.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.275 -0.42 . . . . 75.55 111.388 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.787 ' HA ' HG12 ' A' ' 69' ' ' ILE . 26.7 t70 -69.4 144.87 53.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 73.04 109.85 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 12.9 t -133.45 173.18 11.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.172 -0.677 . . . . 74.55 109.172 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -40.29 92.48 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.164 -0.541 . . . . 74.42 113.824 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -99.75 -46.36 5.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.376 0.588 . . . . 73.01 110.93 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -141.75 177.34 8.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.764 -0.653 . . . . 74.2 110.116 -171.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.787 HG12 ' HA ' ' A' ' 64' ' ' ASP . 11.4 mt -100.45 123.22 53.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.978 -0.749 . . . . 64.0 108.978 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -101.49 121.82 42.67 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.623 -0.431 . . . . 71.35 111.222 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' A' ' 98' ' ' LEU . 15.1 m-85 -78.01 109.01 11.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.774 -0.825 . . . . 73.24 108.774 168.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 113.85 40.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.504 0.669 . . . . 61.14 111.203 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 45.7 tp -113.94 112.16 22.86 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.354 -0.839 . . . . 73.24 109.51 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.68 ' HZ2' ' HG2' ' A' ' 111' ' ' MET . 37.4 t90 -85.19 123.22 30.44 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.617 -0.882 . . . . 74.44 108.617 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 60.8 m -70.8 149.06 95.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.011 -0.54 . . . . 62.45 110.834 -173.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.774 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 17.1 Cg_exo -67.28 101.21 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.166 . . . . 64.14 111.559 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.03 -34.38 20.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.029 -0.532 . . . . 61.02 109.805 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -98.44 9.74 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 72.53 109.903 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.774 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -139.98 155.08 71.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.042 -0.527 . . . . 63.54 110.07 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -151.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.973 2.449 . . . . 73.41 113.603 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 -25.59 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.897 1.073 . . . . 65.55 113.897 -166.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 68.2 mttm -68.59 -48.93 31.64 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.573 0.582 . . . . 73.33 112.573 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.574 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 14.2 Cg_endo -57.74 -27.53 78.17 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.727 1.618 . . . . 71.4 111.758 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -69.8 -40.43 75.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 74.52 109.726 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.04 -26.79 62.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 75.41 111.297 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.4 m -57.08 -52.76 64.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 74.41 110.518 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.487 ' OH ' ' HD3' ' A' ' 30' ' ' LYS . 96.7 m-85 -76.18 -37.94 57.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 75.03 111.192 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.24 65.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 74.32 111.595 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.2 t -88.08 -50.25 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.247 0.546 . . . . 72.53 110.458 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 p -75.86 -11.99 60.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.606 -0.725 . . . . 72.14 112.43 -171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -61.47 -24.31 66.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.035 0.383 . . . . 72.3 112.035 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 51.0 m-20 -83.76 -31.74 25.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.449 . . . . 74.25 110.347 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.3 -38.37 63.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.578 . . . . 73.33 110.394 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 31' ' ' ILE . 64.9 mt -56.9 -47.35 80.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.488 -0.56 . . . . 74.42 109.488 173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.716 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 37.9 tp -62.17 -21.74 65.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.968 -1.015 . . . . 75.12 112.17 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -76.59 -15.08 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.52 0.676 . . . . 74.42 110.411 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.754 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -111.65 -4.58 14.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.044 0.926 . . . . 71.31 108.921 176.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 95' ' ' LEU . 6.5 mt -111.96 13.18 20.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.666 -1.606 . . . . 70.32 112.608 -169.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' ALA . 5.7 m-20 -33.61 -145.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 128.041 2.536 . . . . 75.44 116.741 -152.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.2 16.13 0.02 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 117.729 1.852 . . . . 73.01 117.729 -151.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -55.73 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.161 -1.051 . . . . 64.23 108.161 152.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 69' ' ' ILE . 5.4 m -77.84 117.81 19.56 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.301 -1.499 . . . . 74.52 109.834 -167.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.662 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -85.42 4.37 35.81 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.273 -1.33 . . . . 71.23 111.963 -169.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 t -85.55 146.92 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.775 -0.454 . . . . 73.54 109.775 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -126.18 146.1 50.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.027 -0.533 . . . . 72.4 109.688 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.13 118.28 25.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.202 -0.454 . . . . 64.23 109.916 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 7.2 pt-20 -96.5 117.47 30.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.462 0.649 . . . . 72.23 110.635 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.6 119.9 32.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 74.04 109.621 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -99.37 -13.54 19.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.01 0.433 . . . . 74.05 110.892 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -105.4 166.57 10.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.588 -0.893 . . . . 72.33 108.588 169.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.68 ' HG2' ' HZ2' ' A' ' 74' ' ' TRP . 38.7 mtp -78.28 70.52 4.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.553 0.692 . . . . 64.22 111.262 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.46 -16.0 74.79 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.072 -0.967 . . . . 51.14 110.938 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -62.13 -31.94 72.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.228 -0.486 . . . . 71.33 111.615 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.13 19.23 20.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.387 0.613 . . . . 72.42 110.788 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.17 154.84 44.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.731 -0.668 . . . . 64.11 109.865 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.51 104.28 0.52 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.28 1.986 . . . . 74.41 112.294 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.23 -31.97 11.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.501 0.667 . . . . 73.42 109.68 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.267 -0.879 . . . . 73.12 109.313 177.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 111.685 -0.566 . . . . 62.33 111.685 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -85.99 152.1 23.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.434 0.635 . . . . 73.03 112.009 -176.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 125.27 5.08 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.998 -1.001 . . . . 72.42 110.682 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 44.8 t -89.78 132.59 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.731 0.266 . . . . 64.35 110.479 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.84 140.37 45.72 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.101 -0.333 . . . . 71.2 110.101 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -62.81 -28.97 70.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.981 0.419 . . . . 74.13 111.039 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.23 -28.7 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 74.31 111.01 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 74.11 110.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 98' ' ' LEU . 14.1 t -78.65 -34.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 72.3 110.757 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -25.66 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.807 -0.633 . . . . 75.32 112.219 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.68 ' HG2' HG23 ' A' ' 27' ' ' ILE . 15.6 tpt180 -66.56 -17.35 64.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 75.21 111.468 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.574 ' HA ' HD11 ' A' ' 18' ' ' LEU . 58.7 m-85 -74.42 -19.26 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.046 0.387 . . . . 74.44 112.046 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -77.25 -26.33 52.41 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.882 -0.727 . . . . 63.44 110.054 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -69.2 -33.39 73.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 73.5 109.541 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 15' ' ' PHE . 65.2 mt -70.08 -48.33 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.803 -1.089 . . . . 75.2 111.105 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -82.08 -55.07 4.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.454 -0.794 . . . . 74.44 112.609 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.96 -48.0 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.151 0.426 . . . . 74.4 112.151 -171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -81.32 -11.09 59.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.172 -0.211 . . . . 71.15 111.076 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 59.13 23.6 11.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.143 -0.481 . . . . 72.13 110.348 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -101.76 117.63 35.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.068 -0.514 . . . . 75.02 109.708 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.22 135.92 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.443 0.639 . . . . 71.32 110.654 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -138.48 161.13 37.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.58 -0.896 . . . . 72.02 108.58 177.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.872 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.6 t90 -112.78 123.49 50.42 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.786 -0.82 . . . . 73.45 108.786 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.68 HG23 ' HG2' ' A' ' 14' ' ' ARG . 43.4 pt -110.75 131.29 62.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.642 -0.503 . . . . 74.11 109.642 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.809 HG21 HD23 ' A' ' 53' ' ' LEU . 93.4 t -113.18 113.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.38 -0.373 . . . . 75.31 110.304 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.895 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 44.1 p90 -102.06 151.51 22.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.473 0.654 . . . . 72.11 110.508 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 3.8 tmmm? -114.58 124.11 51.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.057 -0.974 . . . . 75.32 108.641 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 87' ' ' TYR . 48.3 mt -88.88 103.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.719 -0.673 . . . . 73.34 109.665 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 30' ' ' LYS . 25.0 tt0 -139.64 139.3 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 73.14 111.019 -168.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 t30 49.93 46.4 24.32 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.872 0.733 . . . . 70.31 111.581 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' MET . 70.3 p 55.61 25.46 8.1 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.497 0.719 . . . . 73.41 112.666 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -133.71 137.39 45.23 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.013 -0.43 . . . . 75.4 110.414 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 43.9 mm -95.09 109.37 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.951 -0.568 . . . . 63.43 110.1 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.8 135.47 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.026 0.441 . . . . 75.12 110.887 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.895 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.2 p -89.17 140.24 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 73.3 110.038 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.98 -35.43 13.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.922 0.392 . . . . 74.31 110.31 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.644 ' HZ1' ' HB1' ' A' ' 52' ' ' ALA . 8.9 ptmt -171.75 165.45 6.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 73.55 111.686 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.565 ' HB3' HG22 ' A' ' 27' ' ' ILE . 4.9 p-10 -142.98 158.62 43.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.911 . . . . 65.45 108.726 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.77 148.67 20.23 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.259 -1.448 . . . . 61.02 114.951 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.71 129.35 40.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.556 -1.275 . . . . 75.12 107.556 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.99 35.86 7.99 Favored Glycine 0 C--O 1.208 -1.489 0 N-CA-C 108.294 -1.922 . . . . 64.53 108.294 -161.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.872 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 7.4 p30 -44.41 -53.11 7.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.996 1.11 . . . . 75.4 113.996 -173.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.02 -14.35 58.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.439 0.638 . . . . 61.21 110.68 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.98 -49.16 6.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.936 . . . . 72.44 110.885 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 49' ' ' PHE . 1.1 pt-20 -81.2 -36.04 30.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.895 -1.048 . . . . 73.22 111.185 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 9.3 m-85 -72.46 -4.47 30.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.108 0.41 . . . . 73.21 112.108 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -72.83 -13.98 61.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.063 0.459 . . . . 75.54 110.102 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.65 11.96 2.68 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.0 -0.619 . . . . 65.24 112.424 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.644 ' HB1' ' HZ1' ' A' ' 40' ' ' LYS . . . -111.51 12.58 21.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 73.34 111.389 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.809 HD23 HG21 ' A' ' 28' ' ' VAL . 75.0 mt -117.83 140.78 28.14 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 73.43 111.172 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 14.5 Cg_exo -69.14 105.17 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.773 2.315 . . . . 72.13 111.278 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -12.53 61.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.967 -0.561 . . . . 73.15 111.858 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.43 -19.08 24.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.378 -0.373 . . . . 70.3 111.214 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -120.73 173.41 7.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.257 -0.429 . . . . 73.25 110.257 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 6.9 p -97.99 139.09 34.33 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.302 -0.629 . . . . 73.25 109.302 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.9 mmt-85 -134.09 151.83 51.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.957 -0.565 . . . . 75.32 110.043 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.18 105.18 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.128 0.489 . . . . 75.25 109.746 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.547 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -113.3 135.03 12.28 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.818 -0.628 . . . . 64.21 111.743 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 71' ' ' PHE . 27.1 m -125.85 129.09 72.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.255 0.55 . . . . 70.24 110.224 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.57 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -140.36 147.18 39.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.015 -0.538 . . . . 63.44 110.216 177.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.36 143.3 27.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 73.44 110.414 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 34.0 t -122.73 169.56 10.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.518 -0.919 . . . . 71.3 108.518 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.64 -24.18 59.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.105 -0.569 . . . . 74.11 114.084 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -126.94 4.91 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.463 0.631 . . . . 73.52 112.577 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 13.0 ptmt -169.6 151.8 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.222 0.823 . . . . 74.33 113.222 -169.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.8 mm -100.13 125.58 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.277 -0.874 . . . . 71.43 108.802 167.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.428 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mt-30 -116.25 114.95 25.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.471 -0.492 . . . . 74.0 111.975 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' HA ' HG12 ' A' ' 62' ' ' VAL . 29.9 m-85 -85.14 109.54 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 73.34 109.197 170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.67 126.07 64.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.008 0.432 . . . . 75.13 110.949 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 62.9 tp -133.3 108.02 8.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 73.43 110.521 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.432 ' HD1' ' HB3' ' A' ' 108' ' ' ALA . 63.2 t90 -85.47 119.96 26.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.712 -0.847 . . . . 63.21 108.712 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -74.52 148.22 85.45 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.018 -0.273 . . . . 65.3 110.296 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.743 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 71.6 Cg_endo -78.77 121.25 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.321 2.014 . . . . 74.05 113.47 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.06 -20.12 30.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.55 -0.75 . . . . 55.12 110.246 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.69 16.11 21.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.538 0.685 . . . . 71.3 110.31 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -140.66 155.68 69.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 74.44 109.85 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.43 -165.97 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.396 2.731 . . . . 73.1 113.622 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.67 -24.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.768 0.655 . . . . 74.43 112.768 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HG2' ' HE2' ' A' ' 85' ' ' MET . 61.8 mttp -67.05 -48.74 48.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 119.281 -0.39 . . . . 61.04 111.936 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 Cg_exo -55.82 -41.01 81.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.416 1.41 . . . . 74.22 111.468 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -62.86 -51.16 68.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.481 -0.781 . . . . 73.4 111.221 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.502 ' HE2' ' HG2' ' A' ' 82' ' ' LYS . 26.0 ptt? -68.78 -24.35 64.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 73.21 110.925 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.1 m -62.93 -56.17 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.404 -0.362 . . . . 73.24 110.42 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.54 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m-85 -60.97 -37.0 80.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 75.24 111.033 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.27 -31.25 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 74.13 111.777 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 t -66.36 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 64.23 110.901 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.526 ' OG ' HD11 ' A' ' 31' ' ' ILE . 2.0 p -87.19 7.4 28.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.167 -0.47 . . . . 52.02 112.078 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 95' ' ' LEU . 15.9 tttm -57.45 -55.55 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 75.53 111.338 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HA ' HD23 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -76.75 -21.64 54.95 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.17 -0.468 . . . . 71.25 110.332 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.43 92.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.447 -0.797 . . . . 71.42 110.889 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.74 HD12 HD12 ' A' ' 98' ' ' LEU . 4.6 mm? -77.64 -37.25 50.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 70.03 110.276 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 91' ' ' LYS . 4.8 mp -57.04 -43.04 81.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.584 0.706 . . . . 75.4 110.366 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.55 -10.48 59.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.907 -1.042 . . . . 73.23 111.956 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HG2' HG21 ' A' ' 7' ' ' VAL . 52.9 tptt -106.24 -48.58 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.271 0.841 . . . . 74.44 113.271 -169.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.74 HD12 HD12 ' A' ' 94' ' ' LEU . 17.8 mt -89.0 -45.05 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.765 1.024 . . . . 70.31 113.765 -162.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 4.8 t70 -156.54 -166.53 2.16 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.467 -0.493 . . . . 74.1 111.254 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -88.09 16.18 52.86 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 110.722 -0.951 . . . . 75.31 110.722 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.81 179.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.268 1.027 . . . . 75.01 113.034 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.577 HG22 HG22 ' A' ' 104' ' ' VAL . 2.1 m -83.36 139.95 32.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.838 -0.619 . . . . 72.54 110.764 -167.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -81.16 2.01 29.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.576 -0.738 . . . . 52.3 112.048 -174.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 102' ' ' THR . 40.6 t -76.69 147.08 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.906 0.384 . . . . 64.1 110.279 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.16 144.36 34.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.302 -0.629 . . . . 61.55 109.302 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -118.93 118.64 32.07 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.179 -0.209 . . . . 70.32 110.482 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.0 pt-20 -104.04 118.56 36.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.364 0.602 . . . . 74.52 110.129 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HB3' ' HD1' ' A' ' 74' ' ' TRP . . . -97.51 143.08 28.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 65.44 110.678 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -6.09 6.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 65.31 109.473 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.75 -162.03 1.18 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.77 -1.105 . . . . 74.32 109.691 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.9 mtp -85.57 28.2 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.746 0.308 . . . . 71.12 111.259 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.36 -23.02 59.44 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.838 -0.696 . . . . 72.41 111.871 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.39 -51.81 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.221 0.534 . . . . 65.3 110.478 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 114' ' ' LEU . 1.3 pt? -84.25 23.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 65.25 111.051 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . . . -117.56 160.57 37.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.339 -0.615 . . . . 75.53 109.339 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 13.2 Cg_endo -56.28 107.89 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.41 2.073 . . . . 71.23 112.403 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.425 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.1 mp -76.12 -32.6 59.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 75.1 110.097 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.669 -0.696 . . . . 61.33 109.787 177.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 113.959 0.343 . . . . 72.31 113.959 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.39 144.07 33.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.106 0.453 . . . . 73.32 109.878 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.49 116.49 5.59 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.081 -0.808 . . . . 74.12 111.081 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.44 130.66 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.754 0.311 . . . . 73.45 111.05 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.61 131.03 44.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 73.22 111.362 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.2 -18.02 37.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.915 -0.584 . . . . 71.33 111.641 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -68.1 -25.44 65.32 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.631 0.253 . . . . 72.43 110.642 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -53.12 -45.2 68.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 75.1 110.867 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t -61.72 -39.68 84.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.208 -0.451 . . . . 73.21 111.092 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.99 68.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 54.54 111.183 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 14' ' ' ARG . 22.0 mmt180 -75.65 -18.73 59.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.21 111.364 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.59 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 88.1 m-85 -84.0 -21.91 31.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.355 0.598 . . . . 73.42 109.444 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -45.27 44.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 74.01 109.267 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.654 ' HA ' ' CG ' ' A' ' 21' ' ' ARG . 11.0 mm-40 -65.16 -15.63 62.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.193 0.521 . . . . 74.13 110.696 171.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 23.7 tp -86.58 -61.59 1.7 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.761 -0.654 . . . . 74.12 111.002 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -82.51 -50.6 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.379 0.511 . . . . 75.51 112.379 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.5 mm -68.41 -28.51 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 74.11 110.777 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.654 ' CG ' ' HA ' ' A' ' 17' ' ' GLU . 39.5 mmt180 -85.91 -10.54 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 74.54 110.691 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 59.37 45.25 14.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.974 -0.557 . . . . 73.43 111.798 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 t -143.59 151.98 40.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.385 -0.598 . . . . 75.34 109.385 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG11 ' OD2' ' A' ' 64' ' ' ASP . 33.1 m -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.596 -0.442 . . . . 74.44 110.677 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -140.69 164.23 30.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.379 0.609 . . . . 75.34 111.424 173.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.657 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 5.8 t90 -129.57 123.58 31.71 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.218 -1.03 . . . . 75.51 108.218 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.894 HG21 ' HB2' ' A' ' 41' ' ' ASP . 15.0 pt -116.15 134.56 59.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.697 -0.483 . . . . 72.13 109.697 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.1 109.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.138 0.494 . . . . 73.11 110.913 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.816 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -101.91 147.84 26.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 73.42 109.638 175.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -113.99 125.29 53.84 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.103 0.478 . . . . 75.24 110.802 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.733 HG12 HD11 ' A' ' 36' ' ' ILE . 62.2 mt -83.07 103.43 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.587 -0.894 . . . . 73.15 108.587 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -146.35 139.89 25.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.541 -173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.69 31.15 20.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 74.5 110.118 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 65.97 20.13 11.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.593 -0.73 . . . . 71.22 110.655 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -130.02 143.61 50.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.593 -0.73 . . . . 73.13 110.098 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.733 HD11 HG12 ' A' ' 31' ' ' ILE . 10.7 mm -111.91 111.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 65.32 110.58 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.7 154.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.736 0.303 . . . . 75.43 110.412 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.816 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 11.4 t -83.49 132.44 31.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.082 -0.508 . . . . 75.12 110.396 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.23 -37.74 32.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.92 -0.77 . . . . 74.23 108.92 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' LYS . 10.9 ptmm? -173.56 164.66 4.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.041 -0.982 . . . . 75.0 110.039 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.894 ' HB2' HG21 ' A' ' 27' ' ' ILE . 2.3 p-10 -126.19 148.07 49.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.0 161.52 12.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.92 -1.133 . . . . 73.15 113.977 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -137.49 129.27 28.69 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 72.13 106.782 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.8 36.99 35.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.016 -2.033 . . . . 70.22 108.016 -159.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 2.5 m-20 -44.56 -52.77 7.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.398 -1.401 . . . . 75.31 113.933 -163.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -66.02 -34.85 79.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.13 -0.486 . . . . 75.53 111.208 -172.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -89.57 -34.95 16.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.882 0.372 . . . . 65.21 111.108 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.6 ' HG2' ' HB1' ' A' ' 52' ' ' ALA . 7.8 tt0 -62.17 -50.22 72.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 71.05 110.611 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.65 -0.6 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.166 0.432 . . . . 73.32 112.166 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 48.5 mtp180 -81.27 -15.35 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 75.42 110.832 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.05 -19.85 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.106 -1.045 . . . . 72.51 113.63 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HB1' ' HG2' ' A' ' 48' ' ' GLU . . . -58.51 -59.52 5.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 74.31 110.807 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.27 85.94 4.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.836 -0.62 . . . . 74.42 110.223 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.28 117.92 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.047 1.831 . . . . 75.24 109.594 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.61 78.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.006 0.373 . . . . 73.24 112.006 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.5 t30 67.12 -47.28 0.48 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.622 0.769 . . . . 71.11 111.144 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.41 172.04 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 72.34 108.63 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.498 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 5.4 p -78.8 139.55 38.37 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.535 -0.466 . . . . 73.44 110.478 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -151.1 163.79 37.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.989 -0.745 . . . . 75.41 108.989 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.738 ' HD2' ' HE1' ' A' ' 29' ' ' PHE . 6.9 t80 -109.73 116.05 30.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.503 0.668 . . . . 73.44 110.419 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.657 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.29 135.23 10.5 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 115.377 -0.829 . . . . 70.12 111.829 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 27' ' ' ILE . 34.0 m -105.34 122.45 58.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 117.465 0.633 . . . . 64.21 110.362 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.633 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 6.2 t80 -135.59 132.26 36.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.523 -0.762 . . . . 75.51 109.684 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' HG11 ' A' ' 24' ' ' VAL . 10.0 p-10 -102.91 143.32 32.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.686 0.755 . . . . 74.23 111.023 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.7 t -112.38 169.62 8.75 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.401 -0.963 . . . . 73.51 108.401 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.53 -24.75 68.08 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.755 -0.736 . . . . 52.34 112.511 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 -46.51 6.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.782 0.29 . . . . 74.4 111.782 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HB3' ' HZ2' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -151.94 167.81 27.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.541 0.21 . . . . 73.13 110.688 -176.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.413 HG12 ' CB ' ' A' ' 64' ' ' ASP . 7.6 mt -100.7 139.3 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.551 -0.537 . . . . 75.03 109.551 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -117.65 118.3 31.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.942 0.401 . . . . 72.55 110.71 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.42 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 61.4 m-85 -79.44 110.04 14.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.844 -0.798 . . . . 71.41 108.844 171.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.198 -0.455 . . . . 75.12 111.385 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 63.7 tp -141.18 82.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.526 -0.761 . . . . 64.44 109.489 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -85.71 149.36 25.35 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.647 -0.501 . . . . 75.41 109.647 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 57.8 m -97.8 147.28 32.81 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.832 -0.433 . . . . 72.5 109.832 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.714 ' HG2' ' HB1' ' A' ' 79' ' ' ALA . 7.7 Cg_endo -91.78 144.11 2.94 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.146 2.564 . . . . 61.22 112.798 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -80.36 -7.03 58.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.608 0.718 . . . . 65.23 109.583 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -107.46 15.64 24.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.052 -0.976 . . . . 74.45 110.334 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.714 ' HB1' ' HG2' ' A' ' 76' ' ' PRO . . . -141.65 154.39 66.15 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 121.866 -0.521 . . . . 73.42 111.028 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 19.0 Cg_endo -91.59 -178.33 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.135 2.557 . . . . 65.23 112.801 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.33 3.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.853 -0.612 . . . . 74.21 112.077 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 ttmt -68.32 -58.1 7.87 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 121.195 -0.202 . . . . 73.01 110.954 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.538 ' O ' ' HD1' ' A' ' 87' ' ' TYR . 60.0 Cg_endo -74.05 -26.93 12.45 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.222 1.281 . . . . 74.43 111.579 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -32.49 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 75.33 111.104 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.9 -29.57 55.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.12 110.746 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -66.66 -44.85 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 74.32 110.634 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 31' ' ' ILE . 77.1 m-85 -64.35 -30.22 71.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 74.43 110.266 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.18 62.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.908 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -84.72 -53.94 5.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.472 . . . . 72.14 110.711 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -72.53 -17.07 61.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 75.14 112.012 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -33.21 74.96 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.731 0.271 . . . . 73.4 111.731 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.74 -45.47 43.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 70.31 110.22 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.638 -0.71 . . . . 75.32 110.948 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.589 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.7 mm? -64.15 -48.81 74.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.848 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD13 ' HA ' ' A' ' 103' ' ' ALA . 7.8 tt -56.66 -43.95 80.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 74.21 110.578 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -67.76 -27.7 66.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.217 0.532 . . . . 73.25 110.733 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.15 -43.14 12.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.839 0.681 . . . . 75.22 112.839 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 3.5 pp -88.72 -36.74 15.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.471 1.286 . . . . 74.41 114.471 -162.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.586 ' N ' HD11 ' A' ' 98' ' ' LEU . 38.7 t0 -150.3 170.81 18.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.348 -0.941 . . . . 72.35 112.501 -174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.12 61.53 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.93 -1.032 . . . . 72.32 110.657 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -179.35 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.315 1.046 . . . . 63.04 112.749 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.426 HG23 HG22 ' A' ' 104' ' ' VAL . 5.6 m -82.85 139.62 33.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.612 -0.722 . . . . 74.3 109.991 -172.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.606 ' HA ' HD13 ' A' ' 95' ' ' LEU . . . -75.14 4.49 6.78 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.361 0.504 . . . . 74.45 112.361 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.426 HG22 HG23 ' A' ' 102' ' ' THR . 43.5 t -82.29 147.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.841 -0.429 . . . . 75.04 109.841 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.4 130.99 35.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.684 -0.488 . . . . 74.1 109.684 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.49 117.08 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.055 -0.52 . . . . 74.21 110.541 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.3 pt-20 -123.58 121.63 36.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 73.34 109.721 175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.84 148.58 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.868 -0.606 . . . . 72.12 110.471 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.45 11.64 27.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 73.44 110.328 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -131.12 168.48 17.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 74.5 109.991 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.48 73.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.253 0.464 . . . . 75.0 112.253 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.27 -17.59 64.35 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.683 -0.967 . . . . 72.1 110.683 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.19 -46.78 75.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.455 -0.872 . . . . 75.23 111.835 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.1 pp -105.19 23.18 14.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 74.24 111.166 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.34 54.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 73.33 110.827 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.98 116.88 3.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 71.41 111.786 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.491 HD21 ' HD2' ' A' ' 63' ' ' TYR . 6.4 mp -71.89 -55.94 6.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.207 -0.451 . . . . 73.15 111.216 -177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.117 -0.944 . . . . 74.4 111.015 -177.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 120.906 0.17 . . . . 74.2 112.852 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.7 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -97.91 149.74 22.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.928 0.394 . . . . 74.23 110.304 178.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.34 109.91 1.77 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.661 -0.976 . . . . 74.43 110.661 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 36' ' ' ILE . 16.7 m -101.35 134.55 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.095 0.474 . . . . 73.34 111.801 -173.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.618 ' HB2' HG13 ' A' ' 37' ' ' VAL . 12.5 t70 -71.85 148.44 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.527 -0.76 . . . . 73.25 110.504 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.22 -20.4 44.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.444 0.535 . . . . 73.43 112.444 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -60.89 -31.91 71.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 73.45 110.711 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.1 m -61.44 -47.95 83.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 71.0 110.277 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.592 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 42.0 t -63.58 -40.85 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.51 -0.768 . . . . 75.2 110.769 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 70.35 111.05 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 25.2 mmt180 -63.97 -40.78 97.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 74.33 111.223 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 14.4 m-85 -58.62 -33.34 69.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.135 0.493 . . . . 74.4 110.476 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -42.47 73.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 71.02 110.566 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.16 -41.83 99.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 71.55 110.353 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 14' ' ' ARG . 83.1 mt -50.22 -57.14 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.302 -0.863 . . . . 62.24 111.264 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -83.04 -51.92 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 64.33 112.083 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.05 -55.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.845 0.313 . . . . 63.41 111.845 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -71.95 -14.92 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.234 -0.186 . . . . 73.43 110.831 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 60.27 24.08 13.51 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.882 0.739 . . . . 72.3 110.98 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.1 p -105.15 100.47 10.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.867 -0.606 . . . . 73.13 109.478 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.82 133.62 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.466 0.65 . . . . 71.34 110.458 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.6 mppt? -137.66 146.29 43.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 74.51 108.687 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.685 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.5 t90 -91.41 122.73 34.26 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.571 -1.27 . . . . 72.44 107.571 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.754 HG23 ' HB3' ' A' ' 41' ' ' ASP . 40.1 pt -107.12 131.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.143 0.497 . . . . 74.43 110.561 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.744 HG22 HD21 ' A' ' 53' ' ' LEU . 88.2 t -112.64 116.02 51.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.551 -0.75 . . . . 73.11 109.397 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 37.4 p90 -116.79 163.37 16.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.694 -0.684 . . . . 74.23 110.393 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -112.27 124.79 53.24 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.412 -0.588 . . . . 75.25 109.412 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.709 HG23 HG12 ' A' ' 36' ' ' ILE . 25.9 mt -99.12 102.71 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.262 -1.014 . . . . 75.05 108.262 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.11 137.49 32.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.466 -0.334 . . . . 74.24 110.678 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.3 t30 49.21 46.39 22.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.733 -0.667 . . . . 74.53 111.328 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p 56.64 22.58 6.89 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.999 0.919 . . . . 72.41 113.135 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -132.65 126.84 33.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.315 -0.624 . . . . 72.41 109.315 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.709 HG12 HG23 ' A' ' 31' ' ' ILE . 58.1 mt -112.94 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.6 . . . . 74.03 111.436 -171.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 8' ' ' ASP . 14.0 m -129.38 141.45 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 72.21 110.992 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 4.6 p -86.46 133.99 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 62.1 110.522 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -100.49 -36.29 9.25 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.155 0.503 . . . . 74.31 109.912 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -138.69 141.06 38.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 75.34 111.428 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.754 ' HB3' HG23 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -133.0 131.62 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 168.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.45 14.73 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.344 -1.408 . . . . 60.51 113.74 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -103.17 160.6 14.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.379 -0.971 . . . . 75.24 108.379 172.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.53 42.95 98.74 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.393 -1.883 . . . . 34.5 108.393 -163.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.443 HD21 ' HB2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -44.7 -51.39 9.3 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.129 1.372 . . . . 74.11 113.041 -166.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.32 64.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.089 -0.505 . . . . 70.41 111.914 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.76 -52.19 5.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.72 0.295 . . . . 74.43 110.962 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.21 -33.62 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 64.15 111.492 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.68 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 20.5 m-85 -84.39 -0.08 51.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.932 0.715 . . . . 75.24 112.932 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 50.7 mtm180 -68.12 -25.27 65.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.158 0.504 . . . . 75.3 110.199 174.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.64 28.68 3.72 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.766 -0.731 . . . . 72.53 112.147 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -129.07 -19.65 3.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.513 0.19 . . . . 73.31 111.513 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.744 HD21 HG22 ' A' ' 28' ' ' VAL . 66.1 mt -98.88 121.88 54.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.938 0.399 . . . . 72.44 111.086 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -96.57 102.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.275 2.65 . . . . 74.24 111.975 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -13.27 6.91 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.986 0.422 . . . . 74.31 112.109 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -57.49 -31.09 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 52.44 111.83 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.639 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 3.2 p30 -139.52 158.02 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.812 -0.44 . . . . 74.25 109.812 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.838 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 14.3 p -97.07 141.77 29.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.492 0.553 . . . . 75.33 112.492 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -150.76 154.24 36.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.062 -1.088 . . . . 74.52 108.062 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.562 ' HD2' ' HD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -95.98 123.41 39.56 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.512 -0.475 . . . . 73.35 110.642 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.685 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.94 133.76 9.85 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.213 -0.755 . . . . 74.3 111.213 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.42 121.53 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.54 0.686 . . . . 74.53 110.818 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 3.2 t80 -122.71 143.62 49.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.241 -0.891 . . . . 72.45 108.966 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.7 t70 -115.22 140.71 48.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.11 0.481 . . . . 74.31 110.075 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.75 168.92 16.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.73 -0.668 . . . . 74.55 109.475 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.57 -25.98 61.64 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 114.791 0.676 . . . . 74.54 114.791 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.47 -5.1 13.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.158 0.799 . . . . 72.22 113.158 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.891 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -171.37 161.84 6.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.602 0.593 . . . . 74.42 112.602 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.1 mm -93.08 134.35 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 72.43 108.932 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -115.01 106.65 14.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.842 0.354 . . . . 74.14 111.307 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.515 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . 43.3 m-85 -83.51 109.9 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.922 -0.77 . . . . 72.43 108.922 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.32 124.76 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.048 0.452 . . . . 74.33 111.441 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 65.9 tp -128.2 105.36 8.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.71 -0.677 . . . . 75.21 110.301 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -86.2 109.64 19.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 74.52 109.283 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.2 p -79.83 150.61 72.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.228 -0.442 . . . . 71.41 110.564 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.838 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 72.0 Cg_endo -82.75 97.92 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.458 2.105 . . . . 74.15 112.405 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.591 ' HB2' ' HB2' ' A' ' 109' ' ' HIS . 34.5 t70 -76.63 -14.99 59.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.494 0.664 . . . . 73.54 109.765 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.52 8.47 21.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 75.24 109.552 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.709 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . . . -144.36 175.23 2.91 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.711 -0.677 . . . . 53.03 109.661 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 21.8 Cg_endo -62.83 154.71 64.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.973 1.782 . . . . 74.2 111.643 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.33 12.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.028 0.381 . . . . 75.42 112.028 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 59.4 tttm -69.69 -50.98 16.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.496 -0.32 . . . . 73.33 111.814 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 51.3 Cg_exo -55.77 -24.26 45.65 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.471 2.114 . . . . 73.25 112.943 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.489 ' HD3' ' OE1' ' A' ' 107' ' ' GLU . 11.0 ttm180 -60.45 -33.91 73.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.147 0.499 . . . . 74.2 110.133 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.8 mtt -71.57 -33.6 69.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 71.05 110.692 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -63.77 -47.5 80.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 72.55 110.529 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.562 ' HD2' ' HD2' ' A' ' 60' ' ' PHE . 41.5 m-85 -67.77 -37.24 81.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.05 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.47 65.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.169 0.509 . . . . 74.24 111.086 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -86.46 -54.58 4.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.85 -0.614 . . . . 75.01 110.91 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -77.48 -9.23 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.588 0.588 . . . . 75.45 112.588 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.704 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -58.24 -24.53 59.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.704 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 4.8 t70 -81.8 -25.7 35.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.818 0.342 . . . . 71.31 110.876 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.7 ' HB1' ' HE3' ' A' ' 5' ' ' MET . . . -70.91 -19.01 62.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 71.3 110.448 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 48.6 mt -92.14 -56.97 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.263 -0.881 . . . . 64.51 109.87 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 103' ' ' ALA . 43.8 tp -53.64 -58.94 5.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.61 -1.177 . . . . 72.13 113.079 -170.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 3.7 tmmm? -65.38 -20.34 66.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.053 -0.521 . . . . 75.42 111.523 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.66 -22.94 12.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.981 0.734 . . . . 75.45 112.981 -172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 99' ' ' ASP . 4.3 pp -87.08 -39.6 15.44 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 118.914 -1.114 . . . . 74.13 112.166 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.44 ' N ' HD11 ' A' ' 98' ' ' LEU . 17.0 t70 -154.07 177.05 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.17 -0.612 . . . . 74.54 111.637 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 13.44 42.63 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.899 -0.88 . . . . 43.42 110.899 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.077 0.951 . . . . 74.2 112.695 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 104' ' ' VAL . 2.5 m -84.32 136.22 33.99 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.477 -0.783 . . . . 71.24 110.403 -171.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -77.29 4.52 10.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.81 -0.632 . . . . 72.12 112.029 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 HG23 ' A' ' 102' ' ' THR . 46.8 t -82.75 147.41 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.202 0.525 . . . . 74.12 110.428 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.26 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.772 -0.649 . . . . 70.42 109.715 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 tp -108.76 117.23 33.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.34 -0.391 . . . . 73.23 110.265 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.7 117.16 29.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.526 -0.546 . . . . 73.1 109.526 175.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.4 35.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.136 -0.484 . . . . 50.52 111.041 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p-80 -119.25 2.16 11.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.409 -0.589 . . . . 72.53 109.409 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 153.56 42.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.108 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 68.3 mtt -77.63 47.31 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 74.13 111.702 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.69 -17.07 64.49 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.213 -0.755 . . . . 73.14 111.213 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -64.0 -45.8 87.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.963 0.505 . . . . 73.33 111.197 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 3.5 pp -86.21 10.24 15.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.696 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 159.04 49.57 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.268 -0.424 . . . . 74.44 110.121 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.98 107.53 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.121 1.881 . . . . 75.12 111.351 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.12 -71.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 74.43 111.033 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.607 -0.711 . . . . 74.24 110.483 -178.769 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 CA-C-O 120.685 0.047 . . . . 70.35 113.023 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.452 ' HG3' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -88.27 162.96 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.96 0.41 . . . . 75.22 110.39 178.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.65 108.89 1.65 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.55 -1.02 . . . . 70.1 110.55 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.39 138.67 28.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.481 0.658 . . . . 73.41 111.72 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 10' ' ' ASN . 10.2 t70 -75.62 136.28 40.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.783 -1.099 . . . . 71.12 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.28 -20.05 35.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 72.43 111.639 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.476 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 48.2 t30 -63.4 -34.98 78.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.92 -0.77 . . . . 73.53 108.92 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' HG12 ' A' ' 38' ' ' VAL . 33.1 m -53.69 -52.05 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.142 -0.936 . . . . 73.44 109.859 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.722 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 48.3 t -59.07 -43.39 89.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.555 -0.748 . . . . 74.33 110.957 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.93 86.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 62.15 110.818 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -68.48 -30.76 69.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 73.1 111.311 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.722 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 22.1 m-85 -62.52 -35.65 80.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.109 0.481 . . . . 75.55 109.904 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.9 OUTLIER -67.75 -46.87 70.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 73.44 109.638 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 44.6 mt-10 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 75.35 112.374 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.515 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 4.3 pp -65.21 -29.41 70.22 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.996 -0.681 . . . . 73.51 110.775 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' N ' HD13 ' A' ' 18' ' ' LEU . 1.4 tmtp? -84.26 -58.68 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.488 . . . . 65.03 110.726 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.87 -29.83 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.775 0.658 . . . . 75.44 112.775 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 77.7 mtp180 -91.31 -21.04 21.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.943 -0.473 . . . . 75.2 111.347 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.13 27.75 0.34 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.314 1.046 . . . . 74.31 113.546 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.81 170.58 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.999 -1.111 . . . . 75.51 107.999 166.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 45' ' ' ASN . 8.8 p -92.1 131.19 39.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 55.52 110.668 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.756 ' HB2' ' HZ1' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -140.57 170.6 15.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 72.04 111.32 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.802 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.0 t90 -152.0 129.44 11.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.083 -1.08 . . . . 70.22 108.083 172.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.678 HG21 ' HB3' ' A' ' 41' ' ' ASP . 17.3 pt -124.94 122.72 64.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.998 0.428 . . . . 64.43 109.945 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -106.6 111.24 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.97 0.414 . . . . 74.2 110.973 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 1.033 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.301 0.572 . . . . 73.15 109.991 177.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -114.26 125.06 53.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.241 -0.89 . . . . 74.25 109.234 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.497 HG21 HG12 ' A' ' 36' ' ' ILE . 22.2 mt -97.0 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.254 -1.017 . . . . 71.21 108.254 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.68 137.51 25.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.724 . . . . 75.43 110.204 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 54.63 29.63 11.85 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.578 0.549 . . . . 74.24 111.389 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 34' ' ' THR . 8.0 m 69.93 15.63 7.79 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.932 0.872 . . . . 73.01 110.721 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -107.64 156.64 18.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.71 -0.848 . . . . 74.34 108.71 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.802 HG21 HD13 ' A' ' 94' ' ' LEU . 45.5 mt -132.68 107.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.828 -0.434 . . . . 74.34 109.828 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.11 134.45 57.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.39 . . . . 60.33 110.457 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 1.033 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -79.12 128.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 74.54 111.257 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -84.86 -38.1 19.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 75.31 111.441 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -143.24 142.84 31.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 73.14 110.592 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 27' ' ' ILE . 2.0 p-10 -141.54 128.83 21.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.766 -0.652 . . . . 73.41 109.288 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.78 161.77 27.45 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.631 -0.795 . . . . 55.43 113.522 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -108.59 158.44 17.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.923 -1.14 . . . . 73.53 107.923 169.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.22 34.44 89.97 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.643 -1.383 . . . . 71.51 109.643 -170.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.753 HD22 HG21 ' A' ' 24' ' ' VAL . 6.6 p30 -70.89 -42.42 70.02 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.756 -1.222 . . . . 71.42 112.79 -165.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.65 36.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.927 0.394 . . . . 74.21 110.705 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.598 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 19.7 t70 -89.55 -58.36 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 64.4 111.374 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.15 -38.45 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.78 0.659 . . . . 73.34 112.78 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 6.1 m-30 -79.52 -2.68 43.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.544 . . . . 75.22 112.47 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HE ' ' HA ' ' A' ' 47' ' ' ASP . 45.8 mtm180 -81.04 -12.9 59.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.56 0.695 . . . . 75.43 109.31 173.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.69 13.24 11.84 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.266 -0.879 . . . . 71.4 111.081 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 49' ' ' PHE . . . -130.94 20.38 4.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.477 0.656 . . . . 73.22 110.133 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 53' ' ' LEU . 2.5 pt? -68.66 163.52 54.0 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.986 -1.006 . . . . 74.12 111.016 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.56 163.89 33.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.657 2.238 . . . . 71.23 111.203 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.29 -37.19 61.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.879 0.371 . . . . 75.0 111.022 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.53 14.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.42 0.629 . . . . 71.41 109.451 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.76 151.79 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.917 -1.038 . . . . 73.14 110.423 -172.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -90.38 141.79 28.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.603 -0.271 . . . . 73.43 110.538 175.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 58' ' ' CYS . 43.2 mmt-85 -144.77 157.07 44.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 75.03 110.528 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.47 ' HE2' ' HD1' ' A' ' 87' ' ' TYR . 1.8 m-85 -112.31 117.27 32.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.519 -0.548 . . . . 75.22 109.519 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.802 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.99 130.68 8.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.388 -0.91 . . . . 72.1 113.178 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 42.5 t -98.98 121.01 49.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.881 -0.785 . . . . 74.34 108.881 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -131.83 135.7 46.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.205 0.526 . . . . 75.21 109.86 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 24' ' ' VAL . 5.1 p-10 -99.86 153.72 18.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.266 -0.879 . . . . 72.13 110.861 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.638 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 8.1 t -142.6 169.53 17.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.203 -1.036 . . . . 75.52 108.203 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.23 -27.65 63.15 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.477 0.551 . . . . 74.23 114.477 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.93 -3.38 8.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.538 0.669 . . . . 72.51 111.84 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 15.5 ptmt -149.2 158.31 44.07 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.182 0.808 . . . . 72.03 113.182 -168.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.3 mm -126.22 115.41 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 114.801 -1.09 . . . . 63.34 108.136 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 32.4 mt-30 -115.17 124.31 51.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.153 -0.619 . . . . 75.02 112.197 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.25 109.49 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.98 -0.748 . . . . 73.11 108.98 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.27 125.22 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.054 0.454 . . . . 74.42 110.701 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.621 HD12 ' CE1' ' A' ' 87' ' ' TYR . 40.8 tp -108.05 116.2 31.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.638 -0.71 . . . . 71.12 110.392 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 113' ' ' ASP . 45.7 m95 -85.49 111.82 20.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.019 -1.104 . . . . 73.32 108.019 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 95.1 m -85.87 149.4 50.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.585 -0.446 . . . . 74.13 110.908 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 73.7 Cg_endo -88.32 110.05 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.674 2.249 . . . . 72.03 112.907 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.63 -28.15 33.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.735 -0.666 . . . . 63.13 109.608 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -94.25 9.78 36.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.395 -0.821 . . . . 71.52 110.788 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 76' ' ' PRO . . . -136.66 147.12 58.27 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.312 -0.404 . . . . 75.13 110.796 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.446 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 14.8 Cg_exo -70.71 -176.78 1.88 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.152 2.568 . . . . 71.42 113.062 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.19 -19.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.66 -0.7 . . . . 74.14 112.128 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -67.62 -56.13 12.86 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 111.632 0.234 . . . . 74.14 111.632 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 80' ' ' PRO . 37.3 Cg_exo -59.21 -30.52 93.23 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.712 1.608 . . . . 72.43 111.747 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.627 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 61.1 ttt180 -68.25 -44.81 74.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 73.21 111.001 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.0 mtt -70.78 -22.22 62.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.616 0.246 . . . . 73.3 111.212 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -60.55 -48.83 80.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 65.13 111.312 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 27.0 p90 -81.72 -28.42 33.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.764 -0.374 . . . . 70.11 110.979 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -68.89 -18.55 64.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.596 0.712 . . . . 74.1 110.923 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -88.19 -17.13 31.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.17 -0.923 . . . . 62.21 110.682 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.7 m -111.77 10.53 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 64.03 110.895 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -73.08 -20.16 61.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.923 0.712 . . . . 75.54 112.923 -172.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.559 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 41.8 m-20 -79.26 -22.26 44.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.606 0.241 . . . . 75.43 111.345 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.452 ' HB3' ' HG3' ' A' ' 5' ' ' MET . . . -61.47 -17.74 55.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.03 111.703 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.802 HD13 HG21 ' A' ' 36' ' ' ILE . 90.7 mt -104.57 -51.87 3.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.403 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.27 -44.1 75.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.269 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.71 -10.24 59.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 73.04 111.063 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -104.88 -39.8 6.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 62.31 112.618 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.619 HD11 ' N ' ' A' ' 99' ' ' ASP . 3.3 pp -89.73 -43.14 10.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.135 1.531 . . . . 75.41 115.135 -161.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.619 ' N ' HD11 ' A' ' 98' ' ' LEU . 20.8 t70 -155.03 -177.13 6.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.033 0.833 . . . . 71.33 111.983 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -97.61 12.87 64.52 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.26 -0.882 . . . . 73.52 111.194 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.57 178.48 0.04 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.553 0.741 . . . . 43.42 111.98 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.536 HG21 HG23 ' A' ' 104' ' ' VAL . 5.4 m -84.02 136.85 33.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.909 0.385 . . . . 71.53 110.546 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.49 4.66 7.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.69 -0.686 . . . . 64.23 111.984 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.536 HG23 HG21 ' A' ' 102' ' ' THR . 85.7 t -73.17 145.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 75.54 109.969 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.51 151.81 45.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.527 . . . . 75.33 109.935 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -124.61 117.91 25.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.787 0.327 . . . . 70.33 110.367 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.507 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 7.4 pt-20 -94.04 145.22 24.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 72.11 110.516 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.88 119.94 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.886 -0.597 . . . . 72.4 109.906 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -129.67 -0.71 4.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 74.3 110.045 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.12 -149.66 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.266 -0.879 . . . . 74.23 108.801 174.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 77.8 mtp -100.45 24.12 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.129 0.49 . . . . 74.31 110.751 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.1 -15.73 78.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.629 -0.714 . . . . 64.35 111.504 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 11.3 p-10 -57.32 -47.74 80.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.548 0.739 . . . . 75.41 111.798 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 3.9 pp -99.92 5.52 45.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.221 0.534 . . . . 75.15 111.008 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.52 151.36 39.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.963 -0.562 . . . . 73.53 109.979 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.42 113.7 3.7 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.5 2.133 . . . . 72.34 111.498 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.23 -98.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 74.03 110.385 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.944 -1.027 . . . . 73.22 109.511 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 111.357 -0.697 . . . . 73.1 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.751 ' HE2' ' HB2' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -71.46 151.2 44.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.198 -0.501 . . . . 74.33 110.667 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.587 ' O ' ' HD2' ' A' ' 35' ' ' LYS . . . -110.18 109.38 2.65 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.566 -0.826 . . . . 40.44 111.584 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.4 t -79.23 149.51 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 3.7 p-10 -82.9 165.46 19.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.161 0.505 . . . . 73.1 110.542 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 1.3 pm0 -84.47 -17.57 38.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.617 -0.72 . . . . 75.21 112.027 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.69 -32.94 35.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 73.31 110.226 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.0 t -54.34 -55.49 27.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 72.4 110.548 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.16 -34.67 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 71.32 110.812 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.08 -39.03 79.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 44.34 111.693 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.713 ' HG2' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -60.55 -25.5 66.2 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.22 0.452 . . . . 73.42 112.22 -173.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m-85 -60.27 -20.94 61.11 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.855 0.317 . . . . 63.21 111.855 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 2.0 p30 -64.3 -39.51 94.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.109 0.48 . . . . 74.53 110.005 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.534 ' HB3' HG21 ' A' ' 23' ' ' THR . 41.8 mt-10 -82.53 -43.91 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.263 -0.643 . . . . 60.35 109.263 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 26.3 tp -53.76 -61.19 2.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.179 -1.373 . . . . 74.45 111.284 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -85.86 -65.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.243 0.544 . . . . 75.41 112.371 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 50.1 mm -59.65 -51.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.224 -0.898 . . . . 74.43 113.068 -165.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.645 ' HB2' HG22 ' A' ' 23' ' ' THR . 68.2 mtp180 -83.96 -4.82 59.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.861 0.363 . . . . 74.12 110.869 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 27.8 mtpt 55.9 24.34 7.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.624 -0.716 . . . . 74.31 111.79 -176.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 21' ' ' ARG . 4.4 t -107.14 93.51 4.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.318 -0.993 . . . . 75.41 108.318 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.38 138.16 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.552 -0.749 . . . . 75.21 111.684 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.09 138.65 46.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 72.34 108.669 174.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.844 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -86.08 123.56 31.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.039 -1.097 . . . . 75.43 108.039 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 14' ' ' ARG . 23.3 pt -115.87 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.918 -0.583 . . . . 75.54 110.89 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 40' ' ' LYS . 23.3 m -106.35 127.78 61.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.961 -0.563 . . . . 73.2 110.538 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -102.7 162.96 12.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.443 0.639 . . . . 73.23 110.253 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 28.3 ttpt -113.14 123.02 49.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.715 -1.13 . . . . 71.43 108.457 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.612 HG21 HG12 ' A' ' 36' ' ' ILE . 31.1 mt -99.71 104.05 15.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.713 -0.847 . . . . 71.42 108.713 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.2 139.85 14.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.475 -0.33 . . . . 70.4 110.364 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 t30 61.01 32.17 19.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.493 . . . . 64.5 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 5' ' ' MET . 9.7 m 68.18 6.45 5.27 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.649 -0.705 . . . . 71.31 110.975 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 55.2 tptt -110.95 132.19 54.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.55 109.813 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.612 HG12 HG21 ' A' ' 31' ' ' ILE . 54.8 mt -113.11 110.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.166 -0.679 . . . . 74.32 109.166 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.471 HG23 ' HE3' ' A' ' 35' ' ' LYS . 5.1 t -126.27 136.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 123.053 0.22 . . . . 71.14 111.181 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 29' ' ' PHE . 56.2 t -59.48 121.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 O-C-N 123.286 0.366 . . . . 75.2 110.027 172.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 8.5 mm-40 -96.8 -26.04 15.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.424 -0.353 . . . . 61.11 110.47 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HB3' HG23 ' A' ' 28' ' ' VAL . 16.3 tppt? -146.98 141.54 26.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 75.52 112.212 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.68 131.06 47.97 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.695 -1.224 . . . . 75.24 107.695 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.36 157.39 24.47 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.036 -1.078 . . . . 55.22 111.899 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -123.1 143.66 49.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.234 -0.654 . . . . 73.13 109.234 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.41 41.22 37.86 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.395 -1.882 . . . . 74.4 108.395 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 1.7 m-20 -44.42 -51.39 8.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 113.443 -1.378 . . . . 74.13 113.155 -166.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -65.38 -28.81 69.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.927 -0.579 . . . . 43.52 112.121 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -89.35 -44.83 9.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.815 0.341 . . . . 73.33 110.631 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.02 -49.82 74.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.724 -0.671 . . . . 73.53 110.661 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' HE1' ' HG2' ' A' ' 40' ' ' LYS . 12.9 m-85 -75.35 8.33 2.84 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.118 0.784 . . . . 74.43 113.118 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 78.4 mtp180 -78.32 -11.95 59.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.604 -0.517 . . . . 71.41 109.604 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.32 11.82 0.57 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.651 -0.704 . . . . 72.34 112.593 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.91 8.7 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.961 0.38 . . . . 74.22 111.638 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.57 68.89 74.82 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 63.44 112.011 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.14 27.66 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.633 2.222 . . . . 64.12 111.824 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 57' ' ' ASP . . . -60.76 -35.03 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.671 . . . . 53.34 111.634 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 13.8 t30 76.33 -25.67 0.2 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.711 0.632 . . . . 72.13 110.987 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 55' ' ' ALA . 54.6 m-20 -95.84 171.81 8.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.326 -0.62 . . . . 72.51 109.326 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.1 p -77.79 142.12 38.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 44.11 111.14 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -140.87 160.15 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.45 109.712 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.23 120.39 40.31 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.029 -0.359 . . . . 70.23 110.029 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.844 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.4 136.96 11.44 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.911 -0.661 . . . . 64.12 113.6 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 88.5 t -97.99 120.78 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.913 -0.403 . . . . 75.44 109.913 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 10.4 t80 -142.18 126.55 17.67 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.879 -0.415 . . . . 73.33 109.879 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.24 146.09 30.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.179 0.514 . . . . 71.32 110.342 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.8 t -130.52 162.12 29.95 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.173 -0.677 . . . . 74.44 109.173 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.61 -24.93 71.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 74.14 111.342 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -73.61 -48.26 33.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.36 . . . . 73.05 110.346 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -165.15 164.82 20.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 72.4 111.518 -174.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.52 127.6 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.833 -0.803 . . . . 72.2 108.833 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.43 106.24 10.88 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.776 -0.37 . . . . 74.51 111.363 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.443 ' CE1' HG21 ' A' ' 62' ' ' VAL . 32.8 m-85 -78.77 109.16 12.77 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.828 -0.804 . . . . 74.3 108.828 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.57 137.59 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.433 . . . . 75.32 111.038 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.748 HD21 ' CE1' ' A' ' 87' ' ' TYR . 64.4 tp -144.19 124.9 14.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 74.32 110.872 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.42 ' HE3' ' N ' ' A' ' 75' ' ' CYS . 0.0 OUTLIER -86.49 141.91 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.969 -0.752 . . . . 72.23 108.969 176.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 27.2 p -88.23 151.27 48.65 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 71.33 110.682 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 4.3 Cg_exo -76.93 92.05 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.516 2.144 . . . . 71.55 111.983 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.59 -32.94 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 74.21 110.545 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -88.91 9.34 25.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.744 0.783 . . . . 73.34 110.066 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.14 159.4 52.77 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 71.2 109.469 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.57 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 25.4 Cg_exo -64.15 176.01 2.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.347 2.031 . . . . 65.41 112.158 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.19 4.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.998 0.37 . . . . 75.45 111.998 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.754 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 26.4 ttpp -68.66 -54.94 12.33 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 74.03 111.137 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 42.0 Cg_exo -59.78 -23.63 72.76 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.222 1.948 . . . . 73.31 112.979 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 47.4 ttt-85 -63.98 -39.17 93.53 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.825 0.345 . . . . 72.42 110.378 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 82' ' ' LYS . 55.1 mtm -66.36 -33.22 75.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 75.15 110.426 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.6 m -60.57 -56.86 16.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.574 -0.739 . . . . 74.33 111.561 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.748 ' CE1' HD21 ' A' ' 73' ' ' LEU . 3.4 p90 -75.7 -23.59 56.17 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.472 -0.491 . . . . 75.53 111.399 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.04 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 74.15 110.385 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.1 t -86.55 -8.24 57.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.344 -0.844 . . . . 73.41 110.453 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -123.45 4.23 9.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.007 0.432 . . . . 75.41 111.127 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -21.38 61.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 73.34 111.651 -171.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.64 -21.77 32.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 73.52 111.431 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.751 ' HB2' ' HE2' ' A' ' 5' ' ' MET . . . -58.06 -48.95 78.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 74.35 111.767 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.2 mm? -65.71 -44.79 85.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.345 0.593 . . . . 72.4 110.388 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.962 HD22 ' HA ' ' A' ' 103' ' ' ALA . 7.6 mp -64.22 -24.69 67.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.324 -0.853 . . . . 75.45 110.92 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -81.18 -28.72 34.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 75.43 111.681 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -106.39 -26.46 11.46 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.389 0.885 . . . . 73.34 113.389 -169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 36.2 mt -86.1 -42.99 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 118.806 -1.158 . . . . 74.25 111.566 -170.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 3.0 t70 -155.24 -166.33 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 73.0 111.103 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -97.92 14.0 63.15 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.802 -0.919 . . . . 55.32 110.802 173.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.22 177.66 0.08 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.675 0.79 . . . . 75.33 111.977 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 104' ' ' VAL . 7.0 m -85.28 140.53 30.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.321 -170.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.962 ' HA ' HD22 ' A' ' 95' ' ' LEU . . . -72.13 4.86 3.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.507 -0.769 . . . . 61.34 112.256 -175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 102' ' ' THR . 47.8 t -83.9 147.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.461 0.648 . . . . 75.21 110.436 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.69 155.09 47.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.549 -0.75 . . . . 65.11 109.26 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.6 tp -110.34 116.99 32.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.013 -0.366 . . . . 72.13 110.013 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.9 pt-20 -97.87 128.71 44.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.654 -0.499 . . . . 73.22 109.654 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.23 119.07 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.58 . . . . 72.01 110.18 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 23.5 t-80 -104.6 -45.25 4.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.569 -0.741 . . . . 73.3 110.237 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.03 101.58 4.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.49 -0.323 . . . . 71.05 111.421 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.517 ' HG3' HD11 ' A' ' 114' ' ' LEU . 56.8 ttm 71.18 -4.29 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.705 0.632 . . . . 75.31 112.705 170.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.9 -18.18 61.74 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.899 -0.667 . . . . 74.45 112.901 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.53 -46.88 13.84 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.719 0.408 . . . . 72.24 111.595 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 111' ' ' MET . 3.9 pp -98.06 14.77 26.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.903 0.382 . . . . 72.45 111.841 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.59 154.26 46.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.106 -0.497 . . . . 74.43 109.969 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.6 123.95 10.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.053 2.502 . . . . 74.12 112.489 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.431 HD21 ' HD2' ' A' ' 63' ' ' TYR . 5.6 mp -83.17 -2.45 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 75.05 111.496 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.88 -1.057 . . . . 63.24 111.077 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.313 0 N-CA-C 113.471 0.148 . . . . 71.12 113.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.1 ptt? -109.79 166.49 10.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.941 0.401 . . . . 73.5 110.275 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 132.17 10.69 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.416 -1.074 . . . . 63.25 110.416 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.33 124.87 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 117.129 0.464 . . . . 75.44 110.851 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.62 115.5 4.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.679 . . . . 74.24 111.417 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -84.99 -13.44 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 73.53 111.178 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.3 -35.4 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 74.24 110.604 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 42.2 t -53.35 -40.78 65.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 74.2 111.235 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.74 -47.3 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 72.5 110.751 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -68.46 -28.02 66.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 73.41 110.54 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HG3' HG21 ' A' ' 27' ' ' ILE . 1.8 tmm_? -66.6 -38.33 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 74.44 110.095 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -60.71 -21.12 62.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.648 0.261 . . . . 72.32 111.133 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -75.98 -30.65 58.66 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.863 -0.421 . . . . 74.13 109.863 176.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.19 -38.98 89.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.073 -0.714 . . . . 74.2 109.073 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.76 -43.51 97.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.022 . . . . 74.42 110.909 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.11 -64.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 75.12 111.917 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.49 -54.38 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 73.22 111.917 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -75.46 -16.84 60.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.453 -0.34 . . . . 74.41 110.993 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? 58.49 24.48 11.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.662 0.744 . . . . 75.13 109.965 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.4 p -104.18 116.36 32.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.452 -0.794 . . . . 73.24 109.552 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 7.1 p -88.07 134.3 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.838 -0.745 . . . . 73.43 109.996 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 19.1 ptpt -138.45 150.38 46.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.587 -0.733 . . . . 73.12 110.102 177.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -97.31 123.2 41.04 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.95 -1.13 . . . . 73.14 107.95 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.819 HG21 ' HG3' ' A' ' 14' ' ' ARG . 43.1 pt -117.51 144.77 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.482 -0.326 . . . . 75.23 110.219 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 3.5 m -122.45 114.4 42.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.032 0.444 . . . . 73.51 111.163 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.968 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -94.7 145.75 24.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.494 -0.928 . . . . 73.14 108.494 168.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -112.11 125.14 53.79 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.045 -0.525 . . . . 74.1 109.979 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.595 HG21 HG12 ' A' ' 36' ' ' ILE . 20.6 mt -91.24 102.02 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.37 -0.974 . . . . 74.45 108.37 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.07 147.03 20.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.393 -0.595 . . . . 73.32 109.393 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.48 26.22 15.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.276 0.56 . . . . 72.41 110.179 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' MET . 1.6 m 65.13 28.02 12.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.03 -0.987 . . . . 71.42 111.64 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HE2' HG22 ' A' ' 37' ' ' VAL . 18.8 ptmt -136.94 148.87 47.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.984 -0.376 . . . . 73.52 109.984 171.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.595 HG12 HG21 ' A' ' 31' ' ' ILE . 23.0 mt -113.42 109.94 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.632 -0.507 . . . . 73.4 109.632 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.518 HG22 ' HE2' ' A' ' 35' ' ' LYS . 3.2 t -138.48 136.77 43.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.868 -0.419 . . . . 73.53 109.868 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 86.3 t -62.4 131.27 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.137 0.494 . . . . 71.13 110.49 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.803 ' HG3' ' HD2' ' A' ' 40' ' ' LYS . 16.8 pt-20 -104.99 -31.09 9.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.522 -0.763 . . . . 73.35 111.316 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.803 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 3.0 mptp? -147.65 156.01 42.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.919 0.39 . . . . 70.55 111.123 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.554 ' HB2' HG23 ' A' ' 27' ' ' ILE . 7.1 p-10 -140.31 132.03 27.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.964 -1.125 . . . . 75.32 107.964 170.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.09 13.11 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.059 -1.067 . . . . 63.04 114.366 -168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 3.0 ptpp? -128.6 130.54 47.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.113 -1.069 . . . . 70.23 108.113 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 52.19 8.48 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.991 -2.044 . . . . 73.11 107.991 -163.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 HD21 ' HE1' ' A' ' 63' ' ' TYR . 46.6 m-20 -44.91 -51.93 9.19 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.75 -1.225 . . . . 73.02 113.542 -162.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -49.41 70.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 74.41 111.06 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.512 ' HA ' HH11 ' A' ' 50' ' ' ARG . 19.8 t70 -68.8 -42.64 77.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.079 -0.509 . . . . 73.44 111.595 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 43' ' ' LYS . 10.0 tt0 -65.31 -47.23 77.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 64.43 111.135 -174.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.487 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 27.2 m-85 -71.73 -22.18 61.66 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.057 0.391 . . . . 75.33 112.057 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 18.0 mtp180 -61.61 -22.94 65.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.813 0.34 . . . . 74.33 111.111 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.28 18.13 6.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.717 -0.754 . . . . 62.34 112.055 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -96.22 -73.99 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.873 -0.192 . . . . 71.35 111.278 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 mp -126.65 90.22 50.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.239 0.459 . . . . 75.25 112.239 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.21 48.31 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.906 2.404 . . . . 75.41 109.584 170.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.42 -12.71 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.006 -0.997 . . . . 74.51 112.837 -169.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.606 ' HA ' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 p30 51.6 26.43 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.757 0.823 . . . . 63.13 111.38 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.07 170.72 8.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.756 -1.111 . . . . 74.32 109.14 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.943 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 3.3 p -86.5 134.2 33.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.709 -1.196 . . . . 75.24 110.05 174.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HD2' ' OE2' ' A' ' 39' ' ' GLU . 17.6 mmt85 -143.41 152.06 41.12 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.502 -1.226 . . . . 71.0 108.173 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.682 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -103.53 113.54 27.12 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.721 -0.474 . . . . 75.13 109.721 -178.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.672 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.65 131.73 8.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.985 -0.626 . . . . 72.31 113.114 -175.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 3.0 t -102.74 120.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 75.41 109.309 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.596 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 5.0 t80 -134.69 124.97 26.12 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.409 -0.589 . . . . 64.22 109.409 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 11.3 t70 -92.31 140.93 29.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.741 -0.466 . . . . 70.13 109.741 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.6 t -122.12 171.12 9.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.49 -23.9 55.23 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.236 -0.507 . . . . 75.14 113.829 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -102.25 -26.26 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 73.12 112.873 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -170.27 169.05 7.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.306 0.484 . . . . 73.22 112.306 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.22 129.8 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.597 -0.89 . . . . 75.4 108.597 170.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -118.29 115.27 24.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.078 0.466 . . . . 75.42 111.635 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.719 ' HZ ' HD21 ' A' ' 98' ' ' LEU . 48.4 m-85 -76.17 110.68 10.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.639 -0.71 . . . . 71.45 109.532 166.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.04 112.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.569 -0.53 . . . . 74.51 109.569 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' A' ' 87' ' ' TYR . 36.4 tp -115.97 89.32 3.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.658 -0.701 . . . . 65.53 110.304 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 0.8 OUTLIER -85.59 121.06 27.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.633 -0.876 . . . . 74.42 108.633 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.3 p -96.48 149.98 36.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.857 -0.337 . . . . 61.42 110.856 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.943 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 59.1 Cg_endo -71.8 130.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.42 2.08 . . . . 75.22 113.052 -170.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.68 -40.29 16.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 61.14 110.814 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.89 20.57 5.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 72.0 110.613 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -132.32 157.81 77.27 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.233 -0.44 . . . . 72.24 110.534 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 79' ' ' ALA . 50.7 Cg_endo -69.21 -170.99 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.928 2.419 . . . . 52.31 113.227 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.15 -10.84 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 74.43 112.1 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 39.5 ttmt -68.08 -47.53 40.27 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.189 0.44 . . . . 74.42 112.189 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 15.6 Cg_endo -58.62 -16.78 31.92 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.116 1.877 . . . . 74.34 112.824 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 19.4 mtp-105 -73.93 -32.68 63.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.598 -0.519 . . . . 72.32 109.598 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.7 mmt -78.14 -13.59 59.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.776 -0.647 . . . . 73.13 110.301 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -65.2 -55.78 16.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 63.32 110.779 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 11.0 p90 -77.33 -19.34 56.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 75.22 110.89 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.02 -18.52 60.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.208 0.528 . . . . 74.15 110.316 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 t -82.71 -34.35 27.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.769 -0.651 . . . . 64.11 110.463 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 p -104.76 20.89 17.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.52 110.909 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.632 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 19.7 pttp -56.71 -55.22 36.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.423 -0.808 . . . . 73.42 112.454 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.632 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 8.7 p-10 -85.88 -20.09 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 73.02 111.35 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.18 67.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.644 -0.253 . . . . 74.11 111.349 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 4.2 mm? -66.96 -40.43 87.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.958 -0.386 . . . . 72.4 109.958 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.502 HD23 ' HB1' ' A' ' 103' ' ' ALA . 33.7 tp -67.85 -18.53 64.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.535 -0.757 . . . . 71.33 111.582 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.534 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -111.57 16.45 20.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.564 1.173 . . . . 71.22 108.656 177.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.719 HD21 ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -111.35 10.36 21.56 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.929 -1.487 . . . . 72.14 111.101 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' ALA . 21.8 m-20 -34.69 -145.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.845 2.458 . . . . 74.14 116.491 -151.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.24 15.7 0.02 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 118.013 1.965 . . . . 62.44 118.013 -150.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -56.97 -177.14 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.702 -0.851 . . . . 63.52 108.702 154.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 m -80.47 117.33 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.696 -1.252 . . . . 71.12 109.356 -168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.502 ' HB1' HD23 ' A' ' 95' ' ' LEU . . . -87.49 -0.77 57.3 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.944 -1.026 . . . . 75.25 111.486 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.94 146.33 10.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.638 . . . . 64.32 109.276 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -129.79 146.76 51.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.326 -0.397 . . . . 73.2 110.444 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 tt -119.84 117.39 28.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.117 -0.698 . . . . 73.4 109.117 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 13.4 pt-20 -97.47 141.05 31.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 75.14 110.275 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.68 54.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 73.14 111.062 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -126.07 4.3 7.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.478 -0.783 . . . . 73.23 109.931 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.94 163.55 14.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 74.2 109.119 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 67.5 mtt -78.31 57.87 1.98 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.444 0.64 . . . . 71.04 110.853 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.42 -15.51 68.62 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.95 -1.023 . . . . 50.43 111.598 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.08 -38.83 73.89 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 122.974 0.51 . . . . 75.51 111.165 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.9 pp -98.2 18.95 15.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.117 0.484 . . . . 73.32 110.819 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.02 156.3 54.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 72.11 110.412 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.01 91.24 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.333 2.022 . . . . 74.32 112.043 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.08 -7.54 59.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.064 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.457 -0.783 . . . . 74.34 109.906 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.836 -0.105 . . . . 62.01 112.836 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.44 172.22 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.112 0.482 . . . . 75.23 111.588 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.58 110.1 0.62 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.696 -0.962 . . . . 61.23 110.696 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.85 122.97 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.998 0.399 . . . . 75.41 111.829 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.13 120.84 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.182 -0.673 . . . . 71.44 109.182 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.76 -13.4 61.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.392 0.886 . . . . 74.43 113.392 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.541 HD21 HG12 ' A' ' 38' ' ' VAL . 9.9 t30 -58.9 -30.65 67.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.063 0.459 . . . . 62.33 110.213 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 m -66.95 -41.86 86.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.85 -0.614 . . . . 74.34 110.088 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.85 -43.92 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 74.22 110.893 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.58 63.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 73.32 111.592 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.759 ' HG3' HG22 ' A' ' 27' ' ' ILE . 20.9 mmt180 -64.54 -26.83 68.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.361 . . . . 74.22 111.706 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 82.2 m-85 -82.5 -26.25 32.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 72.13 110.325 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -75.84 -36.85 59.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.26 -0.644 . . . . 75.35 109.26 177.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.83 -19.03 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.551 -0.75 . . . . 70.25 110.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 11.8 mt -63.27 -50.79 68.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.147 -0.479 . . . . 70.15 111.15 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -70.91 -40.37 72.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.859 0.361 . . . . 73.21 111.3 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.22 -63.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.786 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -79.49 -24.02 42.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.491 -0.322 . . . . 75.3 110.725 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 53.6 mttp 59.32 24.79 13.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.797 -0.638 . . . . 75.33 111.222 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -93.2 122.44 35.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.123 -0.695 . . . . 72.14 109.123 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.67 134.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 120.131 -0.628 . . . . 74.52 110.476 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.504 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -141.12 172.14 13.1 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.34 -0.845 . . . . 70.15 109.718 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 45' ' ' ASN . 4.1 t90 -125.97 127.56 46.13 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 74.12 107.482 173.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.759 HG22 ' HG3' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -117.79 128.83 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.065 0.46 . . . . 75.2 110.46 177.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 77.1 t -110.29 120.01 60.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.028 0.442 . . . . 74.02 110.26 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 p90 -116.73 160.98 19.95 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.832 -0.622 . . . . 74.33 110.844 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HE3' ' OE2' ' A' ' 39' ' ' GLU . 38.3 ttmt -115.39 125.11 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.419 -0.809 . . . . 73.53 109.267 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.413 HD13 ' HB2' ' A' ' 90' ' ' SER . 16.3 mt -88.05 102.44 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.693 -1.225 . . . . 72.31 107.693 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.1 138.95 39.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.479 -0.328 . . . . 74.13 110.379 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 34' ' ' THR . 15.8 m120 60.22 22.06 11.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 64.35 110.725 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 33' ' ' ASN . 46.9 m 79.48 -10.13 1.36 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.86 -0.609 . . . . 75.01 111.138 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HE3' HG11 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -102.16 138.3 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.587 -0.523 . . . . 71.4 109.587 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.652 HD12 HD21 ' A' ' 94' ' ' LEU . 57.4 mt -99.34 114.12 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.188 -172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.432 HG11 ' HE3' ' A' ' 35' ' ' LYS . 6.8 m -125.71 135.41 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 75.43 111.155 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -88.67 125.42 41.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.96 0.409 . . . . 71.45 110.077 176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 27.4 mt-10 -79.65 -37.76 35.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.908 -0.587 . . . . 73.32 111.151 -173.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 39' ' ' GLU . 19.3 pttm -171.52 159.59 5.59 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.321 0.581 . . . . 72.34 112.191 -167.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.69 ' CB ' HG21 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -154.29 146.55 23.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.591 -1.186 . . . . 73.21 108.383 173.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.32 161.41 26.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.016 -1.088 . . . . 64.31 112.71 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -93.66 120.52 34.04 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.335 -1.358 . . . . 75.04 107.335 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.52 53.96 0.58 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 107.191 -2.363 . . . . 62.24 107.191 -161.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 38.8 m-20 -61.35 -53.01 62.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.026 -1.087 . . . . 75.35 112.471 -160.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.44 -32.7 42.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.726 -0.472 . . . . 75.21 109.726 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.97 -58.31 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 70.33 111.582 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.66 -46.51 78.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 71.52 111.542 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 27.9 m-85 -73.82 -14.83 61.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.899 0.703 . . . . 74.13 112.899 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.7 -13.19 60.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.962 0.411 . . . . 63.14 110.703 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.98 11.78 6.18 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.617 -0.593 . . . . 62.23 111.617 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -118.61 -0.15 11.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 72.21 111.099 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 87.2 mt -101.53 123.29 44.87 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.239 -0.437 . . . . 54.05 110.092 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 12.8 Cg_exo -70.06 134.1 26.55 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.86 2.373 . . . . 74.42 112.101 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.18 -14.88 57.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 72.43 110.877 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -86.15 -33.11 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 72.3 111.531 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' C ' ' HG3' ' A' ' 76' ' ' PRO . 35.6 t0 -123.34 163.49 20.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.769 0.319 . . . . 73.21 110.965 -172.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.867 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 4.2 p -98.61 138.72 35.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.446 0.641 . . . . 73.44 109.818 173.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -130.07 152.32 49.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.073 -0.967 . . . . 75.13 109.023 172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t80 -107.52 112.05 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.455 -0.572 . . . . 74.11 109.455 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 28' ' ' VAL . . . -120.02 125.9 6.48 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.903 -0.665 . . . . 64.43 111.701 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.17 121.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.559 0.695 . . . . 64.31 109.617 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.48 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 2.1 t80 -113.48 125.67 54.48 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.001 -0.999 . . . . 73.15 109.678 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.567 ' OD1' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -103.62 140.66 37.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.587 0.708 . . . . 73.1 110.582 175.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.0 t -131.02 170.44 14.49 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.776 -0.824 . . . . 64.23 108.776 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.28 -34.16 89.18 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.983 -0.627 . . . . 34.13 112.757 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -81.68 -39.78 23.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.535 0.207 . . . . 73.41 111.502 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -164.59 171.67 14.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.732 0.301 . . . . 74.42 110.773 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.51 140.84 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.458 -0.571 . . . . 75.13 109.458 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -122.04 116.36 24.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.554 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.69 109.18 12.68 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.977 -0.749 . . . . 72.31 108.977 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 115.37 32.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.402 0.62 . . . . 74.04 110.825 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.546 HD22 ' CD1' ' A' ' 87' ' ' TYR . 60.6 tp -119.41 81.93 1.79 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.185 -0.916 . . . . 72.23 109.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -89.6 118.22 29.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.985 -0.552 . . . . 74.11 109.77 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 13.9 p -102.34 147.95 34.73 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.865 -0.42 . . . . 75.42 109.865 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 54.1 Cg_endo -99.52 169.99 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.155 2.57 . . . . 75.44 113.291 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.64 -28.46 66.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.1 -0.954 . . . . 63.25 110.814 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -88.46 9.84 22.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.664 -0.698 . . . . 73.33 111.624 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.28 111.25 63.31 Favored Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 122.061 -0.399 . . . . 74.4 111.247 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.06 -166.76 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 72.15 112.238 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 31.0 m -75.56 -13.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 75.24 112.033 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.843 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 25.5 mtpp -69.27 -58.22 6.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.44 -0.345 . . . . 73.34 111.178 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 7.3 Cg_exo -74.28 -13.93 23.08 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.027 1.818 . . . . 64.44 111.32 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.501 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 2.7 tpt180 -60.92 -47.25 87.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 75.41 110.349 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -76.18 -14.51 60.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.581 . . . . 75.02 110.567 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -69.75 -43.97 71.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.048 -0.523 . . . . 75.54 110.952 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.546 ' CD1' HD22 ' A' ' 73' ' ' LEU . 8.9 p90 -79.5 -30.1 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.558 -0.457 . . . . 73.22 111.272 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.85 -19.95 64.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.139 0.495 . . . . 64.34 111.247 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -86.87 -53.15 5.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.653 -0.703 . . . . 70.3 110.649 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 31' ' ' ILE . 4.1 m -68.39 -25.98 65.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.414 -0.812 . . . . 73.12 111.84 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.636 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -57.5 -27.63 62.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.462 0.541 . . . . 73.13 112.462 -175.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.636 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 27.6 t70 -76.68 -40.11 49.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.833 0.349 . . . . 73.42 110.934 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.66 91.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.826 -0.625 . . . . 64.54 111.267 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.652 HD21 HD12 ' A' ' 36' ' ' ILE . 3.9 mm? -63.8 -50.69 67.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 63.32 110.446 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 103' ' ' ALA . 36.5 tp -57.63 -30.17 65.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 74.42 110.958 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -76.74 -32.09 57.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.601 -0.727 . . . . 74.3 112.535 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -112.07 -14.61 13.41 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.37 1.248 . . . . 75.43 114.37 -166.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 68.5 mt -86.96 -45.38 10.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 118.111 -1.436 . . . . 73.31 112.903 -167.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 20.6 t70 -157.64 -167.07 2.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.438 -0.505 . . . . 65.25 111.124 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -90.33 15.36 60.11 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.385 -1.086 . . . . 74.11 110.385 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.35 179.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.42 1.088 . . . . 61.41 113.272 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -82.97 136.77 34.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.565 -0.743 . . . . 74.24 110.456 -169.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 95' ' ' LEU . . . -79.16 5.39 12.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 70.31 112.466 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.7 148.36 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.947 0.404 . . . . 74.33 110.307 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.99 45.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.342 -0.614 . . . . 71.52 109.342 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 tp -122.64 118.41 28.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.817 0.341 . . . . 71.41 110.694 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 pt-20 -98.37 121.07 39.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.966 -0.561 . . . . 73.45 109.669 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.65 150.94 29.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.077 -0.51 . . . . 74.14 111.021 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -136.34 10.03 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 73.14 110.218 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 111' ' ' MET . 47.0 tt0 -131.34 167.18 19.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 73.53 110.095 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.404 ' N ' ' HG2' ' A' ' 110' ' ' GLU . 86.3 mtp -79.41 6.92 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.608 0.242 . . . . 72.03 111.52 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.91 -20.1 74.18 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.739 -0.743 . . . . 72.35 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.59 -37.29 73.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.296 0.569 . . . . 72.44 110.384 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 pp -89.62 14.46 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 74.14 110.829 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . . . -87.81 162.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.223 -0.658 . . . . 71.32 109.223 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 34.2 Cg_endo -66.65 88.45 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 121.936 1.757 . . . . 72.5 113.026 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -77.66 -71.02 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.421 -0.585 . . . . 73.41 109.421 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.538 -0.744 . . . . 74.32 109.968 178.849 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.495 -0.058 . . . . 70.24 113.099 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.4 ptt? -84.9 159.04 20.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 65.31 110.704 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.46 119.99 4.03 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.811 -0.631 . . . . 74.43 111.778 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 36' ' ' ILE . 62.0 t -73.64 104.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.828 -0.804 . . . . 73.25 108.828 174.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -71.68 142.25 49.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.16 -0.473 . . . . 64.23 110.868 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.481 ' HA ' HG21 ' A' ' 12' ' ' VAL . 20.9 pt-20 -64.83 -15.62 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.721 -0.672 . . . . 75.11 111.337 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -55.23 -40.55 71.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.849 -0.614 . . . . 55.54 110.23 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.1 t -73.89 -44.23 55.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 54.22 111.438 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 9' ' ' GLU . 34.5 m -72.81 -24.31 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 63.53 111.527 -175.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.54 70.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 73.21 110.876 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 33.2 mmt180 -75.33 -23.51 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 74.23 111.226 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 43.4 m-85 -82.82 -23.31 33.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.399 . . . . 73.32 109.99 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.77 84.93 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.381 -0.6 . . . . 72.0 109.381 171.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -71.73 -49.57 38.07 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.473 0.654 . . . . 71.33 109.505 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 16.5 tp -58.59 -47.72 83.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.695 -1.139 . . . . 75.44 112.179 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -73.3 -51.86 16.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.938 0.348 . . . . 74.25 111.938 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.61 -56.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.062 0.393 . . . . 75.33 112.062 -171.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -68.6 -26.3 65.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.711 0.291 . . . . 65.14 110.479 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 58.58 24.42 11.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.552 -0.749 . . . . 63.0 111.491 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 p -92.83 106.37 18.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.05 -1.463 . . . . 74.42 107.05 164.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 64' ' ' ASP . 7.6 p -87.46 136.63 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.656 0.741 . . . . 75.14 111.184 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 41' ' ' ASP . 19.0 ptpt -137.35 140.18 41.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.692 -1.14 . . . . 73.25 109.408 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.98 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.2 t90 -89.04 136.37 33.05 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.152 -1.425 . . . . 74.52 107.152 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.49 132.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.162 0.506 . . . . 73.51 110.642 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -106.52 110.5 31.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.45 -0.795 . . . . 73.32 109.278 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 38' ' ' VAL . 2.6 p90 -115.58 159.5 21.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.645 0.736 . . . . 74.11 111.623 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 34.5 ttmt -123.25 125.36 44.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.775 -1.102 . . . . 73.21 109.242 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 36' ' ' ILE . 56.4 mt -112.3 101.6 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.872 0.368 . . . . 71.55 111.167 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -159.6 170.28 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 73.31 110.383 175.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m120 53.0 39.38 29.35 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.743 0.652 . . . . 71.32 110.942 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 5' ' ' MET . 58.0 p 58.22 20.43 7.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.783 -1.099 . . . . 72.35 113.274 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.2 mmmm -129.88 137.81 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.111 0.481 . . . . 74.33 110.997 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.836 HG21 HG12 ' A' ' 31' ' ' ILE . 56.7 mt -103.15 108.77 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.77 -0.826 . . . . 75.44 108.77 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.96 135.87 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 74.14 111.498 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 29' ' ' PHE . 17.3 t -88.21 133.51 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 75.32 109.181 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 40' ' ' LYS . 10.4 pt-20 -106.9 -18.47 13.91 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.806 -0.758 . . . . 73.13 110.854 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -145.06 140.88 28.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.221 -0.591 . . . . 72.21 111.803 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 27' ' ' ILE . 10.6 p-10 -132.54 132.98 43.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.583 -1.265 . . . . 74.5 107.583 166.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.742 ' HA3' ' HG2' ' A' ' 48' ' ' GLU . . . -116.8 161.86 12.9 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.045 -1.074 . . . . 74.11 114.033 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.4 ptpp? -108.15 124.43 50.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.814 -0.81 . . . . 64.4 108.814 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.3 56.98 3.27 Favored Glycine 0 C--N 1.313 -0.72 0 N-CA-C 108.658 -1.777 . . . . 71.04 108.658 -169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.98 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 28.4 p-10 -41.99 -52.31 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.236 1.569 . . . . 72.54 115.236 -158.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.16 69.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.165 0.432 . . . . 71.31 112.165 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.65 -41.09 18.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.267 0.556 . . . . 74.5 110.327 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.742 ' HG2' ' HA3' ' A' ' 42' ' ' GLY . 6.0 tp10 -48.11 -55.6 9.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.386 -1.279 . . . . 74.5 111.479 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 21.1 m-85 -74.61 -25.01 58.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.997 0.74 . . . . 75.14 112.997 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.73 ' HE ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 ttm105 -65.28 -21.0 66.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.222 0.534 . . . . 73.3 109.721 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.28 12.16 10.5 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.055 -0.593 . . . . 73.31 111.959 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 49' ' ' PHE . . . -108.75 -25.21 10.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.444 0.164 . . . . 73.5 111.083 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.576 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 3.6 mm? -120.9 100.27 46.3 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-O 121.057 0.456 . . . . 74.1 111.992 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -101.2 37.35 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.777 2.985 . . . . 64.03 109.957 166.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.34 -35.44 30.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.083 -0.962 . . . . 74.4 112.732 -165.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 37.0 m-80 65.23 19.98 11.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.567 0.699 . . . . 61.44 109.65 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.43 151.73 23.17 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.958 -1.019 . . . . 71.01 109.667 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 6.6 p -87.47 133.54 33.74 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.916 -1.114 . . . . 75.51 108.907 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -151.47 169.14 22.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.147 -0.933 . . . . 70.03 109.18 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' HE1' ' HD2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -114.55 115.08 26.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.109 0.481 . . . . 74.34 109.921 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.699 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -123.63 136.44 10.36 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.876 -0.678 . . . . 75.0 112.401 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.611 HG21 ' HZ ' ' A' ' 15' ' ' PHE . 33.6 m -117.96 131.68 70.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.983 0.391 . . . . 64.32 110.519 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.752 ' HB2' HD21 ' A' ' 45' ' ' ASN . 0.5 OUTLIER -141.07 149.09 41.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.033 0.444 . . . . 73.41 111.334 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.568 ' HA ' HG12 ' A' ' 69' ' ' ILE . 19.0 t70 -92.03 144.32 25.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.524 -0.762 . . . . 72.04 110.176 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.592 ' SG ' ' HG2' ' A' ' 68' ' ' LYS . 12.1 p -135.44 175.15 9.85 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.001 -1.0 . . . . 61.51 108.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.33 -24.39 45.07 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 114.899 0.72 . . . . 75.43 114.899 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.433 HD21 ' HA ' ' A' ' 67' ' ' ASN . 7.2 m120 -121.54 -15.93 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.416 1.108 . . . . 62.15 113.032 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.592 ' HG2' ' SG ' ' A' ' 65' ' ' CYS . 9.7 ptpt -163.3 168.35 20.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.162 -0.615 . . . . 72.01 112.052 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 101' ' ' ALA . 23.6 mt -113.27 123.77 69.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.028 -0.73 . . . . 74.43 109.028 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.02 133.82 43.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.358 -0.383 . . . . 71.0 111.434 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' HD2' ' HE1' ' A' ' 60' ' ' PHE . 10.8 m-85 -89.84 108.79 19.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 73.12 109.208 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.9 t -104.78 131.35 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.987 0.422 . . . . 70.41 111.602 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.3 tp -127.28 130.12 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.609 -0.723 . . . . 70.53 110.283 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 58' ' ' CYS . 19.1 m95 -90.17 159.36 16.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 74.2 109.936 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 31.0 p -86.14 151.87 54.91 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 51.23 109.557 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.537 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -74.7 79.4 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.293 1.995 . . . . 70.42 111.375 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.96 -38.96 64.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.633 -0.712 . . . . 65.4 110.233 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.11 9.22 28.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 70.53 110.253 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -126.68 165.54 27.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.633 . . . . 52.12 111.009 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.519 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 17.2 Cg_exo -68.92 175.69 7.08 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.939 2.426 . . . . 73.25 112.846 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.84 -8.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.067 -0.515 . . . . 74.33 111.852 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.613 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 67.2 tttt -67.71 -56.03 12.85 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 112.657 0.614 . . . . 74.32 112.657 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 52.5 Cg_exo -53.33 -40.2 78.74 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.285 1.99 . . . . 73.35 113.562 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.44 ' HB2' ' CG ' ' A' ' 76' ' ' PRO . 57.8 ttp85 -60.47 -45.85 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 75.5 111.025 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.77 -26.95 66.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.151 0.5 . . . . 65.12 109.94 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.1 m -71.87 -48.2 47.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.271 -0.877 . . . . 75.21 111.652 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -61.37 -31.53 71.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.837 0.351 . . . . 74.42 111.408 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.33 69.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 70.34 111.719 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -71.29 -30.15 65.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 75.55 111.228 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 94' ' ' LEU . 3.2 p -97.63 12.48 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.275 -0.421 . . . . 75.13 111.825 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -57.24 -52.47 65.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.376 . . . . 72.3 111.694 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -76.56 -31.36 57.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 74.04 111.548 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.27 67.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.987 0.366 . . . . 60.55 111.987 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 36' ' ' ILE . 4.1 mm? -96.15 -42.22 8.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 72.11 109.997 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 103' ' ' ALA . 55.0 tp -55.47 -39.34 70.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 71.11 110.994 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -81.46 -21.59 38.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.435 -0.802 . . . . 72.33 112.191 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -103.18 -32.5 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.818 0.673 . . . . 74.04 112.818 -168.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.671 HD13 HD12 ' A' ' 94' ' ' LEU . 65.5 mt -88.13 -40.65 13.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.746 -0.782 . . . . 63.44 112.762 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 9.8 t70 -151.82 -174.23 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.455 -0.498 . . . . 74.54 111.038 -176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.404 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -95.75 13.6 66.05 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.338 -1.105 . . . . 74.24 110.338 172.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . . . -55.48 177.28 0.05 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.111 0.964 . . . . 75.02 113.13 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.9 m -85.45 140.38 30.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.417 -0.81 . . . . 73.24 111.106 -167.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.616 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -69.3 5.91 1.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.286 -0.87 . . . . 65.01 113.056 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -85.56 149.32 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.922 -0.399 . . . . 75.21 109.922 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -125.61 165.17 19.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.023 -0.362 . . . . 72.33 110.023 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 tt -133.21 117.77 17.82 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.7 -0.482 . . . . 72.52 109.7 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.96 132.92 53.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.48 -0.563 . . . . 73.22 109.48 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.481 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . . . -131.43 162.67 29.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.312 -0.404 . . . . 74.01 110.127 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.534 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 1.9 p80 -112.19 -158.6 0.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.119 -0.491 . . . . 74.32 111.145 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 111' ' ' MET . 0.8 OUTLIER -51.15 157.23 0.93 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.161 0.8 . . . . 64.31 113.161 -170.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 64.4 mtm 79.61 -45.31 0.32 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.597 -1.183 . . . . 74.45 111.789 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.0 -19.1 21.33 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.862 0.705 . . . . 65.1 114.862 -171.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.15 -51.57 69.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.619 0.368 . . . . 63.33 111.263 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.4 pt? -120.32 20.23 11.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 63.32 111.485 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . . . -101.77 155.97 35.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.786 -0.449 . . . . 72.24 109.786 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.73 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 18.9 Cg_endo -59.61 100.18 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.492 2.128 . . . . 71.21 113.316 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 117' ' ' LEU . 4.8 mp -64.47 -54.11 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.808 -0.812 . . . . 75.03 108.808 171.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-N 114.69 -1.141 . . . . 74.23 108.985 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.778 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 1.4 tpt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.943 0.401 . . . . 65.44 110.583 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.22 -19.19 28.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 73.22 111.937 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 m -67.57 134.73 51.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.266 -0.425 . . . . 71.31 111.756 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 61.49 50.57 65.16 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.902 -0.59 . . . . 75.3 112.99 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.414 ' HE2' ' HB2' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -82.55 152.55 25.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 75.2 111.37 -178.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.96 132.77 7.75 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.716 -0.954 . . . . 71.33 110.716 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.26 132.83 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.947 0.403 . . . . 75.55 111.247 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.19 139.25 33.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.757 -0.46 . . . . 62.02 109.757 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -13.83 62.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.2 0.444 . . . . 72.14 112.2 -173.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.8 -32.99 74.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.933 0.397 . . . . 65.14 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.6 m -64.41 -35.32 80.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.901 -0.59 . . . . 73.33 110.453 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.25 -31.55 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.847 -0.615 . . . . 74.42 110.23 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.55 -26.61 68.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.66 -0.7 . . . . 72.03 111.948 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -64.15 -20.11 65.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.945 -0.302 . . . . 73.32 111.525 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.652 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 40.7 m-85 -75.5 -18.24 59.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.29 0.478 . . . . 74.32 112.29 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -82.0 -23.41 36.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.017 -0.673 . . . . 73.15 110.35 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -84.1 -21.09 31.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.27 -1.011 . . . . 72.12 108.27 171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.652 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 27.4 tp -84.17 -59.79 2.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.683 -1.144 . . . . 73.3 111.594 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -76.25 -43.94 39.64 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.375 -0.375 . . . . 73.5 111.82 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.1 mm -66.51 -44.21 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.431 . . . . 74.53 111.662 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -80.51 -10.36 59.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.282 -0.417 . . . . 73.51 110.515 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.2 tttt 56.57 24.3 8.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.46 -0.791 . . . . 74.03 111.14 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -99.82 125.61 45.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.807 -0.812 . . . . 74.44 108.807 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 m -83.83 138.24 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.113 0.482 . . . . 75.1 110.051 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HZ3' ' HA ' ' A' ' 18' ' ' LEU . 30.5 mtmm -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.477 0.656 . . . . 74.14 112.115 -172.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.725 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.9 t90 -142.54 123.76 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.427 -1.323 . . . . 71.14 107.427 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.718 HG21 ' HB2' ' A' ' 41' ' ' ASP . 27.1 pt -119.22 138.98 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.427 -0.583 . . . . 73.04 109.427 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 5.9 p -115.83 120.29 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.839 0.828 . . . . 73.31 111.237 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.826 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -114.94 163.38 15.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.908 -1.042 . . . . 64.12 110.672 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -112.09 127.55 55.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.72 -0.673 . . . . 75.13 109.653 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 86' ' ' THR . 68.8 mt -113.04 100.29 10.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 74.14 110.214 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 86' ' ' THR . 8.8 tp10 -162.55 165.48 25.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.95 -1.13 . . . . 72.54 107.95 171.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 t30 60.6 29.38 18.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.739 0.781 . . . . 71.34 109.936 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 4' ' ' GLY . 50.0 p 57.52 26.97 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.446 -1.252 . . . . 74.41 112.9 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -125.55 136.75 53.65 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.213 -0.304 . . . . 72.24 110.613 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.597 HG23 HD12 ' A' ' 94' ' ' LEU . 9.8 mm -106.34 107.14 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.353 -0.61 . . . . 74.31 109.353 172.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.56 142.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 -0.275 . . . . 74.32 110.467 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.826 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 1.8 m -79.91 146.39 7.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.794 0.331 . . . . 75.41 110.478 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 59' ' ' ARG . 50.2 mt-10 -107.03 -18.54 13.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.327 -0.62 . . . . 75.53 109.327 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.54 145.62 14.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.531 -0.758 . . . . 70.22 110.812 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.718 ' HB2' HG21 ' A' ' 27' ' ' ILE . 3.4 p30 -152.08 133.35 14.44 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.807 -0.812 . . . . 71.21 108.807 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.38 159.27 25.69 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.038 -1.077 . . . . 75.21 113.344 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 43' ' ' LYS . 1.6 ptpp? -114.31 121.54 43.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.513 0.673 . . . . 74.04 109.71 175.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 29.44 1.4 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 108.238 -1.945 . . . . 64.25 108.238 -168.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -44.42 -53.4 6.91 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 115.492 1.664 . . . . 74.44 115.492 -160.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -69.5 -34.75 74.76 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.91 0.337 . . . . 74.51 111.91 -171.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.35 -43.81 11.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.583 0.706 . . . . 63.21 109.932 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.11 -53.52 56.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.485 -1.234 . . . . 63.11 111.518 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' HD1' ' HG ' ' A' ' 53' ' ' LEU . 13.8 m-85 -68.06 -19.05 64.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.871 . . . . 74.32 113.35 -172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.624 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 55.8 mtm-85 -66.33 -30.9 71.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.412 -0.515 . . . . 74.32 110.8 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.0 -20.13 9.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.821 . . . . 73.42 112.498 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 -16.45 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.86 0.319 . . . . 74.11 111.86 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.705 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 35.8 mt -111.99 92.12 17.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.978 0.732 . . . . 75.22 112.978 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -101.04 44.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.875 3.05 . . . . 64.3 108.902 162.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -51.47 -37.95 51.41 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 114.456 1.28 . . . . 75.01 114.456 -163.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 16.6 t-20 68.82 -46.36 0.55 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.473 0.483 . . . . 53.41 111.448 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 55' ' ' ALA . 33.4 t70 -98.74 172.33 7.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.128 -0.487 . . . . 64.44 109.754 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.536 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 9.5 p -84.11 136.08 34.14 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.093 -0.643 . . . . 71.44 109.99 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.532 ' HD2' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mmt85 -135.75 170.5 15.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.059 -1.089 . . . . 75.04 108.059 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.731 ' CE2' ' HB3' ' A' ' 71' ' ' PHE . 2.2 t80 -117.3 119.07 34.01 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.335 -0.546 . . . . 72.14 110.996 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.725 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.07 135.3 10.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 73.2 112.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 2.8 p -106.02 123.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 74.32 110.385 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.58 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 2.4 t80 -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.232 -0.895 . . . . 73.24 109.323 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.53 141.79 31.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 75.4 111.505 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 60.7 m -131.08 169.55 15.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.421 -0.809 . . . . 65.44 109.44 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.9 66.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 33.52 112.478 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -72.45 -34.27 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 73.52 111.374 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -170.53 168.48 7.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 73.31 110.35 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.414 ' HB ' ' HB1' ' A' ' 101' ' ' ALA . 13.2 mt -122.33 118.16 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.271 -0.64 . . . . 73.24 109.271 170.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -112.92 129.14 56.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.321 0.581 . . . . 75.32 110.509 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.731 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.8 m-85 -78.57 114.06 17.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.314 -0.857 . . . . 74.53 109.471 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.36 127.04 43.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.315 0.578 . . . . 62.25 111.511 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 58.4 tp -131.14 107.1 8.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.094 -0.957 . . . . 73.25 110.029 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -85.62 130.29 34.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.871 -0.789 . . . . 72.34 108.871 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -78.14 148.27 74.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.82 0.343 . . . . 74.41 110.624 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.781 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 96.7 Cg_endo -89.43 115.54 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.584 2.189 . . . . 70.13 111.88 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.71 -19.34 41.69 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.48 0.657 . . . . 74.22 109.662 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -102.41 9.88 39.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.379 -0.828 . . . . 74.44 110.639 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.781 ' HB2' ' HB2' ' A' ' 76' ' ' PRO . . . -139.14 152.48 69.88 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 121.962 -0.461 . . . . 72.52 111.013 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 16.7 Cg_exo -68.7 -178.86 2.12 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.177 2.584 . . . . 75.14 113.232 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 85' ' ' MET . 9.1 p -84.64 -8.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 73.5 111.515 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 48.6 mtpt -68.25 -49.73 32.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.393 0.516 . . . . 75.34 112.393 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 26.9 Cg_endo -65.18 -31.54 53.79 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.4 1.4 . . . . 74.51 111.1 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.56 -39.09 92.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.158 -0.928 . . . . 75.11 110.698 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 22.1 mmt -61.34 -39.17 89.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.778 -0.647 . . . . 75.13 111.487 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.738 HG21 HG21 ' A' ' 31' ' ' ILE . 8.2 m -58.08 -43.85 87.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.811 0.339 . . . . 73.32 111.286 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.713 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 90.4 m-85 -66.43 -54.11 27.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 73.51 111.783 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.62 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 73.33 111.808 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -86.48 -45.16 11.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.358 -0.383 . . . . 72.55 111.382 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.589 ' HB2' HG22 ' A' ' 31' ' ' ILE . 8.1 m -79.94 -11.18 59.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.41 -0.359 . . . . 70.12 111.691 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.09 -21.76 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 74.45 111.363 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.73 -37.01 81.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.348 -0.387 . . . . 71.52 110.55 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 5' ' ' MET . . . -64.77 -30.74 71.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 72.54 110.683 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.71 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.0 mm? -73.54 -57.6 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 73.53 109.389 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 103' ' ' ALA . 25.1 tp -54.63 -43.51 72.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.676 -1.147 . . . . 73.02 112.282 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -64.66 -25.17 67.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.979 -0.555 . . . . 74.11 111.585 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.27 -36.8 7.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.379 0.881 . . . . 64.31 113.379 -168.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 1.6 pp -87.11 -37.59 17.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.906 1.076 . . . . 75.1 113.906 -164.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.579 ' N ' HD11 ' A' ' 98' ' ' LEU . 9.1 t70 -151.38 168.47 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.779 -0.769 . . . . 72.04 111.421 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.39 14.11 30.65 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.572 -0.74 . . . . 24.04 111.435 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.414 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.52 179.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.005 0.922 . . . . 71.5 112.645 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -83.4 140.28 32.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.594 -0.73 . . . . 74.24 110.333 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.812 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -78.23 -0.29 27.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 64.13 111.521 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.82 147.96 5.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.12 0.486 . . . . 64.02 109.728 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.97 157.77 30.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.99 -0.55 . . . . 75.23 109.581 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.82 116.54 32.19 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.675 -0.491 . . . . 73.12 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.67 127.58 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.971 -0.381 . . . . 74.02 109.971 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.21 119.04 32.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.96 0.409 . . . . 72.34 110.851 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -111.87 -11.23 13.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.139 -0.689 . . . . 73.21 109.139 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -93.14 -161.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.171 -0.922 . . . . 74.55 108.73 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.6 mtp -86.56 18.36 3.37 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.389 -0.194 . . . . 72.34 110.842 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.18 -33.36 74.67 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 114.416 0.526 . . . . 73.43 114.416 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.65 -51.66 68.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.099 0.476 . . . . 71.45 111.356 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 pp -96.49 12.42 31.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 75.14 111.397 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.582 ' O ' HD11 ' A' ' 117' ' ' LEU . . . -87.73 165.35 30.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 71.23 109.98 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.624 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . 37.0 Cg_endo -67.38 89.56 0.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 121.937 1.758 . . . . 73.12 112.793 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.582 HD11 ' O ' ' A' ' 115' ' ' ALA . 5.6 mp -68.53 -39.7 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.219 -0.66 . . . . 74.44 109.219 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.419 -0.809 . . . . 63.45 109.186 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.684 0.278 . . . . 73.12 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 5' ' ' MET . . . -90.2 -19.7 23.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.703 0.631 . . . . 71.02 112.703 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t -64.42 144.93 56.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.152 -0.219 . . . . 63.45 110.843 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.92 39.47 97.58 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.381 -0.437 . . . . 71.22 112.726 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.503 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -92.17 174.28 7.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.256 0.55 . . . . 73.32 111.213 -178.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.35 118.59 3.57 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.749 -0.941 . . . . 71.15 110.749 171.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.06 124.59 37.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.668 -0.493 . . . . 75.54 109.668 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.9 147.18 24.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.901 0.382 . . . . 74.35 110.378 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.81 -13.06 60.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 72.24 112.431 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -54.9 -27.75 45.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.935 0.398 . . . . 75.24 111.024 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.96 -56.21 14.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 70.53 110.797 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.96 -27.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.517 -0.31 . . . . 74.42 111.558 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -30.82 71.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.259 0.552 . . . . 73.04 110.434 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.425 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -72.32 -38.56 68.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.808 -0.633 . . . . 75.35 110.652 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 82.5 m-85 -60.75 -28.84 69.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.572 -0.285 . . . . 74.24 111.252 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -62.63 -47.22 84.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 65.42 110.375 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.566 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 31.8 mt-10 -67.25 -37.19 83.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 71.1 110.035 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.64 HD11 ' H ' ' A' ' 25' ' ' LYS . 21.5 tp -57.61 -47.93 80.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.996 -1.002 . . . . 73.2 111.052 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -83.43 -58.9 2.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.347 0.499 . . . . 72.54 112.347 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.81 -47.55 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.452 0.538 . . . . 74.14 112.452 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 82.7 mtp180 -72.53 -11.52 60.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.507 0.194 . . . . 75.54 111.193 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 39.7 ttmt 58.95 24.15 12.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.093 0.949 . . . . 72.41 110.136 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -105.76 122.44 46.08 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.104 -0.953 . . . . 72.14 108.544 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.39 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.758 -0.777 . . . . 70.54 110.608 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.64 ' H ' HD11 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -137.94 147.44 44.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 75.51 110.314 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.949 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 4.0 t90 -109.5 124.99 52.0 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.75 -1.574 . . . . 71.53 106.75 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.489 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 29.3 pt -108.43 122.16 62.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.614 -0.834 . . . . 73.42 110.668 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.87 114.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.265 -0.643 . . . . 72.34 109.265 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -112.99 160.2 18.35 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.544 -0.753 . . . . 74.14 111.038 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 3.2 tppp? -113.46 124.47 52.49 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.092 -0.958 . . . . 74.24 108.518 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.583 HD12 HD13 ' A' ' 94' ' ' LEU . 70.3 mt -109.12 101.53 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.027 0.442 . . . . 74.32 110.576 -175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.21 162.09 31.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.554 -0.748 . . . . 72.22 109.323 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.88 40.06 23.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.038 0.447 . . . . 75.21 111.282 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.6 p 56.54 19.31 4.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.802 0.841 . . . . 74.55 113.168 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -127.98 128.54 45.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 74.02 111.07 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mm -93.42 107.99 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 72.21 108.685 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.13 134.37 66.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.709 -0.223 . . . . 72.44 110.477 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 29' ' ' PHE . 21.3 t -91.56 134.14 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.139 -0.689 . . . . 75.14 109.139 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.08 -18.02 12.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.184 -0.672 . . . . 74.42 109.184 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 40' ' ' LYS . 10.0 mtpt -144.64 142.78 30.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.565 0.698 . . . . 73.31 112.723 175.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.465 ' CB ' HG23 ' A' ' 27' ' ' ILE . 3.2 p-10 -131.78 131.69 43.15 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.515 -1.661 . . . . 74.02 106.515 161.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . -107.37 144.68 16.0 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.747 -1.216 . . . . 73.22 113.524 -167.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 3.7 ptpp? -109.21 121.37 45.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.328 -0.989 . . . . 73.24 108.328 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.48 49.67 7.15 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.596 -2.202 . . . . 44.04 107.596 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.949 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 26.8 p-10 -45.09 -51.48 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.469 1.285 . . . . 71.4 114.469 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.13 -23.51 51.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.701 0.286 . . . . 74.34 111.768 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.35 -43.08 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.57 -0.286 . . . . 65.23 111.189 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.83 -53.92 52.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 72.04 110.867 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 33.3 m-85 -68.56 -10.36 55.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.974 0.731 . . . . 74.24 112.974 -172.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -68.02 -15.81 63.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.178 0.513 . . . . 74.42 109.838 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.18 9.19 1.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.929 -0.653 . . . . 61.02 112.339 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 49' ' ' PHE . . . -76.85 -54.43 6.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 74.21 111.073 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.03 78.37 12.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.859 -0.336 . . . . 74.21 111.802 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.69 77.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.165 2.577 . . . . 72.32 110.387 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.49 -14.11 57.37 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.99 0.737 . . . . 64.22 112.99 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 14.4 m120 68.25 8.92 6.9 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.278 0.561 . . . . 65.33 110.737 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -117.26 163.52 16.2 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.034 -0.728 . . . . 73.05 109.034 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 4.9 p -79.37 135.43 36.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 122.295 1.045 . . . . 72.53 110.414 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.91 32.85 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.873 -1.512 . . . . 73.51 108.938 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.0 t80 -102.24 122.22 43.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.927 0.394 . . . . 73.13 110.644 -173.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -122.31 135.95 10.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.16 -0.543 . . . . 75.15 112.161 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.272 0.536 . . . . 71.54 110.74 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.618 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -146.24 148.74 32.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.275 -0.42 . . . . 75.55 111.388 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.787 ' HA ' HG12 ' A' ' 69' ' ' ILE . 26.7 t70 -69.4 144.87 53.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 73.04 109.85 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 12.9 t -133.45 173.18 11.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.172 -0.677 . . . . 74.55 109.172 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -40.29 92.48 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.164 -0.541 . . . . 74.42 113.824 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -99.75 -46.36 5.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.376 0.588 . . . . 73.01 110.93 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.599 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -141.75 177.34 8.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.764 -0.653 . . . . 74.2 110.116 -171.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.787 HG12 ' HA ' ' A' ' 64' ' ' ASP . 11.4 mt -100.45 123.22 53.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.978 -0.749 . . . . 64.0 108.978 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -101.49 121.82 42.67 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.623 -0.431 . . . . 71.35 111.222 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' A' ' 98' ' ' LEU . 15.1 m-85 -78.01 109.01 11.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.774 -0.825 . . . . 73.24 108.774 168.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 113.85 40.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.504 0.669 . . . . 61.14 111.203 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 45.7 tp -113.94 112.16 22.86 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.354 -0.839 . . . . 73.24 109.51 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.68 ' HZ2' ' HG2' ' A' ' 111' ' ' MET . 37.4 t90 -85.19 123.22 30.44 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.617 -0.882 . . . . 74.44 108.617 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 60.8 m -70.8 149.06 95.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.011 -0.54 . . . . 62.45 110.834 -173.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.774 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 17.1 Cg_exo -67.28 101.21 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.166 . . . . 64.14 111.559 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.03 -34.38 20.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.029 -0.532 . . . . 61.02 109.805 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -98.44 9.74 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 72.53 109.903 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.774 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -139.98 155.08 71.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.042 -0.527 . . . . 63.54 110.07 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -151.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.973 2.449 . . . . 73.41 113.603 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 -25.59 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.897 1.073 . . . . 65.55 113.897 -166.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 68.2 mttm -68.59 -48.93 31.64 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.573 0.582 . . . . 73.33 112.573 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.574 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 14.2 Cg_endo -57.74 -27.53 78.17 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.727 1.618 . . . . 71.4 111.758 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -69.8 -40.43 75.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 74.52 109.726 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.04 -26.79 62.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 75.41 111.297 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.4 m -57.08 -52.76 64.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 74.41 110.518 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.487 ' OH ' ' HD3' ' A' ' 30' ' ' LYS . 96.7 m-85 -76.18 -37.94 57.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 75.03 111.192 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.24 65.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 74.32 111.595 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.2 t -88.08 -50.25 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.247 0.546 . . . . 72.53 110.458 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' A' ' 2' ' ' ALA . 8.6 p -75.86 -11.99 60.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.606 -0.725 . . . . 72.14 112.43 -171.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -61.47 -24.31 66.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.035 0.383 . . . . 72.3 112.035 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 51.0 m-20 -83.76 -31.74 25.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.449 . . . . 74.25 110.347 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.3 -38.37 63.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.578 . . . . 73.33 110.394 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.583 HD13 HD12 ' A' ' 31' ' ' ILE . 64.9 mt -56.9 -47.35 80.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.488 -0.56 . . . . 74.42 109.488 173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.716 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 37.9 tp -62.17 -21.74 65.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.968 -1.015 . . . . 75.12 112.17 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -76.59 -15.08 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.52 0.676 . . . . 74.42 110.411 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.754 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -111.65 -4.58 14.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.044 0.926 . . . . 71.31 108.921 176.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.716 ' HB2' ' HA ' ' A' ' 95' ' ' LEU . 6.5 mt -111.96 13.18 20.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.666 -1.606 . . . . 70.32 112.608 -169.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' ALA . 5.7 m-20 -33.61 -145.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 128.041 2.536 . . . . 75.44 116.741 -152.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.2 16.13 0.02 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 117.729 1.852 . . . . 73.01 117.729 -151.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -55.73 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.161 -1.051 . . . . 64.23 108.161 152.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 69' ' ' ILE . 5.4 m -77.84 117.81 19.56 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.301 -1.499 . . . . 74.52 109.834 -167.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.662 ' HB3' HD21 ' A' ' 95' ' ' LEU . . . -85.42 4.37 35.81 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.273 -1.33 . . . . 71.23 111.963 -169.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 t -85.55 146.92 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.775 -0.454 . . . . 73.54 109.775 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -126.18 146.1 50.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.027 -0.533 . . . . 72.4 109.688 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.13 118.28 25.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.202 -0.454 . . . . 64.23 109.916 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 7.2 pt-20 -96.5 117.47 30.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.462 0.649 . . . . 72.23 110.635 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.6 119.9 32.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 74.04 109.621 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -99.37 -13.54 19.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.01 0.433 . . . . 74.05 110.892 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -105.4 166.57 10.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.588 -0.893 . . . . 72.33 108.588 169.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.68 ' HG2' ' HZ2' ' A' ' 74' ' ' TRP . 38.7 mtp -78.28 70.52 4.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.553 0.692 . . . . 64.22 111.262 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.46 -16.0 74.79 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.072 -0.967 . . . . 51.14 110.938 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -62.13 -31.94 72.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.228 -0.486 . . . . 71.33 111.615 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.13 19.23 20.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.387 0.613 . . . . 72.42 110.788 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.17 154.84 44.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.731 -0.668 . . . . 64.11 109.865 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.51 104.28 0.52 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.28 1.986 . . . . 74.41 112.294 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.23 -31.97 11.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.501 0.667 . . . . 73.42 109.68 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.267 -0.879 . . . . 73.12 109.313 177.9 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' ' H ' ' A' ' 3' ' ' SER . 52.6 ttm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.247 -0.279 . . . . 74.44 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 5' ' ' MET . . . -90.92 -19.63 23.1 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 111.797 0.295 . . . . 72.2 111.797 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 1' ' ' MET . 20.5 m -60.02 141.84 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 71.33 111.312 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.94 48.77 81.41 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.685 -0.566 . . . . 62.33 111.685 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.568 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -85.99 152.1 23.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.434 0.635 . . . . 73.03 112.009 -176.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 125.27 5.08 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.998 -1.001 . . . . 72.42 110.682 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 44.8 t -89.78 132.59 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.731 0.266 . . . . 64.35 110.479 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.84 140.37 45.72 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.101 -0.333 . . . . 71.2 110.101 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -62.81 -28.97 70.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.981 0.419 . . . . 74.13 111.039 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.23 -28.7 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 74.31 111.01 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 74.11 110.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 98' ' ' LEU . 14.1 t -78.65 -34.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 72.3 110.757 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -25.66 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.807 -0.633 . . . . 75.32 112.219 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.68 ' HG2' HG23 ' A' ' 27' ' ' ILE . 15.6 tpt180 -66.56 -17.35 64.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 75.21 111.468 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.574 ' HA ' HD11 ' A' ' 18' ' ' LEU . 58.7 m-85 -74.42 -19.26 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.046 0.387 . . . . 74.44 112.046 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -77.25 -26.33 52.41 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.882 -0.727 . . . . 63.44 110.054 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -69.2 -33.39 73.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 73.5 109.541 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 15' ' ' PHE . 65.2 mt -70.08 -48.33 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.803 -1.089 . . . . 75.2 111.105 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -82.08 -55.07 4.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.454 -0.794 . . . . 74.44 112.609 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.96 -48.0 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.151 0.426 . . . . 74.4 112.151 -171.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -81.32 -11.09 59.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.172 -0.211 . . . . 71.15 111.076 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 59.13 23.6 11.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.143 -0.481 . . . . 72.13 110.348 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -101.76 117.63 35.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.068 -0.514 . . . . 75.02 109.708 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.22 135.92 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.443 0.639 . . . . 71.32 110.654 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HB3' ' HZ2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -138.48 161.13 37.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.58 -0.896 . . . . 72.02 108.58 177.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.872 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.6 t90 -112.78 123.49 50.42 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.786 -0.82 . . . . 73.45 108.786 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.68 HG23 ' HG2' ' A' ' 14' ' ' ARG . 43.4 pt -110.75 131.29 62.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.642 -0.503 . . . . 74.11 109.642 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.809 HG21 HD23 ' A' ' 53' ' ' LEU . 93.4 t -113.18 113.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.38 -0.373 . . . . 75.31 110.304 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.895 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 44.1 p90 -102.06 151.51 22.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.473 0.654 . . . . 72.11 110.508 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 3.8 tmmm? -114.58 124.11 51.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.057 -0.974 . . . . 75.32 108.641 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 87' ' ' TYR . 48.3 mt -88.88 103.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.719 -0.673 . . . . 73.34 109.665 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HB2' ' HD2' ' A' ' 30' ' ' LYS . 25.0 tt0 -139.64 139.3 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 73.14 111.019 -168.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 t30 49.93 46.4 24.32 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.872 0.733 . . . . 70.31 111.581 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' MET . 70.3 p 55.61 25.46 8.1 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.497 0.719 . . . . 73.41 112.666 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -133.71 137.39 45.23 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.013 -0.43 . . . . 75.4 110.414 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 43.9 mm -95.09 109.37 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.951 -0.568 . . . . 63.43 110.1 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.8 135.47 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.026 0.441 . . . . 75.12 110.887 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.895 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.2 p -89.17 140.24 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 73.3 110.038 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.98 -35.43 13.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.922 0.392 . . . . 74.31 110.31 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.644 ' HZ1' ' HB1' ' A' ' 52' ' ' ALA . 8.9 ptmt -171.75 165.45 6.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 73.55 111.686 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.565 ' HB3' HG22 ' A' ' 27' ' ' ILE . 4.9 p-10 -142.98 158.62 43.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.911 . . . . 65.45 108.726 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.77 148.67 20.23 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.259 -1.448 . . . . 61.02 114.951 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.71 129.35 40.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.556 -1.275 . . . . 75.12 107.556 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.99 35.86 7.99 Favored Glycine 0 C--O 1.208 -1.489 0 N-CA-C 108.294 -1.922 . . . . 64.53 108.294 -161.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.872 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 7.4 p30 -44.41 -53.11 7.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.996 1.11 . . . . 75.4 113.996 -173.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.02 -14.35 58.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.439 0.638 . . . . 61.21 110.68 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.98 -49.16 6.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.936 . . . . 72.44 110.885 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 49' ' ' PHE . 1.1 pt-20 -81.2 -36.04 30.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.895 -1.048 . . . . 73.22 111.185 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 9.3 m-85 -72.46 -4.47 30.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.108 0.41 . . . . 73.21 112.108 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -72.83 -13.98 61.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.063 0.459 . . . . 75.54 110.102 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.65 11.96 2.68 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.0 -0.619 . . . . 65.24 112.424 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.644 ' HB1' ' HZ1' ' A' ' 40' ' ' LYS . . . -111.51 12.58 21.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 73.34 111.389 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.809 HD23 HG21 ' A' ' 28' ' ' VAL . 75.0 mt -117.83 140.78 28.14 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 73.43 111.172 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 14.5 Cg_exo -69.14 105.17 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.773 2.315 . . . . 72.13 111.278 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -12.53 61.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.967 -0.561 . . . . 73.15 111.858 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.43 -19.08 24.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.378 -0.373 . . . . 70.3 111.214 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -120.73 173.41 7.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.257 -0.429 . . . . 73.25 110.257 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.497 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 6.9 p -97.99 139.09 34.33 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.302 -0.629 . . . . 73.25 109.302 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.9 mmt-85 -134.09 151.83 51.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.957 -0.565 . . . . 75.32 110.043 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.18 105.18 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.128 0.489 . . . . 75.25 109.746 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.547 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -113.3 135.03 12.28 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.818 -0.628 . . . . 64.21 111.743 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 71' ' ' PHE . 27.1 m -125.85 129.09 72.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.255 0.55 . . . . 70.24 110.224 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.57 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -140.36 147.18 39.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.015 -0.538 . . . . 63.44 110.216 177.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.36 143.3 27.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 73.44 110.414 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.471 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 34.0 t -122.73 169.56 10.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.518 -0.919 . . . . 71.3 108.518 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.64 -24.18 59.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.105 -0.569 . . . . 74.11 114.084 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -126.94 4.91 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.463 0.631 . . . . 73.52 112.577 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 13.0 ptmt -169.6 151.8 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.222 0.823 . . . . 74.33 113.222 -169.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.8 mm -100.13 125.58 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.277 -0.874 . . . . 71.43 108.802 167.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.428 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mt-30 -116.25 114.95 25.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.471 -0.492 . . . . 74.0 111.975 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' HA ' HG12 ' A' ' 62' ' ' VAL . 29.9 m-85 -85.14 109.54 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 73.34 109.197 170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.67 126.07 64.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.008 0.432 . . . . 75.13 110.949 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 62.9 tp -133.3 108.02 8.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 73.43 110.521 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.432 ' HD1' ' HB3' ' A' ' 108' ' ' ALA . 63.2 t90 -85.47 119.96 26.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.712 -0.847 . . . . 63.21 108.712 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -74.52 148.22 85.45 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.018 -0.273 . . . . 65.3 110.296 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.743 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 71.6 Cg_endo -78.77 121.25 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.321 2.014 . . . . 74.05 113.47 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.06 -20.12 30.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.55 -0.75 . . . . 55.12 110.246 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.69 16.11 21.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.538 0.685 . . . . 71.3 110.31 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -140.66 155.68 69.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 74.44 109.85 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.43 -165.97 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.396 2.731 . . . . 73.1 113.622 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.67 -24.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.768 0.655 . . . . 74.43 112.768 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HG2' ' HE2' ' A' ' 85' ' ' MET . 61.8 mttp -67.05 -48.74 48.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 119.281 -0.39 . . . . 61.04 111.936 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 Cg_exo -55.82 -41.01 81.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.416 1.41 . . . . 74.22 111.468 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -62.86 -51.16 68.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.481 -0.781 . . . . 73.4 111.221 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.502 ' HE2' ' HG2' ' A' ' 82' ' ' LYS . 26.0 ptt? -68.78 -24.35 64.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 73.21 110.925 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.1 m -62.93 -56.17 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.404 -0.362 . . . . 73.24 110.42 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.54 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m-85 -60.97 -37.0 80.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 75.24 111.033 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.27 -31.25 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 74.13 111.777 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 t -66.36 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 64.23 110.901 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.526 ' OG ' HD11 ' A' ' 31' ' ' ILE . 2.0 p -87.19 7.4 28.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.167 -0.47 . . . . 52.02 112.078 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.605 ' O ' HD12 ' A' ' 95' ' ' LEU . 15.9 tttm -57.45 -55.55 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 75.53 111.338 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HA ' HD23 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -76.75 -21.64 54.95 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.17 -0.468 . . . . 71.25 110.332 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.43 92.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.447 -0.797 . . . . 71.42 110.889 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.74 HD12 HD12 ' A' ' 98' ' ' LEU . 4.6 mm? -77.64 -37.25 50.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 70.03 110.276 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 91' ' ' LYS . 4.8 mp -57.04 -43.04 81.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.584 0.706 . . . . 75.4 110.366 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.55 -10.48 59.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.907 -1.042 . . . . 73.23 111.956 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HG2' HG21 ' A' ' 7' ' ' VAL . 52.9 tptt -106.24 -48.58 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.271 0.841 . . . . 74.44 113.271 -169.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.74 HD12 HD12 ' A' ' 94' ' ' LEU . 17.8 mt -89.0 -45.05 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.765 1.024 . . . . 70.31 113.765 -162.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 4.8 t70 -156.54 -166.53 2.16 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.467 -0.493 . . . . 74.1 111.254 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -88.09 16.18 52.86 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 110.722 -0.951 . . . . 75.31 110.722 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.81 179.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.268 1.027 . . . . 75.01 113.034 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.577 HG22 HG22 ' A' ' 104' ' ' VAL . 2.1 m -83.36 139.95 32.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.838 -0.619 . . . . 72.54 110.764 -167.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.442 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -81.16 2.01 29.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.576 -0.738 . . . . 52.3 112.048 -174.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 102' ' ' THR . 40.6 t -76.69 147.08 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.906 0.384 . . . . 64.1 110.279 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.16 144.36 34.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.302 -0.629 . . . . 61.55 109.302 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -118.93 118.64 32.07 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.179 -0.209 . . . . 70.32 110.482 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.0 pt-20 -104.04 118.56 36.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.364 0.602 . . . . 74.52 110.129 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.432 ' HB3' ' HD1' ' A' ' 74' ' ' TRP . . . -97.51 143.08 28.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 65.44 110.678 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -6.09 6.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 65.31 109.473 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.75 -162.03 1.18 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.77 -1.105 . . . . 74.32 109.691 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.9 mtp -85.57 28.2 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.746 0.308 . . . . 71.12 111.259 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.36 -23.02 59.44 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.838 -0.696 . . . . 72.41 111.871 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.39 -51.81 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.221 0.534 . . . . 65.3 110.478 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 114' ' ' LEU . 1.3 pt? -84.25 23.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 65.25 111.051 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.482 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . . . -117.56 160.57 37.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.339 -0.615 . . . . 75.53 109.339 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 13.2 Cg_endo -56.28 107.89 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.41 2.073 . . . . 71.23 112.403 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.425 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.1 mp -76.12 -32.6 59.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 75.1 110.097 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.669 -0.696 . . . . 61.33 109.787 177.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.572 0.225 . . . . 73.35 110.437 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.52 -20.56 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.091 0.472 . . . . 74.12 111.06 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -80.02 151.11 30.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.906 -0.588 . . . . 74.41 111.064 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.05 29.69 75.16 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.307 -0.861 . . . . 72.31 113.959 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.39 144.07 33.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.106 0.453 . . . . 73.32 109.878 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.49 116.49 5.59 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.081 -0.808 . . . . 74.12 111.081 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.44 130.66 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.754 0.311 . . . . 73.45 111.05 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.61 131.03 44.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 73.22 111.362 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.2 -18.02 37.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.915 -0.584 . . . . 71.33 111.641 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -68.1 -25.44 65.32 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.631 0.253 . . . . 72.43 110.642 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -53.12 -45.2 68.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 75.1 110.867 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t -61.72 -39.68 84.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.208 -0.451 . . . . 73.21 111.092 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.99 68.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 54.54 111.183 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 14' ' ' ARG . 22.0 mmt180 -75.65 -18.73 59.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.21 111.364 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.59 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 88.1 m-85 -84.0 -21.91 31.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.355 0.598 . . . . 73.42 109.444 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -45.27 44.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 74.01 109.267 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.654 ' HA ' ' CG ' ' A' ' 21' ' ' ARG . 11.0 mm-40 -65.16 -15.63 62.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.193 0.521 . . . . 74.13 110.696 171.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 23.7 tp -86.58 -61.59 1.7 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.761 -0.654 . . . . 74.12 111.002 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -82.51 -50.6 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.379 0.511 . . . . 75.51 112.379 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.5 mm -68.41 -28.51 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 74.11 110.777 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.654 ' CG ' ' HA ' ' A' ' 17' ' ' GLU . 39.5 mmt180 -85.91 -10.54 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 74.54 110.691 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 59.37 45.25 14.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.974 -0.557 . . . . 73.43 111.798 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.8 t -143.59 151.98 40.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.385 -0.598 . . . . 75.34 109.385 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG11 ' OD2' ' A' ' 64' ' ' ASP . 33.1 m -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.596 -0.442 . . . . 74.44 110.677 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -140.69 164.23 30.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.379 0.609 . . . . 75.34 111.424 173.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.657 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 5.8 t90 -129.57 123.58 31.71 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.218 -1.03 . . . . 75.51 108.218 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.894 HG21 ' HB2' ' A' ' 41' ' ' ASP . 15.0 pt -116.15 134.56 59.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.697 -0.483 . . . . 72.13 109.697 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.1 109.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.138 0.494 . . . . 73.11 110.913 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.816 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -101.91 147.84 26.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 73.42 109.638 175.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -113.99 125.29 53.84 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.103 0.478 . . . . 75.24 110.802 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.733 HG12 HD11 ' A' ' 36' ' ' ILE . 62.2 mt -83.07 103.43 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.587 -0.894 . . . . 73.15 108.587 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -146.35 139.89 25.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 73.23 110.541 -173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.69 31.15 20.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 74.5 110.118 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 65.97 20.13 11.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.593 -0.73 . . . . 71.22 110.655 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -130.02 143.61 50.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.593 -0.73 . . . . 73.13 110.098 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.733 HD11 HG12 ' A' ' 31' ' ' ILE . 10.7 mm -111.91 111.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 65.32 110.58 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.7 154.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.736 0.303 . . . . 75.43 110.412 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.816 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 11.4 t -83.49 132.44 31.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.082 -0.508 . . . . 75.12 110.396 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.23 -37.74 32.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.92 -0.77 . . . . 74.23 108.92 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' LYS . 10.9 ptmm? -173.56 164.66 4.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.041 -0.982 . . . . 75.0 110.039 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.894 ' HB2' HG21 ' A' ' 27' ' ' ILE . 2.3 p-10 -126.19 148.07 49.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.801 -1.185 . . . . 74.14 107.801 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.0 161.52 12.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.92 -1.133 . . . . 73.15 113.977 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -137.49 129.27 28.69 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 72.13 106.782 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.8 36.99 35.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.016 -2.033 . . . . 70.22 108.016 -159.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 2.5 m-20 -44.56 -52.77 7.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.398 -1.401 . . . . 75.31 113.933 -163.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -66.02 -34.85 79.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.13 -0.486 . . . . 75.53 111.208 -172.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -89.57 -34.95 16.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.882 0.372 . . . . 65.21 111.108 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.6 ' HG2' ' HB1' ' A' ' 52' ' ' ALA . 7.8 tt0 -62.17 -50.22 72.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 71.05 110.611 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.65 -0.6 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.166 0.432 . . . . 73.32 112.166 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.61 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 48.5 mtp180 -81.27 -15.35 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 75.42 110.832 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.05 -19.85 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.106 -1.045 . . . . 72.51 113.63 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.6 ' HB1' ' HG2' ' A' ' 48' ' ' GLU . . . -58.51 -59.52 5.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 74.31 110.807 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.27 85.94 4.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.836 -0.62 . . . . 74.42 110.223 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.28 117.92 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.047 1.831 . . . . 75.24 109.594 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.61 78.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.006 0.373 . . . . 73.24 112.006 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.5 t30 67.12 -47.28 0.48 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.622 0.769 . . . . 71.11 111.144 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.41 172.04 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 72.34 108.63 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.498 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 5.4 p -78.8 139.55 38.37 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.535 -0.466 . . . . 73.44 110.478 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -151.1 163.79 37.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.989 -0.745 . . . . 75.41 108.989 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.738 ' HD2' ' HE1' ' A' ' 29' ' ' PHE . 6.9 t80 -109.73 116.05 30.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.503 0.668 . . . . 73.44 110.419 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.657 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.29 135.23 10.5 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 115.377 -0.829 . . . . 70.12 111.829 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.475 HG21 HG12 ' A' ' 27' ' ' ILE . 34.0 m -105.34 122.45 58.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 117.465 0.633 . . . . 64.21 110.362 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.633 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 6.2 t80 -135.59 132.26 36.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.523 -0.762 . . . . 75.51 109.684 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' OD2' HG11 ' A' ' 24' ' ' VAL . 10.0 p-10 -102.91 143.32 32.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.686 0.755 . . . . 74.23 111.023 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.7 t -112.38 169.62 8.75 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.401 -0.963 . . . . 73.51 108.401 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.53 -24.75 68.08 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.755 -0.736 . . . . 52.34 112.511 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 -46.51 6.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.782 0.29 . . . . 74.4 111.782 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.613 ' HB3' ' HZ2' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -151.94 167.81 27.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.541 0.21 . . . . 73.13 110.688 -176.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.413 HG12 ' CB ' ' A' ' 64' ' ' ASP . 7.6 mt -100.7 139.3 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.551 -0.537 . . . . 75.03 109.551 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -117.65 118.3 31.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.942 0.401 . . . . 72.55 110.71 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.42 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 61.4 m-85 -79.44 110.04 14.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.844 -0.798 . . . . 71.41 108.844 171.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.198 -0.455 . . . . 75.12 111.385 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 63.7 tp -141.18 82.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.526 -0.761 . . . . 64.44 109.489 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -85.71 149.36 25.35 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.647 -0.501 . . . . 75.41 109.647 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 57.8 m -97.8 147.28 32.81 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.832 -0.433 . . . . 72.5 109.832 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.714 ' HG2' ' HB1' ' A' ' 79' ' ' ALA . 7.7 Cg_endo -91.78 144.11 2.94 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.146 2.564 . . . . 61.22 112.798 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -80.36 -7.03 58.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.608 0.718 . . . . 65.23 109.583 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -107.46 15.64 24.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.052 -0.976 . . . . 74.45 110.334 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.714 ' HB1' ' HG2' ' A' ' 76' ' ' PRO . . . -141.65 154.39 66.15 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 121.866 -0.521 . . . . 73.42 111.028 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 19.0 Cg_endo -91.59 -178.33 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.135 2.557 . . . . 65.23 112.801 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.33 3.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.853 -0.612 . . . . 74.21 112.077 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 ttmt -68.32 -58.1 7.87 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 121.195 -0.202 . . . . 73.01 110.954 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.538 ' O ' ' HD1' ' A' ' 87' ' ' TYR . 60.0 Cg_endo -74.05 -26.93 12.45 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.222 1.281 . . . . 74.43 111.579 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -32.49 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 75.33 111.104 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.9 -29.57 55.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.12 110.746 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -66.66 -44.85 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 74.32 110.634 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 31' ' ' ILE . 77.1 m-85 -64.35 -30.22 71.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 74.43 110.266 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.18 62.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.908 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -84.72 -53.94 5.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.472 . . . . 72.14 110.711 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -72.53 -17.07 61.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 75.14 112.012 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -33.21 74.96 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.731 0.271 . . . . 73.4 111.731 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.74 -45.47 43.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 70.31 110.22 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.638 -0.71 . . . . 75.32 110.948 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.589 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.7 mm? -64.15 -48.81 74.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.848 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD13 ' HA ' ' A' ' 103' ' ' ALA . 7.8 tt -56.66 -43.95 80.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 74.21 110.578 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -67.76 -27.7 66.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.217 0.532 . . . . 73.25 110.733 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.15 -43.14 12.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.839 0.681 . . . . 75.22 112.839 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 3.5 pp -88.72 -36.74 15.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.471 1.286 . . . . 74.41 114.471 -162.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.586 ' N ' HD11 ' A' ' 98' ' ' LEU . 38.7 t0 -150.3 170.81 18.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.348 -0.941 . . . . 72.35 112.501 -174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.12 61.53 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.93 -1.032 . . . . 72.32 110.657 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -179.35 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.315 1.046 . . . . 63.04 112.749 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.426 HG23 HG22 ' A' ' 104' ' ' VAL . 5.6 m -82.85 139.62 33.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.612 -0.722 . . . . 74.3 109.991 -172.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.606 ' HA ' HD13 ' A' ' 95' ' ' LEU . . . -75.14 4.49 6.78 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.361 0.504 . . . . 74.45 112.361 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.426 HG22 HG23 ' A' ' 102' ' ' THR . 43.5 t -82.29 147.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.841 -0.429 . . . . 75.04 109.841 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.4 130.99 35.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.684 -0.488 . . . . 74.1 109.684 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.49 117.08 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.055 -0.52 . . . . 74.21 110.541 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.3 pt-20 -123.58 121.63 36.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 73.34 109.721 175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.84 148.58 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.868 -0.606 . . . . 72.12 110.471 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.45 11.64 27.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 73.44 110.328 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -131.12 168.48 17.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 74.5 109.991 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.48 73.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.253 0.464 . . . . 75.0 112.253 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.27 -17.59 64.35 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.683 -0.967 . . . . 72.1 110.683 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.19 -46.78 75.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.455 -0.872 . . . . 75.23 111.835 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.61 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.1 pp -105.19 23.18 14.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 74.24 111.166 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.34 54.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 73.33 110.827 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.98 116.88 3.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 71.41 111.786 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.491 HD21 ' HD2' ' A' ' 63' ' ' TYR . 6.4 mp -71.89 -55.94 6.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.207 -0.451 . . . . 73.15 111.216 -177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.117 -0.944 . . . . 74.4 111.015 -177.876 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.989 -0.374 . . . . 71.05 109.989 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.02 21.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.296 -0.411 . . . . 74.42 111.346 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -105.31 160.14 15.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.385 -0.37 . . . . 65.24 110.846 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.4 43.56 98.88 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.58 . . . . 74.2 112.852 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.7 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -97.91 149.74 22.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.928 0.394 . . . . 74.23 110.304 178.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.34 109.91 1.77 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.661 -0.976 . . . . 74.43 110.661 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 36' ' ' ILE . 16.7 m -101.35 134.55 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.095 0.474 . . . . 73.34 111.801 -173.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.618 ' HB2' HG13 ' A' ' 37' ' ' VAL . 12.5 t70 -71.85 148.44 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.527 -0.76 . . . . 73.25 110.504 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.22 -20.4 44.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.444 0.535 . . . . 73.43 112.444 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -60.89 -31.91 71.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 73.45 110.711 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.1 m -61.44 -47.95 83.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 71.0 110.277 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.592 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 42.0 t -63.58 -40.85 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.51 -0.768 . . . . 75.2 110.769 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 70.35 111.05 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 25.2 mmt180 -63.97 -40.78 97.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 74.33 111.223 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.592 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 14.4 m-85 -58.62 -33.34 69.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.135 0.493 . . . . 74.4 110.476 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -42.47 73.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 71.02 110.566 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.16 -41.83 99.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 71.55 110.353 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 14' ' ' ARG . 83.1 mt -50.22 -57.14 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.302 -0.863 . . . . 62.24 111.264 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -83.04 -51.92 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 64.33 112.083 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.05 -55.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.845 0.313 . . . . 63.41 111.845 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -71.95 -14.92 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.234 -0.186 . . . . 73.43 110.831 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 60.27 24.08 13.51 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.882 0.739 . . . . 72.3 110.98 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.1 p -105.15 100.47 10.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.867 -0.606 . . . . 73.13 109.478 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.82 133.62 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.466 0.65 . . . . 71.34 110.458 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.6 mppt? -137.66 146.29 43.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 74.51 108.687 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.685 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.5 t90 -91.41 122.73 34.26 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.571 -1.27 . . . . 72.44 107.571 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.754 HG23 ' HB3' ' A' ' 41' ' ' ASP . 40.1 pt -107.12 131.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.143 0.497 . . . . 74.43 110.561 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.744 HG22 HD21 ' A' ' 53' ' ' LEU . 88.2 t -112.64 116.02 51.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.551 -0.75 . . . . 73.11 109.397 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 37.4 p90 -116.79 163.37 16.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.694 -0.684 . . . . 74.23 110.393 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -112.27 124.79 53.24 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.412 -0.588 . . . . 75.25 109.412 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.709 HG23 HG12 ' A' ' 36' ' ' ILE . 25.9 mt -99.12 102.71 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.262 -1.014 . . . . 75.05 108.262 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.11 137.49 32.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.466 -0.334 . . . . 74.24 110.678 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.3 t30 49.21 46.39 22.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.733 -0.667 . . . . 74.53 111.328 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p 56.64 22.58 6.89 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.999 0.919 . . . . 72.41 113.135 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -132.65 126.84 33.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.315 -0.624 . . . . 72.41 109.315 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.709 HG12 HG23 ' A' ' 31' ' ' ILE . 58.1 mt -112.94 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.6 . . . . 74.03 111.436 -171.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 8' ' ' ASP . 14.0 m -129.38 141.45 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 72.21 110.992 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 4.6 p -86.46 133.99 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 62.1 110.522 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -100.49 -36.29 9.25 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.155 0.503 . . . . 74.31 109.912 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -138.69 141.06 38.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 75.34 111.428 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.754 ' HB3' HG23 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -133.0 131.62 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 168.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.45 14.73 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.344 -1.408 . . . . 60.51 113.74 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -103.17 160.6 14.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.379 -0.971 . . . . 75.24 108.379 172.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.53 42.95 98.74 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.393 -1.883 . . . . 34.5 108.393 -163.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.443 HD21 ' HB2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -44.7 -51.39 9.3 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.129 1.372 . . . . 74.11 113.041 -166.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.32 64.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.089 -0.505 . . . . 70.41 111.914 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.76 -52.19 5.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.72 0.295 . . . . 74.43 110.962 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.21 -33.62 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 64.15 111.492 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.68 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 20.5 m-85 -84.39 -0.08 51.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.932 0.715 . . . . 75.24 112.932 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 50.7 mtm180 -68.12 -25.27 65.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.158 0.504 . . . . 75.3 110.199 174.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.64 28.68 3.72 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.766 -0.731 . . . . 72.53 112.147 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -129.07 -19.65 3.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.513 0.19 . . . . 73.31 111.513 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.744 HD21 HG22 ' A' ' 28' ' ' VAL . 66.1 mt -98.88 121.88 54.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.938 0.399 . . . . 72.44 111.086 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -96.57 102.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.275 2.65 . . . . 74.24 111.975 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -13.27 6.91 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.986 0.422 . . . . 74.31 112.109 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -57.49 -31.09 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 52.44 111.83 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.639 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 3.2 p30 -139.52 158.02 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.812 -0.44 . . . . 74.25 109.812 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.838 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 14.3 p -97.07 141.77 29.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.492 0.553 . . . . 75.33 112.492 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -150.76 154.24 36.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.062 -1.088 . . . . 74.52 108.062 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.562 ' HD2' ' HD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -95.98 123.41 39.56 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.512 -0.475 . . . . 73.35 110.642 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.685 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.94 133.76 9.85 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.213 -0.755 . . . . 74.3 111.213 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.42 121.53 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.54 0.686 . . . . 74.53 110.818 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 3.2 t80 -122.71 143.62 49.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.241 -0.891 . . . . 72.45 108.966 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.7 t70 -115.22 140.71 48.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.11 0.481 . . . . 74.31 110.075 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.75 168.92 16.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.73 -0.668 . . . . 74.55 109.475 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.57 -25.98 61.64 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 114.791 0.676 . . . . 74.54 114.791 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.47 -5.1 13.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.158 0.799 . . . . 72.22 113.158 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.891 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -171.37 161.84 6.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.602 0.593 . . . . 74.42 112.602 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.1 mm -93.08 134.35 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 72.43 108.932 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -115.01 106.65 14.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.842 0.354 . . . . 74.14 111.307 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.515 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . 43.3 m-85 -83.51 109.9 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.922 -0.77 . . . . 72.43 108.922 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.32 124.76 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.048 0.452 . . . . 74.33 111.441 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 65.9 tp -128.2 105.36 8.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.71 -0.677 . . . . 75.21 110.301 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -86.2 109.64 19.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 74.52 109.283 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.2 p -79.83 150.61 72.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.228 -0.442 . . . . 71.41 110.564 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.838 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 72.0 Cg_endo -82.75 97.92 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.458 2.105 . . . . 74.15 112.405 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.591 ' HB2' ' HB2' ' A' ' 109' ' ' HIS . 34.5 t70 -76.63 -14.99 59.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.494 0.664 . . . . 73.54 109.765 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.52 8.47 21.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 75.24 109.552 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.709 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . . . -144.36 175.23 2.91 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.711 -0.677 . . . . 53.03 109.661 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 21.8 Cg_endo -62.83 154.71 64.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.973 1.782 . . . . 74.2 111.643 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.33 12.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.028 0.381 . . . . 75.42 112.028 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 59.4 tttm -69.69 -50.98 16.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.496 -0.32 . . . . 73.33 111.814 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 51.3 Cg_exo -55.77 -24.26 45.65 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.471 2.114 . . . . 73.25 112.943 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.489 ' HD3' ' OE1' ' A' ' 107' ' ' GLU . 11.0 ttm180 -60.45 -33.91 73.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.147 0.499 . . . . 74.2 110.133 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.8 mtt -71.57 -33.6 69.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 71.05 110.692 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -63.77 -47.5 80.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 72.55 110.529 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.562 ' HD2' ' HD2' ' A' ' 60' ' ' PHE . 41.5 m-85 -67.77 -37.24 81.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 74.4 111.05 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.47 65.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.169 0.509 . . . . 74.24 111.086 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -86.46 -54.58 4.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.85 -0.614 . . . . 75.01 110.91 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -77.48 -9.23 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.588 0.588 . . . . 75.45 112.588 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.704 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -58.24 -24.53 59.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.704 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 4.8 t70 -81.8 -25.7 35.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.818 0.342 . . . . 71.31 110.876 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.7 ' HB1' ' HE3' ' A' ' 5' ' ' MET . . . -70.91 -19.01 62.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 71.3 110.448 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 48.6 mt -92.14 -56.97 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.263 -0.881 . . . . 64.51 109.87 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 103' ' ' ALA . 43.8 tp -53.64 -58.94 5.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.61 -1.177 . . . . 72.13 113.079 -170.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.495 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 3.7 tmmm? -65.38 -20.34 66.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.053 -0.521 . . . . 75.42 111.523 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.66 -22.94 12.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.981 0.734 . . . . 75.45 112.981 -172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 99' ' ' ASP . 4.3 pp -87.08 -39.6 15.44 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 118.914 -1.114 . . . . 74.13 112.166 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' N ' HD11 ' A' ' 98' ' ' LEU . 17.0 t70 -154.07 177.05 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.17 -0.612 . . . . 74.54 111.637 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 13.44 42.63 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.899 -0.88 . . . . 43.42 110.899 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.077 0.951 . . . . 74.2 112.695 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.446 HG23 HG23 ' A' ' 104' ' ' VAL . 2.5 m -84.32 136.22 33.99 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.477 -0.783 . . . . 71.24 110.403 -171.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -77.29 4.52 10.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.81 -0.632 . . . . 72.12 112.029 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 HG23 HG23 ' A' ' 102' ' ' THR . 46.8 t -82.75 147.41 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.202 0.525 . . . . 74.12 110.428 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.26 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.772 -0.649 . . . . 70.42 109.715 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 tp -108.76 117.23 33.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.34 -0.391 . . . . 73.23 110.265 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.7 117.16 29.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.526 -0.546 . . . . 73.1 109.526 175.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.4 35.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.136 -0.484 . . . . 50.52 111.041 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p-80 -119.25 2.16 11.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.409 -0.589 . . . . 72.53 109.409 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 153.56 42.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.108 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 68.3 mtt -77.63 47.31 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 74.13 111.702 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.69 -17.07 64.49 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.213 -0.755 . . . . 73.14 111.213 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -64.0 -45.8 87.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.963 0.505 . . . . 73.33 111.197 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 3.5 pp -86.21 10.24 15.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.696 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 159.04 49.57 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.268 -0.424 . . . . 74.44 110.121 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.98 107.53 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.121 1.881 . . . . 75.12 111.351 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.12 -71.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 74.43 111.033 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.607 -0.711 . . . . 74.24 110.483 -178.769 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 3' ' ' SER . 28.4 ttt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.647 -0.501 . . . . 72.44 109.647 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.12 41.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.89 -0.595 . . . . 71.43 111.66 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 1' ' ' MET . 7.7 t -101.39 152.7 20.41 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.991 -0.374 . . . . 74.23 109.991 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.91 33.7 86.34 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.41 -0.424 . . . . 70.35 113.023 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.452 ' HG3' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -88.27 162.96 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.96 0.41 . . . . 75.22 110.39 178.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.65 108.89 1.65 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.55 -1.02 . . . . 70.1 110.55 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.39 138.67 28.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.481 0.658 . . . . 73.41 111.72 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.476 ' OD2' ' HB3' ' A' ' 10' ' ' ASN . 10.2 t70 -75.62 136.28 40.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.783 -1.099 . . . . 71.12 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.28 -20.05 35.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 72.43 111.639 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.476 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 48.2 t30 -63.4 -34.98 78.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.92 -0.77 . . . . 73.53 108.92 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' HG12 ' A' ' 38' ' ' VAL . 33.1 m -53.69 -52.05 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.142 -0.936 . . . . 73.44 109.859 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.722 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 48.3 t -59.07 -43.39 89.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.555 -0.748 . . . . 74.33 110.957 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.93 86.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 62.15 110.818 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -68.48 -30.76 69.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 73.1 111.311 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.722 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 22.1 m-85 -62.52 -35.65 80.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.109 0.481 . . . . 75.55 109.904 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.9 OUTLIER -67.75 -46.87 70.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 73.44 109.638 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.512 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 44.6 mt-10 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 75.35 112.374 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.515 ' HA ' ' HZ3' ' A' ' 25' ' ' LYS . 4.3 pp -65.21 -29.41 70.22 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.996 -0.681 . . . . 73.51 110.775 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' N ' HD13 ' A' ' 18' ' ' LEU . 1.4 tmtp? -84.26 -58.68 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.488 . . . . 65.03 110.726 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.87 -29.83 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.775 0.658 . . . . 75.44 112.775 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 77.7 mtp180 -91.31 -21.04 21.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.943 -0.473 . . . . 75.2 111.347 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.13 27.75 0.34 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.314 1.046 . . . . 74.31 113.546 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.81 170.58 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.999 -1.111 . . . . 75.51 107.999 166.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 45' ' ' ASN . 8.8 p -92.1 131.19 39.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 55.52 110.668 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.756 ' HB2' ' HZ1' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -140.57 170.6 15.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 72.04 111.32 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.802 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.0 t90 -152.0 129.44 11.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.083 -1.08 . . . . 70.22 108.083 172.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.678 HG21 ' HB3' ' A' ' 41' ' ' ASP . 17.3 pt -124.94 122.72 64.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.998 0.428 . . . . 64.43 109.945 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -106.6 111.24 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.97 0.414 . . . . 74.2 110.973 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 1.033 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.301 0.572 . . . . 73.15 109.991 177.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -114.26 125.06 53.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.241 -0.89 . . . . 74.25 109.234 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.497 HG21 HG12 ' A' ' 36' ' ' ILE . 22.2 mt -97.0 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.254 -1.017 . . . . 71.21 108.254 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.68 137.51 25.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.724 . . . . 75.43 110.204 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 54.63 29.63 11.85 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.578 0.549 . . . . 74.24 111.389 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 34' ' ' THR . 8.0 m 69.93 15.63 7.79 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.932 0.872 . . . . 73.01 110.721 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -107.64 156.64 18.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.71 -0.848 . . . . 74.34 108.71 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.802 HG21 HD13 ' A' ' 94' ' ' LEU . 45.5 mt -132.68 107.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.828 -0.434 . . . . 74.34 109.828 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.7 t -133.11 134.45 57.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.39 . . . . 60.33 110.457 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 1.033 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -79.12 128.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 74.54 111.257 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -84.86 -38.1 19.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 75.31 111.441 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -143.24 142.84 31.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 73.14 110.592 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 27' ' ' ILE . 2.0 p-10 -141.54 128.83 21.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.766 -0.652 . . . . 73.41 109.288 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.78 161.77 27.45 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.631 -0.795 . . . . 55.43 113.522 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -108.59 158.44 17.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.923 -1.14 . . . . 73.53 107.923 169.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.22 34.44 89.97 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.643 -1.383 . . . . 71.51 109.643 -170.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.753 HD22 HG21 ' A' ' 24' ' ' VAL . 6.6 p30 -70.89 -42.42 70.02 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.756 -1.222 . . . . 71.42 112.79 -165.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.65 36.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.927 0.394 . . . . 74.21 110.705 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.598 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 19.7 t70 -89.55 -58.36 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 64.4 111.374 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.15 -38.45 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.78 0.659 . . . . 73.34 112.78 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 6.1 m-30 -79.52 -2.68 43.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.544 . . . . 75.22 112.47 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HE ' ' HA ' ' A' ' 47' ' ' ASP . 45.8 mtm180 -81.04 -12.9 59.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.56 0.695 . . . . 75.43 109.31 173.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.69 13.24 11.84 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.266 -0.879 . . . . 71.4 111.081 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 49' ' ' PHE . . . -130.94 20.38 4.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.477 0.656 . . . . 73.22 110.133 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.527 HD22 ' H ' ' A' ' 53' ' ' LEU . 2.5 pt? -68.66 163.52 54.0 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.986 -1.006 . . . . 74.12 111.016 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.56 163.89 33.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.657 2.238 . . . . 71.23 111.203 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.29 -37.19 61.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.879 0.371 . . . . 75.0 111.022 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.53 14.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.42 0.629 . . . . 71.41 109.451 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.76 151.79 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.917 -1.038 . . . . 73.14 110.423 -172.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -90.38 141.79 28.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.603 -0.271 . . . . 73.43 110.538 175.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 58' ' ' CYS . 43.2 mmt-85 -144.77 157.07 44.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 75.03 110.528 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.47 ' HE2' ' HD1' ' A' ' 87' ' ' TYR . 1.8 m-85 -112.31 117.27 32.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.519 -0.548 . . . . 75.22 109.519 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.802 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.99 130.68 8.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.388 -0.91 . . . . 72.1 113.178 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 42.5 t -98.98 121.01 49.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.881 -0.785 . . . . 74.34 108.881 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -131.83 135.7 46.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.205 0.526 . . . . 75.21 109.86 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 24' ' ' VAL . 5.1 p-10 -99.86 153.72 18.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.266 -0.879 . . . . 72.13 110.861 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.638 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 8.1 t -142.6 169.53 17.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.203 -1.036 . . . . 75.52 108.203 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.23 -27.65 63.15 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.477 0.551 . . . . 74.23 114.477 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.93 -3.38 8.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.538 0.669 . . . . 72.51 111.84 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 15.5 ptmt -149.2 158.31 44.07 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.182 0.808 . . . . 72.03 113.182 -168.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.3 mm -126.22 115.41 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 114.801 -1.09 . . . . 63.34 108.136 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 32.4 mt-30 -115.17 124.31 51.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.153 -0.619 . . . . 75.02 112.197 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.25 109.49 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.98 -0.748 . . . . 73.11 108.98 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.27 125.22 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.054 0.454 . . . . 74.42 110.701 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.621 HD12 ' CE1' ' A' ' 87' ' ' TYR . 40.8 tp -108.05 116.2 31.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.638 -0.71 . . . . 71.12 110.392 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 113' ' ' ASP . 45.7 m95 -85.49 111.82 20.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.019 -1.104 . . . . 73.32 108.019 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 95.1 m -85.87 149.4 50.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.585 -0.446 . . . . 74.13 110.908 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.744 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . 73.7 Cg_endo -88.32 110.05 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.674 2.249 . . . . 72.03 112.907 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.63 -28.15 33.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.735 -0.666 . . . . 63.13 109.608 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -94.25 9.78 36.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.395 -0.821 . . . . 71.52 110.788 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 76' ' ' PRO . . . -136.66 147.12 58.27 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.312 -0.404 . . . . 75.13 110.796 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.446 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 14.8 Cg_exo -70.71 -176.78 1.88 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.152 2.568 . . . . 71.42 113.062 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.19 -19.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.66 -0.7 . . . . 74.14 112.128 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -67.62 -56.13 12.86 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 111.632 0.234 . . . . 74.14 111.632 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 80' ' ' PRO . 37.3 Cg_exo -59.21 -30.52 93.23 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.712 1.608 . . . . 72.43 111.747 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.627 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 61.1 ttt180 -68.25 -44.81 74.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 73.21 111.001 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.0 mtt -70.78 -22.22 62.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.616 0.246 . . . . 73.3 111.212 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -60.55 -48.83 80.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 65.13 111.312 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 27.0 p90 -81.72 -28.42 33.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.764 -0.374 . . . . 70.11 110.979 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -68.89 -18.55 64.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.596 0.712 . . . . 74.1 110.923 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -88.19 -17.13 31.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.17 -0.923 . . . . 62.21 110.682 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.7 m -111.77 10.53 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 64.03 110.895 -173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -73.08 -20.16 61.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.923 0.712 . . . . 75.54 112.923 -172.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.559 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 41.8 m-20 -79.26 -22.26 44.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.606 0.241 . . . . 75.43 111.345 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.452 ' HB3' ' HG3' ' A' ' 5' ' ' MET . . . -61.47 -17.74 55.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.03 111.703 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.802 HD13 HG21 ' A' ' 36' ' ' ILE . 90.7 mt -104.57 -51.87 3.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.403 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.27 -44.1 75.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.269 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.71 -10.24 59.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 73.04 111.063 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -104.88 -39.8 6.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 62.31 112.618 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.619 HD11 ' N ' ' A' ' 99' ' ' ASP . 3.3 pp -89.73 -43.14 10.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.135 1.531 . . . . 75.41 115.135 -161.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.619 ' N ' HD11 ' A' ' 98' ' ' LEU . 20.8 t70 -155.03 -177.13 6.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.033 0.833 . . . . 71.33 111.983 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -97.61 12.87 64.52 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.26 -0.882 . . . . 73.52 111.194 170.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.57 178.48 0.04 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.553 0.741 . . . . 43.42 111.98 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.536 HG21 HG23 ' A' ' 104' ' ' VAL . 5.4 m -84.02 136.85 33.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.909 0.385 . . . . 71.53 110.546 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.49 4.66 7.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.69 -0.686 . . . . 64.23 111.984 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.536 HG23 HG21 ' A' ' 102' ' ' THR . 85.7 t -73.17 145.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 75.54 109.969 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.51 151.81 45.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.527 . . . . 75.33 109.935 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -124.61 117.91 25.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.787 0.327 . . . . 70.33 110.367 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.507 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 7.4 pt-20 -94.04 145.22 24.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 72.11 110.516 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.88 119.94 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.886 -0.597 . . . . 72.4 109.906 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -129.67 -0.71 4.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 74.3 110.045 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.12 -149.66 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.266 -0.879 . . . . 74.23 108.801 174.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 77.8 mtp -100.45 24.12 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.129 0.49 . . . . 74.31 110.751 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.1 -15.73 78.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.629 -0.714 . . . . 64.35 111.504 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 11.3 p-10 -57.32 -47.74 80.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.548 0.739 . . . . 75.41 111.798 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.468 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 3.9 pp -99.92 5.52 45.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.221 0.534 . . . . 75.15 111.008 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.52 151.36 39.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.963 -0.562 . . . . 73.53 109.979 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.42 113.7 3.7 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.5 2.133 . . . . 72.34 111.498 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.23 -98.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 74.03 110.385 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.944 -1.027 . . . . 73.22 109.511 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.857 -0.794 . . . . 72.35 108.857 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.18 -23.59 21.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.596 -0.891 . . . . 71.02 108.596 170.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 p -67.1 150.8 48.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.836 -1.075 . . . . 60.53 109.978 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.4 41.77 99.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.739 -0.743 . . . . 73.1 111.357 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.751 ' HE2' ' HB2' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -71.46 151.2 44.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.198 -0.501 . . . . 74.33 110.667 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.587 ' O ' ' HD2' ' A' ' 35' ' ' LYS . . . -110.18 109.38 2.65 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.566 -0.826 . . . . 40.44 111.584 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.4 t -79.23 149.51 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 3.7 p-10 -82.9 165.46 19.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.161 0.505 . . . . 73.1 110.542 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 1.3 pm0 -84.47 -17.57 38.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.617 -0.72 . . . . 75.21 112.027 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.69 -32.94 35.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 73.31 110.226 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.0 t -54.34 -55.49 27.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 72.4 110.548 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.16 -34.67 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 71.32 110.812 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.08 -39.03 79.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 44.34 111.693 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.713 ' HG2' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -60.55 -25.5 66.2 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.22 0.452 . . . . 73.42 112.22 -173.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m-85 -60.27 -20.94 61.11 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.855 0.317 . . . . 63.21 111.855 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 2.0 p30 -64.3 -39.51 94.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.109 0.48 . . . . 74.53 110.005 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' HB3' HG21 ' A' ' 23' ' ' THR . 41.8 mt-10 -82.53 -43.91 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.263 -0.643 . . . . 60.35 109.263 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 26.3 tp -53.76 -61.19 2.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.179 -1.373 . . . . 74.45 111.284 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -85.86 -65.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.243 0.544 . . . . 75.41 112.371 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 50.1 mm -59.65 -51.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.224 -0.898 . . . . 74.43 113.068 -165.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.645 ' HB2' HG22 ' A' ' 23' ' ' THR . 68.2 mtp180 -83.96 -4.82 59.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.861 0.363 . . . . 74.12 110.869 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 27.8 mtpt 55.9 24.34 7.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.624 -0.716 . . . . 74.31 111.79 -176.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.645 HG22 ' HB2' ' A' ' 21' ' ' ARG . 4.4 t -107.14 93.51 4.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.318 -0.993 . . . . 75.41 108.318 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.38 138.16 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.552 -0.749 . . . . 75.21 111.684 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.09 138.65 46.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 72.34 108.669 174.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.844 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -86.08 123.56 31.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.039 -1.097 . . . . 75.43 108.039 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 14' ' ' ARG . 23.3 pt -115.87 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.918 -0.583 . . . . 75.54 110.89 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG23 ' HB3' ' A' ' 40' ' ' LYS . 23.3 m -106.35 127.78 61.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.961 -0.563 . . . . 73.2 110.538 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CD1' HG21 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -102.7 162.96 12.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.443 0.639 . . . . 73.23 110.253 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 28.3 ttpt -113.14 123.02 49.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.715 -1.13 . . . . 71.43 108.457 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.612 HG21 HG12 ' A' ' 36' ' ' ILE . 31.1 mt -99.71 104.05 15.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.713 -0.847 . . . . 71.42 108.713 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.2 139.85 14.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.475 -0.33 . . . . 70.4 110.364 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 t30 61.01 32.17 19.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.493 . . . . 64.5 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.544 HG23 ' HA ' ' A' ' 5' ' ' MET . 9.7 m 68.18 6.45 5.27 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.649 -0.705 . . . . 71.31 110.975 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 55.2 tptt -110.95 132.19 54.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.55 109.813 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.612 HG12 HG21 ' A' ' 31' ' ' ILE . 54.8 mt -113.11 110.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.166 -0.679 . . . . 74.32 109.166 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.471 HG23 ' HE3' ' A' ' 35' ' ' LYS . 5.1 t -126.27 136.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 123.053 0.22 . . . . 71.14 111.181 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 29' ' ' PHE . 56.2 t -59.48 121.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 O-C-N 123.286 0.366 . . . . 75.2 110.027 172.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 8.5 mm-40 -96.8 -26.04 15.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.424 -0.353 . . . . 61.11 110.47 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HB3' HG23 ' A' ' 28' ' ' VAL . 16.3 tppt? -146.98 141.54 26.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 75.52 112.212 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.68 131.06 47.97 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.695 -1.224 . . . . 75.24 107.695 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.36 157.39 24.47 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.036 -1.078 . . . . 55.22 111.899 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -123.1 143.66 49.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.234 -0.654 . . . . 73.13 109.234 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.41 41.22 37.86 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.395 -1.882 . . . . 74.4 108.395 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 1.7 m-20 -44.42 -51.39 8.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 113.443 -1.378 . . . . 74.13 113.155 -166.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -65.38 -28.81 69.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.927 -0.579 . . . . 43.52 112.121 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -89.35 -44.83 9.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.815 0.341 . . . . 73.33 110.631 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.02 -49.82 74.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.724 -0.671 . . . . 73.53 110.661 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' HE1' ' HG2' ' A' ' 40' ' ' LYS . 12.9 m-85 -75.35 8.33 2.84 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.118 0.784 . . . . 74.43 113.118 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 78.4 mtp180 -78.32 -11.95 59.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.604 -0.517 . . . . 71.41 109.604 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.32 11.82 0.57 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.651 -0.704 . . . . 72.34 112.593 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.91 8.7 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.961 0.38 . . . . 74.22 111.638 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.57 68.89 74.82 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 63.44 112.011 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.14 27.66 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.633 2.222 . . . . 64.12 111.824 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 57' ' ' ASP . . . -60.76 -35.03 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.671 . . . . 53.34 111.634 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 13.8 t30 76.33 -25.67 0.2 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.711 0.632 . . . . 72.13 110.987 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 55' ' ' ALA . 54.6 m-20 -95.84 171.81 8.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.326 -0.62 . . . . 72.51 109.326 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.1 p -77.79 142.12 38.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 44.11 111.14 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -140.87 160.15 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 74.45 109.712 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.23 120.39 40.31 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.029 -0.359 . . . . 70.23 110.029 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.844 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.4 136.96 11.44 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.911 -0.661 . . . . 64.12 113.6 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 88.5 t -97.99 120.78 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.913 -0.403 . . . . 75.44 109.913 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 10.4 t80 -142.18 126.55 17.67 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.879 -0.415 . . . . 73.33 109.879 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.24 146.09 30.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.179 0.514 . . . . 71.32 110.342 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.8 t -130.52 162.12 29.95 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.173 -0.677 . . . . 74.44 109.173 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.61 -24.93 71.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 74.14 111.342 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -73.61 -48.26 33.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.36 . . . . 73.05 110.346 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 0.5 OUTLIER -165.15 164.82 20.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 72.4 111.518 -174.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.52 127.6 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.833 -0.803 . . . . 72.2 108.833 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.43 106.24 10.88 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.776 -0.37 . . . . 74.51 111.363 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.443 ' CE1' HG21 ' A' ' 62' ' ' VAL . 32.8 m-85 -78.77 109.16 12.77 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.828 -0.804 . . . . 74.3 108.828 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.57 137.59 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.433 . . . . 75.32 111.038 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.748 HD21 ' CE1' ' A' ' 87' ' ' TYR . 64.4 tp -144.19 124.9 14.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 74.32 110.872 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.42 ' HE3' ' N ' ' A' ' 75' ' ' CYS . 0.0 OUTLIER -86.49 141.91 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.969 -0.752 . . . . 72.23 108.969 176.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 27.2 p -88.23 151.27 48.65 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 71.33 110.682 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.556 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 4.3 Cg_exo -76.93 92.05 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.516 2.144 . . . . 71.55 111.983 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.59 -32.94 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 74.21 110.545 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -88.91 9.34 25.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.744 0.783 . . . . 73.34 110.066 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.14 159.4 52.77 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 71.2 109.469 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.57 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 25.4 Cg_exo -64.15 176.01 2.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.347 2.031 . . . . 65.41 112.158 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.19 4.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.998 0.37 . . . . 75.45 111.998 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.754 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 26.4 ttpp -68.66 -54.94 12.33 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 74.03 111.137 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 42.0 Cg_exo -59.78 -23.63 72.76 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.222 1.948 . . . . 73.31 112.979 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.493 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 47.4 ttt-85 -63.98 -39.17 93.53 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.825 0.345 . . . . 72.42 110.378 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.624 ' HE1' ' HA ' ' A' ' 82' ' ' LYS . 55.1 mtm -66.36 -33.22 75.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 75.15 110.426 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.6 m -60.57 -56.86 16.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.574 -0.739 . . . . 74.33 111.561 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.748 ' CE1' HD21 ' A' ' 73' ' ' LEU . 3.4 p90 -75.7 -23.59 56.17 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.472 -0.491 . . . . 75.53 111.399 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.04 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 74.15 110.385 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.1 t -86.55 -8.24 57.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.344 -0.844 . . . . 73.41 110.453 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -123.45 4.23 9.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.007 0.432 . . . . 75.41 111.127 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -21.38 61.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 73.34 111.651 -171.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.64 -21.77 32.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 73.52 111.431 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.751 ' HB2' ' HE2' ' A' ' 5' ' ' MET . . . -58.06 -48.95 78.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 74.35 111.767 -175.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.605 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.2 mm? -65.71 -44.79 85.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.345 0.593 . . . . 72.4 110.388 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.962 HD22 ' HA ' ' A' ' 103' ' ' ALA . 7.6 mp -64.22 -24.69 67.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.324 -0.853 . . . . 75.45 110.92 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -81.18 -28.72 34.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 75.43 111.681 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -106.39 -26.46 11.46 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.389 0.885 . . . . 73.34 113.389 -169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 36.2 mt -86.1 -42.99 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 118.806 -1.158 . . . . 74.25 111.566 -170.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 3.0 t70 -155.24 -166.33 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 73.0 111.103 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -97.92 14.0 63.15 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.802 -0.919 . . . . 55.32 110.802 173.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.22 177.66 0.08 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.675 0.79 . . . . 75.33 111.977 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 104' ' ' VAL . 7.0 m -85.28 140.53 30.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.321 -170.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.962 ' HA ' HD22 ' A' ' 95' ' ' LEU . . . -72.13 4.86 3.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.507 -0.769 . . . . 61.34 112.256 -175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 102' ' ' THR . 47.8 t -83.9 147.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.461 0.648 . . . . 75.21 110.436 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.69 155.09 47.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.549 -0.75 . . . . 65.11 109.26 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.6 tp -110.34 116.99 32.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.013 -0.366 . . . . 72.13 110.013 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.9 pt-20 -97.87 128.71 44.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.654 -0.499 . . . . 73.22 109.654 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.23 119.07 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.58 . . . . 72.01 110.18 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.461 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 23.5 t-80 -104.6 -45.25 4.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.569 -0.741 . . . . 73.3 110.237 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.03 101.58 4.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.49 -0.323 . . . . 71.05 111.421 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.517 ' HG3' HD11 ' A' ' 114' ' ' LEU . 56.8 ttm 71.18 -4.29 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.705 0.632 . . . . 75.31 112.705 170.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.9 -18.18 61.74 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.899 -0.667 . . . . 74.45 112.901 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.53 -46.88 13.84 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.719 0.408 . . . . 72.24 111.595 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.517 HD11 ' HG3' ' A' ' 111' ' ' MET . 3.9 pp -98.06 14.77 26.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.903 0.382 . . . . 72.45 111.841 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.59 154.26 46.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.106 -0.497 . . . . 74.43 109.969 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.6 123.95 10.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.053 2.502 . . . . 74.12 112.489 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.431 HD21 ' HD2' ' A' ' 63' ' ' TYR . 5.6 mp -83.17 -2.45 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 75.05 111.496 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.88 -1.057 . . . . 63.24 111.077 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.673 0.273 . . . . 75.41 110.561 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.29 -18.95 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.962 0.411 . . . . 73.23 110.887 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 p -101.64 153.37 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.345 -0.389 . . . . 74.31 110.756 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.46 27.32 70.64 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.89 -0.596 . . . . 71.12 113.471 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.1 ptt? -109.79 166.49 10.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.941 0.401 . . . . 73.5 110.275 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 132.17 10.69 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.416 -1.074 . . . . 63.25 110.416 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.33 124.87 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 117.129 0.464 . . . . 75.44 110.851 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.62 115.5 4.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.679 . . . . 74.24 111.417 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -84.99 -13.44 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 73.53 111.178 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.3 -35.4 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 74.24 110.604 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 42.2 t -53.35 -40.78 65.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 74.2 111.235 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.74 -47.3 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 72.5 110.751 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -68.46 -28.02 66.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 73.41 110.54 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.819 ' HG3' HG21 ' A' ' 27' ' ' ILE . 1.8 tmm_? -66.6 -38.33 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 74.44 110.095 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -60.71 -21.12 62.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.648 0.261 . . . . 72.32 111.133 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -75.98 -30.65 58.66 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.863 -0.421 . . . . 74.13 109.863 176.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.19 -38.98 89.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.073 -0.714 . . . . 74.2 109.073 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.76 -43.51 97.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.022 . . . . 74.42 110.909 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.11 -64.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 75.12 111.917 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.49 -54.38 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 73.22 111.917 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -75.46 -16.84 60.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.453 -0.34 . . . . 74.41 110.993 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? 58.49 24.48 11.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.662 0.744 . . . . 75.13 109.965 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.4 p -104.18 116.36 32.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.452 -0.794 . . . . 73.24 109.552 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 7.1 p -88.07 134.3 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.838 -0.745 . . . . 73.43 109.996 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 19.1 ptpt -138.45 150.38 46.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.587 -0.733 . . . . 73.12 110.102 177.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.672 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -97.31 123.2 41.04 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.95 -1.13 . . . . 73.14 107.95 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.819 HG21 ' HG3' ' A' ' 14' ' ' ARG . 43.1 pt -117.51 144.77 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.482 -0.326 . . . . 75.23 110.219 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 3.5 m -122.45 114.4 42.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.032 0.444 . . . . 73.51 111.163 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.968 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -94.7 145.75 24.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.494 -0.928 . . . . 73.14 108.494 168.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -112.11 125.14 53.79 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.045 -0.525 . . . . 74.1 109.979 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.595 HG21 HG12 ' A' ' 36' ' ' ILE . 20.6 mt -91.24 102.02 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.37 -0.974 . . . . 74.45 108.37 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.07 147.03 20.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.393 -0.595 . . . . 73.32 109.393 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.48 26.22 15.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.276 0.56 . . . . 72.41 110.179 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 5' ' ' MET . 1.6 m 65.13 28.02 12.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.03 -0.987 . . . . 71.42 111.64 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HE2' HG22 ' A' ' 37' ' ' VAL . 18.8 ptmt -136.94 148.87 47.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.984 -0.376 . . . . 73.52 109.984 171.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.595 HG12 HG21 ' A' ' 31' ' ' ILE . 23.0 mt -113.42 109.94 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.632 -0.507 . . . . 73.4 109.632 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.518 HG22 ' HE2' ' A' ' 35' ' ' LYS . 3.2 t -138.48 136.77 43.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.868 -0.419 . . . . 73.53 109.868 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 86.3 t -62.4 131.27 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.137 0.494 . . . . 71.13 110.49 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.803 ' HG3' ' HD2' ' A' ' 40' ' ' LYS . 16.8 pt-20 -104.99 -31.09 9.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.522 -0.763 . . . . 73.35 111.316 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.803 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 3.0 mptp? -147.65 156.01 42.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.919 0.39 . . . . 70.55 111.123 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.554 ' HB2' HG23 ' A' ' 27' ' ' ILE . 7.1 p-10 -140.31 132.03 27.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.964 -1.125 . . . . 75.32 107.964 170.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.09 13.11 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.059 -1.067 . . . . 63.04 114.366 -168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 3.0 ptpp? -128.6 130.54 47.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.113 -1.069 . . . . 70.23 108.113 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 52.19 8.48 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.991 -2.044 . . . . 73.11 107.991 -163.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 HD21 ' HE1' ' A' ' 63' ' ' TYR . 46.6 m-20 -44.91 -51.93 9.19 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.75 -1.225 . . . . 73.02 113.542 -162.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -49.41 70.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 74.41 111.06 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.512 ' HA ' HH11 ' A' ' 50' ' ' ARG . 19.8 t70 -68.8 -42.64 77.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.079 -0.509 . . . . 73.44 111.595 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 43' ' ' LYS . 10.0 tt0 -65.31 -47.23 77.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 64.43 111.135 -174.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 27.2 m-85 -71.73 -22.18 61.66 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.057 0.391 . . . . 75.33 112.057 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.623 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 18.0 mtp180 -61.61 -22.94 65.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.813 0.34 . . . . 74.33 111.111 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.28 18.13 6.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.717 -0.754 . . . . 62.34 112.055 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -96.22 -73.99 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.873 -0.192 . . . . 71.35 111.278 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 mp -126.65 90.22 50.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.239 0.459 . . . . 75.25 112.239 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.21 48.31 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.906 2.404 . . . . 75.41 109.584 170.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.42 -12.71 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.006 -0.997 . . . . 74.51 112.837 -169.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.606 ' HA ' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 p30 51.6 26.43 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.757 0.823 . . . . 63.13 111.38 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.07 170.72 8.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.756 -1.111 . . . . 74.32 109.14 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.943 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 3.3 p -86.5 134.2 33.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.709 -1.196 . . . . 75.24 110.05 174.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' HD2' ' OE2' ' A' ' 39' ' ' GLU . 17.6 mmt85 -143.41 152.06 41.12 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.502 -1.226 . . . . 71.0 108.173 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.682 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -103.53 113.54 27.12 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.721 -0.474 . . . . 75.13 109.721 -178.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.672 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.65 131.73 8.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.985 -0.626 . . . . 72.31 113.114 -175.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 3.0 t -102.74 120.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 75.41 109.309 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.596 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 5.0 t80 -134.69 124.97 26.12 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.409 -0.589 . . . . 64.22 109.409 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 11.3 t70 -92.31 140.93 29.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.741 -0.466 . . . . 70.13 109.741 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.6 t -122.12 171.12 9.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.49 -23.9 55.23 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.236 -0.507 . . . . 75.14 113.829 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -102.25 -26.26 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 73.12 112.873 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -170.27 169.05 7.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.306 0.484 . . . . 73.22 112.306 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.22 129.8 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.597 -0.89 . . . . 75.4 108.597 170.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -118.29 115.27 24.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.078 0.466 . . . . 75.42 111.635 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.719 ' HZ ' HD21 ' A' ' 98' ' ' LEU . 48.4 m-85 -76.17 110.68 10.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.639 -0.71 . . . . 71.45 109.532 166.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.04 112.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.569 -0.53 . . . . 74.51 109.569 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' A' ' 87' ' ' TYR . 36.4 tp -115.97 89.32 3.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.658 -0.701 . . . . 65.53 110.304 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 0.8 OUTLIER -85.59 121.06 27.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.633 -0.876 . . . . 74.42 108.633 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.3 p -96.48 149.98 36.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.857 -0.337 . . . . 61.42 110.856 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.943 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 59.1 Cg_endo -71.8 130.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.42 2.08 . . . . 75.22 113.052 -170.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.68 -40.29 16.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 61.14 110.814 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.89 20.57 5.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 72.0 110.613 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -132.32 157.81 77.27 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.233 -0.44 . . . . 72.24 110.534 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 79' ' ' ALA . 50.7 Cg_endo -69.21 -170.99 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.928 2.419 . . . . 52.31 113.227 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.15 -10.84 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 74.43 112.1 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 39.5 ttmt -68.08 -47.53 40.27 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.189 0.44 . . . . 74.42 112.189 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 15.6 Cg_endo -58.62 -16.78 31.92 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.116 1.877 . . . . 74.34 112.824 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.55 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 19.4 mtp-105 -73.93 -32.68 63.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.598 -0.519 . . . . 72.32 109.598 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 24.7 mmt -78.14 -13.59 59.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.776 -0.647 . . . . 73.13 110.301 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -65.2 -55.78 16.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 63.32 110.779 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 11.0 p90 -77.33 -19.34 56.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 75.22 110.89 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.02 -18.52 60.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.208 0.528 . . . . 74.15 110.316 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 t -82.71 -34.35 27.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.769 -0.651 . . . . 64.11 110.463 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 p -104.76 20.89 17.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.52 110.909 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.632 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 19.7 pttp -56.71 -55.22 36.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.423 -0.808 . . . . 73.42 112.454 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.632 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 8.7 p-10 -85.88 -20.09 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 73.02 111.35 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.18 67.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.644 -0.253 . . . . 74.11 111.349 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 4.2 mm? -66.96 -40.43 87.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.958 -0.386 . . . . 72.4 109.958 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.502 HD23 ' HB1' ' A' ' 103' ' ' ALA . 33.7 tp -67.85 -18.53 64.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.535 -0.757 . . . . 71.33 111.582 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.534 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -111.57 16.45 20.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.564 1.173 . . . . 71.22 108.656 177.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.719 HD21 ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -111.35 10.36 21.56 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.929 -1.487 . . . . 72.14 111.101 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' ALA . 21.8 m-20 -34.69 -145.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.845 2.458 . . . . 74.14 116.491 -151.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.24 15.7 0.02 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 118.013 1.965 . . . . 62.44 118.013 -150.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -56.97 -177.14 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.702 -0.851 . . . . 63.52 108.702 154.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 m -80.47 117.33 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.696 -1.252 . . . . 71.12 109.356 -168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.502 ' HB1' HD23 ' A' ' 95' ' ' LEU . . . -87.49 -0.77 57.3 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.944 -1.026 . . . . 75.25 111.486 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.94 146.33 10.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.638 . . . . 64.32 109.276 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -129.79 146.76 51.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.326 -0.397 . . . . 73.2 110.444 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 tt -119.84 117.39 28.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.117 -0.698 . . . . 73.4 109.117 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 13.4 pt-20 -97.47 141.05 31.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 75.14 110.275 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.68 54.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 73.14 111.062 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -126.07 4.3 7.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.478 -0.783 . . . . 73.23 109.931 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.94 163.55 14.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 74.2 109.119 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 67.5 mtt -78.31 57.87 1.98 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.444 0.64 . . . . 71.04 110.853 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.42 -15.51 68.62 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.95 -1.023 . . . . 50.43 111.598 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.08 -38.83 73.89 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 122.974 0.51 . . . . 75.51 111.165 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.9 pp -98.2 18.95 15.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.117 0.484 . . . . 73.32 110.819 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.02 156.3 54.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 72.11 110.412 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.01 91.24 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.333 2.022 . . . . 74.32 112.043 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.08 -7.54 59.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.064 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.457 -0.783 . . . . 74.34 109.906 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 65.5 mtm . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.372 -0.603 . . . . 74.43 109.372 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.05 69.92 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.963 0.411 . . . . 74.42 110.664 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 p -69.31 119.06 13.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.872 -0.604 . . . . 73.14 110.56 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.77 40.39 98.07 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.153 -0.476 . . . . 62.01 112.836 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.44 172.22 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.112 0.482 . . . . 75.23 111.588 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.58 110.1 0.62 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.696 -0.962 . . . . 61.23 110.696 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.85 122.97 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.998 0.399 . . . . 75.41 111.829 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.13 120.84 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.182 -0.673 . . . . 71.44 109.182 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.76 -13.4 61.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.392 0.886 . . . . 74.43 113.392 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.541 HD21 HG12 ' A' ' 38' ' ' VAL . 9.9 t30 -58.9 -30.65 67.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.063 0.459 . . . . 62.33 110.213 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 m -66.95 -41.86 86.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.85 -0.614 . . . . 74.34 110.088 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.85 -43.92 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 74.22 110.893 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.58 63.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 73.32 111.592 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.759 ' HG3' HG22 ' A' ' 27' ' ' ILE . 20.9 mmt180 -64.54 -26.83 68.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.361 . . . . 74.22 111.706 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 82.2 m-85 -82.5 -26.25 32.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 72.13 110.325 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -75.84 -36.85 59.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.26 -0.644 . . . . 75.35 109.26 177.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.83 -19.03 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.551 -0.75 . . . . 70.25 110.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 11.8 mt -63.27 -50.79 68.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.147 -0.479 . . . . 70.15 111.15 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -70.91 -40.37 72.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.859 0.361 . . . . 73.21 111.3 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.22 -63.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.128 -0.487 . . . . 75.25 111.786 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -79.49 -24.02 42.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.491 -0.322 . . . . 75.3 110.725 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 53.6 mttp 59.32 24.79 13.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.797 -0.638 . . . . 75.33 111.222 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -93.2 122.44 35.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.123 -0.695 . . . . 72.14 109.123 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.67 134.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 120.131 -0.628 . . . . 74.52 110.476 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.504 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -141.12 172.14 13.1 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.34 -0.845 . . . . 70.15 109.718 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.658 ' HB2' ' HB3' ' A' ' 45' ' ' ASN . 4.1 t90 -125.97 127.56 46.13 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 74.12 107.482 173.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.759 HG22 ' HG3' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -117.79 128.83 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.065 0.46 . . . . 75.2 110.46 177.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.504 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 77.1 t -110.29 120.01 60.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.028 0.442 . . . . 74.02 110.26 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 p90 -116.73 160.98 19.95 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.832 -0.622 . . . . 74.33 110.844 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HE3' ' OE2' ' A' ' 39' ' ' GLU . 38.3 ttmt -115.39 125.11 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.419 -0.809 . . . . 73.53 109.267 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.413 HD13 ' HB2' ' A' ' 90' ' ' SER . 16.3 mt -88.05 102.44 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.693 -1.225 . . . . 72.31 107.693 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.1 138.95 39.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.479 -0.328 . . . . 74.13 110.379 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 34' ' ' THR . 15.8 m120 60.22 22.06 11.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 64.35 110.725 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 33' ' ' ASN . 46.9 m 79.48 -10.13 1.36 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.86 -0.609 . . . . 75.01 111.138 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HE3' HG11 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -102.16 138.3 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.587 -0.523 . . . . 71.4 109.587 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.652 HD12 HD21 ' A' ' 94' ' ' LEU . 57.4 mt -99.34 114.12 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.392 -0.367 . . . . 71.32 111.188 -172.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG11 ' HE3' ' A' ' 35' ' ' LYS . 6.8 m -125.71 135.41 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 75.43 111.155 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -88.67 125.42 41.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.96 0.409 . . . . 71.45 110.077 176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 27.4 mt-10 -79.65 -37.76 35.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.908 -0.587 . . . . 73.32 111.151 -173.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 39' ' ' GLU . 19.3 pttm -171.52 159.59 5.59 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.321 0.581 . . . . 72.34 112.191 -167.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.69 ' CB ' HG21 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -154.29 146.55 23.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.591 -1.186 . . . . 73.21 108.383 173.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.32 161.41 26.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.016 -1.088 . . . . 64.31 112.71 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -93.66 120.52 34.04 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.335 -1.358 . . . . 75.04 107.335 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.52 53.96 0.58 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 107.191 -2.363 . . . . 62.24 107.191 -161.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 38.8 m-20 -61.35 -53.01 62.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.026 -1.087 . . . . 75.35 112.471 -160.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.44 -32.7 42.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.726 -0.472 . . . . 75.21 109.726 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.97 -58.31 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 70.33 111.582 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.66 -46.51 78.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 71.52 111.542 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.653 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 27.9 m-85 -73.82 -14.83 61.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.899 0.703 . . . . 74.13 112.899 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.7 -13.19 60.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.962 0.411 . . . . 63.14 110.703 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.98 11.78 6.18 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.617 -0.593 . . . . 62.23 111.617 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -118.61 -0.15 11.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 72.21 111.099 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 87.2 mt -101.53 123.29 44.87 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.239 -0.437 . . . . 54.05 110.092 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 12.8 Cg_exo -70.06 134.1 26.55 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.86 2.373 . . . . 74.42 112.101 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.18 -14.88 57.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 72.43 110.877 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -86.15 -33.11 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 72.3 111.531 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' C ' ' HG3' ' A' ' 76' ' ' PRO . 35.6 t0 -123.34 163.49 20.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.769 0.319 . . . . 73.21 110.965 -172.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.867 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 4.2 p -98.61 138.72 35.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.446 0.641 . . . . 73.44 109.818 173.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -130.07 152.32 49.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.073 -0.967 . . . . 75.13 109.023 172.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t80 -107.52 112.05 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.455 -0.572 . . . . 74.11 109.455 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 28' ' ' VAL . . . -120.02 125.9 6.48 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.903 -0.665 . . . . 64.43 111.701 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.17 121.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.559 0.695 . . . . 64.31 109.617 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.48 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 2.1 t80 -113.48 125.67 54.48 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.001 -0.999 . . . . 73.15 109.678 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.567 ' OD1' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -103.62 140.66 37.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.587 0.708 . . . . 73.1 110.582 175.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.0 t -131.02 170.44 14.49 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.776 -0.824 . . . . 64.23 108.776 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.28 -34.16 89.18 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.983 -0.627 . . . . 34.13 112.757 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -81.68 -39.78 23.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.535 0.207 . . . . 73.41 111.502 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -164.59 171.67 14.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.732 0.301 . . . . 74.42 110.773 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.51 140.84 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.458 -0.571 . . . . 75.13 109.458 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -122.04 116.36 24.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.554 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.69 109.18 12.68 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.977 -0.749 . . . . 72.31 108.977 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 115.37 32.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.402 0.62 . . . . 74.04 110.825 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.546 HD22 ' CD1' ' A' ' 87' ' ' TYR . 60.6 tp -119.41 81.93 1.79 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.185 -0.916 . . . . 72.23 109.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -89.6 118.22 29.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.985 -0.552 . . . . 74.11 109.77 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 13.9 p -102.34 147.95 34.73 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.865 -0.42 . . . . 75.42 109.865 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.867 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 54.1 Cg_endo -99.52 169.99 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.155 2.57 . . . . 75.44 113.291 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.64 -28.46 66.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.1 -0.954 . . . . 63.25 110.814 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -88.46 9.84 22.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.664 -0.698 . . . . 73.33 111.624 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.28 111.25 63.31 Favored Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 122.061 -0.399 . . . . 74.4 111.247 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.06 -166.76 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 72.15 112.238 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 31.0 m -75.56 -13.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 75.24 112.033 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.843 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 25.5 mtpp -69.27 -58.22 6.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.44 -0.345 . . . . 73.34 111.178 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 7.3 Cg_exo -74.28 -13.93 23.08 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.027 1.818 . . . . 64.44 111.32 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.501 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 2.7 tpt180 -60.92 -47.25 87.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 75.41 110.349 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -76.18 -14.51 60.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.581 . . . . 75.02 110.567 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 32.4 m -69.75 -43.97 71.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.048 -0.523 . . . . 75.54 110.952 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.546 ' CD1' HD22 ' A' ' 73' ' ' LEU . 8.9 p90 -79.5 -30.1 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.558 -0.457 . . . . 73.22 111.272 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.85 -19.95 64.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.139 0.495 . . . . 64.34 111.247 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.519 ' OG ' ' HB3' ' A' ' 1' ' ' MET . 6.2 t -86.87 -53.15 5.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.653 -0.703 . . . . 70.3 110.649 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 31' ' ' ILE . 4.1 m -68.39 -25.98 65.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.414 -0.812 . . . . 73.12 111.84 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.636 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -57.5 -27.63 62.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.462 0.541 . . . . 73.13 112.462 -175.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.636 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 27.6 t70 -76.68 -40.11 49.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.833 0.349 . . . . 73.42 110.934 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.66 91.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.826 -0.625 . . . . 64.54 111.267 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.652 HD21 HD12 ' A' ' 36' ' ' ILE . 3.9 mm? -63.8 -50.69 67.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 63.32 110.446 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 103' ' ' ALA . 36.5 tp -57.63 -30.17 65.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 74.42 110.958 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -76.74 -32.09 57.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.601 -0.727 . . . . 74.3 112.535 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -112.07 -14.61 13.41 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.37 1.248 . . . . 75.43 114.37 -166.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 68.5 mt -86.96 -45.38 10.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 118.111 -1.436 . . . . 73.31 112.903 -167.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 20.6 t70 -157.64 -167.07 2.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.438 -0.505 . . . . 65.25 111.124 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -90.33 15.36 60.11 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.385 -1.086 . . . . 74.11 110.385 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.35 179.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.42 1.088 . . . . 61.41 113.272 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -82.97 136.77 34.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.565 -0.743 . . . . 74.24 110.456 -169.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 95' ' ' LEU . . . -79.16 5.39 12.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 70.31 112.466 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.7 148.36 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.947 0.404 . . . . 74.33 110.307 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.99 45.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.342 -0.614 . . . . 71.52 109.342 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 tp -122.64 118.41 28.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.817 0.341 . . . . 71.41 110.694 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.518 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 pt-20 -98.37 121.07 39.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.966 -0.561 . . . . 73.45 109.669 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.65 150.94 29.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.077 -0.51 . . . . 74.14 111.021 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -136.34 10.03 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 73.14 110.218 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' HG2' ' N ' ' A' ' 111' ' ' MET . 47.0 tt0 -131.34 167.18 19.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 73.53 110.095 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.404 ' N ' ' HG2' ' A' ' 110' ' ' GLU . 86.3 mtp -79.41 6.92 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.608 0.242 . . . . 72.03 111.52 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.91 -20.1 74.18 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.739 -0.743 . . . . 72.35 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.59 -37.29 73.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.296 0.569 . . . . 72.44 110.384 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 pp -89.62 14.46 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 74.14 110.829 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' HB2' ' HD2' ' A' ' 116' ' ' PRO . . . -87.81 162.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.223 -0.658 . . . . 71.32 109.223 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 34.2 Cg_endo -66.65 88.45 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 121.936 1.757 . . . . 72.5 113.026 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -77.66 -71.02 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.421 -0.585 . . . . 73.41 109.421 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.538 -0.744 . . . . 74.32 109.968 178.849 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 5' ' ' MET . 52.9 ttm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.452 -0.573 . . . . 74.44 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.64 ' HA ' ' SD ' ' A' ' 5' ' ' MET . . . -81.58 -30.07 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.608 0.596 . . . . 74.02 112.608 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -67.08 117.94 9.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 74.24 111.245 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 61.37 33.76 85.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.742 -0.663 . . . . 70.24 113.099 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' A' ' 2' ' ' ALA . 25.4 ptt? -84.9 159.04 20.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 65.31 110.704 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.46 119.99 4.03 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.811 -0.631 . . . . 74.43 111.778 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.552 HG21 HD12 ' A' ' 36' ' ' ILE . 62.0 t -73.64 104.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.828 -0.804 . . . . 73.25 108.828 174.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -71.68 142.25 49.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.16 -0.473 . . . . 64.23 110.868 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.481 ' HA ' HG21 ' A' ' 12' ' ' VAL . 20.9 pt-20 -64.83 -15.62 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.721 -0.672 . . . . 75.11 111.337 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -55.23 -40.55 71.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.849 -0.614 . . . . 55.54 110.23 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.1 t -73.89 -44.23 55.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 54.22 111.438 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' A' ' 9' ' ' GLU . 34.5 m -72.81 -24.31 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 63.53 111.527 -175.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.54 70.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 73.21 110.876 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 33.2 mmt180 -75.33 -23.51 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 74.23 111.226 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.622 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 43.4 m-85 -82.82 -23.31 33.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.399 . . . . 73.32 109.99 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.77 84.93 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.381 -0.6 . . . . 72.0 109.381 171.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -71.73 -49.57 38.07 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.473 0.654 . . . . 71.33 109.505 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 16.5 tp -58.59 -47.72 83.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.695 -1.139 . . . . 75.44 112.179 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -73.3 -51.86 16.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.938 0.348 . . . . 74.25 111.938 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.61 -56.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.062 0.393 . . . . 75.33 112.062 -171.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -68.6 -26.3 65.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.711 0.291 . . . . 65.14 110.479 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 58.58 24.42 11.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.552 -0.749 . . . . 63.0 111.491 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 p -92.83 106.37 18.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.05 -1.463 . . . . 74.42 107.05 164.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 64' ' ' ASP . 7.6 p -87.46 136.63 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.656 0.741 . . . . 75.14 111.184 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.513 ' HD3' ' HB2' ' A' ' 41' ' ' ASP . 19.0 ptpt -137.35 140.18 41.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.692 -1.14 . . . . 73.25 109.408 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.98 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.2 t90 -89.04 136.37 33.05 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.152 -1.425 . . . . 74.52 107.152 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.49 132.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.162 0.506 . . . . 73.51 110.642 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -106.52 110.5 31.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.45 -0.795 . . . . 73.32 109.278 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.614 ' HB3' HG23 ' A' ' 38' ' ' VAL . 2.6 p90 -115.58 159.5 21.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.645 0.736 . . . . 74.11 111.623 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.455 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 34.5 ttmt -123.25 125.36 44.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.775 -1.102 . . . . 73.21 109.242 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 36' ' ' ILE . 56.4 mt -112.3 101.6 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.872 0.368 . . . . 71.55 111.167 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -159.6 170.28 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 73.31 110.383 175.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m120 53.0 39.38 29.35 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.743 0.652 . . . . 71.32 110.942 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 5' ' ' MET . 58.0 p 58.22 20.43 7.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.783 -1.099 . . . . 72.35 113.274 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.2 mmmm -129.88 137.81 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.111 0.481 . . . . 74.33 110.997 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.836 HG21 HG12 ' A' ' 31' ' ' ILE . 56.7 mt -103.15 108.77 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.77 -0.826 . . . . 75.44 108.77 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.96 135.87 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 74.14 111.498 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG23 ' HB3' ' A' ' 29' ' ' PHE . 17.3 t -88.21 133.51 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 75.32 109.181 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.554 ' HG3' ' HG3' ' A' ' 40' ' ' LYS . 10.4 pt-20 -106.9 -18.47 13.91 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.806 -0.758 . . . . 73.13 110.854 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG3' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -145.06 140.88 28.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.221 -0.591 . . . . 72.21 111.803 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 27' ' ' ILE . 10.6 p-10 -132.54 132.98 43.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.583 -1.265 . . . . 74.5 107.583 166.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.742 ' HA3' ' HG2' ' A' ' 48' ' ' GLU . . . -116.8 161.86 12.9 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.045 -1.074 . . . . 74.11 114.033 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.4 ptpp? -108.15 124.43 50.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.814 -0.81 . . . . 64.4 108.814 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.3 56.98 3.27 Favored Glycine 0 C--N 1.313 -0.72 0 N-CA-C 108.658 -1.777 . . . . 71.04 108.658 -169.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.98 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 28.4 p-10 -41.99 -52.31 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.236 1.569 . . . . 72.54 115.236 -158.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.16 69.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.165 0.432 . . . . 71.31 112.165 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.65 -41.09 18.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.267 0.556 . . . . 74.5 110.327 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.742 ' HG2' ' HA3' ' A' ' 42' ' ' GLY . 6.0 tp10 -48.11 -55.6 9.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.386 -1.279 . . . . 74.5 111.479 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 21.1 m-85 -74.61 -25.01 58.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.997 0.74 . . . . 75.14 112.997 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.73 ' HE ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 ttm105 -65.28 -21.0 66.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.222 0.534 . . . . 73.3 109.721 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.28 12.16 10.5 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.055 -0.593 . . . . 73.31 111.959 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 49' ' ' PHE . . . -108.75 -25.21 10.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.444 0.164 . . . . 73.5 111.083 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.576 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 3.6 mm? -120.9 100.27 46.3 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-O 121.057 0.456 . . . . 74.1 111.992 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -101.2 37.35 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.777 2.985 . . . . 64.03 109.957 166.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.34 -35.44 30.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.083 -0.962 . . . . 74.4 112.732 -165.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 37.0 m-80 65.23 19.98 11.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.567 0.699 . . . . 61.44 109.65 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.43 151.73 23.17 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.958 -1.019 . . . . 71.01 109.667 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 6.6 p -87.47 133.54 33.74 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.916 -1.114 . . . . 75.51 108.907 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -151.47 169.14 22.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.147 -0.933 . . . . 70.03 109.18 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' HE1' ' HD2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -114.55 115.08 26.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.109 0.481 . . . . 74.34 109.921 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.699 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -123.63 136.44 10.36 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.876 -0.678 . . . . 75.0 112.401 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.611 HG21 ' HZ ' ' A' ' 15' ' ' PHE . 33.6 m -117.96 131.68 70.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.983 0.391 . . . . 64.32 110.519 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.752 ' HB2' HD21 ' A' ' 45' ' ' ASN . 0.5 OUTLIER -141.07 149.09 41.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.033 0.444 . . . . 73.41 111.334 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.568 ' HA ' HG12 ' A' ' 69' ' ' ILE . 19.0 t70 -92.03 144.32 25.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.524 -0.762 . . . . 72.04 110.176 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.592 ' SG ' ' HG2' ' A' ' 68' ' ' LYS . 12.1 p -135.44 175.15 9.85 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.001 -1.0 . . . . 61.51 108.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.33 -24.39 45.07 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 114.899 0.72 . . . . 75.43 114.899 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.433 HD21 ' HA ' ' A' ' 67' ' ' ASN . 7.2 m120 -121.54 -15.93 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.416 1.108 . . . . 62.15 113.032 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.592 ' HG2' ' SG ' ' A' ' 65' ' ' CYS . 9.7 ptpt -163.3 168.35 20.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.162 -0.615 . . . . 72.01 112.052 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 101' ' ' ALA . 23.6 mt -113.27 123.77 69.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.028 -0.73 . . . . 74.43 109.028 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.02 133.82 43.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.358 -0.383 . . . . 71.0 111.434 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' HD2' ' HE1' ' A' ' 60' ' ' PHE . 10.8 m-85 -89.84 108.79 19.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 73.12 109.208 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.9 t -104.78 131.35 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.987 0.422 . . . . 70.41 111.602 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.3 tp -127.28 130.12 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.609 -0.723 . . . . 70.53 110.283 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 58' ' ' CYS . 19.1 m95 -90.17 159.36 16.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 74.2 109.936 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 31.0 p -86.14 151.87 54.91 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 51.23 109.557 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.537 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -74.7 79.4 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.293 1.995 . . . . 70.42 111.375 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.96 -38.96 64.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.633 -0.712 . . . . 65.4 110.233 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.11 9.22 28.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 70.53 110.253 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -126.68 165.54 27.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.633 . . . . 52.12 111.009 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.519 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 17.2 Cg_exo -68.92 175.69 7.08 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.939 2.426 . . . . 73.25 112.846 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.84 -8.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.067 -0.515 . . . . 74.33 111.852 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.613 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 67.2 tttt -67.71 -56.03 12.85 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 112.657 0.614 . . . . 74.32 112.657 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 52.5 Cg_exo -53.33 -40.2 78.74 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.285 1.99 . . . . 73.35 113.562 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' HB2' ' CG ' ' A' ' 76' ' ' PRO . 57.8 ttp85 -60.47 -45.85 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 75.5 111.025 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.77 -26.95 66.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.151 0.5 . . . . 65.12 109.94 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.1 m -71.87 -48.2 47.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.271 -0.877 . . . . 75.21 111.652 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -61.37 -31.53 71.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.837 0.351 . . . . 74.42 111.408 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.33 69.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 70.34 111.719 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -71.29 -30.15 65.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 75.55 111.228 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 94' ' ' LEU . 3.2 p -97.63 12.48 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.275 -0.421 . . . . 75.13 111.825 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -57.24 -52.47 65.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.376 . . . . 72.3 111.694 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -76.56 -31.36 57.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 74.04 111.548 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.27 67.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.987 0.366 . . . . 60.55 111.987 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 36' ' ' ILE . 4.1 mm? -96.15 -42.22 8.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 72.11 109.997 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 103' ' ' ALA . 55.0 tp -55.47 -39.34 70.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 71.11 110.994 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -81.46 -21.59 38.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.435 -0.802 . . . . 72.33 112.191 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -103.18 -32.5 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.818 0.673 . . . . 74.04 112.818 -168.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.671 HD13 HD12 ' A' ' 94' ' ' LEU . 65.5 mt -88.13 -40.65 13.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.746 -0.782 . . . . 63.44 112.762 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 9.8 t70 -151.82 -174.23 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.455 -0.498 . . . . 74.54 111.038 -176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.404 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -95.75 13.6 66.05 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.338 -1.105 . . . . 74.24 110.338 172.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' A' ' 69' ' ' ILE . . . -55.48 177.28 0.05 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.111 0.964 . . . . 75.02 113.13 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.9 m -85.45 140.38 30.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.417 -0.81 . . . . 73.24 111.106 -167.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.616 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -69.3 5.91 1.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.286 -0.87 . . . . 65.01 113.056 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -85.56 149.32 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.922 -0.399 . . . . 75.21 109.922 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -125.61 165.17 19.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.023 -0.362 . . . . 72.33 110.023 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 tt -133.21 117.77 17.82 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.7 -0.482 . . . . 72.52 109.7 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.96 132.92 53.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.48 -0.563 . . . . 73.22 109.48 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.481 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . . . -131.43 162.67 29.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.312 -0.404 . . . . 74.01 110.127 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.534 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 1.9 p80 -112.19 -158.6 0.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.119 -0.491 . . . . 74.32 111.145 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 111' ' ' MET . 0.8 OUTLIER -51.15 157.23 0.93 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.161 0.8 . . . . 64.31 113.161 -170.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 64.4 mtm 79.61 -45.31 0.32 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.597 -1.183 . . . . 74.45 111.789 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.0 -19.1 21.33 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.862 0.705 . . . . 65.1 114.862 -171.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.15 -51.57 69.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.619 0.368 . . . . 63.33 111.263 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 2.4 pt? -120.32 20.23 11.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 63.32 111.485 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . . . -101.77 155.97 35.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.786 -0.449 . . . . 72.24 109.786 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.73 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 18.9 Cg_endo -59.61 100.18 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.492 2.128 . . . . 71.21 113.316 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 117' ' ' LEU . 4.8 mp -64.47 -54.11 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.808 -0.812 . . . . 75.03 108.808 171.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-N 114.69 -1.141 . . . . 74.23 108.985 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . . . . . . 0 CA--C 1.517 0.205 0 N-CA-C 112.99 -0.044 . . . . 54.130000000000003 112.99 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 152.55 25.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 73.239999999999995 111.37 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.96 132.77 7.75 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.716 -0.954 . . . . 63.439999999999998 110.716 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 7.5 p -107.26 132.83 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.947 0.403 . . . . 63.32 111.247 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.19 139.25 33.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.757 -0.46 . . . . 62.020000000000003 109.757 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -13.83 62.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.2 0.444 . . . . 72.140000000000001 112.2 -173.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.8 -32.99 74.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.933 0.397 . . . . 65.140000000000001 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.6 m -64.41 -35.32 80.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.901 -0.59 . . . . 61.310000000000002 110.453 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.25 -31.55 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.847 -0.615 . . . . 73.510000000000005 110.23 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.55 -26.61 68.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.66 -0.7 . . . . 71.219999999999999 111.948 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -64.15 -20.11 65.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.945 -0.302 . . . . 64.209999999999994 111.525 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 40.7 m-85 -75.5 -18.24 59.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.29 0.478 . . . . 74.319999999999993 112.29 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -82.0 -23.41 36.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.017 -0.673 . . . . 64.040000000000006 110.35 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG2' HH11 ' A' ' 21' ' ' ARG . 1.1 tm-20 -84.1 -21.09 31.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.27 -1.011 . . . . 72.120000000000005 108.27 171.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 27.4 tp -84.17 -59.79 2.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.683 -1.144 . . . . 73.299999999999997 111.594 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -76.25 -43.94 39.64 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.375 -0.375 . . . . 73.5 111.82 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.1 mm -66.51 -44.21 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.431 . . . . 74.310000000000002 111.662 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' GLU . 58.5 mtp180 -80.51 -10.36 59.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.282 -0.417 . . . . 73.510000000000005 110.515 -177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.2 tttt 56.57 24.3 8.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.46 -0.791 . . . . 73.030000000000001 111.14 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -99.82 125.61 45.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.807 -0.812 . . . . 73.510000000000005 108.807 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 m -83.83 138.24 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.113 0.482 . . . . 75.099999999999994 110.051 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.477 0.656 . . . . 74.140000000000001 112.115 -172.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.762 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.9 t90 -142.54 123.76 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.427 -1.323 . . . . 54.140000000000001 107.427 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 41' ' ' ASP . 27.1 pt -119.22 138.98 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.427 -0.583 . . . . 65.209999999999994 109.427 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 5.9 p -115.83 120.29 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.839 0.828 . . . . 73.310000000000002 111.237 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -114.94 163.38 15.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.908 -1.042 . . . . 63.450000000000003 110.672 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -112.09 127.55 55.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.72 -0.673 . . . . 75.129999999999995 109.653 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 86' ' ' THR . 68.8 mt -113.04 100.29 10.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 71.420000000000002 110.214 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HA ' HG21 ' A' ' 86' ' ' THR . 8.8 tp10 -162.55 165.48 25.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.95 -1.13 . . . . 72.540000000000006 107.95 171.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 t30 60.6 29.38 18.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.739 0.781 . . . . 71.340000000000003 109.936 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 4' ' ' GLY . 50.0 p 57.52 26.97 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.446 -1.252 . . . . 55.399999999999999 112.9 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -125.55 136.75 53.65 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.213 -0.304 . . . . 72.239999999999995 110.613 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 94' ' ' LEU . 9.8 mm -106.34 107.14 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.353 -0.61 . . . . 53.439999999999998 109.353 172.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.56 142.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 -0.275 . . . . 74.230000000000004 110.467 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 1.8 m -79.91 146.39 7.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.794 0.331 . . . . 75.409999999999997 110.478 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' OE1' ' HD2' ' A' ' 59' ' ' ARG . 50.2 mt-10 -107.03 -18.54 13.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.327 -0.62 . . . . 75.530000000000001 109.327 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . 18.3 tppt? -160.54 145.62 14.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.531 -0.758 . . . . 70.219999999999999 110.812 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 27' ' ' ILE . 3.4 p30 -152.08 133.35 14.44 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.807 -0.812 . . . . 71.209999999999994 108.807 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.38 159.27 25.69 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.038 -1.077 . . . . 75.209999999999994 113.344 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -114.31 121.54 43.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.513 0.673 . . . . 74.040000000000006 109.71 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 29.44 1.4 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 108.238 -1.945 . . . . 64.25 108.238 -168.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -44.42 -53.4 6.91 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 115.492 1.664 . . . . 74.439999999999998 115.492 -160.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -69.5 -34.75 74.76 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.91 0.337 . . . . 74.510000000000005 111.91 -171.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.35 -43.81 11.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.583 0.706 . . . . 54.020000000000003 109.932 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.11 -53.52 56.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.485 -1.234 . . . . 63.109999999999999 111.518 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' HD1' ' HG ' ' A' ' 53' ' ' LEU . 13.8 m-85 -68.06 -19.05 64.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.871 . . . . 61.030000000000001 113.35 -172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 55.8 mtm-85 -66.33 -30.9 71.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.412 -0.515 . . . . 74.319999999999993 110.8 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.0 -20.13 9.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.821 . . . . 73.420000000000002 112.498 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -84.84 -16.45 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.86 0.319 . . . . 43.109999999999999 111.86 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 35.8 mt -111.99 92.12 17.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.978 0.732 . . . . 71.349999999999994 112.978 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 52' ' ' ALA . 73.9 Cg_endo -101.04 44.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.875 3.05 . . . . 64.299999999999997 108.902 162.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -51.47 -37.95 51.41 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 114.456 1.28 . . . . 75.010000000000005 114.456 -163.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 16.6 t-20 68.82 -46.36 0.55 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.473 0.483 . . . . 53.409999999999997 111.448 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.74 172.33 7.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.128 -0.487 . . . . 64.439999999999998 109.754 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 9.5 p -84.11 136.08 34.14 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.093 -0.643 . . . . 64.019999999999996 109.99 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HD2' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mmt85 -135.75 170.5 15.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.059 -1.089 . . . . 73.25 108.059 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 71' ' ' PHE . 2.2 t80 -117.3 119.07 34.01 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.335 -0.546 . . . . 71.299999999999997 110.996 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.762 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.07 135.3 10.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 73.200000000000003 112.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 2.8 p -106.02 123.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 72.239999999999995 110.385 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 2.4 t80 -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.232 -0.895 . . . . 73.239999999999995 109.323 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.53 141.79 31.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 75.400000000000006 111.505 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 60.7 m -131.08 169.55 15.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.421 -0.809 . . . . 63.200000000000003 109.44 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.9 66.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 33.520000000000003 112.478 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -72.45 -34.27 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 44.409999999999997 111.374 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -170.53 168.48 7.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.35 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.413 ' HB ' ' HB1' ' A' ' 101' ' ' ALA . 13.2 mt -122.33 118.16 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.271 -0.64 . . . . 63.119999999999997 109.271 170.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -112.92 129.14 56.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.321 0.581 . . . . 75.319999999999993 110.509 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.737 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.8 m-85 -78.57 114.06 17.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.314 -0.857 . . . . 74.530000000000001 109.471 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.36 127.04 43.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.315 0.578 . . . . 62.25 111.511 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 58.4 tp -131.14 107.1 8.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.094 -0.957 . . . . 73.109999999999999 110.029 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -85.62 130.29 34.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.871 -0.789 . . . . 72.340000000000003 108.871 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -78.14 148.27 74.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.82 0.343 . . . . 62.109999999999999 110.624 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.833 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.7 Cg_endo -89.43 115.54 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.584 2.189 . . . . 70.129999999999995 111.88 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.71 -19.34 41.69 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.48 0.657 . . . . 74.219999999999999 109.662 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -102.41 9.88 39.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.379 -0.828 . . . . 74.439999999999998 110.639 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -139.14 152.48 69.88 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 121.962 -0.461 . . . . 72.420000000000002 111.013 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 16.7 Cg_exo -68.7 -178.86 2.12 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.177 2.584 . . . . 70.5 113.232 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 85' ' ' MET . 9.1 p -84.64 -8.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 71.030000000000001 111.515 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 48.6 mtpt -68.25 -49.73 32.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.393 0.516 . . . . 74.340000000000003 112.393 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 26.9 Cg_endo -65.18 -31.54 53.79 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.4 1.4 . . . . 74.510000000000005 111.1 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.56 -39.09 92.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.158 -0.928 . . . . 75.109999999999999 110.698 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 22.1 mmt -61.34 -39.17 89.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.778 -0.647 . . . . 71.230000000000004 111.487 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.756 HG22 HG22 ' A' ' 31' ' ' ILE . 8.2 m -58.08 -43.85 87.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.811 0.339 . . . . 73.319999999999993 111.286 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.721 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 90.4 m-85 -66.43 -54.11 27.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 73.510000000000005 111.783 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.62 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 61.140000000000001 111.808 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -86.48 -45.16 11.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.358 -0.383 . . . . 71.209999999999994 111.382 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' ILE . 8.1 m -79.94 -11.18 59.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.41 -0.359 . . . . 70.049999999999997 111.691 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.09 -21.76 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 74.450000000000003 111.363 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.73 -37.01 81.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.348 -0.387 . . . . 54.539999999999999 110.55 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.74 71.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 72.319999999999993 110.683 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.0 mm? -73.54 -57.6 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 53.530000000000001 109.389 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' HA ' ' A' ' 103' ' ' ALA . 25.1 tp -54.63 -43.51 72.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.676 -1.147 . . . . 71.420000000000002 112.282 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -64.66 -25.17 67.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.979 -0.555 . . . . 74.109999999999999 111.585 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.27 -36.8 7.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.379 0.881 . . . . 64.310000000000002 113.379 -168.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 1.6 pp -87.11 -37.59 17.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.906 1.076 . . . . 75.099999999999994 113.906 -164.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 t70 -151.38 168.47 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.779 -0.769 . . . . 72.040000000000006 111.421 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.39 14.11 30.65 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.572 -0.74 . . . . 23.210000000000001 111.435 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.52 179.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.005 0.922 . . . . 71.5 112.645 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -83.4 140.28 32.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.594 -0.73 . . . . 74.239999999999995 110.333 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.797 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -78.23 -0.29 27.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 64.129999999999995 111.521 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.82 147.96 5.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.12 0.486 . . . . 64.019999999999996 109.728 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.97 157.77 30.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.99 -0.55 . . . . 74.010000000000005 109.581 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.82 116.54 32.19 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.675 -0.491 . . . . 73.120000000000005 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.67 127.58 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.971 -0.381 . . . . 74.019999999999996 109.971 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.21 119.04 32.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.96 0.409 . . . . 65.109999999999999 110.851 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -111.87 -11.23 13.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.139 -0.689 . . . . 73.209999999999994 109.139 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -93.14 -161.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.171 -0.922 . . . . 72.109999999999999 108.73 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.6 mtp -86.56 18.36 3.37 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.389 -0.194 . . . . 63.100000000000001 110.842 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.18 -33.36 74.67 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 114.416 0.526 . . . . 71.019999999999996 114.416 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.65 -51.66 68.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.099 0.476 . . . . 71.450000000000003 111.356 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 2.9 pp -96.49 12.42 31.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 65.340000000000003 111.397 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -87.73 165.35 30.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 71.230000000000004 109.98 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.661 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . 37.0 Cg_endo -67.38 89.56 0.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 121.937 1.758 . . . . 73.120000000000005 112.793 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 115' ' ' ALA . 5.6 mp -68.53 -39.7 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.219 -0.66 . . . . 74.030000000000001 109.219 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.419 -0.809 . . . . 53.039999999999999 109.186 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.193 0 CA-C-O 120.938 0.188 . . . . 65.109999999999999 112.726 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 174.28 7.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.256 0.55 . . . . 73.319999999999993 111.213 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.35 118.59 3.57 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.749 -0.941 . . . . 64.409999999999997 110.749 171.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.06 124.59 37.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.668 -0.493 . . . . 74.310000000000002 109.668 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.9 147.18 24.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.901 0.382 . . . . 73.010000000000005 110.378 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 9' ' ' GLU . 6.2 pt-20 -74.81 -13.06 60.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 61.420000000000002 112.431 -174.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -54.9 -27.75 45.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.935 0.398 . . . . 75.140000000000001 111.024 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.96 -56.21 14.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 65.239999999999995 110.797 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.96 -27.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.517 -0.31 . . . . 74.420000000000002 111.558 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -30.82 71.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.259 0.552 . . . . 73.040000000000006 110.434 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -72.32 -38.56 68.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.808 -0.633 . . . . 73.219999999999999 110.652 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 82.5 m-85 -60.75 -28.84 69.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.572 -0.285 . . . . 74.239999999999995 111.252 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -62.63 -47.22 84.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 65.420000000000002 110.375 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 31.8 mt-10 -67.25 -37.19 83.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 63.25 110.035 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' H ' ' A' ' 25' ' ' LYS . 21.5 tp -57.61 -47.93 80.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.996 -1.002 . . . . 72.329999999999998 111.052 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -83.43 -58.9 2.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.347 0.499 . . . . 72.540000000000006 112.347 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.81 -47.55 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.452 0.538 . . . . 63.450000000000003 112.452 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 82.7 mtp180 -72.53 -11.52 60.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.507 0.194 . . . . 75.540000000000006 111.193 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 39.7 ttmt 58.95 24.15 12.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.093 0.949 . . . . 72.409999999999997 110.136 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -105.76 122.44 46.08 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.104 -0.953 . . . . 72.140000000000001 108.544 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.39 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.758 -0.777 . . . . 54.119999999999997 110.608 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' H ' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -137.94 147.44 44.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 75.510000000000005 110.314 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 4.0 t90 -109.5 124.99 52.0 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.75 -1.574 . . . . 71.349999999999994 106.75 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.495 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 29.3 pt -108.43 122.16 62.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.614 -0.834 . . . . 73.420000000000002 110.668 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.87 114.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.265 -0.643 . . . . 72.340000000000003 109.265 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -112.99 160.2 18.35 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.544 -0.753 . . . . 72.010000000000005 111.038 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 3.2 tppp? -113.46 124.47 52.49 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.092 -0.958 . . . . 63.130000000000003 108.518 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 94' ' ' LEU . 70.3 mt -109.12 101.53 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.027 0.442 . . . . 71.230000000000004 110.576 -175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.21 162.09 31.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.554 -0.748 . . . . 61.100000000000001 109.323 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 t30 58.88 40.06 23.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.038 0.447 . . . . 71.129999999999995 111.282 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.6 p 56.54 19.31 4.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.802 0.841 . . . . 74.549999999999997 113.168 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -127.98 128.54 45.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 73.409999999999997 111.07 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mm -93.42 107.99 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 72.209999999999994 108.685 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.13 134.37 66.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.709 -0.223 . . . . 63.329999999999998 110.477 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 29' ' ' PHE . 21.3 t -91.56 134.14 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.139 -0.689 . . . . 75.140000000000001 109.139 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.08 -18.02 12.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.184 -0.672 . . . . 74.420000000000002 109.184 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -144.64 142.78 30.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.565 0.698 . . . . 72.450000000000003 112.723 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 27' ' ' ILE . 3.2 p-10 -131.78 131.69 43.15 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.515 -1.661 . . . . 74.019999999999996 106.515 161.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . -107.37 144.68 16.0 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.747 -1.216 . . . . 73.219999999999999 113.524 -167.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 3.7 ptpp? -109.21 121.37 45.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.328 -0.989 . . . . 72.209999999999994 108.328 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.48 49.67 7.15 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.596 -2.202 . . . . 43.030000000000001 107.596 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.978 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 26.8 p-10 -45.09 -51.48 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.469 1.285 . . . . 71.400000000000006 114.469 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.13 -23.51 51.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.701 0.286 . . . . 34.210000000000001 111.768 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.35 -43.08 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.57 -0.286 . . . . 65.230000000000004 111.189 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.83 -53.92 52.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 72.040000000000006 110.867 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 33.3 m-85 -68.56 -10.36 55.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.974 0.731 . . . . 73.340000000000003 112.974 -172.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -68.02 -15.81 63.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.178 0.513 . . . . 74.230000000000004 109.838 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.18 9.19 1.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.929 -0.653 . . . . 34.229999999999997 112.339 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -76.85 -54.43 6.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 74.209999999999994 111.073 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.03 78.37 12.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.859 -0.336 . . . . 73.0 111.802 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.69 77.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.165 2.577 . . . . 65.120000000000005 110.387 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.49 -14.11 57.37 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.99 0.737 . . . . 64.219999999999999 112.99 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 14.4 m120 68.25 8.92 6.9 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.278 0.561 . . . . 54.140000000000001 110.737 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -117.26 163.52 16.2 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.034 -0.728 . . . . 72.129999999999995 109.034 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 4.9 p -79.37 135.43 36.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 122.295 1.045 . . . . 72.530000000000001 110.414 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.91 32.85 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.873 -1.512 . . . . 73.510000000000005 108.938 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.0 t80 -102.24 122.22 43.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.927 0.394 . . . . 64.120000000000005 110.644 -173.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -122.31 135.95 10.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.16 -0.543 . . . . 75.150000000000006 112.161 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.272 0.536 . . . . 52.229999999999997 110.74 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.629 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -146.24 148.74 32.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.275 -0.42 . . . . 75.549999999999997 111.388 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.805 ' HA ' HG12 ' A' ' 69' ' ' ILE . 26.7 t70 -69.4 144.87 53.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 73.040000000000006 109.85 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 12.9 t -133.45 173.18 11.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.172 -0.677 . . . . 74.549999999999997 109.172 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -40.29 92.48 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.164 -0.541 . . . . 65.349999999999994 113.824 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -99.75 -46.36 5.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.376 0.588 . . . . 61.32 110.93 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' CYS . 0.3 OUTLIER -141.75 177.34 8.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.764 -0.653 . . . . 73.319999999999993 110.116 -171.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.805 HG12 ' HA ' ' A' ' 64' ' ' ASP . 11.4 mt -100.45 123.22 53.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.978 -0.749 . . . . 62.25 108.978 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -101.49 121.82 42.67 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.623 -0.431 . . . . 62.450000000000003 111.222 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.429 ' CE2' HD12 ' A' ' 98' ' ' LEU . 15.1 m-85 -78.01 109.01 11.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.774 -0.825 . . . . 73.239999999999995 108.774 168.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 113.85 40.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 111.203 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 45.7 tp -113.94 112.16 22.86 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.354 -0.839 . . . . 73.239999999999995 109.51 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.698 ' HZ2' ' HG2' ' A' ' 111' ' ' MET . 37.4 t90 -85.19 123.22 30.44 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.617 -0.882 . . . . 73.420000000000002 108.617 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 60.8 m -70.8 149.06 95.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.011 -0.54 . . . . 62.450000000000003 110.834 -173.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.808 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 17.1 Cg_exo -67.28 101.21 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.166 . . . . 64.140000000000001 111.559 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.03 -34.38 20.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.029 -0.532 . . . . 61.020000000000003 109.805 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -98.44 9.74 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 72.530000000000001 109.903 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -139.98 155.08 71.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.042 -0.527 . . . . 55.530000000000001 110.07 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -151.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.973 2.449 . . . . 73.409999999999997 113.603 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 -25.59 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.897 1.073 . . . . 65.549999999999997 113.897 -166.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 68.2 mttm -68.59 -48.93 31.64 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.573 0.582 . . . . 73.329999999999998 112.573 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.584 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 14.2 Cg_endo -57.74 -27.53 78.17 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.727 1.618 . . . . 44.219999999999999 111.758 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -69.8 -40.43 75.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 74.519999999999996 109.726 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.04 -26.79 62.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 75.409999999999997 111.297 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.4 m -57.08 -52.76 64.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 74.409999999999997 110.518 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' OH ' ' HD3' ' A' ' 30' ' ' LYS . 96.7 m-85 -76.18 -37.94 57.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 73.219999999999999 111.192 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.24 65.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 74.319999999999993 111.595 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.2 t -88.08 -50.25 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.247 0.546 . . . . 72.530000000000001 110.458 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 p -75.86 -11.99 60.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.606 -0.725 . . . . 72.140000000000001 112.43 -171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -61.47 -24.31 66.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.035 0.383 . . . . 72.299999999999997 112.035 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 51.0 m-20 -83.76 -31.74 25.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.449 . . . . 73.099999999999994 110.347 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.3 -38.37 63.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.578 . . . . 70.150000000000006 110.394 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.611 HD11 HD11 ' A' ' 31' ' ' ILE . 64.9 mt -56.9 -47.35 80.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.488 -0.56 . . . . 65.540000000000006 109.488 173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 37.9 tp -62.17 -21.74 65.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.968 -1.015 . . . . 75.120000000000005 112.17 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -76.59 -15.08 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.52 0.676 . . . . 74.420000000000002 110.411 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -111.65 -4.58 14.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.044 0.926 . . . . 61.299999999999997 108.921 176.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB2' ' HA ' ' A' ' 95' ' ' LEU . 6.5 mt -111.96 13.18 20.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.666 -1.606 . . . . 70.319999999999993 112.608 -169.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' ALA . 5.7 m-20 -33.61 -145.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 128.041 2.536 . . . . 70.129999999999995 116.741 -152.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.2 16.13 0.02 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 117.729 1.852 . . . . 61.310000000000002 117.729 -151.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -55.73 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.161 -1.051 . . . . 61.549999999999997 108.161 152.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 69' ' ' ILE . 5.4 m -77.84 117.81 19.56 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.301 -1.499 . . . . 74.519999999999996 109.834 -167.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -85.42 4.37 35.81 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.273 -1.33 . . . . 54.119999999999997 111.963 -169.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 t -85.55 146.92 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.775 -0.454 . . . . 73.540000000000006 109.775 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -126.18 146.1 50.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.027 -0.533 . . . . 50.219999999999999 109.688 176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.13 118.28 25.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.202 -0.454 . . . . 52.229999999999997 109.916 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 7.2 pt-20 -96.5 117.47 30.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.462 0.649 . . . . 72.230000000000004 110.635 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.6 119.9 32.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 62.130000000000003 109.621 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -99.37 -13.54 19.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.01 0.433 . . . . 74.049999999999997 110.892 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -105.4 166.57 10.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.588 -0.893 . . . . 72.329999999999998 108.588 169.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.698 ' HG2' ' HZ2' ' A' ' 74' ' ' TRP . 38.7 mtp -78.28 70.52 4.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.553 0.692 . . . . 53.520000000000003 111.262 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.46 -16.0 74.79 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.072 -0.967 . . . . 42.439999999999998 110.938 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -62.13 -31.94 72.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.228 -0.486 . . . . 71.329999999999998 111.615 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.13 19.23 20.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.387 0.613 . . . . 61.200000000000003 110.788 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.17 154.84 44.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.731 -0.668 . . . . 43.210000000000001 109.865 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.51 104.28 0.52 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.28 1.986 . . . . 52.439999999999998 112.294 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.23 -31.97 11.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.501 0.667 . . . . 73.230000000000004 109.68 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.267 -0.879 . . . . 73.120000000000005 109.313 177.9 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 111.685 -0.566 . . . . 62.329999999999998 111.685 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -85.99 152.1 23.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.434 0.635 . . . . 73.030000000000001 112.009 -176.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 125.27 5.08 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.998 -1.001 . . . . 72.420000000000002 110.682 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 44.8 t -89.78 132.59 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.731 0.266 . . . . 63.439999999999998 110.479 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.84 140.37 45.72 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.101 -0.333 . . . . 71.200000000000003 110.101 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -62.81 -28.97 70.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.981 0.419 . . . . 74.129999999999995 111.039 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.23 -28.7 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 71.420000000000002 111.01 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 110.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 HD22 ' A' ' 98' ' ' LEU . 14.1 t -78.65 -34.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 71.5 110.757 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -25.66 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.807 -0.633 . . . . 53.32 112.219 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.707 ' HG2' HG21 ' A' ' 27' ' ' ILE . 15.6 tpt180 -66.56 -17.35 64.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 73.430000000000007 111.468 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 18' ' ' LEU . 58.7 m-85 -74.42 -19.26 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.046 0.387 . . . . 74.140000000000001 112.046 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -77.25 -26.33 52.41 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.882 -0.727 . . . . 55.450000000000003 110.054 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -69.2 -33.39 73.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 65.329999999999998 109.541 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 15' ' ' PHE . 65.2 mt -70.08 -48.33 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.803 -1.089 . . . . 71.329999999999998 111.105 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -82.08 -55.07 4.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.454 -0.794 . . . . 71.519999999999996 112.609 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.96 -48.0 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.151 0.426 . . . . 74.400000000000006 112.151 -171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -81.32 -11.09 59.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.172 -0.211 . . . . 71.150000000000006 111.076 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 59.13 23.6 11.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.143 -0.481 . . . . 72.129999999999995 110.348 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -101.76 117.63 35.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.068 -0.514 . . . . 74.209999999999994 109.708 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.22 135.92 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.443 0.639 . . . . 71.319999999999993 110.654 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -138.48 161.13 37.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.58 -0.896 . . . . 71.409999999999997 108.58 177.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.6 t90 -112.78 123.49 50.42 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.786 -0.82 . . . . 73.450000000000003 108.786 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 14' ' ' ARG . 43.4 pt -110.75 131.29 62.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.642 -0.503 . . . . 74.109999999999999 109.642 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 53' ' ' LEU . 93.4 t -113.18 113.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.38 -0.373 . . . . 75.310000000000002 110.304 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 44.1 p90 -102.06 151.51 22.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.473 0.654 . . . . 63.340000000000003 110.508 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 3.8 tmmm? -114.58 124.11 51.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.057 -0.974 . . . . 75.319999999999993 108.641 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 87' ' ' TYR . 48.3 mt -88.88 103.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.719 -0.673 . . . . 52.009999999999998 109.665 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 30' ' ' LYS . 25.0 tt0 -139.64 139.3 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 73.140000000000001 111.019 -168.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 t30 49.93 46.4 24.32 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.872 0.733 . . . . 70.310000000000002 111.581 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' MET . 70.3 p 55.61 25.46 8.1 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.497 0.719 . . . . 73.409999999999997 112.666 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HG2' HG13 ' A' ' 37' ' ' VAL . 7.1 ttpm? -133.71 137.39 45.23 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.013 -0.43 . . . . 75.400000000000006 110.414 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 43.9 mm -95.09 109.37 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.951 -0.568 . . . . 54.340000000000003 110.1 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG13 ' HG2' ' A' ' 35' ' ' LYS . 16.3 m -133.8 135.47 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.026 0.441 . . . . 75.120000000000005 110.887 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.935 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.2 p -89.17 140.24 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 71.430000000000007 110.038 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.98 -35.43 13.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.922 0.392 . . . . 74.310000000000002 110.31 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 8.9 ptmt -171.75 165.45 6.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 64.239999999999995 111.686 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG22 ' A' ' 27' ' ' ILE . 4.9 p-10 -142.98 158.62 43.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.911 . . . . 65.450000000000003 108.726 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.77 148.67 20.23 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.259 -1.448 . . . . 61.020000000000003 114.951 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.71 129.35 40.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.556 -1.275 . . . . 75.120000000000005 107.556 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.99 35.86 7.99 Favored Glycine 0 C--O 1.208 -1.489 0 N-CA-C 108.294 -1.922 . . . . 54.509999999999998 108.294 -161.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.909 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 7.4 p30 -44.41 -53.11 7.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.996 1.11 . . . . 75.400000000000006 113.996 -173.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.02 -14.35 58.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.439 0.638 . . . . 61.210000000000001 110.68 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.98 -49.16 6.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.936 . . . . 71.200000000000003 110.885 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 49' ' ' PHE . 1.1 pt-20 -81.2 -36.04 30.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.895 -1.048 . . . . 73.219999999999999 111.185 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 9.3 m-85 -72.46 -4.47 30.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.108 0.41 . . . . 73.209999999999994 112.108 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -72.83 -13.98 61.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.063 0.459 . . . . 75.540000000000006 110.102 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.65 11.96 2.68 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.0 -0.619 . . . . 61.100000000000001 112.424 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -111.51 12.58 21.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 64.519999999999996 111.389 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 28' ' ' VAL . 75.0 mt -117.83 140.78 28.14 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 72.209999999999994 111.172 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 14.5 Cg_exo -69.14 105.17 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.773 2.315 . . . . 64.409999999999997 111.278 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -12.53 61.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.967 -0.561 . . . . 63.149999999999999 111.858 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.43 -19.08 24.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.378 -0.373 . . . . 70.299999999999997 111.214 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -120.73 173.41 7.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.257 -0.429 . . . . 63.340000000000003 110.257 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 6.9 p -97.99 139.09 34.33 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.302 -0.629 . . . . 73.25 109.302 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.9 mmt-85 -134.09 151.83 51.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.957 -0.565 . . . . 71.530000000000001 110.043 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.18 105.18 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.128 0.489 . . . . 75.25 109.746 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -113.3 135.03 12.28 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.818 -0.628 . . . . 52.100000000000001 111.743 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 71' ' ' PHE . 27.1 m -125.85 129.09 72.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.255 0.55 . . . . 44.229999999999997 110.224 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -140.36 147.18 39.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.015 -0.538 . . . . 62.240000000000002 110.216 177.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.36 143.3 27.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 110.414 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 34.0 t -122.73 169.56 10.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.518 -0.919 . . . . 71.299999999999997 108.518 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.64 -24.18 59.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.105 -0.569 . . . . 70.420000000000002 114.084 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -126.94 4.91 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.463 0.631 . . . . 73.519999999999996 112.577 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 13.0 ptmt -169.6 151.8 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.222 0.823 . . . . 74.329999999999998 113.222 -169.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.8 mm -100.13 125.58 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.277 -0.874 . . . . 71.430000000000007 108.802 167.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mt-30 -116.25 114.95 25.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.471 -0.492 . . . . 74.0 111.975 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.653 ' HA ' HG12 ' A' ' 62' ' ' VAL . 29.9 m-85 -85.14 109.54 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 73.209999999999994 109.197 170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.67 126.07 64.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.008 0.432 . . . . 75.129999999999995 110.949 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 62.9 tp -133.3 108.02 8.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 60.240000000000002 110.521 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.408 ' HD1' ' HB3' ' A' ' 108' ' ' ALA . 63.2 t90 -85.47 119.96 26.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.712 -0.847 . . . . 63.210000000000001 108.712 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -74.52 148.22 85.45 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.018 -0.273 . . . . 65.299999999999997 110.296 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.799 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 71.6 Cg_endo -78.77 121.25 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.321 2.014 . . . . 74.049999999999997 113.47 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.06 -20.12 30.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.55 -0.75 . . . . 54.329999999999998 110.246 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.69 16.11 21.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.538 0.685 . . . . 71.299999999999997 110.31 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -140.66 155.68 69.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 74.439999999999998 109.85 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -76.43 -165.97 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.396 2.731 . . . . 63.310000000000002 113.622 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.67 -24.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.768 0.655 . . . . 54.439999999999998 112.768 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 61.8 mttp -67.05 -48.74 48.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 119.281 -0.39 . . . . 61.039999999999999 111.936 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 Cg_exo -55.82 -41.01 81.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.416 1.41 . . . . 74.219999999999999 111.468 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -62.86 -51.16 68.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.481 -0.781 . . . . 73.400000000000006 111.221 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 82' ' ' LYS . 26.0 ptt? -68.78 -24.35 64.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 53.439999999999998 110.925 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.1 m -62.93 -56.17 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.404 -0.362 . . . . 64.439999999999998 110.42 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m-85 -60.97 -37.0 80.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 75.239999999999995 111.033 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.27 -31.25 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 63.329999999999998 111.777 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 t -66.36 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 64.209999999999994 110.901 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' HD13 ' A' ' 31' ' ' ILE . 2.0 p -87.19 7.4 28.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.167 -0.47 . . . . 52.020000000000003 112.078 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.615 ' O ' HD13 ' A' ' 95' ' ' LEU . 15.9 tttm -57.45 -55.55 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 75.530000000000001 111.338 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.443 ' HA ' HD22 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -76.75 -21.64 54.95 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.17 -0.468 . . . . 51.509999999999998 110.332 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.43 92.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.447 -0.797 . . . . 70.340000000000003 110.889 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.75 HD12 HD11 ' A' ' 98' ' ' LEU . 4.6 mm? -77.64 -37.25 50.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 70.030000000000001 110.276 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 91' ' ' LYS . 4.8 mp -57.04 -43.04 81.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.584 0.706 . . . . 72.25 110.366 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.55 -10.48 59.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.907 -1.042 . . . . 73.230000000000004 111.956 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' A' ' 7' ' ' VAL . 52.9 tptt -106.24 -48.58 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.271 0.841 . . . . 74.439999999999998 113.271 -169.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 94' ' ' LEU . 17.8 mt -89.0 -45.05 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.765 1.024 . . . . 70.230000000000004 113.765 -162.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 4.8 t70 -156.54 -166.53 2.16 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.467 -0.493 . . . . 74.099999999999994 111.254 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -88.09 16.18 52.86 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 110.722 -0.951 . . . . 75.310000000000002 110.722 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.81 179.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.268 1.027 . . . . 75.010000000000005 113.034 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.588 HG22 HG23 ' A' ' 104' ' ' VAL . 2.1 m -83.36 139.95 32.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.838 -0.619 . . . . 72.540000000000006 110.764 -167.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -81.16 2.01 29.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.576 -0.738 . . . . 45.219999999999999 112.048 -174.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' THR . 40.6 t -76.69 147.08 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.906 0.384 . . . . 64.099999999999994 110.279 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.16 144.36 34.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.302 -0.629 . . . . 54.340000000000003 109.302 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -118.93 118.64 32.07 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.179 -0.209 . . . . 62.119999999999997 110.482 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.0 pt-20 -104.04 118.56 36.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.364 0.602 . . . . 74.310000000000002 110.129 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 74' ' ' TRP . . . -97.51 143.08 28.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 65.439999999999998 110.678 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -6.09 6.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 65.129999999999995 109.473 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.75 -162.03 1.18 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.77 -1.105 . . . . 70.430000000000007 109.691 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.9 mtp -85.57 28.2 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.746 0.308 . . . . 71.120000000000005 111.259 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.36 -23.02 59.44 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.838 -0.696 . . . . 72.409999999999997 111.871 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.39 -51.81 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.221 0.534 . . . . 44.25 110.478 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 114' ' ' LEU . 1.3 pt? -84.25 23.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 65.25 111.051 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -117.56 160.57 37.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.339 -0.615 . . . . 75.530000000000001 109.339 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 13.2 Cg_endo -56.28 107.89 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.41 2.073 . . . . 71.230000000000004 112.403 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.1 mp -76.12 -32.6 59.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 75.099999999999994 110.097 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.669 -0.696 . . . . 60.020000000000003 109.787 177.461 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 113.959 0.343 . . . . 72.129999999999995 113.959 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.39 144.07 33.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.106 0.453 . . . . 73.109999999999999 109.878 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.49 116.49 5.59 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.081 -0.808 . . . . 74.120000000000005 111.081 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.44 130.66 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.754 0.311 . . . . 72.540000000000006 111.05 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.61 131.03 44.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 34.109999999999999 111.362 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.2 -18.02 37.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.915 -0.584 . . . . 44.229999999999997 111.641 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -68.1 -25.44 65.32 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.631 0.253 . . . . 44.329999999999998 110.642 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -53.12 -45.2 68.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 75.099999999999994 110.867 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t -61.72 -39.68 84.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.208 -0.451 . . . . 63.009999999999998 111.092 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.99 68.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 54.539999999999999 111.183 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 14' ' ' ARG . 22.0 mmt180 -75.65 -18.73 59.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.209999999999994 111.364 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 88.1 m-85 -84.0 -21.91 31.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.355 0.598 . . . . 73.099999999999994 109.444 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -45.27 44.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 74.010000000000005 109.267 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 21' ' ' ARG . 11.0 mm-40 -65.16 -15.63 62.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.193 0.521 . . . . 74.129999999999995 110.696 171.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 23.7 tp -86.58 -61.59 1.7 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.761 -0.654 . . . . 34.149999999999999 111.002 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -82.51 -50.6 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.379 0.511 . . . . 63.229999999999997 112.379 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.5 mm -68.41 -28.51 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 74.109999999999999 110.777 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 17' ' ' GLU . 39.5 mmt180 -85.91 -10.54 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 74.540000000000006 110.691 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 59.37 45.25 14.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.974 -0.557 . . . . 73.430000000000007 111.798 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 18' ' ' LEU . 13.8 t -143.59 151.98 40.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.385 -0.598 . . . . 74.450000000000003 109.385 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG12 ' OD2' ' A' ' 64' ' ' ASP . 33.1 m -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.596 -0.442 . . . . 71.219999999999999 110.677 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -140.69 164.23 30.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.379 0.609 . . . . 72.239999999999995 111.424 173.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 5.8 t90 -129.57 123.58 31.71 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.218 -1.03 . . . . 75.510000000000005 108.218 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.925 HG22 ' HB2' ' A' ' 41' ' ' ASP . 15.0 pt -116.15 134.56 59.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.697 -0.483 . . . . 72.129999999999995 109.697 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.1 109.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.138 0.494 . . . . 62.43 110.913 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -101.91 147.84 26.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 73.420000000000002 109.638 175.355 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -113.99 125.29 53.84 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.103 0.478 . . . . 72.230000000000004 110.802 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.75 HG12 HD12 ' A' ' 36' ' ' ILE . 62.2 mt -83.07 103.43 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.587 -0.894 . . . . 72.340000000000003 108.587 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -146.35 139.89 25.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 71.510000000000005 110.541 -173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.69 31.15 20.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 74.5 110.118 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 65.97 20.13 11.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.593 -0.73 . . . . 54.210000000000001 110.655 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -130.02 143.61 50.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.593 -0.73 . . . . 64.129999999999995 110.098 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.75 HD12 HG12 ' A' ' 31' ' ' ILE . 10.7 mm -111.91 111.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 64.409999999999997 110.58 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.7 154.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.736 0.303 . . . . 75.430000000000007 110.412 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 11.4 t -83.49 132.44 31.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.082 -0.508 . . . . 63.229999999999997 110.396 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.23 -37.74 32.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.92 -0.77 . . . . 62.130000000000003 108.92 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 10.9 ptmm? -173.56 164.66 4.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.041 -0.982 . . . . 72.530000000000001 110.039 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.925 ' HB2' HG22 ' A' ' 27' ' ' ILE . 2.3 p-10 -126.19 148.07 49.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.801 -1.185 . . . . 64.400000000000006 107.801 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.0 161.52 12.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.92 -1.133 . . . . 51.149999999999999 113.977 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -137.49 129.27 28.69 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 52.409999999999997 106.782 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.8 36.99 35.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.016 -2.033 . . . . 70.219999999999999 108.016 -159.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 2.5 m-20 -44.56 -52.77 7.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.398 -1.401 . . . . 71.420000000000002 113.933 -163.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -66.02 -34.85 79.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.13 -0.486 . . . . 73.120000000000005 111.208 -172.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -89.57 -34.95 16.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.882 0.372 . . . . 65.209999999999994 111.108 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 7.8 tt0 -62.17 -50.22 72.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 71.049999999999997 110.611 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.65 -0.6 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.166 0.432 . . . . 73.319999999999993 112.166 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 48.5 mtp180 -81.27 -15.35 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 75.420000000000002 110.832 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.05 -19.85 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.106 -1.045 . . . . 72.129999999999995 113.63 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -58.51 -59.52 5.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 70.129999999999995 110.807 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.27 85.94 4.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.836 -0.62 . . . . 74.420000000000002 110.223 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.28 117.92 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.047 1.831 . . . . 75.239999999999995 109.594 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.61 78.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.006 0.373 . . . . 72.030000000000001 112.006 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.5 t30 67.12 -47.28 0.48 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.622 0.769 . . . . 71.109999999999999 111.144 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.41 172.04 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 72.340000000000003 108.63 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 5.4 p -78.8 139.55 38.37 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.535 -0.466 . . . . 73.439999999999998 110.478 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -151.1 163.79 37.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.989 -0.745 . . . . 74.230000000000004 108.989 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.734 ' HD2' ' HE1' ' A' ' 29' ' ' PHE . 6.9 t80 -109.73 116.05 30.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.503 0.668 . . . . 52.130000000000003 110.419 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.713 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.29 135.23 10.5 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 115.377 -0.829 . . . . 64.540000000000006 111.829 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 27' ' ' ILE . 34.0 m -105.34 122.45 58.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 117.465 0.633 . . . . 64.209999999999994 110.362 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 6.2 t80 -135.59 132.26 36.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.523 -0.762 . . . . 63.329999999999998 109.684 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' OD2' HG12 ' A' ' 24' ' ' VAL . 10.0 p-10 -102.91 143.32 32.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.686 0.755 . . . . 74.230000000000004 111.023 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.7 t -112.38 169.62 8.75 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.401 -0.963 . . . . 73.510000000000005 108.401 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.53 -24.75 68.08 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.755 -0.736 . . . . 44.229999999999997 112.511 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -95.99 -46.51 6.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.782 0.29 . . . . 74.400000000000006 111.782 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.94 167.81 27.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.541 0.21 . . . . 73.129999999999995 110.688 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.407 HG12 ' CB ' ' A' ' 64' ' ' ASP . 7.6 mt -100.7 139.3 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.551 -0.537 . . . . 70.319999999999993 109.551 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -117.65 118.3 31.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.942 0.401 . . . . 72.549999999999997 110.71 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.42 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 61.4 m-85 -79.44 110.04 14.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.844 -0.798 . . . . 71.409999999999997 108.844 171.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.198 -0.455 . . . . 65.319999999999993 111.385 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 63.7 tp -141.18 82.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.526 -0.761 . . . . 61.140000000000001 109.489 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -85.71 149.36 25.35 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.647 -0.501 . . . . 75.409999999999997 109.647 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 57.8 m -97.8 147.28 32.81 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.832 -0.433 . . . . 72.5 109.832 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 7.7 Cg_endo -91.78 144.11 2.94 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.146 2.564 . . . . 52.140000000000001 112.798 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -80.36 -7.03 58.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.608 0.718 . . . . 65.230000000000004 109.583 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -107.46 15.64 24.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.052 -0.976 . . . . 74.450000000000003 110.334 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . . . -141.65 154.39 66.15 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 121.866 -0.521 . . . . 53.409999999999997 111.028 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 19.0 Cg_endo -91.59 -178.33 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.135 2.557 . . . . 65.230000000000004 112.801 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.33 3.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.853 -0.612 . . . . 65.439999999999998 112.077 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 ttmt -68.32 -58.1 7.87 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 121.195 -0.202 . . . . 73.010000000000005 110.954 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' O ' ' HD1' ' A' ' 87' ' ' TYR . 60.0 Cg_endo -74.05 -26.93 12.45 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.222 1.281 . . . . 34.219999999999999 111.579 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -32.49 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 65.230000000000004 111.104 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.9 -29.57 55.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.120000000000005 110.746 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -66.66 -44.85 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 74.319999999999993 110.634 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.547 ' CD2' HD12 ' A' ' 31' ' ' ILE . 77.1 m-85 -64.35 -30.22 71.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 74.430000000000007 110.266 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.18 62.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 74.129999999999995 110.908 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -84.72 -53.94 5.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.472 . . . . 72.140000000000001 110.711 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -72.53 -17.07 61.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 75.140000000000001 112.012 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -33.21 74.96 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.731 0.271 . . . . 64.530000000000001 111.731 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.74 -45.47 43.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 70.310000000000002 110.22 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.638 -0.71 . . . . 71.420000000000002 110.948 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.7 mm? -64.15 -48.81 74.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 53.409999999999997 110.848 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.8 tt -56.66 -43.95 80.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 74.209999999999994 110.578 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -67.76 -27.7 66.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.217 0.532 . . . . 24.420000000000002 110.733 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.15 -43.14 12.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.839 0.681 . . . . 75.219999999999999 112.839 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 3.5 pp -88.72 -36.74 15.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.471 1.286 . . . . 74.409999999999997 114.471 -162.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.591 ' N ' HD12 ' A' ' 98' ' ' LEU . 38.7 t0 -150.3 170.81 18.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.348 -0.941 . . . . 72.109999999999999 112.501 -174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.12 61.53 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.93 -1.032 . . . . 72.319999999999993 110.657 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -179.35 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.315 1.046 . . . . 63.039999999999999 112.749 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 104' ' ' VAL . 5.6 m -82.85 139.62 33.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.612 -0.722 . . . . 74.299999999999997 109.991 -172.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -75.14 4.49 6.78 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.361 0.504 . . . . 63.409999999999997 112.361 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 102' ' ' THR . 43.5 t -82.29 147.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.841 -0.429 . . . . 75.040000000000006 109.841 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.4 130.99 35.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.684 -0.488 . . . . 74.099999999999994 109.684 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.49 117.08 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.055 -0.52 . . . . 54.43 110.541 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.3 pt-20 -123.58 121.63 36.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 73.340000000000003 109.721 175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.84 148.58 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.868 -0.606 . . . . 72.120000000000005 110.471 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.45 11.64 27.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 73.439999999999998 110.328 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -131.12 168.48 17.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 74.5 109.991 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.48 73.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.253 0.464 . . . . 75.0 112.253 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.27 -17.59 64.35 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.683 -0.967 . . . . 54.409999999999997 110.683 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.19 -46.78 75.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.455 -0.872 . . . . 75.230000000000004 111.835 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.1 pp -105.19 23.18 14.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 74.239999999999995 111.166 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.34 54.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 71.099999999999994 110.827 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.98 116.88 3.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 52.130000000000003 111.786 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 63' ' ' TYR . 6.4 mp -71.89 -55.94 6.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.216 -177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.117 -0.944 . . . . 63.32 111.015 -177.876 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 120.906 0.17 . . . . 63.039999999999999 112.852 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.91 149.74 22.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 110.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.34 109.91 1.77 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.661 -0.976 . . . . 25.129999999999999 110.661 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 HD12 ' A' ' 36' ' ' ILE . 16.7 m -101.35 134.55 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.095 0.474 . . . . 63.5 111.801 -173.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 37' ' ' VAL . 12.5 t70 -71.85 148.44 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.527 -0.76 . . . . 73.230000000000004 110.504 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.22 -20.4 44.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.444 0.535 . . . . 73.430000000000007 112.444 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -60.89 -31.91 71.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 53.140000000000001 110.711 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.1 m -61.44 -47.95 83.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 71.0 110.277 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.603 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 42.0 t -63.58 -40.85 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.51 -0.768 . . . . 65.230000000000004 110.769 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 70.349999999999994 111.05 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.683 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 25.2 mmt180 -63.97 -40.78 97.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 111.223 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 14.4 m-85 -58.62 -33.34 69.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.135 0.493 . . . . 65.140000000000001 110.476 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.71 -42.47 73.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 71.019999999999996 110.566 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.16 -41.83 99.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 62.43 110.353 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 14' ' ' ARG . 83.1 mt -50.22 -57.14 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.302 -0.863 . . . . 50.329999999999998 111.264 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -83.04 -51.92 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 64.030000000000001 112.083 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.05 -55.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.845 0.313 . . . . 63.409999999999997 111.845 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -71.95 -14.92 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.234 -0.186 . . . . 62.450000000000003 110.831 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 60.27 24.08 13.51 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.882 0.739 . . . . 72.299999999999997 110.98 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.1 p -105.15 100.47 10.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.867 -0.606 . . . . 54.200000000000003 109.478 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.82 133.62 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.466 0.65 . . . . 71.129999999999995 110.458 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.6 mppt? -137.66 146.29 43.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 73.209999999999994 108.687 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.726 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.5 t90 -91.41 122.73 34.26 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.571 -1.27 . . . . 71.219999999999999 107.571 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.784 HG22 ' HB3' ' A' ' 41' ' ' ASP . 40.1 pt -107.12 131.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.143 0.497 . . . . 72.430000000000007 110.561 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 53' ' ' LEU . 88.2 t -112.64 116.02 51.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.551 -0.75 . . . . 62.32 109.397 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 37.4 p90 -116.79 163.37 16.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.694 -0.684 . . . . 74.230000000000004 110.393 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -112.27 124.79 53.24 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.412 -0.588 . . . . 75.25 109.412 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 36' ' ' ILE . 25.9 mt -99.12 102.71 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.262 -1.014 . . . . 74.420000000000002 108.262 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.11 137.49 32.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.466 -0.334 . . . . 73.239999999999995 110.678 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.3 t30 49.21 46.39 22.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.733 -0.667 . . . . 74.129999999999995 111.328 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p 56.64 22.58 6.89 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.999 0.919 . . . . 72.409999999999997 113.135 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -132.65 126.84 33.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.315 -0.624 . . . . 72.409999999999997 109.315 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 31' ' ' ILE . 58.1 mt -112.94 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.6 . . . . 73.510000000000005 111.436 -171.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 8' ' ' ASP . 14.0 m -129.38 141.45 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 72.209999999999994 110.992 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 4.6 p -86.46 133.99 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 41.520000000000003 110.522 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -100.49 -36.29 9.25 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.155 0.503 . . . . 74.310000000000002 109.912 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -138.69 141.06 38.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 75.340000000000003 111.428 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HB3' HG22 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -133.0 131.62 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.093 -1.077 . . . . 73.340000000000003 108.093 168.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.45 14.73 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.344 -1.408 . . . . 31.109999999999999 113.74 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -103.17 160.6 14.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.379 -0.971 . . . . 71.140000000000001 108.379 172.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.53 42.95 98.74 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.393 -1.883 . . . . 32.210000000000001 108.393 -163.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -44.7 -51.39 9.3 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.129 1.372 . . . . 64.310000000000002 113.041 -166.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.32 64.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.089 -0.505 . . . . 54.32 111.914 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.76 -52.19 5.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.72 0.295 . . . . 74.430000000000007 110.962 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.21 -33.62 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 64.019999999999996 111.492 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.677 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 20.5 m-85 -84.39 -0.08 51.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.932 0.715 . . . . 75.239999999999995 112.932 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 50.7 mtm180 -68.12 -25.27 65.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.158 0.504 . . . . 75.299999999999997 110.199 174.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.64 28.68 3.72 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.766 -0.731 . . . . 61.520000000000003 112.147 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -129.07 -19.65 3.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.513 0.19 . . . . 63.200000000000003 111.513 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 66.1 mt -98.88 121.88 54.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.938 0.399 . . . . 63.109999999999999 111.086 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 38.3 Cg_endo -96.57 102.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.275 2.65 . . . . 32.409999999999997 111.975 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -13.27 6.91 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.986 0.422 . . . . 74.310000000000002 112.109 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -57.49 -31.09 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 52.439999999999998 111.83 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.651 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 3.2 p30 -139.52 158.02 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.812 -0.44 . . . . 63.240000000000002 109.812 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.843 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 14.3 p -97.07 141.77 29.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.492 0.553 . . . . 71.030000000000001 112.492 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -150.76 154.24 36.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.062 -1.088 . . . . 63.140000000000001 108.062 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.556 ' HD2' ' HD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -95.98 123.41 39.56 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.512 -0.475 . . . . 73.349999999999994 110.642 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.726 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.94 133.76 9.85 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.213 -0.755 . . . . 72.129999999999995 111.213 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.42 121.53 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.54 0.686 . . . . 51.340000000000003 110.818 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 3.2 t80 -122.71 143.62 49.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.241 -0.891 . . . . 72.450000000000003 108.966 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.7 t70 -115.22 140.71 48.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.11 0.481 . . . . 74.200000000000003 110.075 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.75 168.92 16.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.73 -0.668 . . . . 74.549999999999997 109.475 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.57 -25.98 61.64 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 114.791 0.676 . . . . 65.140000000000001 114.791 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.47 -5.1 13.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.158 0.799 . . . . 72.219999999999999 113.158 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -171.37 161.84 6.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.602 0.593 . . . . 74.049999999999997 112.602 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.1 mm -93.08 134.35 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 72.430000000000007 108.932 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -115.01 106.65 14.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.842 0.354 . . . . 74.140000000000001 111.307 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.517 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . 43.3 m-85 -83.51 109.9 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.922 -0.77 . . . . 72.430000000000007 108.922 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.32 124.76 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.048 0.452 . . . . 71.299999999999997 111.441 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 65.9 tp -128.2 105.36 8.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.71 -0.677 . . . . 64.049999999999997 110.301 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -86.2 109.64 19.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 74.519999999999996 109.283 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.2 p -79.83 150.61 72.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.564 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 72.0 Cg_endo -82.75 97.92 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.458 2.105 . . . . 74.150000000000006 112.405 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 109' ' ' HIS . 34.5 t70 -76.63 -14.99 59.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.494 0.664 . . . . 71.349999999999994 109.765 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.52 8.47 21.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 51.009999999999998 109.552 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' A' ' 80' ' ' PRO . . . -144.36 175.23 2.91 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.711 -0.677 . . . . 51.530000000000001 109.661 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 21.8 Cg_endo -62.83 154.71 64.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.973 1.782 . . . . 62.43 111.643 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.33 12.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.028 0.381 . . . . 75.420000000000002 112.028 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.618 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 59.4 tttm -69.69 -50.98 16.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.496 -0.32 . . . . 73.329999999999998 111.814 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 51.3 Cg_exo -55.77 -24.26 45.65 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.471 2.114 . . . . 71.340000000000003 112.943 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.499 ' HD3' ' OE1' ' A' ' 107' ' ' GLU . 11.0 ttm180 -60.45 -33.91 73.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.147 0.499 . . . . 55.210000000000001 110.133 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.8 mtt -71.57 -33.6 69.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 71.049999999999997 110.692 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -63.77 -47.5 80.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 62.219999999999999 110.529 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HD2' ' HD2' ' A' ' 60' ' ' PHE . 41.5 m-85 -67.77 -37.24 81.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 72.030000000000001 111.05 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.47 65.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.169 0.509 . . . . 74.239999999999995 111.086 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -86.46 -54.58 4.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.85 -0.614 . . . . 75.010000000000005 110.91 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -77.48 -9.23 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.588 0.588 . . . . 43.219999999999999 112.588 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.703 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -58.24 -24.53 59.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.549 0.574 . . . . 75.540000000000006 112.549 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.703 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 4.8 t70 -81.8 -25.7 35.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.818 0.342 . . . . 71.310000000000002 110.876 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.01 62.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 71.299999999999997 110.448 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 48.6 mt -92.14 -56.97 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.263 -0.881 . . . . 50.219999999999999 109.87 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 103' ' ' ALA . 43.8 tp -53.64 -58.94 5.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.61 -1.177 . . . . 72.109999999999999 113.079 -170.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 96' ' ' LYS . 3.7 tmmm? -65.38 -20.34 66.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.053 -0.521 . . . . 75.420000000000002 111.523 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.66 -22.94 12.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.981 0.734 . . . . 75.450000000000003 112.981 -172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 99' ' ' ASP . 4.3 pp -87.08 -39.6 15.44 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 118.914 -1.114 . . . . 74.129999999999995 112.166 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 98' ' ' LEU . 17.0 t70 -154.07 177.05 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.17 -0.612 . . . . 74.540000000000006 111.637 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 13.44 42.63 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.899 -0.88 . . . . 43.420000000000002 110.899 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.077 0.951 . . . . 74.200000000000003 112.695 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 104' ' ' VAL . 2.5 m -84.32 136.22 33.99 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.477 -0.783 . . . . 71.239999999999995 110.403 -171.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -77.29 4.52 10.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.81 -0.632 . . . . 44.0 112.029 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 102' ' ' THR . 46.8 t -82.75 147.41 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.202 0.525 . . . . 74.120000000000005 110.428 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.26 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.772 -0.649 . . . . 70.420000000000002 109.715 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 tp -108.76 117.23 33.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.34 -0.391 . . . . 73.230000000000004 110.265 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.7 117.16 29.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.526 -0.546 . . . . 72.340000000000003 109.526 175.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.4 35.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.136 -0.484 . . . . 50.149999999999999 111.041 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p-80 -119.25 2.16 11.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.409 -0.589 . . . . 72.530000000000001 109.409 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 153.56 42.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.416 -0.811 . . . . 73.340000000000003 110.108 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 68.3 mtt -77.63 47.31 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 74.129999999999995 111.702 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.69 -17.07 64.49 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.213 -0.755 . . . . 73.140000000000001 111.213 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -64.0 -45.8 87.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.963 0.505 . . . . 73.010000000000005 111.197 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 3.5 pp -86.21 10.24 15.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.317 -0.401 . . . . 75.329999999999998 111.696 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 159.04 49.57 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.268 -0.424 . . . . 74.439999999999998 110.121 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.98 107.53 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.121 1.881 . . . . 45.350000000000001 111.351 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.3 mp -72.12 -71.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 73.329999999999998 111.033 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.607 -0.711 . . . . 65.420000000000002 110.483 -178.769 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 CA-C-O 120.685 0.047 . . . . 70.349999999999994 113.023 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.46 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -88.27 162.96 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.96 0.41 . . . . 75.219999999999999 110.39 178.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.65 108.89 1.65 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.55 -1.02 . . . . 65.340000000000003 110.55 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.39 138.67 28.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.481 0.658 . . . . 72.010000000000005 111.72 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 10' ' ' ASN . 10.2 t70 -75.62 136.28 40.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.783 -1.099 . . . . 71.120000000000005 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.28 -20.05 35.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 72.430000000000007 111.639 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 48.2 t30 -63.4 -34.98 78.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.92 -0.77 . . . . 73.530000000000001 108.92 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 38' ' ' VAL . 33.1 m -53.69 -52.05 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.142 -0.936 . . . . 73.439999999999998 109.859 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 48.3 t -59.07 -43.39 89.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.555 -0.748 . . . . 74.329999999999998 110.957 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.93 86.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 44.009999999999998 110.818 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -68.48 -30.76 69.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 70.329999999999998 111.311 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 22.1 m-85 -62.52 -35.65 80.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.109 0.481 . . . . 75.549999999999997 109.904 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.75 -46.87 70.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 73.439999999999998 109.638 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 44.6 mt-10 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 75.349999999999994 112.374 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 19' ' ' LYS . 4.3 pp -65.21 -29.41 70.22 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.996 -0.681 . . . . 52.020000000000003 110.775 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.4 tmtp? -84.26 -58.68 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.488 . . . . 65.030000000000001 110.726 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.87 -29.83 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.775 0.658 . . . . 74.340000000000003 112.775 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 77.7 mtp180 -91.31 -21.04 21.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.943 -0.473 . . . . 71.019999999999996 111.347 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.13 27.75 0.34 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.314 1.046 . . . . 73.329999999999998 113.546 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.81 170.58 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.999 -1.111 . . . . 73.120000000000005 107.999 166.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 45' ' ' ASN . 8.8 p -92.1 131.19 39.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 55.520000000000003 110.668 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.653 ' HZ3' ' HB2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -140.57 170.6 15.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 63.149999999999999 111.32 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.857 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.0 t90 -152.0 129.44 11.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.083 -1.08 . . . . 70.219999999999999 108.083 172.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 41' ' ' ASP . 17.3 pt -124.94 122.72 64.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.998 0.428 . . . . 63.200000000000003 109.945 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -106.6 111.24 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.97 0.414 . . . . 74.200000000000003 110.973 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.301 0.572 . . . . 73.150000000000006 109.991 177.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -114.26 125.06 53.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.241 -0.89 . . . . 72.239999999999995 109.234 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.505 HG23 HG12 ' A' ' 36' ' ' ILE . 22.2 mt -97.0 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.254 -1.017 . . . . 71.209999999999994 108.254 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.68 137.51 25.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.724 . . . . 75.430000000000007 110.204 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 54.63 29.63 11.85 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.578 0.549 . . . . 53.210000000000001 111.389 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m 69.93 15.63 7.79 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.932 0.872 . . . . 73.010000000000005 110.721 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -107.64 156.64 18.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.71 -0.848 . . . . 64.439999999999998 108.71 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.804 HG21 HD11 ' A' ' 94' ' ' LEU . 45.5 mt -132.68 107.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.828 -0.434 . . . . 64.310000000000002 109.828 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 8' ' ' ASP . 55.7 t -133.11 134.45 57.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.39 . . . . 54.219999999999999 110.457 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.031 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -79.12 128.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 73.430000000000007 111.257 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -84.86 -38.1 19.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 75.310000000000002 111.441 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -143.24 142.84 31.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 73.140000000000001 110.592 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' A' ' 27' ' ' ILE . 2.0 p-10 -141.54 128.83 21.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.766 -0.652 . . . . 73.409999999999997 109.288 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.78 161.77 27.45 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.631 -0.795 . . . . 55.43 113.522 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -108.59 158.44 17.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.923 -1.14 . . . . 73.299999999999997 107.923 169.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.22 34.44 89.97 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.643 -1.383 . . . . 61.32 109.643 -170.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.81 HD21 HG22 ' A' ' 24' ' ' VAL . 6.6 p30 -70.89 -42.42 70.02 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.756 -1.222 . . . . 71.420000000000002 112.79 -165.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.65 36.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.927 0.394 . . . . 74.209999999999994 110.705 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.624 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 19.7 t70 -89.55 -58.36 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 64.400000000000006 111.374 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.15 -38.45 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.78 0.659 . . . . 71.519999999999996 112.78 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 6.1 m-30 -79.52 -2.68 43.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.544 . . . . 72.200000000000003 112.47 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 47' ' ' ASP . 45.8 mtm180 -81.04 -12.9 59.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.56 0.695 . . . . 75.430000000000007 109.31 173.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.69 13.24 11.84 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.266 -0.879 . . . . 62.509999999999998 111.081 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -130.94 20.38 4.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.477 0.656 . . . . 62.009999999999998 110.133 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.5 pt? -68.66 163.52 54.0 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.986 -1.006 . . . . 74.120000000000005 111.016 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.56 163.89 33.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.657 2.238 . . . . 71.230000000000004 111.203 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.29 -37.19 61.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.879 0.371 . . . . 75.0 111.022 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.53 14.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.42 0.629 . . . . 71.409999999999997 109.451 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.76 151.79 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.917 -1.038 . . . . 70.329999999999998 110.423 -172.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -90.38 141.79 28.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.603 -0.271 . . . . 65.040000000000006 110.538 175.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 58' ' ' CYS . 43.2 mmt-85 -144.77 157.07 44.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 75.030000000000001 110.528 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HE2' ' HD1' ' A' ' 87' ' ' TYR . 1.8 m-85 -112.31 117.27 32.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.519 -0.548 . . . . 75.219999999999999 109.519 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.857 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.99 130.68 8.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.388 -0.91 . . . . 51.210000000000001 113.178 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 42.5 t -98.98 121.01 49.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.881 -0.785 . . . . 74.340000000000003 108.881 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -131.83 135.7 46.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.205 0.526 . . . . 75.209999999999994 109.86 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 24' ' ' VAL . 5.1 p-10 -99.86 153.72 18.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.266 -0.879 . . . . 71.439999999999998 110.861 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 8.1 t -142.6 169.53 17.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.203 -1.036 . . . . 75.519999999999996 108.203 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.23 -27.65 63.15 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.477 0.551 . . . . 74.230000000000004 114.477 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.93 -3.38 8.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.538 0.669 . . . . 72.510000000000005 111.84 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 15.5 ptmt -149.2 158.31 44.07 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.182 0.808 . . . . 71.129999999999995 113.182 -168.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.3 mm -126.22 115.41 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 114.801 -1.09 . . . . 63.340000000000003 108.136 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 30.3 mt-30 -115.17 124.31 51.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.153 -0.619 . . . . 75.019999999999996 112.197 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.25 109.49 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.98 -0.748 . . . . 54.439999999999998 108.98 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.27 125.22 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.054 0.454 . . . . 74.420000000000002 110.701 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 87' ' ' TYR . 40.8 tp -108.05 116.2 31.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.638 -0.71 . . . . 71.120000000000005 110.392 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 113' ' ' ASP . 45.7 m95 -85.49 111.82 20.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.019 -1.104 . . . . 73.319999999999993 108.019 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 95.1 m -85.87 149.4 50.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.585 -0.446 . . . . 74.030000000000001 110.908 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 73.7 Cg_endo -88.32 110.05 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.674 2.249 . . . . 72.030000000000001 112.907 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.63 -28.15 33.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.735 -0.666 . . . . 63.130000000000003 109.608 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -94.25 9.78 36.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.395 -0.821 . . . . 71.519999999999996 110.788 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -136.66 147.12 58.27 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.312 -0.404 . . . . 75.129999999999995 110.796 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 14.8 Cg_exo -70.71 -176.78 1.88 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.152 2.568 . . . . 71.420000000000002 113.062 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.19 -19.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.66 -0.7 . . . . 73.400000000000006 112.128 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 14.6 mptt -67.62 -56.13 12.86 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 111.632 0.234 . . . . 62.130000000000003 111.632 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' PRO . 37.3 Cg_exo -59.21 -30.52 93.23 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.712 1.608 . . . . 72.430000000000007 111.747 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 61.1 ttt180 -68.25 -44.81 74.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 64.140000000000001 111.001 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.0 mtt -70.78 -22.22 62.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.616 0.246 . . . . 73.299999999999997 111.212 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -60.55 -48.83 80.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 65.129999999999995 111.312 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 27.0 p90 -81.72 -28.42 33.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.764 -0.374 . . . . 70.109999999999999 110.979 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -68.89 -18.55 64.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.596 0.712 . . . . 73.25 110.923 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -88.19 -17.13 31.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.17 -0.923 . . . . 62.210000000000001 110.682 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 31' ' ' ILE . 6.7 m -111.77 10.53 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 64.030000000000001 110.895 -173.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -73.08 -20.16 61.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.923 0.712 . . . . 75.540000000000006 112.923 -172.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.558 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 41.8 m-20 -79.26 -22.26 44.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.606 0.241 . . . . 70.109999999999999 111.345 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 5' ' ' MET . . . -61.47 -17.74 55.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.030000000000001 111.703 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.804 HD11 HG21 ' A' ' 36' ' ' ILE . 90.7 mt -104.57 -51.87 3.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.21 -0.45 . . . . 71.340000000000003 110.403 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.27 -44.1 75.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 61.32 111.269 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.71 -10.24 59.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 73.040000000000006 111.063 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -104.88 -39.8 6.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 62.119999999999997 112.618 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 99' ' ' ASP . 3.3 pp -89.73 -43.14 10.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.135 1.531 . . . . 75.409999999999997 115.135 -161.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.623 ' N ' HD12 ' A' ' 98' ' ' LEU . 20.8 t70 -155.03 -177.13 6.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.033 0.833 . . . . 71.329999999999998 111.983 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.61 12.87 64.52 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.26 -0.882 . . . . 73.519999999999996 111.194 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.57 178.48 0.04 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.553 0.741 . . . . 43.420000000000002 111.98 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 104' ' ' VAL . 5.4 m -84.02 136.85 33.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.909 0.385 . . . . 60.200000000000003 110.546 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.49 4.66 7.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.69 -0.686 . . . . 64.230000000000004 111.984 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 102' ' ' THR . 85.7 t -73.17 145.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 74.430000000000007 109.969 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.51 151.81 45.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.527 . . . . 75.329999999999998 109.935 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -124.61 117.91 25.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.787 0.327 . . . . 64.040000000000006 110.367 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.518 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 7.4 pt-20 -94.04 145.22 24.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 72.109999999999999 110.516 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.88 119.94 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.886 -0.597 . . . . 72.400000000000006 109.906 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -129.67 -0.71 4.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 64.120000000000005 110.045 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.12 -149.66 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.266 -0.879 . . . . 63.43 108.801 174.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 77.8 mtp -100.45 24.12 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.129 0.49 . . . . 74.310000000000002 110.751 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.1 -15.73 78.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.629 -0.714 . . . . 34.009999999999998 111.504 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 11.3 p-10 -57.32 -47.74 80.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.548 0.739 . . . . 75.409999999999997 111.798 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 3.9 pp -99.92 5.52 45.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.221 0.534 . . . . 72.230000000000004 111.008 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -94.52 151.36 39.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.963 -0.562 . . . . 61.140000000000001 109.979 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 12.1 Cg_exo -71.42 113.7 3.7 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.5 2.133 . . . . 72.340000000000003 111.498 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.23 -98.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 72.150000000000006 110.385 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.944 -1.027 . . . . 73.219999999999999 109.511 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 111.357 -0.697 . . . . 73.099999999999994 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.584 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -71.46 151.2 44.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.198 -0.501 . . . . 74.329999999999998 110.667 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.593 ' O ' ' HD2' ' A' ' 35' ' ' LYS . . . -110.18 109.38 2.65 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.566 -0.826 . . . . 40.439999999999998 111.584 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.4 t -79.23 149.51 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.228 -0.656 . . . . 74.140000000000001 109.228 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 3.7 p-10 -82.9 165.46 19.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.161 0.505 . . . . 54.340000000000003 110.542 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 1.3 pm0 -84.47 -17.57 38.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.617 -0.72 . . . . 75.209999999999994 112.027 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.69 -32.94 35.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 73.310000000000002 110.226 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.0 t -54.34 -55.49 27.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 71.340000000000003 110.548 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.16 -34.67 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 71.319999999999993 110.812 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.08 -39.03 79.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 44.340000000000003 111.693 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -60.55 -25.5 66.2 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.22 0.452 . . . . 52.439999999999998 112.22 -173.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m-85 -60.27 -20.94 61.11 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.855 0.317 . . . . 61.210000000000001 111.855 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 2.0 p30 -64.3 -39.51 94.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.109 0.48 . . . . 65.329999999999998 110.005 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 23' ' ' THR . 41.8 mt-10 -82.53 -43.91 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.263 -0.643 . . . . 50.229999999999997 109.263 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 26.3 tp -53.76 -61.19 2.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.179 -1.373 . . . . 63.340000000000003 111.284 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -85.86 -65.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.243 0.544 . . . . 74.420000000000002 112.371 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 50.1 mm -59.65 -51.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.224 -0.898 . . . . 72.430000000000007 113.068 -165.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.677 ' HB2' HG22 ' A' ' 23' ' ' THR . 68.2 mtp180 -83.96 -4.82 59.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.861 0.363 . . . . 74.120000000000005 110.869 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 27.8 mtpt 55.9 24.34 7.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.624 -0.716 . . . . 74.310000000000002 111.79 -176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 21' ' ' ARG . 4.4 t -107.14 93.51 4.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.318 -0.993 . . . . 75.409999999999997 108.318 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.38 138.16 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.552 -0.749 . . . . 65.200000000000003 111.684 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.09 138.65 46.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 72.340000000000003 108.669 174.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.9 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -86.08 123.56 31.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.039 -1.097 . . . . 75.430000000000007 108.039 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.74 HG21 ' HG2' ' A' ' 14' ' ' ARG . 23.3 pt -115.87 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.918 -0.583 . . . . 75.540000000000006 110.89 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' LYS . 23.3 m -106.35 127.78 61.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.961 -0.563 . . . . 64.230000000000004 110.538 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -102.7 162.96 12.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.443 0.639 . . . . 64.530000000000001 110.253 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 30' ' ' LYS . 28.3 ttpt -113.14 123.02 49.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.715 -1.13 . . . . 71.430000000000007 108.457 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 36' ' ' ILE . 31.1 mt -99.71 104.05 15.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.713 -0.847 . . . . 63.340000000000003 108.713 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.2 139.85 14.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.475 -0.33 . . . . 70.400000000000006 110.364 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 t30 61.01 32.17 19.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.493 . . . . 64.5 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 5' ' ' MET . 9.7 m 68.18 6.45 5.27 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.649 -0.705 . . . . 71.310000000000002 110.975 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 55.2 tptt -110.95 132.19 54.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 109.813 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 31' ' ' ILE . 54.8 mt -113.11 110.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.166 -0.679 . . . . 72.439999999999998 109.166 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 35' ' ' LYS . 5.1 t -126.27 136.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 123.053 0.22 . . . . 63.299999999999997 111.181 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 29' ' ' PHE . 56.2 t -59.48 121.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 O-C-N 123.286 0.366 . . . . 64.519999999999996 110.027 172.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 8.5 mm-40 -96.8 -26.04 15.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.424 -0.353 . . . . 61.109999999999999 110.47 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 28' ' ' VAL . 16.3 tppt? -146.98 141.54 26.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 71.310000000000002 112.212 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.68 131.06 47.97 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.695 -1.224 . . . . 75.019999999999996 107.695 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.36 157.39 24.47 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.036 -1.078 . . . . 55.219999999999999 111.899 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -123.1 143.66 49.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.234 -0.654 . . . . 63.310000000000002 109.234 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.41 41.22 37.86 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.395 -1.882 . . . . 74.400000000000006 108.395 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 1.7 m-20 -44.42 -51.39 8.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 113.443 -1.378 . . . . 74.129999999999995 113.155 -166.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -65.38 -28.81 69.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.927 -0.579 . . . . 43.520000000000003 112.121 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -89.35 -44.83 9.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.815 0.341 . . . . 73.329999999999998 110.631 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.02 -49.82 74.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.724 -0.671 . . . . 73.530000000000001 110.661 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HE1' ' HG2' ' A' ' 40' ' ' LYS . 12.9 m-85 -75.35 8.33 2.84 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.118 0.784 . . . . 74.430000000000007 113.118 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 78.4 mtp180 -78.32 -11.95 59.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.604 -0.517 . . . . 62.32 109.604 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.32 11.82 0.57 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.651 -0.704 . . . . 65.420000000000002 112.593 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.91 8.7 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.961 0.38 . . . . 61.130000000000003 111.638 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.57 68.89 74.82 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 61.340000000000003 112.011 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.14 27.66 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.633 2.222 . . . . 61.450000000000003 111.824 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -60.76 -35.03 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.671 . . . . 53.340000000000003 111.634 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 28.7 t-20 76.33 -25.67 0.2 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.711 0.632 . . . . 60.200000000000003 110.987 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 55' ' ' ALA . 54.6 m-20 -95.84 171.81 8.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.326 -0.62 . . . . 72.510000000000005 109.326 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.1 p -77.79 142.12 38.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 44.109999999999999 111.14 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -140.87 160.15 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 72.340000000000003 109.712 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.23 120.39 40.31 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.029 -0.359 . . . . 63.539999999999999 110.029 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.9 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.4 136.96 11.44 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.911 -0.661 . . . . 64.120000000000005 113.6 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 88.5 t -97.99 120.78 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.913 -0.403 . . . . 75.099999999999994 109.913 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' HD2' HD22 ' A' ' 117' ' ' LEU . 10.4 t80 -142.18 126.55 17.67 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.879 -0.415 . . . . 73.329999999999998 109.879 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.24 146.09 30.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.179 0.514 . . . . 71.319999999999993 110.342 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.8 t -130.52 162.12 29.95 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.173 -0.677 . . . . 74.439999999999998 109.173 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.61 -24.93 71.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 74.140000000000001 111.342 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -73.61 -48.26 33.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.36 . . . . 73.049999999999997 110.346 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.15 164.82 20.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 72.400000000000006 111.518 -174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.52 127.6 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.833 -0.803 . . . . 72.200000000000003 108.833 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.43 106.24 10.88 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.776 -0.37 . . . . 74.510000000000005 111.363 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 62' ' ' VAL . 32.8 m-85 -78.77 109.16 12.77 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.828 -0.804 . . . . 74.299999999999997 108.828 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.57 137.59 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.433 . . . . 63.43 111.038 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 87' ' ' TYR . 64.4 tp -144.19 124.9 14.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.0 110.872 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.425 ' HE3' ' N ' ' A' ' 75' ' ' CYS . 0.0 OUTLIER -86.49 141.91 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.969 -0.752 . . . . 63.149999999999999 108.969 176.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 27.2 p -88.23 151.27 48.65 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 63.409999999999997 110.682 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 4.3 Cg_exo -76.93 92.05 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.516 2.144 . . . . 71.549999999999997 111.983 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.59 -32.94 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 74.209999999999994 110.545 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.91 9.34 25.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.744 0.783 . . . . 73.340000000000003 110.066 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.14 159.4 52.77 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 60.32 109.469 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 25.4 Cg_exo -64.15 176.01 2.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.347 2.031 . . . . 65.409999999999997 112.158 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.19 4.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.998 0.37 . . . . 75.450000000000003 111.998 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.767 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 26.4 ttpp -68.66 -54.94 12.33 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 74.030000000000001 111.137 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 42.0 Cg_exo -59.78 -23.63 72.76 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.222 1.948 . . . . 60.340000000000003 112.979 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 47.4 ttt-85 -63.98 -39.17 93.53 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.825 0.345 . . . . 72.310000000000002 110.378 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.1 mtm -66.36 -33.22 75.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 75.150000000000006 110.426 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.6 m -60.57 -56.86 16.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.574 -0.739 . . . . 74.040000000000006 111.561 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.755 ' CE1' HD21 ' A' ' 73' ' ' LEU . 3.4 p90 -75.7 -23.59 56.17 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.472 -0.491 . . . . 74.129999999999995 111.399 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.04 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 74.150000000000006 110.385 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.1 t -86.55 -8.24 57.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.344 -0.844 . . . . 72.329999999999998 110.453 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -123.45 4.23 9.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.007 0.432 . . . . 63.310000000000002 111.127 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -71.91 -21.38 61.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 72.400000000000006 111.651 -171.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.64 -21.77 32.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 73.310000000000002 111.431 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.95 78.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 71.299999999999997 111.767 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.2 mm? -65.71 -44.79 85.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.345 0.593 . . . . 52.409999999999997 110.388 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.986 HD23 ' HA ' ' A' ' 103' ' ' ALA . 7.6 mp -64.22 -24.69 67.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.324 -0.853 . . . . 73.099999999999994 110.92 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -81.18 -28.72 34.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 62.450000000000003 111.681 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -106.39 -26.46 11.46 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.389 0.885 . . . . 73.340000000000003 113.389 -169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 36.2 mt -86.1 -42.99 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 118.806 -1.158 . . . . 74.25 111.566 -170.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.24 -166.33 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 73.0 111.103 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.92 14.0 63.15 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.802 -0.919 . . . . 55.32 110.802 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.22 177.66 0.08 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.675 0.79 . . . . 75.329999999999998 111.977 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 104' ' ' VAL . 7.0 m -85.28 140.53 30.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.321 -170.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.986 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -72.13 4.86 3.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.507 -0.769 . . . . 61.340000000000003 112.256 -175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.569 HG23 HG22 ' A' ' 102' ' ' THR . 47.8 t -83.9 147.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.461 0.648 . . . . 62.43 110.436 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.69 155.09 47.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.549 -0.75 . . . . 51.039999999999999 109.26 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.6 tp -110.34 116.99 32.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.013 -0.366 . . . . 64.230000000000004 110.013 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.9 pt-20 -97.87 128.71 44.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.654 -0.499 . . . . 73.219999999999999 109.654 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.23 119.07 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.58 . . . . 52.450000000000003 110.18 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 23.5 t-80 -104.6 -45.25 4.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.569 -0.741 . . . . 63.140000000000001 110.237 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.03 101.58 4.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.49 -0.323 . . . . 70.129999999999995 111.421 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.525 ' HG3' HD11 ' A' ' 114' ' ' LEU . 56.8 ttm 71.18 -4.29 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.705 0.632 . . . . 74.450000000000003 112.705 170.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.9 -18.18 61.74 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.899 -0.667 . . . . 61.310000000000002 112.901 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.53 -46.88 13.84 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.719 0.408 . . . . 72.239999999999995 111.595 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.525 HD11 ' HG3' ' A' ' 111' ' ' MET . 3.9 pp -98.06 14.77 26.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.903 0.382 . . . . 62.0 111.841 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.59 154.26 46.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.106 -0.497 . . . . 74.430000000000007 109.969 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.6 123.95 10.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.053 2.502 . . . . 73.239999999999995 112.489 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.437 HD22 ' HD2' ' A' ' 63' ' ' TYR . 5.6 mp -83.17 -2.45 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 73.129999999999995 111.496 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.88 -1.057 . . . . 63.240000000000002 111.077 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.313 0 N-CA-C 113.471 0.148 . . . . 51.119999999999997 113.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.1 ptt? -109.79 166.49 10.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.941 0.401 . . . . 73.420000000000002 110.275 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 132.17 10.69 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.416 -1.074 . . . . 63.25 110.416 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.33 124.87 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 117.129 0.464 . . . . 64.400000000000006 110.851 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.62 115.5 4.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.679 . . . . 63.210000000000001 111.417 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -84.99 -13.44 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 73.530000000000001 111.178 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.3 -35.4 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 74.239999999999995 110.604 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 42.2 t -53.35 -40.78 65.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 74.200000000000003 111.235 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.74 -47.3 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 72.5 110.751 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -68.46 -28.02 66.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 73.409999999999997 110.54 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.836 ' HG3' HG21 ' A' ' 27' ' ' ILE . 1.8 tmm_? -66.6 -38.33 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 74.439999999999998 110.095 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -60.71 -21.12 62.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.648 0.261 . . . . 63.25 111.133 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 4.7 m-20 -75.98 -30.65 58.66 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.863 -0.421 . . . . 74.129999999999995 109.863 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.19 -38.98 89.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.073 -0.714 . . . . 73.530000000000001 109.073 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.76 -43.51 97.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.022 . . . . 74.420000000000002 110.909 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.11 -64.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 111.917 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.49 -54.38 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 70.409999999999997 111.917 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -75.46 -16.84 60.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.453 -0.34 . . . . 71.219999999999999 110.993 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? 58.49 24.48 11.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.662 0.744 . . . . 75.129999999999995 109.965 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.4 p -104.18 116.36 32.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.452 -0.794 . . . . 73.239999999999995 109.552 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 7.1 p -88.07 134.3 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.838 -0.745 . . . . 73.430000000000007 109.996 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 19.1 ptpt -138.45 150.38 46.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.587 -0.733 . . . . 72.109999999999999 110.102 177.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -97.31 123.2 41.04 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.95 -1.13 . . . . 72.430000000000007 107.95 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.836 HG21 ' HG3' ' A' ' 14' ' ' ARG . 43.1 pt -117.51 144.77 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.482 -0.326 . . . . 75.230000000000004 110.219 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.45 114.4 42.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.032 0.444 . . . . 62.219999999999999 111.163 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -94.7 145.75 24.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.494 -0.928 . . . . 73.030000000000001 108.494 168.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -112.11 125.14 53.79 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.045 -0.525 . . . . 65.239999999999995 109.979 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 36' ' ' ILE . 20.6 mt -91.24 102.02 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.37 -0.974 . . . . 74.450000000000003 108.37 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.07 147.03 20.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.393 -0.595 . . . . 73.319999999999993 109.393 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.48 26.22 15.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.276 0.56 . . . . 63.200000000000003 110.179 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' MET . 1.6 m 65.13 28.02 12.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.03 -0.987 . . . . 65.219999999999999 111.64 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE2' HG21 ' A' ' 37' ' ' VAL . 18.8 ptmt -136.94 148.87 47.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.984 -0.376 . . . . 64.310000000000002 109.984 171.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG23 ' A' ' 31' ' ' ILE . 23.0 mt -113.42 109.94 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.632 -0.507 . . . . 73.400000000000006 109.632 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 35' ' ' LYS . 3.2 t -138.48 136.77 43.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.868 -0.419 . . . . 73.530000000000001 109.868 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.022 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 86.3 t -62.4 131.27 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.137 0.494 . . . . 53.420000000000002 110.49 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG3' ' HD2' ' A' ' 40' ' ' LYS . 16.8 pt-20 -104.99 -31.09 9.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.522 -0.763 . . . . 61.420000000000002 111.316 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 3.0 mptp? -147.65 156.01 42.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.919 0.39 . . . . 62.350000000000001 111.123 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' HG22 ' A' ' 27' ' ' ILE . 7.1 p-10 -140.31 132.03 27.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.964 -1.125 . . . . 75.319999999999993 107.964 170.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.09 13.11 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.059 -1.067 . . . . 44.25 114.366 -168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 3.0 ptpp? -128.6 130.54 47.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.113 -1.069 . . . . 61.32 108.113 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 52.19 8.48 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.991 -2.044 . . . . 72.319999999999993 107.991 -163.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.486 HD22 ' HE1' ' A' ' 63' ' ' TYR . 46.6 m-20 -44.91 -51.93 9.19 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.75 -1.225 . . . . 72.400000000000006 113.542 -162.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -49.41 70.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 44.420000000000002 111.06 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.531 ' HA ' HH11 ' A' ' 50' ' ' ARG . 19.8 t70 -68.8 -42.64 77.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.079 -0.509 . . . . 73.439999999999998 111.595 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 43' ' ' LYS . 10.0 tt0 -65.31 -47.23 77.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 64.430000000000007 111.135 -174.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 27.2 m-85 -71.73 -22.18 61.66 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.057 0.391 . . . . 75.329999999999998 112.057 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 18.0 mtp180 -61.61 -22.94 65.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.813 0.34 . . . . 73.430000000000007 111.111 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.28 18.13 6.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.717 -0.754 . . . . 62.340000000000003 112.055 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -96.22 -73.99 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.873 -0.192 . . . . 71.349999999999994 111.278 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 mp -126.65 90.22 50.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.239 0.459 . . . . 75.25 112.239 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.21 48.31 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.906 2.404 . . . . 74.209999999999994 109.584 170.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.42 -12.71 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.006 -0.997 . . . . 74.510000000000005 112.837 -169.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.603 ' HA ' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 p30 51.6 26.43 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.757 0.823 . . . . 60.119999999999997 111.38 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.07 170.72 8.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.756 -1.111 . . . . 65.430000000000007 109.14 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.955 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 3.3 p -86.5 134.2 33.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.709 -1.196 . . . . 73.319999999999993 110.05 174.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 39' ' ' GLU . 17.6 mmt85 -143.41 152.06 41.12 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.502 -1.226 . . . . 71.0 108.173 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.692 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -103.53 113.54 27.12 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.721 -0.474 . . . . 64.510000000000005 109.721 -178.137 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.65 131.73 8.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.985 -0.626 . . . . 72.310000000000002 113.114 -175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 3.0 t -102.74 120.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 75.409999999999997 109.309 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 5.0 t80 -134.69 124.97 26.12 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.409 -0.589 . . . . 64.219999999999999 109.409 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 11.3 t70 -92.31 140.93 29.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.741 -0.466 . . . . 70.129999999999995 109.741 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.6 t -122.12 171.12 9.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.772 -0.825 . . . . 74.519999999999996 108.772 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.49 -23.9 55.23 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.236 -0.507 . . . . 75.019999999999996 113.829 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -102.25 -26.26 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 73.120000000000005 112.873 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -170.27 169.05 7.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.306 0.484 . . . . 73.219999999999999 112.306 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.22 129.8 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.597 -0.89 . . . . 73.450000000000003 108.597 170.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -118.29 115.27 24.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.078 0.466 . . . . 54.109999999999999 111.635 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.731 ' HZ ' HD22 ' A' ' 98' ' ' LEU . 48.4 m-85 -76.17 110.68 10.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.639 -0.71 . . . . 71.450000000000003 109.532 166.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.04 112.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.569 -0.53 . . . . 61.420000000000002 109.569 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 87' ' ' TYR . 36.4 tp -115.97 89.32 3.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.658 -0.701 . . . . 65.530000000000001 110.304 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.674 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 0.8 OUTLIER -85.59 121.06 27.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.633 -0.876 . . . . 71.450000000000003 108.633 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.3 p -96.48 149.98 36.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.857 -0.337 . . . . 61.420000000000002 110.856 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.955 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 59.1 Cg_endo -71.8 130.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.42 2.08 . . . . 75.219999999999999 113.052 -170.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.68 -40.29 16.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 61.140000000000001 110.814 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.89 20.57 5.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 72.0 110.613 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -132.32 157.81 77.27 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.233 -0.44 . . . . 62.0 110.534 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 50.7 Cg_endo -69.21 -170.99 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.928 2.419 . . . . 44.25 113.227 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.15 -10.84 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 42.420000000000002 112.1 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 39.5 ttmt -68.08 -47.53 40.27 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.189 0.44 . . . . 71.129999999999995 112.189 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 15.6 Cg_endo -58.62 -16.78 31.92 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.824 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.552 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 19.4 mtp-105 -73.93 -32.68 63.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.598 -0.519 . . . . 72.319999999999993 109.598 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 24.7 mmt -78.14 -13.59 59.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 110.301 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -65.2 -55.78 16.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 53.229999999999997 110.779 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 73' ' ' LEU . 11.0 p90 -77.33 -19.34 56.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 74.420000000000002 110.89 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 85' ' ' MET . . . -75.02 -18.52 60.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.208 0.528 . . . . 73.340000000000003 110.316 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 t -82.71 -34.35 27.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.769 -0.651 . . . . 64.109999999999999 110.463 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 p -104.76 20.89 17.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.519999999999996 110.909 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 19.7 pttp -56.71 -55.22 36.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.423 -0.808 . . . . 73.420000000000002 112.454 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.631 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 8.7 p-10 -85.88 -20.09 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 72.0 111.35 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.18 67.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.644 -0.253 . . . . 74.109999999999999 111.349 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 4.2 mm? -66.96 -40.43 87.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.958 -0.386 . . . . 72.010000000000005 109.958 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 33.7 tp -67.85 -18.53 64.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.535 -0.757 . . . . 61.539999999999999 111.582 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 74.129999999999995 110.534 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -111.57 16.45 20.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.564 1.173 . . . . 71.219999999999999 108.656 177.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.731 HD22 ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -111.35 10.36 21.56 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.929 -1.487 . . . . 54.439999999999998 111.101 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' ALA . 21.8 m-20 -34.69 -145.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.845 2.458 . . . . 62.310000000000002 116.491 -151.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.24 15.7 0.02 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 118.013 1.965 . . . . 62.439999999999998 118.013 -150.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -56.97 -177.14 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.702 -0.851 . . . . 52.32 108.702 154.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 m -80.47 117.33 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.696 -1.252 . . . . 61.229999999999997 109.356 -168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -87.49 -0.77 57.3 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.944 -1.026 . . . . 51.140000000000001 111.486 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.94 146.33 10.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.638 . . . . 64.319999999999993 109.276 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -129.79 146.76 51.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.326 -0.397 . . . . 73.200000000000003 110.444 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 tt -119.84 117.39 28.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.117 -0.698 . . . . 62.43 109.117 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 13.4 pt-20 -97.47 141.05 31.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 74.310000000000002 110.275 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.68 54.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 73.140000000000001 111.062 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -126.07 4.3 7.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.478 -0.783 . . . . 73.230000000000004 109.931 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.94 163.55 14.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 73.129999999999995 109.119 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 67.5 mtt -78.31 57.87 1.98 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.444 0.64 . . . . 65.019999999999996 110.853 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.42 -15.51 68.62 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.95 -1.023 . . . . 50.43 111.598 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.08 -38.83 73.89 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 122.974 0.51 . . . . 75.510000000000005 111.165 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.9 pp -98.2 18.95 15.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.117 0.484 . . . . 73.209999999999994 110.819 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.02 156.3 54.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 64.109999999999999 110.412 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.01 91.24 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.333 2.022 . . . . 74.319999999999993 112.043 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.08 -7.54 59.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 111.064 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.457 -0.783 . . . . 74.340000000000003 109.906 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.836 -0.105 . . . . 61.119999999999997 112.836 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.44 172.22 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.112 0.482 . . . . 54.100000000000001 111.588 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.58 110.1 0.62 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.696 -0.962 . . . . 61.229999999999997 110.696 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.85 122.97 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.998 0.399 . . . . 64.099999999999994 111.829 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.13 120.84 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.182 -0.673 . . . . 71.439999999999998 109.182 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.76 -13.4 61.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.392 0.886 . . . . 72.349999999999994 113.392 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.9 -30.65 67.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.063 0.459 . . . . 53.409999999999997 110.213 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 m -66.95 -41.86 86.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.85 -0.614 . . . . 74.340000000000003 110.088 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.85 -43.92 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 70.239999999999995 110.893 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.58 63.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 73.319999999999993 111.592 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.773 ' HG3' HG21 ' A' ' 27' ' ' ILE . 20.9 mmt180 -64.54 -26.83 68.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.361 . . . . 74.219999999999999 111.706 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 82.2 m-85 -82.5 -26.25 32.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 64.400000000000006 110.325 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.84 -36.85 59.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.26 -0.644 . . . . 74.140000000000001 109.26 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.83 -19.03 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.551 -0.75 . . . . 65.420000000000002 110.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 11.8 mt -63.27 -50.79 68.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.147 -0.479 . . . . 53.420000000000002 111.15 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -70.91 -40.37 72.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.859 0.361 . . . . 73.209999999999994 111.3 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.22 -63.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 111.786 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -79.49 -24.02 42.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.491 -0.322 . . . . 75.299999999999997 110.725 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 53.6 mttp 59.32 24.79 13.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.797 -0.638 . . . . 73.209999999999994 111.222 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -93.2 122.44 35.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.123 -0.695 . . . . 62.350000000000001 109.123 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.67 134.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 120.131 -0.628 . . . . 73.140000000000001 110.476 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -141.12 172.14 13.1 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.34 -0.845 . . . . 64.340000000000003 109.718 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB2' ' HB3' ' A' ' 45' ' ' ASN . 4.1 t90 -125.97 127.56 46.13 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 74.120000000000005 107.482 173.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.773 HG21 ' HG3' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -117.79 128.83 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.065 0.46 . . . . 64.219999999999999 110.46 177.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 77.1 t -110.29 120.01 60.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.028 0.442 . . . . 71.230000000000004 110.26 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 p90 -116.73 160.98 19.95 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.832 -0.622 . . . . 74.25 110.844 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 39' ' ' GLU . 38.3 ttmt -115.39 125.11 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.419 -0.809 . . . . 62.210000000000001 109.267 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 90' ' ' SER . 16.3 mt -88.05 102.44 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.693 -1.225 . . . . 70.329999999999998 107.693 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.1 138.95 39.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.479 -0.328 . . . . 73.340000000000003 110.379 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 34' ' ' THR . 88.7 m-20 60.22 22.06 11.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 64.349999999999994 110.725 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 33' ' ' ASN . 46.9 m 79.48 -10.13 1.36 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.86 -0.609 . . . . 62.009999999999998 111.138 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE3' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -102.16 138.3 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.587 -0.523 . . . . 71.400000000000006 109.587 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.657 HD13 HD21 ' A' ' 94' ' ' LEU . 57.4 mt -99.34 114.12 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.392 -0.367 . . . . 62.210000000000001 111.188 -172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HE3' ' A' ' 35' ' ' LYS . 6.8 m -125.71 135.41 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 71.510000000000005 111.155 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -88.67 125.42 41.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.96 0.409 . . . . 70.519999999999996 110.077 176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 27.4 mt-10 -79.65 -37.76 35.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.908 -0.587 . . . . 73.319999999999993 111.151 -173.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' HB2' ' A' ' 39' ' ' GLU . 19.3 pttm -171.52 159.59 5.59 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.321 0.581 . . . . 70.430000000000007 112.191 -167.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.711 ' CB ' HG22 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -154.29 146.55 23.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.591 -1.186 . . . . 73.209999999999994 108.383 173.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.32 161.41 26.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.016 -1.088 . . . . 64.310000000000002 112.71 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -93.66 120.52 34.04 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.335 -1.358 . . . . 61.420000000000002 107.335 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.52 53.96 0.58 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 107.191 -2.363 . . . . 62.240000000000002 107.191 -161.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 38.8 m-20 -61.35 -53.01 62.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.026 -1.087 . . . . 54.399999999999999 112.471 -160.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.44 -32.7 42.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.726 -0.472 . . . . 75.209999999999994 109.726 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.97 -58.31 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 70.329999999999998 111.582 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.66 -46.51 78.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 71.519999999999996 111.542 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 27.9 m-85 -73.82 -14.83 61.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.899 0.703 . . . . 72.230000000000004 112.899 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.7 -13.19 60.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.962 0.411 . . . . 63.140000000000001 110.703 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.98 11.78 6.18 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.617 -0.593 . . . . 55.240000000000002 111.617 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -118.61 -0.15 11.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 111.099 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 87.2 mt -101.53 123.29 44.87 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.239 -0.437 . . . . 53.030000000000001 110.092 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 12.8 Cg_exo -70.06 134.1 26.55 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.86 2.373 . . . . 74.219999999999999 112.101 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.18 -14.88 57.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 72.430000000000007 110.877 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -86.15 -33.11 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 61.210000000000001 111.531 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' C ' ' HG3' ' A' ' 76' ' ' PRO . 35.6 t0 -123.34 163.49 20.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.769 0.319 . . . . 73.209999999999994 110.965 -172.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.885 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 4.2 p -98.61 138.72 35.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.446 0.641 . . . . 73.439999999999998 109.818 173.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 30' ' ' LYS . 18.8 mmt85 -130.07 152.32 49.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.073 -0.967 . . . . 74.209999999999994 109.023 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t80 -107.52 112.05 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.455 -0.572 . . . . 74.109999999999999 109.455 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 28' ' ' VAL . . . -120.02 125.9 6.48 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.903 -0.665 . . . . 63.200000000000003 111.701 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.17 121.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.559 0.695 . . . . 64.310000000000002 109.617 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 2.1 t80 -113.48 125.67 54.48 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.001 -0.999 . . . . 73.150000000000006 109.678 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.588 ' CG ' HD21 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -103.62 140.66 37.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.587 0.708 . . . . 73.099999999999994 110.582 175.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.0 t -131.02 170.44 14.49 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.776 -0.824 . . . . 64.230000000000004 108.776 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.28 -34.16 89.18 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.983 -0.627 . . . . 34.130000000000003 112.757 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -81.68 -39.78 23.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.535 0.207 . . . . 54.439999999999998 111.502 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -164.59 171.67 14.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 110.773 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.51 140.84 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.458 -0.571 . . . . 74.239999999999995 109.458 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -122.04 116.36 24.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.554 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.69 109.18 12.68 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.977 -0.749 . . . . 55.530000000000001 108.977 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 115.37 32.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.402 0.62 . . . . 60.109999999999999 110.825 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 60.6 tp -119.41 81.93 1.79 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.185 -0.916 . . . . 72.230000000000004 109.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -89.6 118.22 29.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.985 -0.552 . . . . 74.109999999999999 109.77 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 13.9 p -102.34 147.95 34.73 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.865 -0.42 . . . . 63.039999999999999 109.865 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 54.1 Cg_endo -99.52 169.99 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.155 2.57 . . . . 71.530000000000001 113.291 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.64 -28.46 66.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.1 -0.954 . . . . 63.25 110.814 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -88.46 9.84 22.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.664 -0.698 . . . . 73.329999999999998 111.624 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . . . -107.28 111.25 63.31 Favored Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 122.061 -0.399 . . . . 74.400000000000006 111.247 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 7.0 Cg_exo -74.06 -166.76 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 65.340000000000003 112.238 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 31.0 m -75.56 -13.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 63.200000000000003 112.033 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 25.5 mtpp -69.27 -58.22 6.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.44 -0.345 . . . . 71.120000000000005 111.178 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.86 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 7.3 Cg_exo -74.28 -13.93 23.08 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.027 1.818 . . . . 51.439999999999998 111.32 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 2.7 tpt180 -60.92 -47.25 87.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 75.409999999999997 110.349 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -76.18 -14.51 60.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.581 . . . . 72.140000000000001 110.567 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -69.75 -43.97 71.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.048 -0.523 . . . . 71.200000000000003 110.952 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CE1' HD21 ' A' ' 73' ' ' LEU . 8.9 p90 -79.5 -30.1 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.558 -0.457 . . . . 73.219999999999999 111.272 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.85 -19.95 64.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.247 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -86.87 -53.15 5.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.653 -0.703 . . . . 70.299999999999997 110.649 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' HD13 ' A' ' 31' ' ' ILE . 4.1 m -68.39 -25.98 65.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.414 -0.812 . . . . 71.530000000000001 111.84 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -57.5 -27.63 62.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.462 0.541 . . . . 60.340000000000003 112.462 -175.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.64 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 27.6 t70 -76.68 -40.11 49.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.833 0.349 . . . . 73.420000000000002 110.934 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.66 91.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.826 -0.625 . . . . 64.540000000000006 111.267 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.657 HD21 HD13 ' A' ' 36' ' ' ILE . 3.9 mm? -63.8 -50.69 67.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 63.32 110.446 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 103' ' ' ALA . 36.5 tp -57.63 -30.17 65.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 74.239999999999995 110.958 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -76.74 -32.09 57.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.601 -0.727 . . . . 74.299999999999997 112.535 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -112.07 -14.61 13.41 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.37 1.248 . . . . 75.430000000000007 114.37 -166.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 68.5 mt -86.96 -45.38 10.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 118.111 -1.436 . . . . 73.109999999999999 112.903 -167.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 20.6 t70 -157.64 -167.07 2.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.438 -0.505 . . . . 65.25 111.124 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -90.33 15.36 60.11 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.385 -1.086 . . . . 74.109999999999999 110.385 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.35 179.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.42 1.088 . . . . 45.240000000000002 113.272 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -82.97 136.77 34.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.565 -0.743 . . . . 74.239999999999995 110.456 -169.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -79.16 5.39 12.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 61.149999999999999 112.466 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.7 148.36 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.947 0.404 . . . . 74.329999999999998 110.307 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.99 45.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.342 -0.614 . . . . 62.530000000000001 109.342 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 tp -122.64 118.41 28.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.817 0.341 . . . . 62.229999999999997 110.694 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 pt-20 -98.37 121.07 39.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.966 -0.561 . . . . 73.450000000000003 109.669 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.65 150.94 29.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 111.021 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -136.34 10.03 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 72.329999999999998 110.218 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 111' ' ' MET . 47.0 tt0 -131.34 167.18 19.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 73.530000000000001 110.095 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.419 ' N ' ' HG2' ' A' ' 110' ' ' GLU . 86.3 mtp -79.41 6.92 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.608 0.242 . . . . 64.030000000000001 111.52 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.91 -20.1 74.18 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.739 -0.743 . . . . 43.219999999999999 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.59 -37.29 73.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.296 0.569 . . . . 72.230000000000004 110.384 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 pp -89.62 14.46 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 74.140000000000001 110.829 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -87.81 162.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.223 -0.658 . . . . 71.319999999999993 109.223 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 34.2 Cg_endo -66.65 88.45 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 121.936 1.757 . . . . 72.5 113.026 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -77.66 -71.02 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.421 -0.585 . . . . 61.130000000000003 109.421 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.538 -0.744 . . . . 72.420000000000002 109.968 178.849 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.495 -0.058 . . . . 70.239999999999995 113.099 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.4 ptt? -84.9 159.04 20.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 65.310000000000002 110.704 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.46 119.99 4.03 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.811 -0.631 . . . . 70.040000000000006 111.778 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 36' ' ' ILE . 62.0 t -73.64 104.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.828 -0.804 . . . . 73.25 108.828 174.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -71.68 142.25 49.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.16 -0.473 . . . . 61.240000000000002 110.868 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 12' ' ' VAL . 20.9 pt-20 -64.83 -15.62 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.721 -0.672 . . . . 75.109999999999999 111.337 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -55.23 -40.55 71.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.849 -0.614 . . . . 55.539999999999999 110.23 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.1 t -73.89 -44.23 55.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 53.399999999999999 111.438 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 9' ' ' GLU . 34.5 m -72.81 -24.31 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 63.530000000000001 111.527 -175.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.54 70.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 64.109999999999999 110.876 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 33.2 mmt180 -75.33 -23.51 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 70.219999999999999 111.226 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 43.4 m-85 -82.82 -23.31 33.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.399 . . . . 73.319999999999993 109.99 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.77 84.93 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.381 -0.6 . . . . 70.040000000000006 109.381 171.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -71.73 -49.57 38.07 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.473 0.654 . . . . 71.25 109.505 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 16.5 tp -58.59 -47.72 83.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.695 -1.139 . . . . 73.019999999999996 112.179 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -73.3 -51.86 16.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.938 0.348 . . . . 74.25 111.938 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.61 -56.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.062 0.393 . . . . 75.329999999999998 112.062 -171.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -68.6 -26.3 65.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.711 0.291 . . . . 65.140000000000001 110.479 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 58.58 24.42 11.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.552 -0.749 . . . . 63.0 111.491 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 p -92.83 106.37 18.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.05 -1.463 . . . . 74.420000000000002 107.05 164.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 64' ' ' ASP . 7.6 p -87.46 136.63 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.656 0.741 . . . . 75.140000000000001 111.184 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 41' ' ' ASP . 19.0 ptpt -137.35 140.18 41.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.692 -1.14 . . . . 62.149999999999999 109.408 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 1.014 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.2 t90 -89.04 136.37 33.05 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.152 -1.425 . . . . 74.519999999999996 107.152 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.49 132.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.162 0.506 . . . . 73.510000000000005 110.642 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -106.52 110.5 31.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.45 -0.795 . . . . 73.109999999999999 109.278 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.624 ' HB3' HG22 ' A' ' 38' ' ' VAL . 2.6 p90 -115.58 159.5 21.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.645 0.736 . . . . 74.109999999999999 111.623 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 34.5 ttmt -123.25 125.36 44.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.775 -1.102 . . . . 73.209999999999994 109.242 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.854 HG12 HG23 ' A' ' 36' ' ' ILE . 56.4 mt -112.3 101.6 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.872 0.368 . . . . 71.549999999999997 111.167 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -159.6 170.28 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 73.310000000000002 110.383 175.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m120 53.0 39.38 29.35 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.743 0.652 . . . . 53.240000000000002 110.942 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' MET . 58.0 p 58.22 20.43 7.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.783 -1.099 . . . . 71.049999999999997 113.274 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 9.2 mmmm -129.88 137.81 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.111 0.481 . . . . 72.439999999999998 110.997 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.854 HG23 HG12 ' A' ' 31' ' ' ILE . 56.7 mt -103.15 108.77 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.77 -0.826 . . . . 72.420000000000002 108.77 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.96 135.87 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 71.349999999999994 111.498 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 29' ' ' PHE . 17.3 t -88.21 133.51 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 75.319999999999993 109.181 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' ' HG3' ' A' ' 40' ' ' LYS . 10.4 pt-20 -106.9 -18.47 13.91 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.806 -0.758 . . . . 73.129999999999995 110.854 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -145.06 140.88 28.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.221 -0.591 . . . . 72.209999999999994 111.803 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.613 ' HB3' HG22 ' A' ' 27' ' ' ILE . 10.6 p-10 -132.54 132.98 43.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.583 -1.265 . . . . 64.420000000000002 107.583 166.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.767 ' HA3' ' HG2' ' A' ' 48' ' ' GLU . . . -116.8 161.86 12.9 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.045 -1.074 . . . . 43.340000000000003 114.033 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.4 ptpp? -108.15 124.43 50.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.814 -0.81 . . . . 64.400000000000006 108.814 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.3 56.98 3.27 Favored Glycine 0 C--N 1.313 -0.72 0 N-CA-C 108.658 -1.777 . . . . 71.040000000000006 108.658 -169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.014 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 28.4 p-10 -41.99 -52.31 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.236 1.569 . . . . 72.540000000000006 115.236 -158.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.16 69.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.165 0.432 . . . . 65.230000000000004 112.165 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.65 -41.09 18.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.267 0.556 . . . . 70.439999999999998 110.327 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HG2' ' HA3' ' A' ' 42' ' ' GLY . 6.0 tp10 -48.11 -55.6 9.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.386 -1.279 . . . . 74.5 111.479 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 21.1 m-85 -74.61 -25.01 58.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.997 0.74 . . . . 75.140000000000001 112.997 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.721 ' HE ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 ttm105 -65.28 -21.0 66.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.222 0.534 . . . . 71.230000000000004 109.721 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.28 12.16 10.5 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.055 -0.593 . . . . 73.310000000000002 111.959 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -108.75 -25.21 10.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.444 0.164 . . . . 64.340000000000003 111.083 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 3.6 mm? -120.9 100.27 46.3 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-O 121.057 0.456 . . . . 74.099999999999994 111.992 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HB3' HD13 ' A' ' 114' ' ' LEU . 91.3 Cg_endo -101.2 37.35 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.777 2.985 . . . . 34.509999999999998 109.957 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.34 -35.44 30.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.083 -0.962 . . . . 74.400000000000006 112.732 -165.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 37.0 m-80 65.23 19.98 11.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.567 0.699 . . . . 61.439999999999998 109.65 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.43 151.73 23.17 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.958 -1.019 . . . . 60.439999999999998 109.667 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 6.6 p -87.47 133.54 33.74 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.916 -1.114 . . . . 75.510000000000005 108.907 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -151.47 169.14 22.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.147 -0.933 . . . . 70.030000000000001 109.18 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' HE1' ' HD2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -114.55 115.08 26.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.109 0.481 . . . . 62.5 109.921 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.752 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -123.63 136.44 10.36 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.876 -0.678 . . . . 75.0 112.401 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 15' ' ' PHE . 33.6 m -117.96 131.68 70.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.983 0.391 . . . . 64.319999999999993 110.519 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.786 ' HB2' HD22 ' A' ' 45' ' ' ASN . 0.5 OUTLIER -141.07 149.09 41.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.033 0.444 . . . . 73.409999999999997 111.334 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.588 ' HA ' HG12 ' A' ' 69' ' ' ILE . 19.0 t70 -92.03 144.32 25.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.524 -0.762 . . . . 72.040000000000006 110.176 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.622 ' SG ' ' HG2' ' A' ' 68' ' ' LYS . 12.1 p -135.44 175.15 9.85 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.001 -1.0 . . . . 61.509999999999998 108.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.33 -24.39 45.07 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 114.899 0.72 . . . . 42.340000000000003 114.899 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -121.54 -15.93 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.416 1.108 . . . . 62.149999999999999 113.032 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HG2' ' SG ' ' A' ' 65' ' ' CYS . 9.7 ptpt -163.3 168.35 20.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.162 -0.615 . . . . 72.010000000000005 112.052 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 64' ' ' ASP . 23.6 mt -113.27 123.77 69.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.028 -0.73 . . . . 74.430000000000007 109.028 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.02 133.82 43.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.358 -0.383 . . . . 71.0 111.434 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' HD2' ' HE1' ' A' ' 60' ' ' PHE . 10.8 m-85 -89.84 108.79 19.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 60.409999999999997 109.208 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.9 t -104.78 131.35 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.987 0.422 . . . . 61.409999999999997 111.602 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.3 tp -127.28 130.12 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.609 -0.723 . . . . 70.530000000000001 110.283 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 58' ' ' CYS . 19.1 m95 -90.17 159.36 16.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 109.936 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 31.0 p -86.14 151.87 54.91 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 44.229999999999997 109.557 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -74.7 79.4 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.293 1.995 . . . . 54.219999999999999 111.375 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.96 -38.96 64.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.633 -0.712 . . . . 54.43 110.233 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.11 9.22 28.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 70.310000000000002 110.253 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -126.68 165.54 27.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.633 . . . . 50.210000000000001 111.009 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.534 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 17.2 Cg_exo -68.92 175.69 7.08 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.939 2.426 . . . . 73.25 112.846 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.84 -8.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.067 -0.515 . . . . 74.329999999999998 111.852 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 67.2 tttt -67.71 -56.03 12.85 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 112.657 0.614 . . . . 74.319999999999993 112.657 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 52.5 Cg_exo -53.33 -40.2 78.74 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.285 1.99 . . . . 73.219999999999999 113.562 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 76' ' ' PRO . 57.8 ttp85 -60.47 -45.85 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 60.210000000000001 111.025 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.77 -26.95 66.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.151 0.5 . . . . 65.120000000000005 109.94 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.1 m -71.87 -48.2 47.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.271 -0.877 . . . . 74.129999999999995 111.652 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -61.37 -31.53 71.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.837 0.351 . . . . 74.420000000000002 111.408 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.33 69.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 70.340000000000003 111.719 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -71.29 -30.15 65.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 63.450000000000003 111.228 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 94' ' ' LEU . 3.2 p -97.63 12.48 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.275 -0.421 . . . . 62.210000000000001 111.825 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -57.24 -52.47 65.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.376 . . . . 71.209999999999994 111.694 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -76.56 -31.36 57.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 72.299999999999997 111.548 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.27 67.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.987 0.366 . . . . 53.009999999999998 111.987 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 36' ' ' ILE . 4.1 mm? -96.15 -42.22 8.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 72.109999999999999 109.997 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 103' ' ' ALA . 55.0 tp -55.47 -39.34 70.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 63.530000000000001 110.994 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -81.46 -21.59 38.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.435 -0.802 . . . . 65.530000000000001 112.191 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -32.5 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.818 0.673 . . . . 74.040000000000006 112.818 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.687 HD11 HD12 ' A' ' 94' ' ' LEU . 65.5 mt -88.13 -40.65 13.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.746 -0.782 . . . . 63.439999999999998 112.762 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -151.82 -174.23 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.455 -0.498 . . . . 74.540000000000006 111.038 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.75 13.6 66.05 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.338 -1.105 . . . . 74.239999999999995 110.338 172.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.48 177.28 0.05 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.111 0.964 . . . . 74.209999999999994 113.13 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 104' ' ' VAL . 4.9 m -85.45 140.38 30.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.417 -0.81 . . . . 73.239999999999995 111.106 -167.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -69.3 5.91 1.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.286 -0.87 . . . . 32.450000000000003 113.056 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 102' ' ' THR . 46.0 t -85.56 149.32 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.922 -0.399 . . . . 75.209999999999994 109.922 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -125.61 165.17 19.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.023 -0.362 . . . . 72.329999999999998 110.023 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 tt -133.21 117.77 17.82 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.7 -0.482 . . . . 72.420000000000002 109.7 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.96 132.92 53.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.48 -0.563 . . . . 73.219999999999999 109.48 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . . . -131.43 162.67 29.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.312 -0.404 . . . . 74.010000000000005 110.127 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.557 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 1.9 p80 -112.19 -158.6 0.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.119 -0.491 . . . . 74.319999999999993 111.145 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.478 ' H ' ' HB2' ' A' ' 109' ' ' HIS . 0.8 OUTLIER -51.15 157.23 0.93 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.161 0.8 . . . . 64.310000000000002 113.161 -170.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 64.4 mtm 79.61 -45.31 0.32 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.597 -1.183 . . . . 70.340000000000003 111.789 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.0 -19.1 21.33 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.862 0.705 . . . . 65.099999999999994 114.862 -171.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.15 -51.57 69.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.619 0.368 . . . . 63.329999999999998 111.263 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 114' ' ' LEU . 2.4 pt? -120.32 20.23 11.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 63.109999999999999 111.485 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -101.77 155.97 35.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.786 -0.449 . . . . 72.239999999999995 109.786 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.721 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 18.9 Cg_endo -59.61 100.18 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.492 2.128 . . . . 71.209999999999994 113.316 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 117' ' ' LEU . 4.8 mp -64.47 -54.11 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.808 -0.812 . . . . 75.030000000000001 108.808 171.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-N 114.69 -1.141 . . . . 74.230000000000004 108.985 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 1.4 tpt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.943 0.401 . . . . 65.439999999999998 110.583 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.22 -19.19 28.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 73.219999999999999 111.937 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 m -67.57 134.73 51.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.266 -0.425 . . . . 61.119999999999997 111.756 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 61.49 50.57 65.16 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.902 -0.59 . . . . 54.130000000000003 112.99 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 152.55 25.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 73.239999999999995 111.37 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.96 132.77 7.75 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.716 -0.954 . . . . 63.439999999999998 110.716 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 7.5 p -107.26 132.83 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.947 0.403 . . . . 63.32 111.247 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.19 139.25 33.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.757 -0.46 . . . . 62.020000000000003 109.757 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -13.83 62.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.2 0.444 . . . . 72.140000000000001 112.2 -173.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.8 -32.99 74.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.933 0.397 . . . . 65.140000000000001 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.6 m -64.41 -35.32 80.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.901 -0.59 . . . . 61.310000000000002 110.453 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.25 -31.55 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.847 -0.615 . . . . 73.510000000000005 110.23 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.55 -26.61 68.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.66 -0.7 . . . . 71.219999999999999 111.948 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -64.15 -20.11 65.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.945 -0.302 . . . . 64.209999999999994 111.525 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 40.7 m-85 -75.5 -18.24 59.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.29 0.478 . . . . 74.319999999999993 112.29 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -82.0 -23.41 36.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.017 -0.673 . . . . 64.040000000000006 110.35 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG2' HH11 ' A' ' 21' ' ' ARG . 1.1 tm-20 -84.1 -21.09 31.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.27 -1.011 . . . . 72.120000000000005 108.27 171.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 27.4 tp -84.17 -59.79 2.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.683 -1.144 . . . . 73.299999999999997 111.594 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -76.25 -43.94 39.64 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.375 -0.375 . . . . 73.5 111.82 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.1 mm -66.51 -44.21 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.431 . . . . 74.310000000000002 111.662 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' GLU . 58.5 mtp180 -80.51 -10.36 59.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.282 -0.417 . . . . 73.510000000000005 110.515 -177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.2 tttt 56.57 24.3 8.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.46 -0.791 . . . . 73.030000000000001 111.14 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -99.82 125.61 45.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.807 -0.812 . . . . 73.510000000000005 108.807 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 m -83.83 138.24 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.113 0.482 . . . . 75.099999999999994 110.051 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.477 0.656 . . . . 74.140000000000001 112.115 -172.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.762 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.9 t90 -142.54 123.76 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.427 -1.323 . . . . 54.140000000000001 107.427 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 41' ' ' ASP . 27.1 pt -119.22 138.98 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.427 -0.583 . . . . 65.209999999999994 109.427 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 5.9 p -115.83 120.29 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.839 0.828 . . . . 73.310000000000002 111.237 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -114.94 163.38 15.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.908 -1.042 . . . . 63.450000000000003 110.672 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -112.09 127.55 55.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.72 -0.673 . . . . 75.129999999999995 109.653 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 86' ' ' THR . 68.8 mt -113.04 100.29 10.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 71.420000000000002 110.214 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HA ' HG21 ' A' ' 86' ' ' THR . 8.8 tp10 -162.55 165.48 25.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.95 -1.13 . . . . 72.540000000000006 107.95 171.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 t30 60.6 29.38 18.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.739 0.781 . . . . 71.340000000000003 109.936 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 4' ' ' GLY . 50.0 p 57.52 26.97 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.446 -1.252 . . . . 55.399999999999999 112.9 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -125.55 136.75 53.65 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.213 -0.304 . . . . 72.239999999999995 110.613 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 94' ' ' LEU . 9.8 mm -106.34 107.14 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.353 -0.61 . . . . 53.439999999999998 109.353 172.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.56 142.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 -0.275 . . . . 74.230000000000004 110.467 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 1.8 m -79.91 146.39 7.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.794 0.331 . . . . 75.409999999999997 110.478 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' OE1' ' HD2' ' A' ' 59' ' ' ARG . 50.2 mt-10 -107.03 -18.54 13.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.327 -0.62 . . . . 75.530000000000001 109.327 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . 18.3 tppt? -160.54 145.62 14.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.531 -0.758 . . . . 70.219999999999999 110.812 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 27' ' ' ILE . 3.4 p30 -152.08 133.35 14.44 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.807 -0.812 . . . . 71.209999999999994 108.807 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.38 159.27 25.69 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.038 -1.077 . . . . 75.209999999999994 113.344 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -114.31 121.54 43.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.513 0.673 . . . . 74.040000000000006 109.71 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 29.44 1.4 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 108.238 -1.945 . . . . 64.25 108.238 -168.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -44.42 -53.4 6.91 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 115.492 1.664 . . . . 74.439999999999998 115.492 -160.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -69.5 -34.75 74.76 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.91 0.337 . . . . 74.510000000000005 111.91 -171.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.35 -43.81 11.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.583 0.706 . . . . 54.020000000000003 109.932 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.11 -53.52 56.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.485 -1.234 . . . . 63.109999999999999 111.518 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' HD1' ' HG ' ' A' ' 53' ' ' LEU . 13.8 m-85 -68.06 -19.05 64.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.871 . . . . 61.030000000000001 113.35 -172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 55.8 mtm-85 -66.33 -30.9 71.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.412 -0.515 . . . . 74.319999999999993 110.8 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.0 -20.13 9.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.821 . . . . 73.420000000000002 112.498 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -84.84 -16.45 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.86 0.319 . . . . 43.109999999999999 111.86 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 35.8 mt -111.99 92.12 17.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.978 0.732 . . . . 71.349999999999994 112.978 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 52' ' ' ALA . 73.9 Cg_endo -101.04 44.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.875 3.05 . . . . 64.299999999999997 108.902 162.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -51.47 -37.95 51.41 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 114.456 1.28 . . . . 75.010000000000005 114.456 -163.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 16.6 t-20 68.82 -46.36 0.55 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.473 0.483 . . . . 53.409999999999997 111.448 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.74 172.33 7.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.128 -0.487 . . . . 64.439999999999998 109.754 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 9.5 p -84.11 136.08 34.14 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.093 -0.643 . . . . 64.019999999999996 109.99 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HD2' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mmt85 -135.75 170.5 15.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.059 -1.089 . . . . 73.25 108.059 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 71' ' ' PHE . 2.2 t80 -117.3 119.07 34.01 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.335 -0.546 . . . . 71.299999999999997 110.996 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.762 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.07 135.3 10.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 73.200000000000003 112.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 2.8 p -106.02 123.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 72.239999999999995 110.385 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 2.4 t80 -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.232 -0.895 . . . . 73.239999999999995 109.323 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.53 141.79 31.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 75.400000000000006 111.505 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 60.7 m -131.08 169.55 15.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.421 -0.809 . . . . 63.200000000000003 109.44 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.9 66.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 33.520000000000003 112.478 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -72.45 -34.27 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 44.409999999999997 111.374 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -170.53 168.48 7.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 110.35 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.413 ' HB ' ' HB1' ' A' ' 101' ' ' ALA . 13.2 mt -122.33 118.16 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.271 -0.64 . . . . 63.119999999999997 109.271 170.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -112.92 129.14 56.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.321 0.581 . . . . 75.319999999999993 110.509 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.737 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.8 m-85 -78.57 114.06 17.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.314 -0.857 . . . . 74.530000000000001 109.471 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.36 127.04 43.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.315 0.578 . . . . 62.25 111.511 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 58.4 tp -131.14 107.1 8.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.094 -0.957 . . . . 73.109999999999999 110.029 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -85.62 130.29 34.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.871 -0.789 . . . . 72.340000000000003 108.871 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -78.14 148.27 74.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.82 0.343 . . . . 62.109999999999999 110.624 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.833 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.7 Cg_endo -89.43 115.54 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.584 2.189 . . . . 70.129999999999995 111.88 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.71 -19.34 41.69 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.48 0.657 . . . . 74.219999999999999 109.662 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -102.41 9.88 39.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.379 -0.828 . . . . 74.439999999999998 110.639 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -139.14 152.48 69.88 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 121.962 -0.461 . . . . 72.420000000000002 111.013 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 16.7 Cg_exo -68.7 -178.86 2.12 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.177 2.584 . . . . 70.5 113.232 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 85' ' ' MET . 9.1 p -84.64 -8.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 71.030000000000001 111.515 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 48.6 mtpt -68.25 -49.73 32.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.393 0.516 . . . . 74.340000000000003 112.393 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 26.9 Cg_endo -65.18 -31.54 53.79 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.4 1.4 . . . . 74.510000000000005 111.1 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.56 -39.09 92.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.158 -0.928 . . . . 75.109999999999999 110.698 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 22.1 mmt -61.34 -39.17 89.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.778 -0.647 . . . . 71.230000000000004 111.487 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.756 HG22 HG22 ' A' ' 31' ' ' ILE . 8.2 m -58.08 -43.85 87.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.811 0.339 . . . . 73.319999999999993 111.286 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.721 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 90.4 m-85 -66.43 -54.11 27.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 73.510000000000005 111.783 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.62 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 61.140000000000001 111.808 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -86.48 -45.16 11.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.358 -0.383 . . . . 71.209999999999994 111.382 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' ILE . 8.1 m -79.94 -11.18 59.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.41 -0.359 . . . . 70.049999999999997 111.691 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.09 -21.76 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 74.450000000000003 111.363 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.73 -37.01 81.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.348 -0.387 . . . . 54.539999999999999 110.55 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.74 71.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 72.319999999999993 110.683 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.0 mm? -73.54 -57.6 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 53.530000000000001 109.389 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' HA ' ' A' ' 103' ' ' ALA . 25.1 tp -54.63 -43.51 72.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.676 -1.147 . . . . 71.420000000000002 112.282 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -64.66 -25.17 67.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.979 -0.555 . . . . 74.109999999999999 111.585 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.27 -36.8 7.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.379 0.881 . . . . 64.310000000000002 113.379 -168.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 1.6 pp -87.11 -37.59 17.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.906 1.076 . . . . 75.099999999999994 113.906 -164.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 t70 -151.38 168.47 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.779 -0.769 . . . . 72.040000000000006 111.421 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.39 14.11 30.65 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.572 -0.74 . . . . 23.210000000000001 111.435 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.52 179.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.005 0.922 . . . . 71.5 112.645 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -83.4 140.28 32.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.594 -0.73 . . . . 74.239999999999995 110.333 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.797 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -78.23 -0.29 27.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 64.129999999999995 111.521 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.82 147.96 5.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.12 0.486 . . . . 64.019999999999996 109.728 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.97 157.77 30.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.99 -0.55 . . . . 74.010000000000005 109.581 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.82 116.54 32.19 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.675 -0.491 . . . . 73.120000000000005 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.67 127.58 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.971 -0.381 . . . . 74.019999999999996 109.971 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.21 119.04 32.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.96 0.409 . . . . 65.109999999999999 110.851 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -111.87 -11.23 13.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.139 -0.689 . . . . 73.209999999999994 109.139 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -93.14 -161.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.171 -0.922 . . . . 72.109999999999999 108.73 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.6 mtp -86.56 18.36 3.37 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.389 -0.194 . . . . 63.100000000000001 110.842 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.18 -33.36 74.67 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 114.416 0.526 . . . . 71.019999999999996 114.416 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.65 -51.66 68.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.099 0.476 . . . . 71.450000000000003 111.356 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 2.9 pp -96.49 12.42 31.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 65.340000000000003 111.397 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -87.73 165.35 30.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 71.230000000000004 109.98 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.661 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . 37.0 Cg_endo -67.38 89.56 0.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 121.937 1.758 . . . . 73.120000000000005 112.793 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 115' ' ' ALA . 5.6 mp -68.53 -39.7 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.219 -0.66 . . . . 74.030000000000001 109.219 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.419 -0.809 . . . . 53.039999999999999 109.186 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.684 0.278 . . . . 71.049999999999997 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 90' ' ' SER . . . -90.2 -19.7 23.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.703 0.631 . . . . 50.229999999999997 112.703 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t -64.42 144.93 56.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.152 -0.219 . . . . 51.350000000000001 110.843 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.92 39.47 97.58 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.381 -0.437 . . . . 65.109999999999999 112.726 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -92.17 174.28 7.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.256 0.55 . . . . 73.319999999999993 111.213 -178.006 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.35 118.59 3.57 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.749 -0.941 . . . . 64.409999999999997 110.749 171.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.06 124.59 37.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.668 -0.493 . . . . 74.310000000000002 109.668 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.9 147.18 24.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.901 0.382 . . . . 73.010000000000005 110.378 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 9' ' ' GLU . 6.2 pt-20 -74.81 -13.06 60.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 61.420000000000002 112.431 -174.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -54.9 -27.75 45.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.935 0.398 . . . . 75.140000000000001 111.024 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.96 -56.21 14.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 65.239999999999995 110.797 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.96 -27.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.517 -0.31 . . . . 74.420000000000002 111.558 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -30.82 71.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.259 0.552 . . . . 73.040000000000006 110.434 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -72.32 -38.56 68.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.808 -0.633 . . . . 73.219999999999999 110.652 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 82.5 m-85 -60.75 -28.84 69.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.572 -0.285 . . . . 74.239999999999995 111.252 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -62.63 -47.22 84.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 65.420000000000002 110.375 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 31.8 mt-10 -67.25 -37.19 83.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 63.25 110.035 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' H ' ' A' ' 25' ' ' LYS . 21.5 tp -57.61 -47.93 80.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.996 -1.002 . . . . 72.329999999999998 111.052 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -83.43 -58.9 2.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.347 0.499 . . . . 72.540000000000006 112.347 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.81 -47.55 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.452 0.538 . . . . 63.450000000000003 112.452 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 82.7 mtp180 -72.53 -11.52 60.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.507 0.194 . . . . 75.540000000000006 111.193 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 39.7 ttmt 58.95 24.15 12.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.093 0.949 . . . . 72.409999999999997 110.136 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -105.76 122.44 46.08 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.104 -0.953 . . . . 72.140000000000001 108.544 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.39 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.758 -0.777 . . . . 54.119999999999997 110.608 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' H ' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -137.94 147.44 44.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 75.510000000000005 110.314 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 4.0 t90 -109.5 124.99 52.0 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.75 -1.574 . . . . 71.349999999999994 106.75 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.495 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 29.3 pt -108.43 122.16 62.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.614 -0.834 . . . . 73.420000000000002 110.668 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.87 114.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.265 -0.643 . . . . 72.340000000000003 109.265 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -112.99 160.2 18.35 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.544 -0.753 . . . . 72.010000000000005 111.038 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 3.2 tppp? -113.46 124.47 52.49 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.092 -0.958 . . . . 63.130000000000003 108.518 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 94' ' ' LEU . 70.3 mt -109.12 101.53 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.027 0.442 . . . . 71.230000000000004 110.576 -175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.21 162.09 31.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.554 -0.748 . . . . 61.100000000000001 109.323 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 t30 58.88 40.06 23.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.038 0.447 . . . . 71.129999999999995 111.282 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.6 p 56.54 19.31 4.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.802 0.841 . . . . 74.549999999999997 113.168 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -127.98 128.54 45.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 73.409999999999997 111.07 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mm -93.42 107.99 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 72.209999999999994 108.685 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.13 134.37 66.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.709 -0.223 . . . . 63.329999999999998 110.477 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 29' ' ' PHE . 21.3 t -91.56 134.14 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.139 -0.689 . . . . 75.140000000000001 109.139 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.08 -18.02 12.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.184 -0.672 . . . . 74.420000000000002 109.184 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -144.64 142.78 30.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.565 0.698 . . . . 72.450000000000003 112.723 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 27' ' ' ILE . 3.2 p-10 -131.78 131.69 43.15 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.515 -1.661 . . . . 74.019999999999996 106.515 161.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . -107.37 144.68 16.0 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.747 -1.216 . . . . 73.219999999999999 113.524 -167.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 3.7 ptpp? -109.21 121.37 45.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.328 -0.989 . . . . 72.209999999999994 108.328 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.48 49.67 7.15 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.596 -2.202 . . . . 43.030000000000001 107.596 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.978 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 26.8 p-10 -45.09 -51.48 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.469 1.285 . . . . 71.400000000000006 114.469 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.13 -23.51 51.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.701 0.286 . . . . 34.210000000000001 111.768 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.35 -43.08 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.57 -0.286 . . . . 65.230000000000004 111.189 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.83 -53.92 52.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 72.040000000000006 110.867 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 33.3 m-85 -68.56 -10.36 55.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.974 0.731 . . . . 73.340000000000003 112.974 -172.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -68.02 -15.81 63.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.178 0.513 . . . . 74.230000000000004 109.838 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.18 9.19 1.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.929 -0.653 . . . . 34.229999999999997 112.339 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -76.85 -54.43 6.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 74.209999999999994 111.073 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.03 78.37 12.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.859 -0.336 . . . . 73.0 111.802 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.69 77.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.165 2.577 . . . . 65.120000000000005 110.387 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.49 -14.11 57.37 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.99 0.737 . . . . 64.219999999999999 112.99 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 14.4 m120 68.25 8.92 6.9 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.278 0.561 . . . . 54.140000000000001 110.737 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -117.26 163.52 16.2 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.034 -0.728 . . . . 72.129999999999995 109.034 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 4.9 p -79.37 135.43 36.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 122.295 1.045 . . . . 72.530000000000001 110.414 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.91 32.85 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.873 -1.512 . . . . 73.510000000000005 108.938 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.0 t80 -102.24 122.22 43.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.927 0.394 . . . . 64.120000000000005 110.644 -173.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -122.31 135.95 10.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.16 -0.543 . . . . 75.150000000000006 112.161 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.272 0.536 . . . . 52.229999999999997 110.74 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.629 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -146.24 148.74 32.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.275 -0.42 . . . . 75.549999999999997 111.388 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.805 ' HA ' HG12 ' A' ' 69' ' ' ILE . 26.7 t70 -69.4 144.87 53.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 73.040000000000006 109.85 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 12.9 t -133.45 173.18 11.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.172 -0.677 . . . . 74.549999999999997 109.172 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -40.29 92.48 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.164 -0.541 . . . . 65.349999999999994 113.824 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -99.75 -46.36 5.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.376 0.588 . . . . 61.32 110.93 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' CYS . 0.3 OUTLIER -141.75 177.34 8.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.764 -0.653 . . . . 73.319999999999993 110.116 -171.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.805 HG12 ' HA ' ' A' ' 64' ' ' ASP . 11.4 mt -100.45 123.22 53.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.978 -0.749 . . . . 62.25 108.978 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -101.49 121.82 42.67 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.623 -0.431 . . . . 62.450000000000003 111.222 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.429 ' CE2' HD12 ' A' ' 98' ' ' LEU . 15.1 m-85 -78.01 109.01 11.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.774 -0.825 . . . . 73.239999999999995 108.774 168.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 113.85 40.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.504 0.669 . . . . 61.140000000000001 111.203 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 45.7 tp -113.94 112.16 22.86 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.354 -0.839 . . . . 73.239999999999995 109.51 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.698 ' HZ2' ' HG2' ' A' ' 111' ' ' MET . 37.4 t90 -85.19 123.22 30.44 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.617 -0.882 . . . . 73.420000000000002 108.617 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 60.8 m -70.8 149.06 95.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.011 -0.54 . . . . 62.450000000000003 110.834 -173.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.808 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 17.1 Cg_exo -67.28 101.21 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.166 . . . . 64.140000000000001 111.559 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.03 -34.38 20.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.029 -0.532 . . . . 61.020000000000003 109.805 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -98.44 9.74 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 72.530000000000001 109.903 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -139.98 155.08 71.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.042 -0.527 . . . . 55.530000000000001 110.07 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -151.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.973 2.449 . . . . 73.409999999999997 113.603 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 -25.59 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.897 1.073 . . . . 65.549999999999997 113.897 -166.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 68.2 mttm -68.59 -48.93 31.64 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.573 0.582 . . . . 73.329999999999998 112.573 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.584 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 14.2 Cg_endo -57.74 -27.53 78.17 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.727 1.618 . . . . 44.219999999999999 111.758 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -69.8 -40.43 75.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 74.519999999999996 109.726 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.04 -26.79 62.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 75.409999999999997 111.297 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.4 m -57.08 -52.76 64.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 74.409999999999997 110.518 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' OH ' ' HD3' ' A' ' 30' ' ' LYS . 96.7 m-85 -76.18 -37.94 57.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 73.219999999999999 111.192 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.24 65.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 74.319999999999993 111.595 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.2 t -88.08 -50.25 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.247 0.546 . . . . 72.530000000000001 110.458 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 8.6 p -75.86 -11.99 60.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.606 -0.725 . . . . 72.140000000000001 112.43 -171.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -61.47 -24.31 66.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.035 0.383 . . . . 72.299999999999997 112.035 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 51.0 m-20 -83.76 -31.74 25.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.449 . . . . 73.099999999999994 110.347 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.3 -38.37 63.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.578 . . . . 70.150000000000006 110.394 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.611 HD11 HD11 ' A' ' 31' ' ' ILE . 64.9 mt -56.9 -47.35 80.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.488 -0.56 . . . . 65.540000000000006 109.488 173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 37.9 tp -62.17 -21.74 65.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.968 -1.015 . . . . 75.120000000000005 112.17 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -76.59 -15.08 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.52 0.676 . . . . 74.420000000000002 110.411 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -111.65 -4.58 14.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.044 0.926 . . . . 61.299999999999997 108.921 176.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB2' ' HA ' ' A' ' 95' ' ' LEU . 6.5 mt -111.96 13.18 20.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.666 -1.606 . . . . 70.319999999999993 112.608 -169.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' ALA . 5.7 m-20 -33.61 -145.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 128.041 2.536 . . . . 70.129999999999995 116.741 -152.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.2 16.13 0.02 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 117.729 1.852 . . . . 61.310000000000002 117.729 -151.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -55.73 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.161 -1.051 . . . . 61.549999999999997 108.161 152.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 69' ' ' ILE . 5.4 m -77.84 117.81 19.56 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.301 -1.499 . . . . 74.519999999999996 109.834 -167.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -85.42 4.37 35.81 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.273 -1.33 . . . . 54.119999999999997 111.963 -169.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 t -85.55 146.92 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.775 -0.454 . . . . 73.540000000000006 109.775 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -126.18 146.1 50.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.027 -0.533 . . . . 50.219999999999999 109.688 176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.13 118.28 25.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.202 -0.454 . . . . 52.229999999999997 109.916 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 7.2 pt-20 -96.5 117.47 30.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.462 0.649 . . . . 72.230000000000004 110.635 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.6 119.9 32.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 62.130000000000003 109.621 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -99.37 -13.54 19.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.01 0.433 . . . . 74.049999999999997 110.892 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -105.4 166.57 10.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.588 -0.893 . . . . 72.329999999999998 108.588 169.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.698 ' HG2' ' HZ2' ' A' ' 74' ' ' TRP . 38.7 mtp -78.28 70.52 4.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.553 0.692 . . . . 53.520000000000003 111.262 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.46 -16.0 74.79 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.072 -0.967 . . . . 42.439999999999998 110.938 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -62.13 -31.94 72.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.228 -0.486 . . . . 71.329999999999998 111.615 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.13 19.23 20.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.387 0.613 . . . . 61.200000000000003 110.788 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.17 154.84 44.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.731 -0.668 . . . . 43.210000000000001 109.865 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.51 104.28 0.52 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.28 1.986 . . . . 52.439999999999998 112.294 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.23 -31.97 11.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.501 0.667 . . . . 73.230000000000004 109.68 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.267 -0.879 . . . . 73.120000000000005 109.313 177.9 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 3' ' ' SER . 52.6 ttm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.247 -0.279 . . . . 74.439999999999998 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 5' ' ' MET . . . -90.92 -19.63 23.1 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 111.797 0.295 . . . . 72.200000000000003 111.797 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.519 ' H ' ' HG2' ' A' ' 1' ' ' MET . 20.5 m -60.02 141.84 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 64.120000000000005 111.312 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.94 48.77 81.41 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.685 -0.566 . . . . 62.329999999999998 111.685 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.571 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -85.99 152.1 23.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.434 0.635 . . . . 73.030000000000001 112.009 -176.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 125.27 5.08 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.998 -1.001 . . . . 72.420000000000002 110.682 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 44.8 t -89.78 132.59 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.731 0.266 . . . . 63.439999999999998 110.479 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.84 140.37 45.72 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.101 -0.333 . . . . 71.200000000000003 110.101 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -62.81 -28.97 70.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.981 0.419 . . . . 74.129999999999995 111.039 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.23 -28.7 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 71.420000000000002 111.01 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 74.109999999999999 110.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 HD22 ' A' ' 98' ' ' LEU . 14.1 t -78.65 -34.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 71.5 110.757 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -25.66 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.807 -0.633 . . . . 53.32 112.219 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.707 ' HG2' HG21 ' A' ' 27' ' ' ILE . 15.6 tpt180 -66.56 -17.35 64.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 73.430000000000007 111.468 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 18' ' ' LEU . 58.7 m-85 -74.42 -19.26 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.046 0.387 . . . . 74.140000000000001 112.046 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -77.25 -26.33 52.41 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.882 -0.727 . . . . 55.450000000000003 110.054 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -69.2 -33.39 73.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 65.329999999999998 109.541 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 15' ' ' PHE . 65.2 mt -70.08 -48.33 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.803 -1.089 . . . . 71.329999999999998 111.105 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -82.08 -55.07 4.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.454 -0.794 . . . . 71.519999999999996 112.609 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.96 -48.0 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.151 0.426 . . . . 74.400000000000006 112.151 -171.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -81.32 -11.09 59.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.172 -0.211 . . . . 71.150000000000006 111.076 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 59.13 23.6 11.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.143 -0.481 . . . . 72.129999999999995 110.348 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -101.76 117.63 35.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.068 -0.514 . . . . 74.209999999999994 109.708 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.22 135.92 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.443 0.639 . . . . 71.319999999999993 110.654 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -138.48 161.13 37.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.58 -0.896 . . . . 71.409999999999997 108.58 177.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.6 t90 -112.78 123.49 50.42 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.786 -0.82 . . . . 73.450000000000003 108.786 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 14' ' ' ARG . 43.4 pt -110.75 131.29 62.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.642 -0.503 . . . . 74.109999999999999 109.642 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 53' ' ' LEU . 93.4 t -113.18 113.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.38 -0.373 . . . . 75.310000000000002 110.304 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 44.1 p90 -102.06 151.51 22.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.473 0.654 . . . . 63.340000000000003 110.508 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 3.8 tmmm? -114.58 124.11 51.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.057 -0.974 . . . . 75.319999999999993 108.641 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 87' ' ' TYR . 48.3 mt -88.88 103.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.719 -0.673 . . . . 52.009999999999998 109.665 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 30' ' ' LYS . 25.0 tt0 -139.64 139.3 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 73.140000000000001 111.019 -168.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 t30 49.93 46.4 24.32 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.872 0.733 . . . . 70.310000000000002 111.581 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' MET . 70.3 p 55.61 25.46 8.1 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.497 0.719 . . . . 73.409999999999997 112.666 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HG2' HG13 ' A' ' 37' ' ' VAL . 7.1 ttpm? -133.71 137.39 45.23 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.013 -0.43 . . . . 75.400000000000006 110.414 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 43.9 mm -95.09 109.37 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.951 -0.568 . . . . 54.340000000000003 110.1 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG13 ' HG2' ' A' ' 35' ' ' LYS . 16.3 m -133.8 135.47 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.026 0.441 . . . . 75.120000000000005 110.887 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.935 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.2 p -89.17 140.24 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 71.430000000000007 110.038 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.98 -35.43 13.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.922 0.392 . . . . 74.310000000000002 110.31 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 8.9 ptmt -171.75 165.45 6.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 64.239999999999995 111.686 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG22 ' A' ' 27' ' ' ILE . 4.9 p-10 -142.98 158.62 43.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.911 . . . . 65.450000000000003 108.726 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.77 148.67 20.23 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.259 -1.448 . . . . 61.020000000000003 114.951 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.71 129.35 40.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.556 -1.275 . . . . 75.120000000000005 107.556 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.99 35.86 7.99 Favored Glycine 0 C--O 1.208 -1.489 0 N-CA-C 108.294 -1.922 . . . . 54.509999999999998 108.294 -161.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.909 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 7.4 p30 -44.41 -53.11 7.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.996 1.11 . . . . 75.400000000000006 113.996 -173.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.02 -14.35 58.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.439 0.638 . . . . 61.210000000000001 110.68 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.98 -49.16 6.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.936 . . . . 71.200000000000003 110.885 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 49' ' ' PHE . 1.1 pt-20 -81.2 -36.04 30.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.895 -1.048 . . . . 73.219999999999999 111.185 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 9.3 m-85 -72.46 -4.47 30.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.108 0.41 . . . . 73.209999999999994 112.108 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -72.83 -13.98 61.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.063 0.459 . . . . 75.540000000000006 110.102 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.65 11.96 2.68 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.0 -0.619 . . . . 61.100000000000001 112.424 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -111.51 12.58 21.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 64.519999999999996 111.389 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 28' ' ' VAL . 75.0 mt -117.83 140.78 28.14 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 72.209999999999994 111.172 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 14.5 Cg_exo -69.14 105.17 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.773 2.315 . . . . 64.409999999999997 111.278 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -12.53 61.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.967 -0.561 . . . . 63.149999999999999 111.858 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.43 -19.08 24.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.378 -0.373 . . . . 70.299999999999997 111.214 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -120.73 173.41 7.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.257 -0.429 . . . . 63.340000000000003 110.257 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 6.9 p -97.99 139.09 34.33 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.302 -0.629 . . . . 73.25 109.302 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.9 mmt-85 -134.09 151.83 51.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.957 -0.565 . . . . 71.530000000000001 110.043 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.18 105.18 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.128 0.489 . . . . 75.25 109.746 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -113.3 135.03 12.28 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.818 -0.628 . . . . 52.100000000000001 111.743 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 71' ' ' PHE . 27.1 m -125.85 129.09 72.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.255 0.55 . . . . 44.229999999999997 110.224 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -140.36 147.18 39.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.015 -0.538 . . . . 62.240000000000002 110.216 177.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.36 143.3 27.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 110.414 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 34.0 t -122.73 169.56 10.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.518 -0.919 . . . . 71.299999999999997 108.518 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.64 -24.18 59.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.105 -0.569 . . . . 70.420000000000002 114.084 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -126.94 4.91 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.463 0.631 . . . . 73.519999999999996 112.577 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 13.0 ptmt -169.6 151.8 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.222 0.823 . . . . 74.329999999999998 113.222 -169.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.8 mm -100.13 125.58 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.277 -0.874 . . . . 71.430000000000007 108.802 167.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mt-30 -116.25 114.95 25.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.471 -0.492 . . . . 74.0 111.975 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.653 ' HA ' HG12 ' A' ' 62' ' ' VAL . 29.9 m-85 -85.14 109.54 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 73.209999999999994 109.197 170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.67 126.07 64.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.008 0.432 . . . . 75.129999999999995 110.949 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 62.9 tp -133.3 108.02 8.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 60.240000000000002 110.521 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.408 ' HD1' ' HB3' ' A' ' 108' ' ' ALA . 63.2 t90 -85.47 119.96 26.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.712 -0.847 . . . . 63.210000000000001 108.712 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -74.52 148.22 85.45 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.018 -0.273 . . . . 65.299999999999997 110.296 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.799 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 71.6 Cg_endo -78.77 121.25 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.321 2.014 . . . . 74.049999999999997 113.47 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.06 -20.12 30.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.55 -0.75 . . . . 54.329999999999998 110.246 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.69 16.11 21.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.538 0.685 . . . . 71.299999999999997 110.31 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -140.66 155.68 69.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 74.439999999999998 109.85 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -76.43 -165.97 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.396 2.731 . . . . 63.310000000000002 113.622 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.67 -24.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.768 0.655 . . . . 54.439999999999998 112.768 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 61.8 mttp -67.05 -48.74 48.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 119.281 -0.39 . . . . 61.039999999999999 111.936 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 Cg_exo -55.82 -41.01 81.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.416 1.41 . . . . 74.219999999999999 111.468 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -62.86 -51.16 68.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.481 -0.781 . . . . 73.400000000000006 111.221 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 82' ' ' LYS . 26.0 ptt? -68.78 -24.35 64.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 53.439999999999998 110.925 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.1 m -62.93 -56.17 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.404 -0.362 . . . . 64.439999999999998 110.42 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m-85 -60.97 -37.0 80.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 75.239999999999995 111.033 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.27 -31.25 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 63.329999999999998 111.777 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 t -66.36 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 64.209999999999994 110.901 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' HD13 ' A' ' 31' ' ' ILE . 2.0 p -87.19 7.4 28.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.167 -0.47 . . . . 52.020000000000003 112.078 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.615 ' O ' HD13 ' A' ' 95' ' ' LEU . 15.9 tttm -57.45 -55.55 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 75.530000000000001 111.338 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.443 ' HA ' HD22 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -76.75 -21.64 54.95 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.17 -0.468 . . . . 51.509999999999998 110.332 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.43 92.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.447 -0.797 . . . . 70.340000000000003 110.889 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.75 HD12 HD11 ' A' ' 98' ' ' LEU . 4.6 mm? -77.64 -37.25 50.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 70.030000000000001 110.276 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 91' ' ' LYS . 4.8 mp -57.04 -43.04 81.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.584 0.706 . . . . 72.25 110.366 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.55 -10.48 59.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.907 -1.042 . . . . 73.230000000000004 111.956 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' A' ' 7' ' ' VAL . 52.9 tptt -106.24 -48.58 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.271 0.841 . . . . 74.439999999999998 113.271 -169.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 94' ' ' LEU . 17.8 mt -89.0 -45.05 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.765 1.024 . . . . 70.230000000000004 113.765 -162.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 4.8 t70 -156.54 -166.53 2.16 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.467 -0.493 . . . . 74.099999999999994 111.254 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -88.09 16.18 52.86 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 110.722 -0.951 . . . . 75.310000000000002 110.722 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.81 179.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.268 1.027 . . . . 75.010000000000005 113.034 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.588 HG22 HG23 ' A' ' 104' ' ' VAL . 2.1 m -83.36 139.95 32.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.838 -0.619 . . . . 72.540000000000006 110.764 -167.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -81.16 2.01 29.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.576 -0.738 . . . . 45.219999999999999 112.048 -174.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' THR . 40.6 t -76.69 147.08 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.906 0.384 . . . . 64.099999999999994 110.279 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.16 144.36 34.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.302 -0.629 . . . . 54.340000000000003 109.302 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -118.93 118.64 32.07 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.179 -0.209 . . . . 62.119999999999997 110.482 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.0 pt-20 -104.04 118.56 36.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.364 0.602 . . . . 74.310000000000002 110.129 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 74' ' ' TRP . . . -97.51 143.08 28.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 65.439999999999998 110.678 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -6.09 6.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 65.129999999999995 109.473 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.75 -162.03 1.18 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.77 -1.105 . . . . 70.430000000000007 109.691 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.9 mtp -85.57 28.2 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.746 0.308 . . . . 71.120000000000005 111.259 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.36 -23.02 59.44 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.838 -0.696 . . . . 72.409999999999997 111.871 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.39 -51.81 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.221 0.534 . . . . 44.25 110.478 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 114' ' ' LEU . 1.3 pt? -84.25 23.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 65.25 111.051 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -117.56 160.57 37.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.339 -0.615 . . . . 75.530000000000001 109.339 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 13.2 Cg_endo -56.28 107.89 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.41 2.073 . . . . 71.230000000000004 112.403 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.1 mp -76.12 -32.6 59.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 75.099999999999994 110.097 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.669 -0.696 . . . . 60.020000000000003 109.787 177.461 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.572 0.225 . . . . 73.349999999999994 110.437 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.52 -20.56 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.091 0.472 . . . . 65.209999999999994 111.06 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -80.02 151.11 30.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.906 -0.588 . . . . 55.310000000000002 111.064 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.05 29.69 75.16 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.307 -0.861 . . . . 72.129999999999995 113.959 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.39 144.07 33.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.106 0.453 . . . . 73.109999999999999 109.878 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.49 116.49 5.59 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.081 -0.808 . . . . 74.120000000000005 111.081 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.44 130.66 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.754 0.311 . . . . 72.540000000000006 111.05 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.61 131.03 44.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 34.109999999999999 111.362 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.2 -18.02 37.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.915 -0.584 . . . . 44.229999999999997 111.641 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -68.1 -25.44 65.32 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.631 0.253 . . . . 44.329999999999998 110.642 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -53.12 -45.2 68.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 75.099999999999994 110.867 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t -61.72 -39.68 84.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.208 -0.451 . . . . 63.009999999999998 111.092 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.99 68.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 54.539999999999999 111.183 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 14' ' ' ARG . 22.0 mmt180 -75.65 -18.73 59.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.209999999999994 111.364 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 88.1 m-85 -84.0 -21.91 31.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.355 0.598 . . . . 73.099999999999994 109.444 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -45.27 44.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 74.010000000000005 109.267 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 21' ' ' ARG . 11.0 mm-40 -65.16 -15.63 62.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.193 0.521 . . . . 74.129999999999995 110.696 171.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 23.7 tp -86.58 -61.59 1.7 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.761 -0.654 . . . . 34.149999999999999 111.002 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -82.51 -50.6 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.379 0.511 . . . . 63.229999999999997 112.379 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.5 mm -68.41 -28.51 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 74.109999999999999 110.777 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 17' ' ' GLU . 39.5 mmt180 -85.91 -10.54 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 74.540000000000006 110.691 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 59.37 45.25 14.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.974 -0.557 . . . . 73.430000000000007 111.798 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 18' ' ' LEU . 13.8 t -143.59 151.98 40.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.385 -0.598 . . . . 74.450000000000003 109.385 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG12 ' OD2' ' A' ' 64' ' ' ASP . 33.1 m -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.596 -0.442 . . . . 71.219999999999999 110.677 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -140.69 164.23 30.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.379 0.609 . . . . 72.239999999999995 111.424 173.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 5.8 t90 -129.57 123.58 31.71 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.218 -1.03 . . . . 75.510000000000005 108.218 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.925 HG22 ' HB2' ' A' ' 41' ' ' ASP . 15.0 pt -116.15 134.56 59.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.697 -0.483 . . . . 72.129999999999995 109.697 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.1 109.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.138 0.494 . . . . 62.43 110.913 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -101.91 147.84 26.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 73.420000000000002 109.638 175.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -113.99 125.29 53.84 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.103 0.478 . . . . 72.230000000000004 110.802 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.75 HG12 HD12 ' A' ' 36' ' ' ILE . 62.2 mt -83.07 103.43 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.587 -0.894 . . . . 72.340000000000003 108.587 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -146.35 139.89 25.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 71.510000000000005 110.541 -173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.69 31.15 20.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 74.5 110.118 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 65.97 20.13 11.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.593 -0.73 . . . . 54.210000000000001 110.655 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -130.02 143.61 50.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.593 -0.73 . . . . 64.129999999999995 110.098 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.75 HD12 HG12 ' A' ' 31' ' ' ILE . 10.7 mm -111.91 111.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 64.409999999999997 110.58 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.7 154.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.736 0.303 . . . . 75.430000000000007 110.412 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 11.4 t -83.49 132.44 31.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.082 -0.508 . . . . 63.229999999999997 110.396 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.23 -37.74 32.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.92 -0.77 . . . . 62.130000000000003 108.92 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 10.9 ptmm? -173.56 164.66 4.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.041 -0.982 . . . . 72.530000000000001 110.039 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.925 ' HB2' HG22 ' A' ' 27' ' ' ILE . 2.3 p-10 -126.19 148.07 49.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.801 -1.185 . . . . 64.400000000000006 107.801 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.0 161.52 12.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.92 -1.133 . . . . 51.149999999999999 113.977 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -137.49 129.27 28.69 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 52.409999999999997 106.782 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.8 36.99 35.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.016 -2.033 . . . . 70.219999999999999 108.016 -159.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 2.5 m-20 -44.56 -52.77 7.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.398 -1.401 . . . . 71.420000000000002 113.933 -163.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -66.02 -34.85 79.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.13 -0.486 . . . . 73.120000000000005 111.208 -172.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -89.57 -34.95 16.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.882 0.372 . . . . 65.209999999999994 111.108 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 7.8 tt0 -62.17 -50.22 72.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 71.049999999999997 110.611 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.65 -0.6 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.166 0.432 . . . . 73.319999999999993 112.166 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 48.5 mtp180 -81.27 -15.35 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 75.420000000000002 110.832 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.05 -19.85 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.106 -1.045 . . . . 72.129999999999995 113.63 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -58.51 -59.52 5.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 70.129999999999995 110.807 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.27 85.94 4.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.836 -0.62 . . . . 74.420000000000002 110.223 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.28 117.92 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.047 1.831 . . . . 75.239999999999995 109.594 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.61 78.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.006 0.373 . . . . 72.030000000000001 112.006 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.5 t30 67.12 -47.28 0.48 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.622 0.769 . . . . 71.109999999999999 111.144 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.41 172.04 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 72.340000000000003 108.63 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 5.4 p -78.8 139.55 38.37 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.535 -0.466 . . . . 73.439999999999998 110.478 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -151.1 163.79 37.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.989 -0.745 . . . . 74.230000000000004 108.989 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.734 ' HD2' ' HE1' ' A' ' 29' ' ' PHE . 6.9 t80 -109.73 116.05 30.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.503 0.668 . . . . 52.130000000000003 110.419 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.713 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.29 135.23 10.5 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 115.377 -0.829 . . . . 64.540000000000006 111.829 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 27' ' ' ILE . 34.0 m -105.34 122.45 58.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 117.465 0.633 . . . . 64.209999999999994 110.362 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 6.2 t80 -135.59 132.26 36.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.523 -0.762 . . . . 63.329999999999998 109.684 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' OD2' HG12 ' A' ' 24' ' ' VAL . 10.0 p-10 -102.91 143.32 32.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.686 0.755 . . . . 74.230000000000004 111.023 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.7 t -112.38 169.62 8.75 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.401 -0.963 . . . . 73.510000000000005 108.401 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.53 -24.75 68.08 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.755 -0.736 . . . . 44.229999999999997 112.511 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -95.99 -46.51 6.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.782 0.29 . . . . 74.400000000000006 111.782 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.94 167.81 27.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.541 0.21 . . . . 73.129999999999995 110.688 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.407 HG12 ' CB ' ' A' ' 64' ' ' ASP . 7.6 mt -100.7 139.3 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.551 -0.537 . . . . 70.319999999999993 109.551 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -117.65 118.3 31.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.942 0.401 . . . . 72.549999999999997 110.71 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.42 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 61.4 m-85 -79.44 110.04 14.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.844 -0.798 . . . . 71.409999999999997 108.844 171.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.198 -0.455 . . . . 65.319999999999993 111.385 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 63.7 tp -141.18 82.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.526 -0.761 . . . . 61.140000000000001 109.489 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -85.71 149.36 25.35 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.647 -0.501 . . . . 75.409999999999997 109.647 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 57.8 m -97.8 147.28 32.81 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.832 -0.433 . . . . 72.5 109.832 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 7.7 Cg_endo -91.78 144.11 2.94 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.146 2.564 . . . . 52.140000000000001 112.798 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -80.36 -7.03 58.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.608 0.718 . . . . 65.230000000000004 109.583 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -107.46 15.64 24.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.052 -0.976 . . . . 74.450000000000003 110.334 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . . . -141.65 154.39 66.15 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 121.866 -0.521 . . . . 53.409999999999997 111.028 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 19.0 Cg_endo -91.59 -178.33 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.135 2.557 . . . . 65.230000000000004 112.801 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.33 3.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.853 -0.612 . . . . 65.439999999999998 112.077 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 ttmt -68.32 -58.1 7.87 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 121.195 -0.202 . . . . 73.010000000000005 110.954 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' O ' ' HD1' ' A' ' 87' ' ' TYR . 60.0 Cg_endo -74.05 -26.93 12.45 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.222 1.281 . . . . 34.219999999999999 111.579 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -32.49 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 65.230000000000004 111.104 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.9 -29.57 55.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.120000000000005 110.746 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -66.66 -44.85 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 74.319999999999993 110.634 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.547 ' CD2' HD12 ' A' ' 31' ' ' ILE . 77.1 m-85 -64.35 -30.22 71.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 74.430000000000007 110.266 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.18 62.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 74.129999999999995 110.908 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -84.72 -53.94 5.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.472 . . . . 72.140000000000001 110.711 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -72.53 -17.07 61.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 75.140000000000001 112.012 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -33.21 74.96 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.731 0.271 . . . . 64.530000000000001 111.731 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.74 -45.47 43.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 70.310000000000002 110.22 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.638 -0.71 . . . . 71.420000000000002 110.948 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.7 mm? -64.15 -48.81 74.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 53.409999999999997 110.848 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.8 tt -56.66 -43.95 80.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 74.209999999999994 110.578 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -67.76 -27.7 66.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.217 0.532 . . . . 24.420000000000002 110.733 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.15 -43.14 12.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.839 0.681 . . . . 75.219999999999999 112.839 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 3.5 pp -88.72 -36.74 15.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.471 1.286 . . . . 74.409999999999997 114.471 -162.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.591 ' N ' HD12 ' A' ' 98' ' ' LEU . 38.7 t0 -150.3 170.81 18.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.348 -0.941 . . . . 72.109999999999999 112.501 -174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.12 61.53 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.93 -1.032 . . . . 72.319999999999993 110.657 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -179.35 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.315 1.046 . . . . 63.039999999999999 112.749 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 104' ' ' VAL . 5.6 m -82.85 139.62 33.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.612 -0.722 . . . . 74.299999999999997 109.991 -172.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -75.14 4.49 6.78 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.361 0.504 . . . . 63.409999999999997 112.361 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 102' ' ' THR . 43.5 t -82.29 147.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.841 -0.429 . . . . 75.040000000000006 109.841 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.4 130.99 35.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.684 -0.488 . . . . 74.099999999999994 109.684 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.49 117.08 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.055 -0.52 . . . . 54.43 110.541 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.3 pt-20 -123.58 121.63 36.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 73.340000000000003 109.721 175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.84 148.58 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.868 -0.606 . . . . 72.120000000000005 110.471 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.45 11.64 27.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 73.439999999999998 110.328 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -131.12 168.48 17.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 74.5 109.991 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.48 73.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.253 0.464 . . . . 75.0 112.253 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.27 -17.59 64.35 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.683 -0.967 . . . . 54.409999999999997 110.683 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.19 -46.78 75.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.455 -0.872 . . . . 75.230000000000004 111.835 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.1 pp -105.19 23.18 14.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 74.239999999999995 111.166 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.34 54.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 71.099999999999994 110.827 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.98 116.88 3.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 52.130000000000003 111.786 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 63' ' ' TYR . 6.4 mp -71.89 -55.94 6.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 111.216 -177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.117 -0.944 . . . . 63.32 111.015 -177.876 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.989 -0.374 . . . . 60.039999999999999 109.989 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.02 21.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.296 -0.411 . . . . 74.420000000000002 111.346 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -105.31 160.14 15.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.385 -0.37 . . . . 65.239999999999995 110.846 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.4 43.56 98.88 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.58 . . . . 63.039999999999999 112.852 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.91 149.74 22.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.928 0.394 . . . . 71.420000000000002 110.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.34 109.91 1.77 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.661 -0.976 . . . . 25.129999999999999 110.661 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 HD12 ' A' ' 36' ' ' ILE . 16.7 m -101.35 134.55 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.095 0.474 . . . . 63.5 111.801 -173.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 37' ' ' VAL . 12.5 t70 -71.85 148.44 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.527 -0.76 . . . . 73.230000000000004 110.504 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.22 -20.4 44.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.444 0.535 . . . . 73.430000000000007 112.444 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -60.89 -31.91 71.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 53.140000000000001 110.711 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.1 m -61.44 -47.95 83.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 71.0 110.277 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.603 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 42.0 t -63.58 -40.85 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.51 -0.768 . . . . 65.230000000000004 110.769 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 70.349999999999994 111.05 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.683 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 25.2 mmt180 -63.97 -40.78 97.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 111.223 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 14.4 m-85 -58.62 -33.34 69.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.135 0.493 . . . . 65.140000000000001 110.476 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.71 -42.47 73.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 71.019999999999996 110.566 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.16 -41.83 99.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 62.43 110.353 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 14' ' ' ARG . 83.1 mt -50.22 -57.14 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.302 -0.863 . . . . 50.329999999999998 111.264 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -83.04 -51.92 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 64.030000000000001 112.083 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.05 -55.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.845 0.313 . . . . 63.409999999999997 111.845 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -71.95 -14.92 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.234 -0.186 . . . . 62.450000000000003 110.831 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 60.27 24.08 13.51 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.882 0.739 . . . . 72.299999999999997 110.98 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.1 p -105.15 100.47 10.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.867 -0.606 . . . . 54.200000000000003 109.478 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.82 133.62 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.466 0.65 . . . . 71.129999999999995 110.458 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.6 mppt? -137.66 146.29 43.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 73.209999999999994 108.687 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.726 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.5 t90 -91.41 122.73 34.26 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.571 -1.27 . . . . 71.219999999999999 107.571 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.784 HG22 ' HB3' ' A' ' 41' ' ' ASP . 40.1 pt -107.12 131.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.143 0.497 . . . . 72.430000000000007 110.561 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 53' ' ' LEU . 88.2 t -112.64 116.02 51.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.551 -0.75 . . . . 62.32 109.397 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 37.4 p90 -116.79 163.37 16.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.694 -0.684 . . . . 74.230000000000004 110.393 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -112.27 124.79 53.24 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.412 -0.588 . . . . 75.25 109.412 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 36' ' ' ILE . 25.9 mt -99.12 102.71 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.262 -1.014 . . . . 74.420000000000002 108.262 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.11 137.49 32.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.466 -0.334 . . . . 73.239999999999995 110.678 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.3 t30 49.21 46.39 22.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.733 -0.667 . . . . 74.129999999999995 111.328 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p 56.64 22.58 6.89 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.999 0.919 . . . . 72.409999999999997 113.135 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -132.65 126.84 33.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.315 -0.624 . . . . 72.409999999999997 109.315 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 31' ' ' ILE . 58.1 mt -112.94 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.6 . . . . 73.510000000000005 111.436 -171.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 8' ' ' ASP . 14.0 m -129.38 141.45 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 72.209999999999994 110.992 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 4.6 p -86.46 133.99 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 41.520000000000003 110.522 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -100.49 -36.29 9.25 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.155 0.503 . . . . 74.310000000000002 109.912 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -138.69 141.06 38.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 75.340000000000003 111.428 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HB3' HG22 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -133.0 131.62 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.093 -1.077 . . . . 73.340000000000003 108.093 168.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.45 14.73 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.344 -1.408 . . . . 31.109999999999999 113.74 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -103.17 160.6 14.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.379 -0.971 . . . . 71.140000000000001 108.379 172.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.53 42.95 98.74 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.393 -1.883 . . . . 32.210000000000001 108.393 -163.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -44.7 -51.39 9.3 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.129 1.372 . . . . 64.310000000000002 113.041 -166.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.32 64.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.089 -0.505 . . . . 54.32 111.914 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.76 -52.19 5.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.72 0.295 . . . . 74.430000000000007 110.962 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.21 -33.62 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 64.019999999999996 111.492 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.677 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 20.5 m-85 -84.39 -0.08 51.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.932 0.715 . . . . 75.239999999999995 112.932 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 50.7 mtm180 -68.12 -25.27 65.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.158 0.504 . . . . 75.299999999999997 110.199 174.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.64 28.68 3.72 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.766 -0.731 . . . . 61.520000000000003 112.147 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -129.07 -19.65 3.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.513 0.19 . . . . 63.200000000000003 111.513 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 66.1 mt -98.88 121.88 54.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.938 0.399 . . . . 63.109999999999999 111.086 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 38.3 Cg_endo -96.57 102.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.275 2.65 . . . . 32.409999999999997 111.975 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -13.27 6.91 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.986 0.422 . . . . 74.310000000000002 112.109 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -57.49 -31.09 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 52.439999999999998 111.83 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.651 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 3.2 p30 -139.52 158.02 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.812 -0.44 . . . . 63.240000000000002 109.812 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.843 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 14.3 p -97.07 141.77 29.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.492 0.553 . . . . 71.030000000000001 112.492 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -150.76 154.24 36.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.062 -1.088 . . . . 63.140000000000001 108.062 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.556 ' HD2' ' HD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -95.98 123.41 39.56 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.512 -0.475 . . . . 73.349999999999994 110.642 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.726 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.94 133.76 9.85 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.213 -0.755 . . . . 72.129999999999995 111.213 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.42 121.53 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.54 0.686 . . . . 51.340000000000003 110.818 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 3.2 t80 -122.71 143.62 49.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.241 -0.891 . . . . 72.450000000000003 108.966 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.7 t70 -115.22 140.71 48.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.11 0.481 . . . . 74.200000000000003 110.075 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.75 168.92 16.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.73 -0.668 . . . . 74.549999999999997 109.475 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.57 -25.98 61.64 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 114.791 0.676 . . . . 65.140000000000001 114.791 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.47 -5.1 13.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.158 0.799 . . . . 72.219999999999999 113.158 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB3' ' NZ ' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -171.37 161.84 6.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.602 0.593 . . . . 74.049999999999997 112.602 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.1 mm -93.08 134.35 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 72.430000000000007 108.932 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -115.01 106.65 14.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.842 0.354 . . . . 74.140000000000001 111.307 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.517 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . 43.3 m-85 -83.51 109.9 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.922 -0.77 . . . . 72.430000000000007 108.922 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.32 124.76 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.048 0.452 . . . . 71.299999999999997 111.441 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 65.9 tp -128.2 105.36 8.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.71 -0.677 . . . . 64.049999999999997 110.301 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -86.2 109.64 19.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 74.519999999999996 109.283 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.2 p -79.83 150.61 72.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.228 -0.442 . . . . 71.409999999999997 110.564 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 72.0 Cg_endo -82.75 97.92 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.458 2.105 . . . . 74.150000000000006 112.405 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 109' ' ' HIS . 34.5 t70 -76.63 -14.99 59.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.494 0.664 . . . . 71.349999999999994 109.765 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.52 8.47 21.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 51.009999999999998 109.552 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' A' ' 80' ' ' PRO . . . -144.36 175.23 2.91 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.711 -0.677 . . . . 51.530000000000001 109.661 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 21.8 Cg_endo -62.83 154.71 64.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.973 1.782 . . . . 62.43 111.643 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.33 12.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.028 0.381 . . . . 75.420000000000002 112.028 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.618 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 59.4 tttm -69.69 -50.98 16.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.496 -0.32 . . . . 73.329999999999998 111.814 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 51.3 Cg_exo -55.77 -24.26 45.65 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.471 2.114 . . . . 71.340000000000003 112.943 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.499 ' HD3' ' OE1' ' A' ' 107' ' ' GLU . 11.0 ttm180 -60.45 -33.91 73.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.147 0.499 . . . . 55.210000000000001 110.133 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.8 mtt -71.57 -33.6 69.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 71.049999999999997 110.692 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -63.77 -47.5 80.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 62.219999999999999 110.529 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HD2' ' HD2' ' A' ' 60' ' ' PHE . 41.5 m-85 -67.77 -37.24 81.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 72.030000000000001 111.05 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.47 65.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.169 0.509 . . . . 74.239999999999995 111.086 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -86.46 -54.58 4.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.85 -0.614 . . . . 75.010000000000005 110.91 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -77.48 -9.23 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.588 0.588 . . . . 43.219999999999999 112.588 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.703 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -58.24 -24.53 59.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.549 0.574 . . . . 75.540000000000006 112.549 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.703 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 4.8 t70 -81.8 -25.7 35.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.818 0.342 . . . . 71.310000000000002 110.876 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.01 62.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 71.299999999999997 110.448 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 48.6 mt -92.14 -56.97 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.263 -0.881 . . . . 50.219999999999999 109.87 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 103' ' ' ALA . 43.8 tp -53.64 -58.94 5.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.61 -1.177 . . . . 72.109999999999999 113.079 -170.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 96' ' ' LYS . 3.7 tmmm? -65.38 -20.34 66.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.053 -0.521 . . . . 75.420000000000002 111.523 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.66 -22.94 12.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.981 0.734 . . . . 75.450000000000003 112.981 -172.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 99' ' ' ASP . 4.3 pp -87.08 -39.6 15.44 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 118.914 -1.114 . . . . 74.129999999999995 112.166 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 98' ' ' LEU . 17.0 t70 -154.07 177.05 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.17 -0.612 . . . . 74.540000000000006 111.637 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 13.44 42.63 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.899 -0.88 . . . . 43.420000000000002 110.899 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.077 0.951 . . . . 74.200000000000003 112.695 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 104' ' ' VAL . 2.5 m -84.32 136.22 33.99 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.477 -0.783 . . . . 71.239999999999995 110.403 -171.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -77.29 4.52 10.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.81 -0.632 . . . . 44.0 112.029 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 102' ' ' THR . 46.8 t -82.75 147.41 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.202 0.525 . . . . 74.120000000000005 110.428 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.26 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.772 -0.649 . . . . 70.420000000000002 109.715 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 tp -108.76 117.23 33.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.34 -0.391 . . . . 73.230000000000004 110.265 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.7 117.16 29.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.526 -0.546 . . . . 72.340000000000003 109.526 175.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.4 35.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.136 -0.484 . . . . 50.149999999999999 111.041 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p-80 -119.25 2.16 11.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.409 -0.589 . . . . 72.530000000000001 109.409 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 153.56 42.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.416 -0.811 . . . . 73.340000000000003 110.108 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 68.3 mtt -77.63 47.31 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 74.129999999999995 111.702 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.69 -17.07 64.49 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.213 -0.755 . . . . 73.140000000000001 111.213 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -64.0 -45.8 87.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.963 0.505 . . . . 73.010000000000005 111.197 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 3.5 pp -86.21 10.24 15.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.317 -0.401 . . . . 75.329999999999998 111.696 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 159.04 49.57 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.268 -0.424 . . . . 74.439999999999998 110.121 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.98 107.53 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.121 1.881 . . . . 45.350000000000001 111.351 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.3 mp -72.12 -71.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 73.329999999999998 111.033 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.607 -0.711 . . . . 65.420000000000002 110.483 -178.769 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 3' ' ' SER . 28.4 ttt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.647 -0.501 . . . . 64.109999999999999 109.647 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.12 41.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.89 -0.595 . . . . 70.439999999999998 111.66 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 1' ' ' MET . 7.7 t -101.39 152.7 20.41 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.991 -0.374 . . . . 74.230000000000004 109.991 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.91 33.7 86.34 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.41 -0.424 . . . . 70.349999999999994 113.023 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.46 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -88.27 162.96 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.96 0.41 . . . . 75.219999999999999 110.39 178.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.65 108.89 1.65 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.55 -1.02 . . . . 65.340000000000003 110.55 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.39 138.67 28.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.481 0.658 . . . . 72.010000000000005 111.72 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 10' ' ' ASN . 10.2 t70 -75.62 136.28 40.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.783 -1.099 . . . . 71.120000000000005 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.28 -20.05 35.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 72.430000000000007 111.639 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 48.2 t30 -63.4 -34.98 78.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.92 -0.77 . . . . 73.530000000000001 108.92 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 38' ' ' VAL . 33.1 m -53.69 -52.05 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.142 -0.936 . . . . 73.439999999999998 109.859 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 48.3 t -59.07 -43.39 89.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.555 -0.748 . . . . 74.329999999999998 110.957 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.93 86.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 44.009999999999998 110.818 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -68.48 -30.76 69.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 70.329999999999998 111.311 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 22.1 m-85 -62.52 -35.65 80.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.109 0.481 . . . . 75.549999999999997 109.904 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -67.75 -46.87 70.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 73.439999999999998 109.638 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 44.6 mt-10 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 75.349999999999994 112.374 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 19' ' ' LYS . 4.3 pp -65.21 -29.41 70.22 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.996 -0.681 . . . . 52.020000000000003 110.775 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.4 tmtp? -84.26 -58.68 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.488 . . . . 65.030000000000001 110.726 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.87 -29.83 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.775 0.658 . . . . 74.340000000000003 112.775 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 77.7 mtp180 -91.31 -21.04 21.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.943 -0.473 . . . . 71.019999999999996 111.347 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.13 27.75 0.34 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.314 1.046 . . . . 73.329999999999998 113.546 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.81 170.58 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.999 -1.111 . . . . 73.120000000000005 107.999 166.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 45' ' ' ASN . 8.8 p -92.1 131.19 39.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 55.520000000000003 110.668 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.653 ' HZ3' ' HB2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -140.57 170.6 15.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 63.149999999999999 111.32 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.857 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.0 t90 -152.0 129.44 11.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.083 -1.08 . . . . 70.219999999999999 108.083 172.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 41' ' ' ASP . 17.3 pt -124.94 122.72 64.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.998 0.428 . . . . 63.200000000000003 109.945 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -106.6 111.24 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.97 0.414 . . . . 74.200000000000003 110.973 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.301 0.572 . . . . 73.150000000000006 109.991 177.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -114.26 125.06 53.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.241 -0.89 . . . . 72.239999999999995 109.234 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.505 HG23 HG12 ' A' ' 36' ' ' ILE . 22.2 mt -97.0 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.254 -1.017 . . . . 71.209999999999994 108.254 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.68 137.51 25.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.724 . . . . 75.430000000000007 110.204 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 54.63 29.63 11.85 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.578 0.549 . . . . 53.210000000000001 111.389 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m 69.93 15.63 7.79 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.932 0.872 . . . . 73.010000000000005 110.721 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -107.64 156.64 18.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.71 -0.848 . . . . 64.439999999999998 108.71 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.804 HG21 HD11 ' A' ' 94' ' ' LEU . 45.5 mt -132.68 107.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.828 -0.434 . . . . 64.310000000000002 109.828 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 8' ' ' ASP . 55.7 t -133.11 134.45 57.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.39 . . . . 54.219999999999999 110.457 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.031 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -79.12 128.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 73.430000000000007 111.257 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -84.86 -38.1 19.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 75.310000000000002 111.441 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -143.24 142.84 31.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 73.140000000000001 110.592 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' A' ' 27' ' ' ILE . 2.0 p-10 -141.54 128.83 21.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.766 -0.652 . . . . 73.409999999999997 109.288 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.78 161.77 27.45 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.631 -0.795 . . . . 55.43 113.522 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -108.59 158.44 17.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.923 -1.14 . . . . 73.299999999999997 107.923 169.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.22 34.44 89.97 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.643 -1.383 . . . . 61.32 109.643 -170.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.81 HD21 HG22 ' A' ' 24' ' ' VAL . 6.6 p30 -70.89 -42.42 70.02 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.756 -1.222 . . . . 71.420000000000002 112.79 -165.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.65 36.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.927 0.394 . . . . 74.209999999999994 110.705 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.624 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 19.7 t70 -89.55 -58.36 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 64.400000000000006 111.374 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.15 -38.45 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.78 0.659 . . . . 71.519999999999996 112.78 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 6.1 m-30 -79.52 -2.68 43.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.544 . . . . 72.200000000000003 112.47 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 47' ' ' ASP . 45.8 mtm180 -81.04 -12.9 59.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.56 0.695 . . . . 75.430000000000007 109.31 173.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.69 13.24 11.84 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.266 -0.879 . . . . 62.509999999999998 111.081 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -130.94 20.38 4.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.477 0.656 . . . . 62.009999999999998 110.133 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.5 pt? -68.66 163.52 54.0 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.986 -1.006 . . . . 74.120000000000005 111.016 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.56 163.89 33.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.657 2.238 . . . . 71.230000000000004 111.203 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.29 -37.19 61.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.879 0.371 . . . . 75.0 111.022 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.53 14.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.42 0.629 . . . . 71.409999999999997 109.451 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.76 151.79 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.917 -1.038 . . . . 70.329999999999998 110.423 -172.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -90.38 141.79 28.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.603 -0.271 . . . . 65.040000000000006 110.538 175.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 58' ' ' CYS . 43.2 mmt-85 -144.77 157.07 44.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 75.030000000000001 110.528 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HE2' ' HD1' ' A' ' 87' ' ' TYR . 1.8 m-85 -112.31 117.27 32.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.519 -0.548 . . . . 75.219999999999999 109.519 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.857 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.99 130.68 8.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.388 -0.91 . . . . 51.210000000000001 113.178 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 42.5 t -98.98 121.01 49.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.881 -0.785 . . . . 74.340000000000003 108.881 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -131.83 135.7 46.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.205 0.526 . . . . 75.209999999999994 109.86 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 24' ' ' VAL . 5.1 p-10 -99.86 153.72 18.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.266 -0.879 . . . . 71.439999999999998 110.861 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 8.1 t -142.6 169.53 17.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.203 -1.036 . . . . 75.519999999999996 108.203 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.23 -27.65 63.15 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.477 0.551 . . . . 74.230000000000004 114.477 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.93 -3.38 8.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.538 0.669 . . . . 72.510000000000005 111.84 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 15.5 ptmt -149.2 158.31 44.07 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.182 0.808 . . . . 71.129999999999995 113.182 -168.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.3 mm -126.22 115.41 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 114.801 -1.09 . . . . 63.340000000000003 108.136 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 30.3 mt-30 -115.17 124.31 51.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.153 -0.619 . . . . 75.019999999999996 112.197 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.25 109.49 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.98 -0.748 . . . . 54.439999999999998 108.98 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.27 125.22 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.054 0.454 . . . . 74.420000000000002 110.701 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 87' ' ' TYR . 40.8 tp -108.05 116.2 31.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.638 -0.71 . . . . 71.120000000000005 110.392 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 113' ' ' ASP . 45.7 m95 -85.49 111.82 20.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.019 -1.104 . . . . 73.319999999999993 108.019 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 95.1 m -85.87 149.4 50.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.585 -0.446 . . . . 74.030000000000001 110.908 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 73.7 Cg_endo -88.32 110.05 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.674 2.249 . . . . 72.030000000000001 112.907 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.63 -28.15 33.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.735 -0.666 . . . . 63.130000000000003 109.608 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -94.25 9.78 36.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.395 -0.821 . . . . 71.519999999999996 110.788 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -136.66 147.12 58.27 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.312 -0.404 . . . . 75.129999999999995 110.796 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 14.8 Cg_exo -70.71 -176.78 1.88 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.152 2.568 . . . . 71.420000000000002 113.062 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.19 -19.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.66 -0.7 . . . . 73.400000000000006 112.128 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 14.6 mptt -67.62 -56.13 12.86 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 111.632 0.234 . . . . 62.130000000000003 111.632 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' PRO . 37.3 Cg_exo -59.21 -30.52 93.23 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.712 1.608 . . . . 72.430000000000007 111.747 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 61.1 ttt180 -68.25 -44.81 74.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 64.140000000000001 111.001 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.0 mtt -70.78 -22.22 62.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.616 0.246 . . . . 73.299999999999997 111.212 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -60.55 -48.83 80.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 65.129999999999995 111.312 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 27.0 p90 -81.72 -28.42 33.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.764 -0.374 . . . . 70.109999999999999 110.979 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -68.89 -18.55 64.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.596 0.712 . . . . 73.25 110.923 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -88.19 -17.13 31.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.17 -0.923 . . . . 62.210000000000001 110.682 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 31' ' ' ILE . 6.7 m -111.77 10.53 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 64.030000000000001 110.895 -173.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -73.08 -20.16 61.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.923 0.712 . . . . 75.540000000000006 112.923 -172.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.558 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 41.8 m-20 -79.26 -22.26 44.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.606 0.241 . . . . 70.109999999999999 111.345 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 5' ' ' MET . . . -61.47 -17.74 55.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.030000000000001 111.703 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.804 HD11 HG21 ' A' ' 36' ' ' ILE . 90.7 mt -104.57 -51.87 3.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.21 -0.45 . . . . 71.340000000000003 110.403 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.27 -44.1 75.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 61.32 111.269 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.71 -10.24 59.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 73.040000000000006 111.063 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -104.88 -39.8 6.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 62.119999999999997 112.618 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 99' ' ' ASP . 3.3 pp -89.73 -43.14 10.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.135 1.531 . . . . 75.409999999999997 115.135 -161.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.623 ' N ' HD12 ' A' ' 98' ' ' LEU . 20.8 t70 -155.03 -177.13 6.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.033 0.833 . . . . 71.329999999999998 111.983 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.61 12.87 64.52 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.26 -0.882 . . . . 73.519999999999996 111.194 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.57 178.48 0.04 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.553 0.741 . . . . 43.420000000000002 111.98 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 104' ' ' VAL . 5.4 m -84.02 136.85 33.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.909 0.385 . . . . 60.200000000000003 110.546 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.49 4.66 7.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.69 -0.686 . . . . 64.230000000000004 111.984 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 102' ' ' THR . 85.7 t -73.17 145.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 74.430000000000007 109.969 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.51 151.81 45.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.527 . . . . 75.329999999999998 109.935 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -124.61 117.91 25.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.787 0.327 . . . . 64.040000000000006 110.367 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.518 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 7.4 pt-20 -94.04 145.22 24.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 72.109999999999999 110.516 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.88 119.94 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.886 -0.597 . . . . 72.400000000000006 109.906 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -129.67 -0.71 4.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 64.120000000000005 110.045 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.12 -149.66 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.266 -0.879 . . . . 63.43 108.801 174.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 77.8 mtp -100.45 24.12 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.129 0.49 . . . . 74.310000000000002 110.751 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.1 -15.73 78.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.629 -0.714 . . . . 34.009999999999998 111.504 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 11.3 p-10 -57.32 -47.74 80.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.548 0.739 . . . . 75.409999999999997 111.798 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 3.9 pp -99.92 5.52 45.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.221 0.534 . . . . 72.230000000000004 111.008 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -94.52 151.36 39.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.963 -0.562 . . . . 61.140000000000001 109.979 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 12.1 Cg_exo -71.42 113.7 3.7 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.5 2.133 . . . . 72.340000000000003 111.498 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.23 -98.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 72.150000000000006 110.385 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.944 -1.027 . . . . 73.219999999999999 109.511 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.857 -0.794 . . . . 54.32 108.857 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.18 -23.59 21.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.596 -0.891 . . . . 43.210000000000001 108.596 170.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 p -67.1 150.8 48.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.836 -1.075 . . . . 60.530000000000001 109.978 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.4 41.77 99.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.739 -0.743 . . . . 73.099999999999994 111.357 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.584 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -71.46 151.2 44.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.198 -0.501 . . . . 74.329999999999998 110.667 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.593 ' O ' ' HD2' ' A' ' 35' ' ' LYS . . . -110.18 109.38 2.65 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.566 -0.826 . . . . 40.439999999999998 111.584 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.4 t -79.23 149.51 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.228 -0.656 . . . . 74.140000000000001 109.228 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 3.7 p-10 -82.9 165.46 19.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.161 0.505 . . . . 54.340000000000003 110.542 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 1.3 pm0 -84.47 -17.57 38.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.617 -0.72 . . . . 75.209999999999994 112.027 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.69 -32.94 35.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 73.310000000000002 110.226 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.0 t -54.34 -55.49 27.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 71.340000000000003 110.548 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.16 -34.67 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 71.319999999999993 110.812 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.08 -39.03 79.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 44.340000000000003 111.693 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -60.55 -25.5 66.2 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.22 0.452 . . . . 52.439999999999998 112.22 -173.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m-85 -60.27 -20.94 61.11 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.855 0.317 . . . . 61.210000000000001 111.855 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 2.0 p30 -64.3 -39.51 94.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.109 0.48 . . . . 65.329999999999998 110.005 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 23' ' ' THR . 41.8 mt-10 -82.53 -43.91 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.263 -0.643 . . . . 50.229999999999997 109.263 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 26.3 tp -53.76 -61.19 2.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.179 -1.373 . . . . 63.340000000000003 111.284 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -85.86 -65.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.243 0.544 . . . . 74.420000000000002 112.371 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 50.1 mm -59.65 -51.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.224 -0.898 . . . . 72.430000000000007 113.068 -165.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.677 ' HB2' HG22 ' A' ' 23' ' ' THR . 68.2 mtp180 -83.96 -4.82 59.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.861 0.363 . . . . 74.120000000000005 110.869 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 27.8 mtpt 55.9 24.34 7.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.624 -0.716 . . . . 74.310000000000002 111.79 -176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 21' ' ' ARG . 4.4 t -107.14 93.51 4.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.318 -0.993 . . . . 75.409999999999997 108.318 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.38 138.16 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.552 -0.749 . . . . 65.200000000000003 111.684 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.09 138.65 46.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 72.340000000000003 108.669 174.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.9 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -86.08 123.56 31.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.039 -1.097 . . . . 75.430000000000007 108.039 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.74 HG21 ' HG2' ' A' ' 14' ' ' ARG . 23.3 pt -115.87 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.918 -0.583 . . . . 75.540000000000006 110.89 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' LYS . 23.3 m -106.35 127.78 61.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.961 -0.563 . . . . 64.230000000000004 110.538 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -102.7 162.96 12.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.443 0.639 . . . . 64.530000000000001 110.253 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 30' ' ' LYS . 28.3 ttpt -113.14 123.02 49.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.715 -1.13 . . . . 71.430000000000007 108.457 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 36' ' ' ILE . 31.1 mt -99.71 104.05 15.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.713 -0.847 . . . . 63.340000000000003 108.713 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.2 139.85 14.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.475 -0.33 . . . . 70.400000000000006 110.364 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 t30 61.01 32.17 19.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.493 . . . . 64.5 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 5' ' ' MET . 9.7 m 68.18 6.45 5.27 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.649 -0.705 . . . . 71.310000000000002 110.975 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 55.2 tptt -110.95 132.19 54.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 109.813 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 31' ' ' ILE . 54.8 mt -113.11 110.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.166 -0.679 . . . . 72.439999999999998 109.166 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 35' ' ' LYS . 5.1 t -126.27 136.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 123.053 0.22 . . . . 63.299999999999997 111.181 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 29' ' ' PHE . 56.2 t -59.48 121.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 O-C-N 123.286 0.366 . . . . 64.519999999999996 110.027 172.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 8.5 mm-40 -96.8 -26.04 15.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.424 -0.353 . . . . 61.109999999999999 110.47 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 28' ' ' VAL . 16.3 tppt? -146.98 141.54 26.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 71.310000000000002 112.212 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.68 131.06 47.97 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.695 -1.224 . . . . 75.019999999999996 107.695 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.36 157.39 24.47 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.036 -1.078 . . . . 55.219999999999999 111.899 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -123.1 143.66 49.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.234 -0.654 . . . . 63.310000000000002 109.234 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.41 41.22 37.86 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.395 -1.882 . . . . 74.400000000000006 108.395 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 1.7 m-20 -44.42 -51.39 8.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 113.443 -1.378 . . . . 74.129999999999995 113.155 -166.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -65.38 -28.81 69.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.927 -0.579 . . . . 43.520000000000003 112.121 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -89.35 -44.83 9.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.815 0.341 . . . . 73.329999999999998 110.631 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.02 -49.82 74.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.724 -0.671 . . . . 73.530000000000001 110.661 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HE1' ' HG2' ' A' ' 40' ' ' LYS . 12.9 m-85 -75.35 8.33 2.84 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.118 0.784 . . . . 74.430000000000007 113.118 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 78.4 mtp180 -78.32 -11.95 59.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.604 -0.517 . . . . 62.32 109.604 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.32 11.82 0.57 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.651 -0.704 . . . . 65.420000000000002 112.593 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.91 8.7 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.961 0.38 . . . . 61.130000000000003 111.638 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.57 68.89 74.82 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 61.340000000000003 112.011 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.14 27.66 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.633 2.222 . . . . 61.450000000000003 111.824 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -60.76 -35.03 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.671 . . . . 53.340000000000003 111.634 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 28.7 t-20 76.33 -25.67 0.2 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.711 0.632 . . . . 60.200000000000003 110.987 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 55' ' ' ALA . 54.6 m-20 -95.84 171.81 8.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.326 -0.62 . . . . 72.510000000000005 109.326 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.1 p -77.79 142.12 38.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 44.109999999999999 111.14 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -140.87 160.15 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 72.340000000000003 109.712 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.23 120.39 40.31 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.029 -0.359 . . . . 63.539999999999999 110.029 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.9 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.4 136.96 11.44 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.911 -0.661 . . . . 64.120000000000005 113.6 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 88.5 t -97.99 120.78 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.913 -0.403 . . . . 75.099999999999994 109.913 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' HD2' HD22 ' A' ' 117' ' ' LEU . 10.4 t80 -142.18 126.55 17.67 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.879 -0.415 . . . . 73.329999999999998 109.879 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.24 146.09 30.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.179 0.514 . . . . 71.319999999999993 110.342 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.8 t -130.52 162.12 29.95 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.173 -0.677 . . . . 74.439999999999998 109.173 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.61 -24.93 71.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 74.140000000000001 111.342 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -73.61 -48.26 33.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.36 . . . . 73.049999999999997 110.346 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.15 164.82 20.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 72.400000000000006 111.518 -174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.52 127.6 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.833 -0.803 . . . . 72.200000000000003 108.833 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.43 106.24 10.88 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.776 -0.37 . . . . 74.510000000000005 111.363 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 62' ' ' VAL . 32.8 m-85 -78.77 109.16 12.77 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.828 -0.804 . . . . 74.299999999999997 108.828 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.57 137.59 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.433 . . . . 63.43 111.038 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 87' ' ' TYR . 64.4 tp -144.19 124.9 14.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.0 110.872 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.425 ' HE3' ' N ' ' A' ' 75' ' ' CYS . 0.0 OUTLIER -86.49 141.91 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.969 -0.752 . . . . 63.149999999999999 108.969 176.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 27.2 p -88.23 151.27 48.65 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 63.409999999999997 110.682 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 4.3 Cg_exo -76.93 92.05 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.516 2.144 . . . . 71.549999999999997 111.983 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.59 -32.94 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 74.209999999999994 110.545 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -88.91 9.34 25.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.744 0.783 . . . . 73.340000000000003 110.066 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.14 159.4 52.77 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 60.32 109.469 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 25.4 Cg_exo -64.15 176.01 2.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.347 2.031 . . . . 65.409999999999997 112.158 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.19 4.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.998 0.37 . . . . 75.450000000000003 111.998 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.767 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 26.4 ttpp -68.66 -54.94 12.33 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 74.030000000000001 111.137 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 42.0 Cg_exo -59.78 -23.63 72.76 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.222 1.948 . . . . 60.340000000000003 112.979 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 47.4 ttt-85 -63.98 -39.17 93.53 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.825 0.345 . . . . 72.310000000000002 110.378 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.1 mtm -66.36 -33.22 75.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 75.150000000000006 110.426 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.6 m -60.57 -56.86 16.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.574 -0.739 . . . . 74.040000000000006 111.561 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.755 ' CE1' HD21 ' A' ' 73' ' ' LEU . 3.4 p90 -75.7 -23.59 56.17 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.472 -0.491 . . . . 74.129999999999995 111.399 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.04 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 74.150000000000006 110.385 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.1 t -86.55 -8.24 57.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.344 -0.844 . . . . 72.329999999999998 110.453 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -123.45 4.23 9.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.007 0.432 . . . . 63.310000000000002 111.127 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -71.91 -21.38 61.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 72.400000000000006 111.651 -171.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.64 -21.77 32.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 73.310000000000002 111.431 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.95 78.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 71.299999999999997 111.767 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.2 mm? -65.71 -44.79 85.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.345 0.593 . . . . 52.409999999999997 110.388 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.986 HD23 ' HA ' ' A' ' 103' ' ' ALA . 7.6 mp -64.22 -24.69 67.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.324 -0.853 . . . . 73.099999999999994 110.92 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -81.18 -28.72 34.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 62.450000000000003 111.681 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -106.39 -26.46 11.46 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.389 0.885 . . . . 73.340000000000003 113.389 -169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 36.2 mt -86.1 -42.99 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 118.806 -1.158 . . . . 74.25 111.566 -170.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.24 -166.33 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 73.0 111.103 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.92 14.0 63.15 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.802 -0.919 . . . . 55.32 110.802 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.22 177.66 0.08 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.675 0.79 . . . . 75.329999999999998 111.977 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 104' ' ' VAL . 7.0 m -85.28 140.53 30.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.321 -170.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.986 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -72.13 4.86 3.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.507 -0.769 . . . . 61.340000000000003 112.256 -175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.569 HG23 HG22 ' A' ' 102' ' ' THR . 47.8 t -83.9 147.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.461 0.648 . . . . 62.43 110.436 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.69 155.09 47.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.549 -0.75 . . . . 51.039999999999999 109.26 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.6 tp -110.34 116.99 32.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.013 -0.366 . . . . 64.230000000000004 110.013 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.9 pt-20 -97.87 128.71 44.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.654 -0.499 . . . . 73.219999999999999 109.654 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.23 119.07 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.58 . . . . 52.450000000000003 110.18 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 23.5 t-80 -104.6 -45.25 4.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.569 -0.741 . . . . 63.140000000000001 110.237 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.03 101.58 4.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.49 -0.323 . . . . 70.129999999999995 111.421 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.525 ' HG3' HD11 ' A' ' 114' ' ' LEU . 56.8 ttm 71.18 -4.29 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.705 0.632 . . . . 74.450000000000003 112.705 170.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.9 -18.18 61.74 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.899 -0.667 . . . . 61.310000000000002 112.901 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.53 -46.88 13.84 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.719 0.408 . . . . 72.239999999999995 111.595 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.525 HD11 ' HG3' ' A' ' 111' ' ' MET . 3.9 pp -98.06 14.77 26.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.903 0.382 . . . . 62.0 111.841 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.59 154.26 46.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.106 -0.497 . . . . 74.430000000000007 109.969 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.6 123.95 10.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.053 2.502 . . . . 73.239999999999995 112.489 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.437 HD22 ' HD2' ' A' ' 63' ' ' TYR . 5.6 mp -83.17 -2.45 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 73.129999999999995 111.496 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.88 -1.057 . . . . 63.240000000000002 111.077 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.673 0.273 . . . . 70.439999999999998 110.561 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.29 -18.95 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.962 0.411 . . . . 64.439999999999998 110.887 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 p -101.64 153.37 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.345 -0.389 . . . . 74.099999999999994 110.756 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.46 27.32 70.64 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.89 -0.596 . . . . 51.119999999999997 113.471 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.1 ptt? -109.79 166.49 10.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.941 0.401 . . . . 73.420000000000002 110.275 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 132.17 10.69 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.416 -1.074 . . . . 63.25 110.416 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.33 124.87 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 117.129 0.464 . . . . 64.400000000000006 110.851 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.62 115.5 4.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.679 . . . . 63.210000000000001 111.417 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -84.99 -13.44 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 73.530000000000001 111.178 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.3 -35.4 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 74.239999999999995 110.604 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 42.2 t -53.35 -40.78 65.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 74.200000000000003 111.235 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.74 -47.3 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 72.5 110.751 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -68.46 -28.02 66.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 73.409999999999997 110.54 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.836 ' HG3' HG21 ' A' ' 27' ' ' ILE . 1.8 tmm_? -66.6 -38.33 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 74.439999999999998 110.095 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -60.71 -21.12 62.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.648 0.261 . . . . 63.25 111.133 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 4.7 m-20 -75.98 -30.65 58.66 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.863 -0.421 . . . . 74.129999999999995 109.863 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.19 -38.98 89.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.073 -0.714 . . . . 73.530000000000001 109.073 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.76 -43.51 97.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.022 . . . . 74.420000000000002 110.909 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.11 -64.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 111.917 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.49 -54.38 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 70.409999999999997 111.917 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -75.46 -16.84 60.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.453 -0.34 . . . . 71.219999999999999 110.993 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? 58.49 24.48 11.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.662 0.744 . . . . 75.129999999999995 109.965 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.4 p -104.18 116.36 32.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.452 -0.794 . . . . 73.239999999999995 109.552 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 7.1 p -88.07 134.3 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.838 -0.745 . . . . 73.430000000000007 109.996 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 19.1 ptpt -138.45 150.38 46.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.587 -0.733 . . . . 72.109999999999999 110.102 177.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -97.31 123.2 41.04 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.95 -1.13 . . . . 72.430000000000007 107.95 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.836 HG21 ' HG3' ' A' ' 14' ' ' ARG . 43.1 pt -117.51 144.77 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.482 -0.326 . . . . 75.230000000000004 110.219 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.45 114.4 42.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.032 0.444 . . . . 62.219999999999999 111.163 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -94.7 145.75 24.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.494 -0.928 . . . . 73.030000000000001 108.494 168.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -112.11 125.14 53.79 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.045 -0.525 . . . . 65.239999999999995 109.979 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 36' ' ' ILE . 20.6 mt -91.24 102.02 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.37 -0.974 . . . . 74.450000000000003 108.37 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.07 147.03 20.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.393 -0.595 . . . . 73.319999999999993 109.393 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.48 26.22 15.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.276 0.56 . . . . 63.200000000000003 110.179 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' MET . 1.6 m 65.13 28.02 12.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.03 -0.987 . . . . 65.219999999999999 111.64 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE2' HG21 ' A' ' 37' ' ' VAL . 18.8 ptmt -136.94 148.87 47.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.984 -0.376 . . . . 64.310000000000002 109.984 171.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG23 ' A' ' 31' ' ' ILE . 23.0 mt -113.42 109.94 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.632 -0.507 . . . . 73.400000000000006 109.632 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 35' ' ' LYS . 3.2 t -138.48 136.77 43.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.868 -0.419 . . . . 73.530000000000001 109.868 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.022 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 86.3 t -62.4 131.27 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.137 0.494 . . . . 53.420000000000002 110.49 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG3' ' HD2' ' A' ' 40' ' ' LYS . 16.8 pt-20 -104.99 -31.09 9.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.522 -0.763 . . . . 61.420000000000002 111.316 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 3.0 mptp? -147.65 156.01 42.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.919 0.39 . . . . 62.350000000000001 111.123 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' HG22 ' A' ' 27' ' ' ILE . 7.1 p-10 -140.31 132.03 27.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.964 -1.125 . . . . 75.319999999999993 107.964 170.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.09 13.11 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.059 -1.067 . . . . 44.25 114.366 -168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 3.0 ptpp? -128.6 130.54 47.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.113 -1.069 . . . . 61.32 108.113 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 52.19 8.48 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.991 -2.044 . . . . 72.319999999999993 107.991 -163.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.486 HD22 ' HE1' ' A' ' 63' ' ' TYR . 46.6 m-20 -44.91 -51.93 9.19 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.75 -1.225 . . . . 72.400000000000006 113.542 -162.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -49.41 70.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 44.420000000000002 111.06 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.531 ' HA ' HH11 ' A' ' 50' ' ' ARG . 19.8 t70 -68.8 -42.64 77.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.079 -0.509 . . . . 73.439999999999998 111.595 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 43' ' ' LYS . 10.0 tt0 -65.31 -47.23 77.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 64.430000000000007 111.135 -174.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 27.2 m-85 -71.73 -22.18 61.66 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.057 0.391 . . . . 75.329999999999998 112.057 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 18.0 mtp180 -61.61 -22.94 65.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.813 0.34 . . . . 73.430000000000007 111.111 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.28 18.13 6.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.717 -0.754 . . . . 62.340000000000003 112.055 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -96.22 -73.99 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.873 -0.192 . . . . 71.349999999999994 111.278 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 mp -126.65 90.22 50.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.239 0.459 . . . . 75.25 112.239 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.21 48.31 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.906 2.404 . . . . 74.209999999999994 109.584 170.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.42 -12.71 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.006 -0.997 . . . . 74.510000000000005 112.837 -169.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.603 ' HA ' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 p30 51.6 26.43 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.757 0.823 . . . . 60.119999999999997 111.38 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.07 170.72 8.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.756 -1.111 . . . . 65.430000000000007 109.14 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.955 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 3.3 p -86.5 134.2 33.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.709 -1.196 . . . . 73.319999999999993 110.05 174.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 39' ' ' GLU . 17.6 mmt85 -143.41 152.06 41.12 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.502 -1.226 . . . . 71.0 108.173 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.692 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -103.53 113.54 27.12 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.721 -0.474 . . . . 64.510000000000005 109.721 -178.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.65 131.73 8.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.985 -0.626 . . . . 72.310000000000002 113.114 -175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 3.0 t -102.74 120.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 75.409999999999997 109.309 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 5.0 t80 -134.69 124.97 26.12 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.409 -0.589 . . . . 64.219999999999999 109.409 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 11.3 t70 -92.31 140.93 29.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.741 -0.466 . . . . 70.129999999999995 109.741 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.6 t -122.12 171.12 9.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.772 -0.825 . . . . 74.519999999999996 108.772 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.49 -23.9 55.23 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.236 -0.507 . . . . 75.019999999999996 113.829 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -102.25 -26.26 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 73.120000000000005 112.873 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -170.27 169.05 7.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.306 0.484 . . . . 73.219999999999999 112.306 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.22 129.8 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.597 -0.89 . . . . 73.450000000000003 108.597 170.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -118.29 115.27 24.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.078 0.466 . . . . 54.109999999999999 111.635 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.731 ' HZ ' HD22 ' A' ' 98' ' ' LEU . 48.4 m-85 -76.17 110.68 10.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.639 -0.71 . . . . 71.450000000000003 109.532 166.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.04 112.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.569 -0.53 . . . . 61.420000000000002 109.569 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 87' ' ' TYR . 36.4 tp -115.97 89.32 3.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.658 -0.701 . . . . 65.530000000000001 110.304 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.674 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 0.8 OUTLIER -85.59 121.06 27.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.633 -0.876 . . . . 71.450000000000003 108.633 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.3 p -96.48 149.98 36.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.857 -0.337 . . . . 61.420000000000002 110.856 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.955 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 59.1 Cg_endo -71.8 130.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.42 2.08 . . . . 75.219999999999999 113.052 -170.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.68 -40.29 16.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 61.140000000000001 110.814 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -91.89 20.57 5.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 72.0 110.613 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -132.32 157.81 77.27 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.233 -0.44 . . . . 62.0 110.534 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 50.7 Cg_endo -69.21 -170.99 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.928 2.419 . . . . 44.25 113.227 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.15 -10.84 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 42.420000000000002 112.1 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 39.5 ttmt -68.08 -47.53 40.27 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.189 0.44 . . . . 71.129999999999995 112.189 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 15.6 Cg_endo -58.62 -16.78 31.92 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.824 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.552 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 19.4 mtp-105 -73.93 -32.68 63.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.598 -0.519 . . . . 72.319999999999993 109.598 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 24.7 mmt -78.14 -13.59 59.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.776 -0.647 . . . . 73.129999999999995 110.301 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -65.2 -55.78 16.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 53.229999999999997 110.779 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 73' ' ' LEU . 11.0 p90 -77.33 -19.34 56.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 74.420000000000002 110.89 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 85' ' ' MET . . . -75.02 -18.52 60.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.208 0.528 . . . . 73.340000000000003 110.316 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 t -82.71 -34.35 27.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.769 -0.651 . . . . 64.109999999999999 110.463 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 p -104.76 20.89 17.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.519999999999996 110.909 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 19.7 pttp -56.71 -55.22 36.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.423 -0.808 . . . . 73.420000000000002 112.454 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.631 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 8.7 p-10 -85.88 -20.09 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 72.0 111.35 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.18 67.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.644 -0.253 . . . . 74.109999999999999 111.349 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 4.2 mm? -66.96 -40.43 87.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.958 -0.386 . . . . 72.010000000000005 109.958 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 33.7 tp -67.85 -18.53 64.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.535 -0.757 . . . . 61.539999999999999 111.582 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 74.129999999999995 110.534 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -111.57 16.45 20.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.564 1.173 . . . . 71.219999999999999 108.656 177.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.731 HD22 ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -111.35 10.36 21.56 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.929 -1.487 . . . . 54.439999999999998 111.101 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' ALA . 21.8 m-20 -34.69 -145.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.845 2.458 . . . . 62.310000000000002 116.491 -151.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.24 15.7 0.02 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 118.013 1.965 . . . . 62.439999999999998 118.013 -150.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -56.97 -177.14 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.702 -0.851 . . . . 52.32 108.702 154.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 m -80.47 117.33 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.696 -1.252 . . . . 61.229999999999997 109.356 -168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -87.49 -0.77 57.3 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.944 -1.026 . . . . 51.140000000000001 111.486 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.94 146.33 10.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.638 . . . . 64.319999999999993 109.276 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -129.79 146.76 51.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.326 -0.397 . . . . 73.200000000000003 110.444 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 tt -119.84 117.39 28.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.117 -0.698 . . . . 62.43 109.117 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 13.4 pt-20 -97.47 141.05 31.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 74.310000000000002 110.275 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.68 54.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 73.140000000000001 111.062 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -126.07 4.3 7.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.478 -0.783 . . . . 73.230000000000004 109.931 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.94 163.55 14.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 73.129999999999995 109.119 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 67.5 mtt -78.31 57.87 1.98 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.444 0.64 . . . . 65.019999999999996 110.853 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.42 -15.51 68.62 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.95 -1.023 . . . . 50.43 111.598 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.08 -38.83 73.89 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 122.974 0.51 . . . . 75.510000000000005 111.165 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.9 pp -98.2 18.95 15.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.117 0.484 . . . . 73.209999999999994 110.819 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.02 156.3 54.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 64.109999999999999 110.412 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.01 91.24 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.333 2.022 . . . . 74.319999999999993 112.043 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.08 -7.54 59.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 111.064 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.457 -0.783 . . . . 74.340000000000003 109.906 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 65.5 mtm . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.372 -0.603 . . . . 74.010000000000005 109.372 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.05 69.92 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.963 0.411 . . . . 74.420000000000002 110.664 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 p -69.31 119.06 13.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.872 -0.604 . . . . 73.140000000000001 110.56 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.77 40.39 98.07 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.153 -0.476 . . . . 61.119999999999997 112.836 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.44 172.22 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.112 0.482 . . . . 54.100000000000001 111.588 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.58 110.1 0.62 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.696 -0.962 . . . . 61.229999999999997 110.696 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.85 122.97 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.998 0.399 . . . . 64.099999999999994 111.829 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.13 120.84 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.182 -0.673 . . . . 71.439999999999998 109.182 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.76 -13.4 61.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.392 0.886 . . . . 72.349999999999994 113.392 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -58.9 -30.65 67.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.063 0.459 . . . . 53.409999999999997 110.213 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 m -66.95 -41.86 86.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.85 -0.614 . . . . 74.340000000000003 110.088 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.85 -43.92 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 70.239999999999995 110.893 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.58 63.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 73.319999999999993 111.592 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.773 ' HG3' HG21 ' A' ' 27' ' ' ILE . 20.9 mmt180 -64.54 -26.83 68.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.361 . . . . 74.219999999999999 111.706 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 82.2 m-85 -82.5 -26.25 32.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 64.400000000000006 110.325 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -75.84 -36.85 59.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.26 -0.644 . . . . 74.140000000000001 109.26 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.83 -19.03 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.551 -0.75 . . . . 65.420000000000002 110.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 11.8 mt -63.27 -50.79 68.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.147 -0.479 . . . . 53.420000000000002 111.15 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -70.91 -40.37 72.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.859 0.361 . . . . 73.209999999999994 111.3 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.22 -63.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 111.786 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -79.49 -24.02 42.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.491 -0.322 . . . . 75.299999999999997 110.725 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 53.6 mttp 59.32 24.79 13.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.797 -0.638 . . . . 73.209999999999994 111.222 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -93.2 122.44 35.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.123 -0.695 . . . . 62.350000000000001 109.123 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.67 134.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 120.131 -0.628 . . . . 73.140000000000001 110.476 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -141.12 172.14 13.1 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.34 -0.845 . . . . 64.340000000000003 109.718 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB2' ' HB3' ' A' ' 45' ' ' ASN . 4.1 t90 -125.97 127.56 46.13 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 74.120000000000005 107.482 173.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.773 HG21 ' HG3' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -117.79 128.83 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.065 0.46 . . . . 64.219999999999999 110.46 177.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 77.1 t -110.29 120.01 60.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.028 0.442 . . . . 71.230000000000004 110.26 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 p90 -116.73 160.98 19.95 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.832 -0.622 . . . . 74.25 110.844 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 39' ' ' GLU . 38.3 ttmt -115.39 125.11 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.419 -0.809 . . . . 62.210000000000001 109.267 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 90' ' ' SER . 16.3 mt -88.05 102.44 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.693 -1.225 . . . . 70.329999999999998 107.693 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.1 138.95 39.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.479 -0.328 . . . . 73.340000000000003 110.379 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 34' ' ' THR . 88.7 m-20 60.22 22.06 11.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 64.349999999999994 110.725 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 33' ' ' ASN . 46.9 m 79.48 -10.13 1.36 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.86 -0.609 . . . . 62.009999999999998 111.138 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE3' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -102.16 138.3 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.587 -0.523 . . . . 71.400000000000006 109.587 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.657 HD13 HD21 ' A' ' 94' ' ' LEU . 57.4 mt -99.34 114.12 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.392 -0.367 . . . . 62.210000000000001 111.188 -172.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HE3' ' A' ' 35' ' ' LYS . 6.8 m -125.71 135.41 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 71.510000000000005 111.155 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -88.67 125.42 41.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.96 0.409 . . . . 70.519999999999996 110.077 176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 27.4 mt-10 -79.65 -37.76 35.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.908 -0.587 . . . . 73.319999999999993 111.151 -173.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' HB2' ' A' ' 39' ' ' GLU . 19.3 pttm -171.52 159.59 5.59 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.321 0.581 . . . . 70.430000000000007 112.191 -167.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.711 ' CB ' HG22 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -154.29 146.55 23.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.591 -1.186 . . . . 73.209999999999994 108.383 173.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.32 161.41 26.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.016 -1.088 . . . . 64.310000000000002 112.71 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -93.66 120.52 34.04 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.335 -1.358 . . . . 61.420000000000002 107.335 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.52 53.96 0.58 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 107.191 -2.363 . . . . 62.240000000000002 107.191 -161.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 38.8 m-20 -61.35 -53.01 62.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.026 -1.087 . . . . 54.399999999999999 112.471 -160.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.44 -32.7 42.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.726 -0.472 . . . . 75.209999999999994 109.726 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.97 -58.31 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 70.329999999999998 111.582 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.66 -46.51 78.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 71.519999999999996 111.542 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 27.9 m-85 -73.82 -14.83 61.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.899 0.703 . . . . 72.230000000000004 112.899 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.7 -13.19 60.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.962 0.411 . . . . 63.140000000000001 110.703 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.98 11.78 6.18 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.617 -0.593 . . . . 55.240000000000002 111.617 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -118.61 -0.15 11.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 111.099 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 87.2 mt -101.53 123.29 44.87 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.239 -0.437 . . . . 53.030000000000001 110.092 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 12.8 Cg_exo -70.06 134.1 26.55 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.86 2.373 . . . . 74.219999999999999 112.101 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.18 -14.88 57.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 72.430000000000007 110.877 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -86.15 -33.11 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 61.210000000000001 111.531 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' C ' ' HG3' ' A' ' 76' ' ' PRO . 35.6 t0 -123.34 163.49 20.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.769 0.319 . . . . 73.209999999999994 110.965 -172.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.885 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 4.2 p -98.61 138.72 35.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.446 0.641 . . . . 73.439999999999998 109.818 173.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 30' ' ' LYS . 18.8 mmt85 -130.07 152.32 49.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.073 -0.967 . . . . 74.209999999999994 109.023 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t80 -107.52 112.05 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.455 -0.572 . . . . 74.109999999999999 109.455 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 28' ' ' VAL . . . -120.02 125.9 6.48 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.903 -0.665 . . . . 63.200000000000003 111.701 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.17 121.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.559 0.695 . . . . 64.310000000000002 109.617 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 2.1 t80 -113.48 125.67 54.48 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.001 -0.999 . . . . 73.150000000000006 109.678 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.588 ' CG ' HD21 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -103.62 140.66 37.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.587 0.708 . . . . 73.099999999999994 110.582 175.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.0 t -131.02 170.44 14.49 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.776 -0.824 . . . . 64.230000000000004 108.776 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.28 -34.16 89.18 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.983 -0.627 . . . . 34.130000000000003 112.757 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -81.68 -39.78 23.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.535 0.207 . . . . 54.439999999999998 111.502 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -164.59 171.67 14.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.732 0.301 . . . . 74.420000000000002 110.773 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.51 140.84 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.458 -0.571 . . . . 74.239999999999995 109.458 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -122.04 116.36 24.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.554 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.69 109.18 12.68 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.977 -0.749 . . . . 55.530000000000001 108.977 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 115.37 32.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.402 0.62 . . . . 60.109999999999999 110.825 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 60.6 tp -119.41 81.93 1.79 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.185 -0.916 . . . . 72.230000000000004 109.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -89.6 118.22 29.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.985 -0.552 . . . . 74.109999999999999 109.77 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 13.9 p -102.34 147.95 34.73 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.865 -0.42 . . . . 63.039999999999999 109.865 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 54.1 Cg_endo -99.52 169.99 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.155 2.57 . . . . 71.530000000000001 113.291 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.64 -28.46 66.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.1 -0.954 . . . . 63.25 110.814 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -88.46 9.84 22.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.664 -0.698 . . . . 73.329999999999998 111.624 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . . . -107.28 111.25 63.31 Favored Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 122.061 -0.399 . . . . 74.400000000000006 111.247 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 7.0 Cg_exo -74.06 -166.76 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 65.340000000000003 112.238 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 31.0 m -75.56 -13.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 63.200000000000003 112.033 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 25.5 mtpp -69.27 -58.22 6.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.44 -0.345 . . . . 71.120000000000005 111.178 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.86 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 7.3 Cg_exo -74.28 -13.93 23.08 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.027 1.818 . . . . 51.439999999999998 111.32 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 2.7 tpt180 -60.92 -47.25 87.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 75.409999999999997 110.349 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -76.18 -14.51 60.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.581 . . . . 72.140000000000001 110.567 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.496 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 32.4 m -69.75 -43.97 71.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.048 -0.523 . . . . 71.200000000000003 110.952 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CE1' HD21 ' A' ' 73' ' ' LEU . 8.9 p90 -79.5 -30.1 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.558 -0.457 . . . . 73.219999999999999 111.272 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.85 -19.95 64.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.247 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 1' ' ' MET . 6.2 t -86.87 -53.15 5.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.653 -0.703 . . . . 70.299999999999997 110.649 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' HD13 ' A' ' 31' ' ' ILE . 4.1 m -68.39 -25.98 65.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.414 -0.812 . . . . 71.530000000000001 111.84 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -57.5 -27.63 62.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.462 0.541 . . . . 60.340000000000003 112.462 -175.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.64 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 27.6 t70 -76.68 -40.11 49.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.833 0.349 . . . . 73.420000000000002 110.934 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.66 91.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.826 -0.625 . . . . 64.540000000000006 111.267 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.657 HD21 HD13 ' A' ' 36' ' ' ILE . 3.9 mm? -63.8 -50.69 67.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 63.32 110.446 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 103' ' ' ALA . 36.5 tp -57.63 -30.17 65.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 74.239999999999995 110.958 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -76.74 -32.09 57.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.601 -0.727 . . . . 74.299999999999997 112.535 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -112.07 -14.61 13.41 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.37 1.248 . . . . 75.430000000000007 114.37 -166.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 68.5 mt -86.96 -45.38 10.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 118.111 -1.436 . . . . 73.109999999999999 112.903 -167.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 20.6 t70 -157.64 -167.07 2.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.438 -0.505 . . . . 65.25 111.124 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -90.33 15.36 60.11 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.385 -1.086 . . . . 74.109999999999999 110.385 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.35 179.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.42 1.088 . . . . 45.240000000000002 113.272 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -82.97 136.77 34.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.565 -0.743 . . . . 74.239999999999995 110.456 -169.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -79.16 5.39 12.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 61.149999999999999 112.466 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.7 148.36 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.947 0.404 . . . . 74.329999999999998 110.307 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.99 45.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.342 -0.614 . . . . 62.530000000000001 109.342 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 tp -122.64 118.41 28.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.817 0.341 . . . . 62.229999999999997 110.694 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 pt-20 -98.37 121.07 39.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.966 -0.561 . . . . 73.450000000000003 109.669 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.65 150.94 29.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 111.021 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -136.34 10.03 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 72.329999999999998 110.218 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 111' ' ' MET . 47.0 tt0 -131.34 167.18 19.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 73.530000000000001 110.095 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.419 ' N ' ' HG2' ' A' ' 110' ' ' GLU . 86.3 mtp -79.41 6.92 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.608 0.242 . . . . 64.030000000000001 111.52 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.91 -20.1 74.18 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.739 -0.743 . . . . 43.219999999999999 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.59 -37.29 73.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.296 0.569 . . . . 72.230000000000004 110.384 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 pp -89.62 14.46 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 74.140000000000001 110.829 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -87.81 162.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.223 -0.658 . . . . 71.319999999999993 109.223 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 34.2 Cg_endo -66.65 88.45 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 121.936 1.757 . . . . 72.5 113.026 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -77.66 -71.02 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.421 -0.585 . . . . 61.130000000000003 109.421 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.538 -0.744 . . . . 72.420000000000002 109.968 178.849 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 5' ' ' MET . 52.9 ttm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.452 -0.573 . . . . 74.439999999999998 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.643 ' HA ' ' SD ' ' A' ' 5' ' ' MET . . . -81.58 -30.07 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.608 0.596 . . . . 64.310000000000002 112.608 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -67.08 117.94 9.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 73.439999999999998 111.245 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 61.37 33.76 85.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.742 -0.663 . . . . 70.239999999999995 113.099 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 2' ' ' ALA . 25.4 ptt? -84.9 159.04 20.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 65.310000000000002 110.704 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.46 119.99 4.03 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.811 -0.631 . . . . 70.040000000000006 111.778 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 36' ' ' ILE . 62.0 t -73.64 104.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.828 -0.804 . . . . 73.25 108.828 174.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -71.68 142.25 49.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.16 -0.473 . . . . 61.240000000000002 110.868 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 12' ' ' VAL . 20.9 pt-20 -64.83 -15.62 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.721 -0.672 . . . . 75.109999999999999 111.337 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -55.23 -40.55 71.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.849 -0.614 . . . . 55.539999999999999 110.23 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.1 t -73.89 -44.23 55.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 53.399999999999999 111.438 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 9' ' ' GLU . 34.5 m -72.81 -24.31 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 63.530000000000001 111.527 -175.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.54 70.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 64.109999999999999 110.876 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 33.2 mmt180 -75.33 -23.51 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 70.219999999999999 111.226 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 43.4 m-85 -82.82 -23.31 33.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.399 . . . . 73.319999999999993 109.99 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.77 84.93 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.381 -0.6 . . . . 70.040000000000006 109.381 171.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -71.73 -49.57 38.07 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.473 0.654 . . . . 71.25 109.505 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 16.5 tp -58.59 -47.72 83.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.695 -1.139 . . . . 73.019999999999996 112.179 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -73.3 -51.86 16.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.938 0.348 . . . . 74.25 111.938 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.61 -56.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.062 0.393 . . . . 75.329999999999998 112.062 -171.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -68.6 -26.3 65.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.711 0.291 . . . . 65.140000000000001 110.479 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 58.58 24.42 11.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.552 -0.749 . . . . 63.0 111.491 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 p -92.83 106.37 18.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.05 -1.463 . . . . 74.420000000000002 107.05 164.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 64' ' ' ASP . 7.6 p -87.46 136.63 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.656 0.741 . . . . 75.140000000000001 111.184 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 41' ' ' ASP . 19.0 ptpt -137.35 140.18 41.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.692 -1.14 . . . . 62.149999999999999 109.408 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 1.014 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.2 t90 -89.04 136.37 33.05 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.152 -1.425 . . . . 74.519999999999996 107.152 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.49 132.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.162 0.506 . . . . 73.510000000000005 110.642 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -106.52 110.5 31.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.45 -0.795 . . . . 73.109999999999999 109.278 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.624 ' HB3' HG22 ' A' ' 38' ' ' VAL . 2.6 p90 -115.58 159.5 21.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.645 0.736 . . . . 74.109999999999999 111.623 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 34.5 ttmt -123.25 125.36 44.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.775 -1.102 . . . . 73.209999999999994 109.242 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.854 HG12 HG23 ' A' ' 36' ' ' ILE . 56.4 mt -112.3 101.6 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.872 0.368 . . . . 71.549999999999997 111.167 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -159.6 170.28 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 73.310000000000002 110.383 175.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m120 53.0 39.38 29.35 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.743 0.652 . . . . 53.240000000000002 110.942 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' MET . 58.0 p 58.22 20.43 7.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.783 -1.099 . . . . 71.049999999999997 113.274 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 35' ' ' LYS . 9.2 mmmm -129.88 137.81 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.111 0.481 . . . . 72.439999999999998 110.997 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.854 HG23 HG12 ' A' ' 31' ' ' ILE . 56.7 mt -103.15 108.77 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.77 -0.826 . . . . 72.420000000000002 108.77 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.96 135.87 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 71.349999999999994 111.498 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 29' ' ' PHE . 17.3 t -88.21 133.51 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 75.319999999999993 109.181 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' ' HG3' ' A' ' 40' ' ' LYS . 10.4 pt-20 -106.9 -18.47 13.91 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.806 -0.758 . . . . 73.129999999999995 110.854 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -145.06 140.88 28.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.221 -0.591 . . . . 72.209999999999994 111.803 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.613 ' HB3' HG22 ' A' ' 27' ' ' ILE . 10.6 p-10 -132.54 132.98 43.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.583 -1.265 . . . . 64.420000000000002 107.583 166.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.767 ' HA3' ' HG2' ' A' ' 48' ' ' GLU . . . -116.8 161.86 12.9 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.045 -1.074 . . . . 43.340000000000003 114.033 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.4 ptpp? -108.15 124.43 50.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.814 -0.81 . . . . 64.400000000000006 108.814 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.3 56.98 3.27 Favored Glycine 0 C--N 1.313 -0.72 0 N-CA-C 108.658 -1.777 . . . . 71.040000000000006 108.658 -169.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.014 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 28.4 p-10 -41.99 -52.31 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.236 1.569 . . . . 72.540000000000006 115.236 -158.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.16 69.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.165 0.432 . . . . 65.230000000000004 112.165 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.65 -41.09 18.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.267 0.556 . . . . 70.439999999999998 110.327 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HG2' ' HA3' ' A' ' 42' ' ' GLY . 6.0 tp10 -48.11 -55.6 9.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.386 -1.279 . . . . 74.5 111.479 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 21.1 m-85 -74.61 -25.01 58.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.997 0.74 . . . . 75.140000000000001 112.997 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.721 ' HE ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 ttm105 -65.28 -21.0 66.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.222 0.534 . . . . 71.230000000000004 109.721 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.28 12.16 10.5 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.055 -0.593 . . . . 73.310000000000002 111.959 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -108.75 -25.21 10.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.444 0.164 . . . . 64.340000000000003 111.083 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 3.6 mm? -120.9 100.27 46.3 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-O 121.057 0.456 . . . . 74.099999999999994 111.992 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HB3' HD13 ' A' ' 114' ' ' LEU . 91.3 Cg_endo -101.2 37.35 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.777 2.985 . . . . 34.509999999999998 109.957 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.34 -35.44 30.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.083 -0.962 . . . . 74.400000000000006 112.732 -165.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 37.0 m-80 65.23 19.98 11.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.567 0.699 . . . . 61.439999999999998 109.65 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.43 151.73 23.17 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.958 -1.019 . . . . 60.439999999999998 109.667 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 6.6 p -87.47 133.54 33.74 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.916 -1.114 . . . . 75.510000000000005 108.907 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -151.47 169.14 22.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.147 -0.933 . . . . 70.030000000000001 109.18 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' HE1' ' HD2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -114.55 115.08 26.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.109 0.481 . . . . 62.5 109.921 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.752 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -123.63 136.44 10.36 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.876 -0.678 . . . . 75.0 112.401 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 15' ' ' PHE . 33.6 m -117.96 131.68 70.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.983 0.391 . . . . 64.319999999999993 110.519 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.786 ' HB2' HD22 ' A' ' 45' ' ' ASN . 0.5 OUTLIER -141.07 149.09 41.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.033 0.444 . . . . 73.409999999999997 111.334 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.588 ' HA ' HG12 ' A' ' 69' ' ' ILE . 19.0 t70 -92.03 144.32 25.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.524 -0.762 . . . . 72.040000000000006 110.176 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.622 ' SG ' ' HG2' ' A' ' 68' ' ' LYS . 12.1 p -135.44 175.15 9.85 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.001 -1.0 . . . . 61.509999999999998 108.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.33 -24.39 45.07 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 114.899 0.72 . . . . 42.340000000000003 114.899 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -121.54 -15.93 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.416 1.108 . . . . 62.149999999999999 113.032 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HG2' ' SG ' ' A' ' 65' ' ' CYS . 9.7 ptpt -163.3 168.35 20.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.162 -0.615 . . . . 72.010000000000005 112.052 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 64' ' ' ASP . 23.6 mt -113.27 123.77 69.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.028 -0.73 . . . . 74.430000000000007 109.028 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.02 133.82 43.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.358 -0.383 . . . . 71.0 111.434 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' HD2' ' HE1' ' A' ' 60' ' ' PHE . 10.8 m-85 -89.84 108.79 19.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 60.409999999999997 109.208 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.9 t -104.78 131.35 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.987 0.422 . . . . 61.409999999999997 111.602 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.3 tp -127.28 130.12 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.609 -0.723 . . . . 70.530000000000001 110.283 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 58' ' ' CYS . 19.1 m95 -90.17 159.36 16.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 109.936 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 31.0 p -86.14 151.87 54.91 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 44.229999999999997 109.557 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -74.7 79.4 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.293 1.995 . . . . 54.219999999999999 111.375 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.96 -38.96 64.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.633 -0.712 . . . . 54.43 110.233 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.11 9.22 28.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 70.310000000000002 110.253 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -126.68 165.54 27.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.633 . . . . 50.210000000000001 111.009 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.534 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 17.2 Cg_exo -68.92 175.69 7.08 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.939 2.426 . . . . 73.25 112.846 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.84 -8.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.067 -0.515 . . . . 74.329999999999998 111.852 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 67.2 tttt -67.71 -56.03 12.85 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 112.657 0.614 . . . . 74.319999999999993 112.657 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 52.5 Cg_exo -53.33 -40.2 78.74 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.285 1.99 . . . . 73.219999999999999 113.562 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 76' ' ' PRO . 57.8 ttp85 -60.47 -45.85 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 60.210000000000001 111.025 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.77 -26.95 66.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.151 0.5 . . . . 65.120000000000005 109.94 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.1 m -71.87 -48.2 47.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.271 -0.877 . . . . 74.129999999999995 111.652 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -61.37 -31.53 71.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.837 0.351 . . . . 74.420000000000002 111.408 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.33 69.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 70.340000000000003 111.719 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -71.29 -30.15 65.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 63.450000000000003 111.228 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 94' ' ' LEU . 3.2 p -97.63 12.48 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.275 -0.421 . . . . 62.210000000000001 111.825 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -57.24 -52.47 65.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.376 . . . . 71.209999999999994 111.694 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -76.56 -31.36 57.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 72.299999999999997 111.548 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.27 67.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.987 0.366 . . . . 53.009999999999998 111.987 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 36' ' ' ILE . 4.1 mm? -96.15 -42.22 8.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 72.109999999999999 109.997 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 103' ' ' ALA . 55.0 tp -55.47 -39.34 70.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 63.530000000000001 110.994 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -81.46 -21.59 38.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.435 -0.802 . . . . 65.530000000000001 112.191 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -32.5 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.818 0.673 . . . . 74.040000000000006 112.818 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.687 HD11 HD12 ' A' ' 94' ' ' LEU . 65.5 mt -88.13 -40.65 13.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.746 -0.782 . . . . 63.439999999999998 112.762 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -151.82 -174.23 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.455 -0.498 . . . . 74.540000000000006 111.038 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.75 13.6 66.05 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.338 -1.105 . . . . 74.239999999999995 110.338 172.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.48 177.28 0.05 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.111 0.964 . . . . 74.209999999999994 113.13 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 104' ' ' VAL . 4.9 m -85.45 140.38 30.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.417 -0.81 . . . . 73.239999999999995 111.106 -167.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -69.3 5.91 1.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.286 -0.87 . . . . 32.450000000000003 113.056 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 102' ' ' THR . 46.0 t -85.56 149.32 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.922 -0.399 . . . . 75.209999999999994 109.922 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -125.61 165.17 19.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.023 -0.362 . . . . 72.329999999999998 110.023 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 tt -133.21 117.77 17.82 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.7 -0.482 . . . . 72.420000000000002 109.7 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.96 132.92 53.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.48 -0.563 . . . . 73.219999999999999 109.48 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . . . -131.43 162.67 29.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.312 -0.404 . . . . 74.010000000000005 110.127 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.557 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 1.9 p80 -112.19 -158.6 0.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.119 -0.491 . . . . 74.319999999999993 111.145 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.478 ' H ' ' HB2' ' A' ' 109' ' ' HIS . 0.8 OUTLIER -51.15 157.23 0.93 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.161 0.8 . . . . 64.310000000000002 113.161 -170.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 64.4 mtm 79.61 -45.31 0.32 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.597 -1.183 . . . . 70.340000000000003 111.789 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.0 -19.1 21.33 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.862 0.705 . . . . 65.099999999999994 114.862 -171.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.15 -51.57 69.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.619 0.368 . . . . 63.329999999999998 111.263 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 114' ' ' LEU . 2.4 pt? -120.32 20.23 11.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 63.109999999999999 111.485 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -101.77 155.97 35.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.786 -0.449 . . . . 72.239999999999995 109.786 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.721 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 18.9 Cg_endo -59.61 100.18 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.492 2.128 . . . . 71.209999999999994 113.316 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 117' ' ' LEU . 4.8 mp -64.47 -54.11 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.808 -0.812 . . . . 75.030000000000001 108.808 171.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-N 114.69 -1.141 . . . . 74.230000000000004 108.985 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . . . . . . 0 CA--C 1.517 0.205 0 N-CA-C 112.99 -0.044 . . . . 54.13 112.99 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 152.55 25.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 73.24 111.37 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.96 132.77 7.75 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.716 -0.954 . . . . 63.44 110.716 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 7.5 p -107.26 132.83 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.947 0.403 . . . . 63.32 111.247 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.19 139.25 33.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.757 -0.46 . . . . 62.02 109.757 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -13.83 62.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.2 0.444 . . . . 72.14 112.2 -173.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.8 -32.99 74.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.933 0.397 . . . . 65.14 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.6 m -64.41 -35.32 80.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.901 -0.59 . . . . 61.31 110.453 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.25 -31.55 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.847 -0.615 . . . . 73.51 110.23 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.55 -26.61 68.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.66 -0.7 . . . . 71.22 111.948 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -64.15 -20.11 65.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.945 -0.302 . . . . 64.21 111.525 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 40.7 m-85 -75.5 -18.24 59.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.29 0.478 . . . . 74.32 112.29 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -82.0 -23.41 36.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.017 -0.673 . . . . 64.04 110.35 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG2' HH11 ' A' ' 21' ' ' ARG . 1.1 tm-20 -84.1 -21.09 31.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.27 -1.011 . . . . 72.12 108.27 171.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 27.4 tp -84.17 -59.79 2.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.683 -1.144 . . . . 73.3 111.594 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -76.25 -43.94 39.64 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.375 -0.375 . . . . 73.5 111.82 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.1 mm -66.51 -44.21 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.431 . . . . 74.31 111.662 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' GLU . 58.5 mtp180 -80.51 -10.36 59.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.282 -0.417 . . . . 73.51 110.515 -177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.2 tttt 56.57 24.3 8.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.46 -0.791 . . . . 73.03 111.14 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -99.82 125.61 45.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.807 -0.812 . . . . 73.51 108.807 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 m -83.83 138.24 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.113 0.482 . . . . 75.1 110.051 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.477 0.656 . . . . 74.14 112.115 -172.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.762 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.9 t90 -142.54 123.76 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.427 -1.323 . . . . 54.14 107.427 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 41' ' ' ASP . 27.1 pt -119.22 138.98 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.427 -0.583 . . . . 65.21 109.427 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 5.9 p -115.83 120.29 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.839 0.828 . . . . 73.31 111.237 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -114.94 163.38 15.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.908 -1.042 . . . . 63.45 110.672 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -112.09 127.55 55.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.72 -0.673 . . . . 75.13 109.653 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 86' ' ' THR . 68.8 mt -113.04 100.29 10.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 71.42 110.214 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HA ' HG21 ' A' ' 86' ' ' THR . 8.8 tp10 -162.55 165.48 25.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.95 -1.13 . . . . 72.54 107.95 171.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 t30 60.6 29.38 18.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.739 0.781 . . . . 71.34 109.936 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 4' ' ' GLY . 50.0 p 57.52 26.97 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.446 -1.252 . . . . 55.4 112.9 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -125.55 136.75 53.65 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.213 -0.304 . . . . 72.24 110.613 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 94' ' ' LEU . 9.8 mm -106.34 107.14 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.353 -0.61 . . . . 53.44 109.353 172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.56 142.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 -0.275 . . . . 74.23 110.467 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 1.8 m -79.91 146.39 7.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.794 0.331 . . . . 75.41 110.478 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.543 ' OE1' ' HD2' ' A' ' 59' ' ' ARG . 50.2 mt-10 -107.03 -18.54 13.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.327 -0.62 . . . . 75.53 109.327 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . 18.3 tppt? -160.54 145.62 14.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.531 -0.758 . . . . 70.22 110.812 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 27' ' ' ILE . 3.4 p30 -152.08 133.35 14.44 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.807 -0.812 . . . . 71.21 108.807 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.38 159.27 25.69 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.038 -1.077 . . . . 75.21 113.344 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -114.31 121.54 43.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.513 0.673 . . . . 74.04 109.71 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 29.44 1.4 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 108.238 -1.945 . . . . 64.25 108.238 -168.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -44.42 -53.4 6.91 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 115.492 1.664 . . . . 74.44 115.492 -160.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -69.5 -34.75 74.76 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.91 0.337 . . . . 74.51 111.91 -171.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.35 -43.81 11.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.583 0.706 . . . . 54.02 109.932 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.11 -53.52 56.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.485 -1.234 . . . . 63.11 111.518 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.7 ' HD1' ' HG ' ' A' ' 53' ' ' LEU . 13.8 m-85 -68.06 -19.05 64.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.871 . . . . 61.03 113.35 -172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 55.8 mtm-85 -66.33 -30.9 71.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.412 -0.515 . . . . 74.32 110.8 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.0 -20.13 9.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.821 . . . . 73.42 112.498 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -84.84 -16.45 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.86 0.319 . . . . 43.11 111.86 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 35.8 mt -111.99 92.12 17.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.978 0.732 . . . . 71.35 112.978 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 52' ' ' ALA . 73.9 Cg_endo -101.04 44.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.875 3.05 . . . . 64.3 108.902 162.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -51.47 -37.95 51.41 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 114.456 1.28 . . . . 75.01 114.456 -163.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 16.6 t-20 68.82 -46.36 0.55 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.473 0.483 . . . . 53.41 111.448 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.74 172.33 7.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.128 -0.487 . . . . 64.44 109.754 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 9.5 p -84.11 136.08 34.14 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.093 -0.643 . . . . 64.02 109.99 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HD2' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mmt85 -135.75 170.5 15.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.059 -1.089 . . . . 73.25 108.059 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 71' ' ' PHE . 2.2 t80 -117.3 119.07 34.01 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.335 -0.546 . . . . 71.3 110.996 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.762 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.07 135.3 10.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 73.2 112.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 2.8 p -106.02 123.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 72.24 110.385 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 2.4 t80 -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.232 -0.895 . . . . 73.24 109.323 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.53 141.79 31.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 75.4 111.505 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 60.7 m -131.08 169.55 15.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.421 -0.809 . . . . 63.2 109.44 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.9 66.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 33.52 112.478 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -72.45 -34.27 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 44.41 111.374 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -170.53 168.48 7.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 73.31 110.35 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.413 ' HB ' ' HB1' ' A' ' 101' ' ' ALA . 13.2 mt -122.33 118.16 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.271 -0.64 . . . . 63.12 109.271 170.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -112.92 129.14 56.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.321 0.581 . . . . 75.32 110.509 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.737 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.8 m-85 -78.57 114.06 17.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.314 -0.857 . . . . 74.53 109.471 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.36 127.04 43.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.315 0.578 . . . . 62.25 111.511 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 58.4 tp -131.14 107.1 8.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.094 -0.957 . . . . 73.11 110.029 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -85.62 130.29 34.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.871 -0.789 . . . . 72.34 108.871 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -78.14 148.27 74.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.82 0.343 . . . . 62.11 110.624 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.833 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.7 Cg_endo -89.43 115.54 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.584 2.189 . . . . 70.13 111.88 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.71 -19.34 41.69 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.48 0.657 . . . . 74.22 109.662 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -102.41 9.88 39.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.379 -0.828 . . . . 74.44 110.639 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -139.14 152.48 69.88 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 121.962 -0.461 . . . . 72.42 111.013 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 16.7 Cg_exo -68.7 -178.86 2.12 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.177 2.584 . . . . 70.5 113.232 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 85' ' ' MET . 9.1 p -84.64 -8.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 71.03 111.515 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 48.6 mtpt -68.25 -49.73 32.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.393 0.516 . . . . 74.34 112.393 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 26.9 Cg_endo -65.18 -31.54 53.79 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.4 1.4 . . . . 74.51 111.1 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.56 -39.09 92.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.158 -0.928 . . . . 75.11 110.698 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 22.1 mmt -61.34 -39.17 89.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.778 -0.647 . . . . 71.23 111.487 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.756 HG22 HG22 ' A' ' 31' ' ' ILE . 8.2 m -58.08 -43.85 87.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.811 0.339 . . . . 73.32 111.286 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.721 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 90.4 m-85 -66.43 -54.11 27.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 73.51 111.783 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.62 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 61.14 111.808 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -86.48 -45.16 11.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.358 -0.383 . . . . 71.21 111.382 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' ILE . 8.1 m -79.94 -11.18 59.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.41 -0.359 . . . . 70.05 111.691 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.09 -21.76 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 74.45 111.363 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.73 -37.01 81.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.348 -0.387 . . . . 54.54 110.55 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.74 71.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 72.32 110.683 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.0 mm? -73.54 -57.6 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 53.53 109.389 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' HA ' ' A' ' 103' ' ' ALA . 25.1 tp -54.63 -43.51 72.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.676 -1.147 . . . . 71.42 112.282 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -64.66 -25.17 67.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.979 -0.555 . . . . 74.11 111.585 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.27 -36.8 7.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.379 0.881 . . . . 64.31 113.379 -168.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 1.6 pp -87.11 -37.59 17.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.906 1.076 . . . . 75.1 113.906 -164.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 t70 -151.38 168.47 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.779 -0.769 . . . . 72.04 111.421 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.39 14.11 30.65 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.572 -0.74 . . . . 23.21 111.435 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.52 179.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.005 0.922 . . . . 71.5 112.645 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -83.4 140.28 32.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.594 -0.73 . . . . 74.24 110.333 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.797 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -78.23 -0.29 27.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 64.13 111.521 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.82 147.96 5.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.12 0.486 . . . . 64.02 109.728 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.97 157.77 30.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.99 -0.55 . . . . 74.01 109.581 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.82 116.54 32.19 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.675 -0.491 . . . . 73.12 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.67 127.58 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.971 -0.381 . . . . 74.02 109.971 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.21 119.04 32.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.96 0.409 . . . . 65.11 110.851 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -111.87 -11.23 13.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.139 -0.689 . . . . 73.21 109.139 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -93.14 -161.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.171 -0.922 . . . . 72.11 108.73 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.6 mtp -86.56 18.36 3.37 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.389 -0.194 . . . . 63.1 110.842 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.18 -33.36 74.67 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 114.416 0.526 . . . . 71.02 114.416 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.65 -51.66 68.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.099 0.476 . . . . 71.45 111.356 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 2.9 pp -96.49 12.42 31.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 65.34 111.397 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -87.73 165.35 30.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 71.23 109.98 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.661 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . 37.0 Cg_endo -67.38 89.56 0.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 121.937 1.758 . . . . 73.12 112.793 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 115' ' ' ALA . 5.6 mp -68.53 -39.7 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.219 -0.66 . . . . 74.03 109.219 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.419 -0.809 . . . . 53.04 109.186 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.193 0 CA-C-O 120.938 0.188 . . . . 65.11 112.726 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.17 174.28 7.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.256 0.55 . . . . 73.32 111.213 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.35 118.59 3.57 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.749 -0.941 . . . . 64.41 110.749 171.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.06 124.59 37.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.668 -0.493 . . . . 74.31 109.668 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.9 147.18 24.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.901 0.382 . . . . 73.01 110.378 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 9' ' ' GLU . 6.2 pt-20 -74.81 -13.06 60.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 61.42 112.431 -174.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -54.9 -27.75 45.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.935 0.398 . . . . 75.14 111.024 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.96 -56.21 14.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 65.24 110.797 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.96 -27.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.517 -0.31 . . . . 74.42 111.558 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -30.82 71.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.259 0.552 . . . . 73.04 110.434 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.437 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -72.32 -38.56 68.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.808 -0.633 . . . . 73.22 110.652 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 82.5 m-85 -60.75 -28.84 69.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.572 -0.285 . . . . 74.24 111.252 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -62.63 -47.22 84.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 65.42 110.375 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 31.8 mt-10 -67.25 -37.19 83.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 63.25 110.035 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' H ' ' A' ' 25' ' ' LYS . 21.5 tp -57.61 -47.93 80.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.996 -1.002 . . . . 72.33 111.052 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -83.43 -58.9 2.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.347 0.499 . . . . 72.54 112.347 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.81 -47.55 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.452 0.538 . . . . 63.45 112.452 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 82.7 mtp180 -72.53 -11.52 60.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.507 0.194 . . . . 75.54 111.193 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 39.7 ttmt 58.95 24.15 12.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.093 0.949 . . . . 72.41 110.136 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -105.76 122.44 46.08 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.104 -0.953 . . . . 72.14 108.544 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.39 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.758 -0.777 . . . . 54.12 110.608 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' H ' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -137.94 147.44 44.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 75.51 110.314 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 4.0 t90 -109.5 124.99 52.0 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.75 -1.574 . . . . 71.35 106.75 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.495 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 29.3 pt -108.43 122.16 62.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.614 -0.834 . . . . 73.42 110.668 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.87 114.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.265 -0.643 . . . . 72.34 109.265 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -112.99 160.2 18.35 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.544 -0.753 . . . . 72.01 111.038 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 3.2 tppp? -113.46 124.47 52.49 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.092 -0.958 . . . . 63.13 108.518 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 94' ' ' LEU . 70.3 mt -109.12 101.53 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.027 0.442 . . . . 71.23 110.576 -175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.21 162.09 31.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.554 -0.748 . . . . 61.1 109.323 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.88 40.06 23.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.038 0.447 . . . . 71.13 111.282 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.6 p 56.54 19.31 4.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.802 0.841 . . . . 74.55 113.168 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -127.98 128.54 45.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 73.41 111.07 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mm -93.42 107.99 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 72.21 108.685 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.13 134.37 66.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.709 -0.223 . . . . 63.33 110.477 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 29' ' ' PHE . 21.3 t -91.56 134.14 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.139 -0.689 . . . . 75.14 109.139 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.08 -18.02 12.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.184 -0.672 . . . . 74.42 109.184 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -144.64 142.78 30.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.565 0.698 . . . . 72.45 112.723 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 27' ' ' ILE . 3.2 p-10 -131.78 131.69 43.15 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.515 -1.661 . . . . 74.02 106.515 161.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . -107.37 144.68 16.0 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.747 -1.216 . . . . 73.22 113.524 -167.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 3.7 ptpp? -109.21 121.37 45.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.328 -0.989 . . . . 72.21 108.328 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.48 49.67 7.15 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.596 -2.202 . . . . 43.03 107.596 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.978 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 26.8 p-10 -45.09 -51.48 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.469 1.285 . . . . 71.4 114.469 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.13 -23.51 51.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.701 0.286 . . . . 34.21 111.768 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.35 -43.08 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.57 -0.286 . . . . 65.23 111.189 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.83 -53.92 52.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 72.04 110.867 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 33.3 m-85 -68.56 -10.36 55.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.974 0.731 . . . . 73.34 112.974 -172.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -68.02 -15.81 63.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.178 0.513 . . . . 74.23 109.838 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.18 9.19 1.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.929 -0.653 . . . . 34.23 112.339 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -76.85 -54.43 6.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 74.21 111.073 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.03 78.37 12.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.859 -0.336 . . . . 73.0 111.802 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.69 77.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.165 2.577 . . . . 65.12 110.387 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.49 -14.11 57.37 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.99 0.737 . . . . 64.22 112.99 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 14.4 m120 68.25 8.92 6.9 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.278 0.561 . . . . 54.14 110.737 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -117.26 163.52 16.2 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.034 -0.728 . . . . 72.13 109.034 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 4.9 p -79.37 135.43 36.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 122.295 1.045 . . . . 72.53 110.414 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.91 32.85 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.873 -1.512 . . . . 73.51 108.938 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.0 t80 -102.24 122.22 43.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.927 0.394 . . . . 64.12 110.644 -173.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -122.31 135.95 10.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.16 -0.543 . . . . 75.15 112.161 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.272 0.536 . . . . 52.23 110.74 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.629 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -146.24 148.74 32.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.275 -0.42 . . . . 75.55 111.388 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.805 ' HA ' HG12 ' A' ' 69' ' ' ILE . 26.7 t70 -69.4 144.87 53.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 73.04 109.85 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 12.9 t -133.45 173.18 11.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.172 -0.677 . . . . 74.55 109.172 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -40.29 92.48 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.164 -0.541 . . . . 65.35 113.824 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -99.75 -46.36 5.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.376 0.588 . . . . 61.32 110.93 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' CYS . 0.3 OUTLIER -141.75 177.34 8.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.764 -0.653 . . . . 73.32 110.116 -171.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.805 HG12 ' HA ' ' A' ' 64' ' ' ASP . 11.4 mt -100.45 123.22 53.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.978 -0.749 . . . . 62.25 108.978 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -101.49 121.82 42.67 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.623 -0.431 . . . . 62.45 111.222 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.429 ' CE2' HD12 ' A' ' 98' ' ' LEU . 15.1 m-85 -78.01 109.01 11.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.774 -0.825 . . . . 73.24 108.774 168.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 113.85 40.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.504 0.669 . . . . 61.14 111.203 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 45.7 tp -113.94 112.16 22.86 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.354 -0.839 . . . . 73.24 109.51 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.698 ' HZ2' ' HG2' ' A' ' 111' ' ' MET . 37.4 t90 -85.19 123.22 30.44 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.617 -0.882 . . . . 73.42 108.617 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 60.8 m -70.8 149.06 95.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.011 -0.54 . . . . 62.45 110.834 -173.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.808 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 17.1 Cg_exo -67.28 101.21 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.166 . . . . 64.14 111.559 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.03 -34.38 20.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.029 -0.532 . . . . 61.02 109.805 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -98.44 9.74 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 72.53 109.903 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -139.98 155.08 71.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.042 -0.527 . . . . 55.53 110.07 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -151.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.973 2.449 . . . . 73.41 113.603 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 -25.59 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.897 1.073 . . . . 65.55 113.897 -166.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 68.2 mttm -68.59 -48.93 31.64 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.573 0.582 . . . . 73.33 112.573 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.584 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 14.2 Cg_endo -57.74 -27.53 78.17 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.727 1.618 . . . . 44.22 111.758 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -69.8 -40.43 75.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 74.52 109.726 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.04 -26.79 62.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 75.41 111.297 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.4 m -57.08 -52.76 64.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 74.41 110.518 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' OH ' ' HD3' ' A' ' 30' ' ' LYS . 96.7 m-85 -76.18 -37.94 57.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 73.22 111.192 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.24 65.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 74.32 111.595 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.2 t -88.08 -50.25 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.247 0.546 . . . . 72.53 110.458 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 p -75.86 -11.99 60.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.606 -0.725 . . . . 72.14 112.43 -171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -61.47 -24.31 66.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.035 0.383 . . . . 72.3 112.035 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 51.0 m-20 -83.76 -31.74 25.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.449 . . . . 73.1 110.347 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.3 -38.37 63.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.578 . . . . 70.15 110.394 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.611 HD11 HD11 ' A' ' 31' ' ' ILE . 64.9 mt -56.9 -47.35 80.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.488 -0.56 . . . . 65.54 109.488 173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 37.9 tp -62.17 -21.74 65.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.968 -1.015 . . . . 75.12 112.17 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -76.59 -15.08 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.52 0.676 . . . . 74.42 110.411 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -111.65 -4.58 14.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.044 0.926 . . . . 61.3 108.921 176.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB2' ' HA ' ' A' ' 95' ' ' LEU . 6.5 mt -111.96 13.18 20.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.666 -1.606 . . . . 70.32 112.608 -169.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' ALA . 5.7 m-20 -33.61 -145.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 128.041 2.536 . . . . 70.13 116.741 -152.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.2 16.13 0.02 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 117.729 1.852 . . . . 61.31 117.729 -151.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -55.73 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.161 -1.051 . . . . 61.55 108.161 152.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 69' ' ' ILE . 5.4 m -77.84 117.81 19.56 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.301 -1.499 . . . . 74.52 109.834 -167.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -85.42 4.37 35.81 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.273 -1.33 . . . . 54.12 111.963 -169.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 t -85.55 146.92 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.775 -0.454 . . . . 73.54 109.775 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -126.18 146.1 50.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.027 -0.533 . . . . 50.22 109.688 176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.13 118.28 25.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.202 -0.454 . . . . 52.23 109.916 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 7.2 pt-20 -96.5 117.47 30.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.462 0.649 . . . . 72.23 110.635 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.6 119.9 32.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 62.13 109.621 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -99.37 -13.54 19.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.01 0.433 . . . . 74.05 110.892 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -105.4 166.57 10.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.588 -0.893 . . . . 72.33 108.588 169.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.698 ' HG2' ' HZ2' ' A' ' 74' ' ' TRP . 38.7 mtp -78.28 70.52 4.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.553 0.692 . . . . 53.52 111.262 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.46 -16.0 74.79 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.072 -0.967 . . . . 42.44 110.938 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -62.13 -31.94 72.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.228 -0.486 . . . . 71.33 111.615 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.13 19.23 20.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.387 0.613 . . . . 61.2 110.788 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.17 154.84 44.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.731 -0.668 . . . . 43.21 109.865 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.51 104.28 0.52 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.28 1.986 . . . . 52.44 112.294 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.23 -31.97 11.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.501 0.667 . . . . 73.23 109.68 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.267 -0.879 . . . . 73.12 109.313 177.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 111.685 -0.566 . . . . 62.33 111.685 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -85.99 152.1 23.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.434 0.635 . . . . 73.03 112.009 -176.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 125.27 5.08 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.998 -1.001 . . . . 72.42 110.682 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 44.8 t -89.78 132.59 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.731 0.266 . . . . 63.44 110.479 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.84 140.37 45.72 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.101 -0.333 . . . . 71.2 110.101 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -62.81 -28.97 70.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.981 0.419 . . . . 74.13 111.039 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.23 -28.7 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 71.42 111.01 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 74.11 110.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 HD22 ' A' ' 98' ' ' LEU . 14.1 t -78.65 -34.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 71.5 110.757 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -25.66 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.807 -0.633 . . . . 53.32 112.219 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.707 ' HG2' HG21 ' A' ' 27' ' ' ILE . 15.6 tpt180 -66.56 -17.35 64.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 73.43 111.468 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 18' ' ' LEU . 58.7 m-85 -74.42 -19.26 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.046 0.387 . . . . 74.14 112.046 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -77.25 -26.33 52.41 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.882 -0.727 . . . . 55.45 110.054 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -69.2 -33.39 73.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 65.33 109.541 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 15' ' ' PHE . 65.2 mt -70.08 -48.33 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.803 -1.089 . . . . 71.33 111.105 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -82.08 -55.07 4.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.454 -0.794 . . . . 71.52 112.609 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.96 -48.0 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.151 0.426 . . . . 74.4 112.151 -171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -81.32 -11.09 59.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.172 -0.211 . . . . 71.15 111.076 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 59.13 23.6 11.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.143 -0.481 . . . . 72.13 110.348 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -101.76 117.63 35.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.068 -0.514 . . . . 74.21 109.708 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.22 135.92 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.443 0.639 . . . . 71.32 110.654 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -138.48 161.13 37.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.58 -0.896 . . . . 71.41 108.58 177.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.6 t90 -112.78 123.49 50.42 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.786 -0.82 . . . . 73.45 108.786 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 14' ' ' ARG . 43.4 pt -110.75 131.29 62.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.642 -0.503 . . . . 74.11 109.642 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 53' ' ' LEU . 93.4 t -113.18 113.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.38 -0.373 . . . . 75.31 110.304 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 44.1 p90 -102.06 151.51 22.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.473 0.654 . . . . 63.34 110.508 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 3.8 tmmm? -114.58 124.11 51.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.057 -0.974 . . . . 75.32 108.641 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 87' ' ' TYR . 48.3 mt -88.88 103.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.719 -0.673 . . . . 52.01 109.665 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 30' ' ' LYS . 25.0 tt0 -139.64 139.3 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 73.14 111.019 -168.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 t30 49.93 46.4 24.32 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.872 0.733 . . . . 70.31 111.581 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' MET . 70.3 p 55.61 25.46 8.1 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.497 0.719 . . . . 73.41 112.666 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HG2' HG13 ' A' ' 37' ' ' VAL . 7.1 ttpm? -133.71 137.39 45.23 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.013 -0.43 . . . . 75.4 110.414 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 43.9 mm -95.09 109.37 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.951 -0.568 . . . . 54.34 110.1 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG13 ' HG2' ' A' ' 35' ' ' LYS . 16.3 m -133.8 135.47 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.026 0.441 . . . . 75.12 110.887 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.935 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.2 p -89.17 140.24 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 71.43 110.038 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.98 -35.43 13.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.922 0.392 . . . . 74.31 110.31 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 8.9 ptmt -171.75 165.45 6.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 64.24 111.686 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG22 ' A' ' 27' ' ' ILE . 4.9 p-10 -142.98 158.62 43.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.911 . . . . 65.45 108.726 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.77 148.67 20.23 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.259 -1.448 . . . . 61.02 114.951 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.71 129.35 40.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.556 -1.275 . . . . 75.12 107.556 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.99 35.86 7.99 Favored Glycine 0 C--O 1.208 -1.489 0 N-CA-C 108.294 -1.922 . . . . 54.51 108.294 -161.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.909 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 7.4 p30 -44.41 -53.11 7.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.996 1.11 . . . . 75.4 113.996 -173.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.02 -14.35 58.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.439 0.638 . . . . 61.21 110.68 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.98 -49.16 6.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.936 . . . . 71.2 110.885 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 49' ' ' PHE . 1.1 pt-20 -81.2 -36.04 30.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.895 -1.048 . . . . 73.22 111.185 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 9.3 m-85 -72.46 -4.47 30.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.108 0.41 . . . . 73.21 112.108 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -72.83 -13.98 61.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.063 0.459 . . . . 75.54 110.102 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.65 11.96 2.68 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.0 -0.619 . . . . 61.1 112.424 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -111.51 12.58 21.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 64.52 111.389 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 28' ' ' VAL . 75.0 mt -117.83 140.78 28.14 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 72.21 111.172 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 14.5 Cg_exo -69.14 105.17 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.773 2.315 . . . . 64.41 111.278 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -12.53 61.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.967 -0.561 . . . . 63.15 111.858 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.43 -19.08 24.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.378 -0.373 . . . . 70.3 111.214 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -120.73 173.41 7.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.257 -0.429 . . . . 63.34 110.257 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 6.9 p -97.99 139.09 34.33 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.302 -0.629 . . . . 73.25 109.302 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.9 mmt-85 -134.09 151.83 51.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.957 -0.565 . . . . 71.53 110.043 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.18 105.18 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.128 0.489 . . . . 75.25 109.746 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -113.3 135.03 12.28 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.818 -0.628 . . . . 52.1 111.743 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 71' ' ' PHE . 27.1 m -125.85 129.09 72.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.255 0.55 . . . . 44.23 110.224 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -140.36 147.18 39.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.015 -0.538 . . . . 62.24 110.216 177.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.36 143.3 27.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 71.44 110.414 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 34.0 t -122.73 169.56 10.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.518 -0.919 . . . . 71.3 108.518 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.64 -24.18 59.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.105 -0.569 . . . . 70.42 114.084 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -126.94 4.91 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.463 0.631 . . . . 73.52 112.577 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 13.0 ptmt -169.6 151.8 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.222 0.823 . . . . 74.33 113.222 -169.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.8 mm -100.13 125.58 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.277 -0.874 . . . . 71.43 108.802 167.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mt-30 -116.25 114.95 25.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.471 -0.492 . . . . 74.0 111.975 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.653 ' HA ' HG12 ' A' ' 62' ' ' VAL . 29.9 m-85 -85.14 109.54 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 73.21 109.197 170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.67 126.07 64.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.008 0.432 . . . . 75.13 110.949 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 62.9 tp -133.3 108.02 8.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 60.24 110.521 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.408 ' HD1' ' HB3' ' A' ' 108' ' ' ALA . 63.2 t90 -85.47 119.96 26.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.712 -0.847 . . . . 63.21 108.712 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -74.52 148.22 85.45 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.018 -0.273 . . . . 65.3 110.296 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.799 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 71.6 Cg_endo -78.77 121.25 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.321 2.014 . . . . 74.05 113.47 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.06 -20.12 30.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.55 -0.75 . . . . 54.33 110.246 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.69 16.11 21.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.538 0.685 . . . . 71.3 110.31 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -140.66 155.68 69.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 74.44 109.85 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -76.43 -165.97 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.396 2.731 . . . . 63.31 113.622 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.67 -24.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.768 0.655 . . . . 54.44 112.768 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 61.8 mttp -67.05 -48.74 48.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 119.281 -0.39 . . . . 61.04 111.936 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 Cg_exo -55.82 -41.01 81.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.416 1.41 . . . . 74.22 111.468 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -62.86 -51.16 68.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.481 -0.781 . . . . 73.4 111.221 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 82' ' ' LYS . 26.0 ptt? -68.78 -24.35 64.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 53.44 110.925 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.1 m -62.93 -56.17 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.404 -0.362 . . . . 64.44 110.42 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m-85 -60.97 -37.0 80.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 75.24 111.033 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.27 -31.25 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 63.33 111.777 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 t -66.36 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 64.21 110.901 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' HD13 ' A' ' 31' ' ' ILE . 2.0 p -87.19 7.4 28.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.167 -0.47 . . . . 52.02 112.078 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.615 ' O ' HD13 ' A' ' 95' ' ' LEU . 15.9 tttm -57.45 -55.55 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 75.53 111.338 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.443 ' HA ' HD22 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -76.75 -21.64 54.95 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.17 -0.468 . . . . 51.51 110.332 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.43 92.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.447 -0.797 . . . . 70.34 110.889 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.75 HD12 HD11 ' A' ' 98' ' ' LEU . 4.6 mm? -77.64 -37.25 50.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 70.03 110.276 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 91' ' ' LYS . 4.8 mp -57.04 -43.04 81.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.584 0.706 . . . . 72.25 110.366 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.55 -10.48 59.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.907 -1.042 . . . . 73.23 111.956 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' A' ' 7' ' ' VAL . 52.9 tptt -106.24 -48.58 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.271 0.841 . . . . 74.44 113.271 -169.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 94' ' ' LEU . 17.8 mt -89.0 -45.05 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.765 1.024 . . . . 70.23 113.765 -162.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 4.8 t70 -156.54 -166.53 2.16 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.467 -0.493 . . . . 74.1 111.254 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -88.09 16.18 52.86 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 110.722 -0.951 . . . . 75.31 110.722 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.81 179.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.268 1.027 . . . . 75.01 113.034 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.588 HG22 HG23 ' A' ' 104' ' ' VAL . 2.1 m -83.36 139.95 32.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.838 -0.619 . . . . 72.54 110.764 -167.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -81.16 2.01 29.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.576 -0.738 . . . . 45.22 112.048 -174.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' THR . 40.6 t -76.69 147.08 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.906 0.384 . . . . 64.1 110.279 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.16 144.36 34.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.302 -0.629 . . . . 54.34 109.302 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -118.93 118.64 32.07 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.179 -0.209 . . . . 62.12 110.482 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.0 pt-20 -104.04 118.56 36.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.364 0.602 . . . . 74.31 110.129 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 74' ' ' TRP . . . -97.51 143.08 28.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 65.44 110.678 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -6.09 6.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 65.13 109.473 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.75 -162.03 1.18 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.77 -1.105 . . . . 70.43 109.691 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.9 mtp -85.57 28.2 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.746 0.308 . . . . 71.12 111.259 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.36 -23.02 59.44 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.838 -0.696 . . . . 72.41 111.871 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.39 -51.81 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.221 0.534 . . . . 44.25 110.478 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.845 ' H ' HD23 ' A' ' 114' ' ' LEU . 1.3 pt? -84.25 23.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 65.25 111.051 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -117.56 160.57 37.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.339 -0.615 . . . . 75.53 109.339 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 13.2 Cg_endo -56.28 107.89 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.41 2.073 . . . . 71.23 112.403 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.1 mp -76.12 -32.6 59.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 75.1 110.097 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.669 -0.696 . . . . 60.02 109.787 177.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 113.959 0.343 . . . . 72.13 113.959 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.39 144.07 33.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.106 0.453 . . . . 73.11 109.878 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.49 116.49 5.59 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.081 -0.808 . . . . 74.12 111.081 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.44 130.66 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.754 0.311 . . . . 72.54 111.05 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.61 131.03 44.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 34.11 111.362 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.2 -18.02 37.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.915 -0.584 . . . . 44.23 111.641 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -68.1 -25.44 65.32 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.631 0.253 . . . . 44.33 110.642 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -53.12 -45.2 68.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 75.1 110.867 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t -61.72 -39.68 84.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.208 -0.451 . . . . 63.01 111.092 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.99 68.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 54.54 111.183 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 14' ' ' ARG . 22.0 mmt180 -75.65 -18.73 59.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.21 111.364 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 88.1 m-85 -84.0 -21.91 31.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.355 0.598 . . . . 73.1 109.444 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -45.27 44.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 74.01 109.267 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 21' ' ' ARG . 11.0 mm-40 -65.16 -15.63 62.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.193 0.521 . . . . 74.13 110.696 171.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 23.7 tp -86.58 -61.59 1.7 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.761 -0.654 . . . . 34.15 111.002 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -82.51 -50.6 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.379 0.511 . . . . 63.23 112.379 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.5 mm -68.41 -28.51 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 74.11 110.777 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 17' ' ' GLU . 39.5 mmt180 -85.91 -10.54 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 74.54 110.691 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 59.37 45.25 14.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.974 -0.557 . . . . 73.43 111.798 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 18' ' ' LEU . 13.8 t -143.59 151.98 40.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.385 -0.598 . . . . 74.45 109.385 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG12 ' OD2' ' A' ' 64' ' ' ASP . 33.1 m -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.596 -0.442 . . . . 71.22 110.677 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -140.69 164.23 30.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.379 0.609 . . . . 72.24 111.424 173.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 5.8 t90 -129.57 123.58 31.71 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.218 -1.03 . . . . 75.51 108.218 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.925 HG22 ' HB2' ' A' ' 41' ' ' ASP . 15.0 pt -116.15 134.56 59.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.697 -0.483 . . . . 72.13 109.697 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.1 109.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.138 0.494 . . . . 62.43 110.913 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -101.91 147.84 26.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 73.42 109.638 175.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -113.99 125.29 53.84 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.103 0.478 . . . . 72.23 110.802 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.75 HG12 HD12 ' A' ' 36' ' ' ILE . 62.2 mt -83.07 103.43 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.587 -0.894 . . . . 72.34 108.587 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -146.35 139.89 25.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 71.51 110.541 -173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.69 31.15 20.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 74.5 110.118 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 65.97 20.13 11.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.593 -0.73 . . . . 54.21 110.655 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -130.02 143.61 50.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.593 -0.73 . . . . 64.13 110.098 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.75 HD12 HG12 ' A' ' 31' ' ' ILE . 10.7 mm -111.91 111.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 64.41 110.58 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.7 154.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.736 0.303 . . . . 75.43 110.412 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 11.4 t -83.49 132.44 31.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.082 -0.508 . . . . 63.23 110.396 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.23 -37.74 32.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.92 -0.77 . . . . 62.13 108.92 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 40' ' ' LYS . 10.9 ptmm? -173.56 164.66 4.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.041 -0.982 . . . . 72.53 110.039 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.925 ' HB2' HG22 ' A' ' 27' ' ' ILE . 2.3 p-10 -126.19 148.07 49.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.801 -1.185 . . . . 64.4 107.801 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.0 161.52 12.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.92 -1.133 . . . . 51.15 113.977 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -137.49 129.27 28.69 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 52.41 106.782 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.8 36.99 35.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.016 -2.033 . . . . 70.22 108.016 -159.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 2.5 m-20 -44.56 -52.77 7.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.398 -1.401 . . . . 71.42 113.933 -163.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -66.02 -34.85 79.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.13 -0.486 . . . . 73.12 111.208 -172.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -89.57 -34.95 16.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.882 0.372 . . . . 65.21 111.108 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 7.8 tt0 -62.17 -50.22 72.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 71.05 110.611 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.65 -0.6 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.166 0.432 . . . . 73.32 112.166 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 48.5 mtp180 -81.27 -15.35 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 75.42 110.832 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.05 -19.85 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.106 -1.045 . . . . 72.13 113.63 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -58.51 -59.52 5.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 70.13 110.807 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.27 85.94 4.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.836 -0.62 . . . . 74.42 110.223 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.28 117.92 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.047 1.831 . . . . 75.24 109.594 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.61 78.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.006 0.373 . . . . 72.03 112.006 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.5 t30 67.12 -47.28 0.48 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.622 0.769 . . . . 71.11 111.144 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.41 172.04 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 72.34 108.63 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 5.4 p -78.8 139.55 38.37 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.535 -0.466 . . . . 73.44 110.478 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -151.1 163.79 37.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.989 -0.745 . . . . 74.23 108.989 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.734 ' HD2' ' HE1' ' A' ' 29' ' ' PHE . 6.9 t80 -109.73 116.05 30.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.503 0.668 . . . . 52.13 110.419 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.713 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.29 135.23 10.5 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 115.377 -0.829 . . . . 64.54 111.829 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 27' ' ' ILE . 34.0 m -105.34 122.45 58.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 117.465 0.633 . . . . 64.21 110.362 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 6.2 t80 -135.59 132.26 36.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.523 -0.762 . . . . 63.33 109.684 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' OD2' HG12 ' A' ' 24' ' ' VAL . 10.0 p-10 -102.91 143.32 32.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.686 0.755 . . . . 74.23 111.023 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.7 t -112.38 169.62 8.75 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.401 -0.963 . . . . 73.51 108.401 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.53 -24.75 68.08 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.755 -0.736 . . . . 44.23 112.511 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 -46.51 6.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.782 0.29 . . . . 74.4 111.782 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.94 167.81 27.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.541 0.21 . . . . 73.13 110.688 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.407 HG12 ' CB ' ' A' ' 64' ' ' ASP . 7.6 mt -100.7 139.3 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.551 -0.537 . . . . 70.32 109.551 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -117.65 118.3 31.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.942 0.401 . . . . 72.55 110.71 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.42 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 61.4 m-85 -79.44 110.04 14.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.844 -0.798 . . . . 71.41 108.844 171.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.198 -0.455 . . . . 65.32 111.385 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 63.7 tp -141.18 82.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.526 -0.761 . . . . 61.14 109.489 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -85.71 149.36 25.35 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.647 -0.501 . . . . 75.41 109.647 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 57.8 m -97.8 147.28 32.81 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.832 -0.433 . . . . 72.5 109.832 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 7.7 Cg_endo -91.78 144.11 2.94 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.146 2.564 . . . . 52.14 112.798 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -80.36 -7.03 58.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.608 0.718 . . . . 65.23 109.583 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -107.46 15.64 24.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.052 -0.976 . . . . 74.45 110.334 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . . . -141.65 154.39 66.15 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 121.866 -0.521 . . . . 53.41 111.028 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 19.0 Cg_endo -91.59 -178.33 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.135 2.557 . . . . 65.23 112.801 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.33 3.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.853 -0.612 . . . . 65.44 112.077 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 ttmt -68.32 -58.1 7.87 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 121.195 -0.202 . . . . 73.01 110.954 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' O ' ' HD1' ' A' ' 87' ' ' TYR . 60.0 Cg_endo -74.05 -26.93 12.45 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.222 1.281 . . . . 34.22 111.579 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -32.49 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 65.23 111.104 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.9 -29.57 55.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.12 110.746 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -66.66 -44.85 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 74.32 110.634 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.547 ' CD2' HD12 ' A' ' 31' ' ' ILE . 77.1 m-85 -64.35 -30.22 71.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 74.43 110.266 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.18 62.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.908 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -84.72 -53.94 5.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.472 . . . . 72.14 110.711 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -72.53 -17.07 61.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 75.14 112.012 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -33.21 74.96 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.731 0.271 . . . . 64.53 111.731 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.74 -45.47 43.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 70.31 110.22 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.638 -0.71 . . . . 71.42 110.948 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.7 mm? -64.15 -48.81 74.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 53.41 110.848 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.8 tt -56.66 -43.95 80.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 74.21 110.578 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -67.76 -27.7 66.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.217 0.532 . . . . 24.42 110.733 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.15 -43.14 12.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.839 0.681 . . . . 75.22 112.839 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 3.5 pp -88.72 -36.74 15.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.471 1.286 . . . . 74.41 114.471 -162.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.591 ' N ' HD12 ' A' ' 98' ' ' LEU . 38.7 t0 -150.3 170.81 18.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.348 -0.941 . . . . 72.11 112.501 -174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.12 61.53 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.93 -1.032 . . . . 72.32 110.657 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -179.35 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.315 1.046 . . . . 63.04 112.749 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 104' ' ' VAL . 5.6 m -82.85 139.62 33.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.612 -0.722 . . . . 74.3 109.991 -172.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -75.14 4.49 6.78 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.361 0.504 . . . . 63.41 112.361 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 102' ' ' THR . 43.5 t -82.29 147.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.841 -0.429 . . . . 75.04 109.841 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.4 130.99 35.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.684 -0.488 . . . . 74.1 109.684 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.49 117.08 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.055 -0.52 . . . . 54.43 110.541 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.3 pt-20 -123.58 121.63 36.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 73.34 109.721 175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.84 148.58 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.868 -0.606 . . . . 72.12 110.471 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.45 11.64 27.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 73.44 110.328 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -131.12 168.48 17.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 74.5 109.991 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.48 73.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.253 0.464 . . . . 75.0 112.253 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.27 -17.59 64.35 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.683 -0.967 . . . . 54.41 110.683 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.19 -46.78 75.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.455 -0.872 . . . . 75.23 111.835 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.1 pp -105.19 23.18 14.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 74.24 111.166 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.34 54.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 71.1 110.827 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.98 116.88 3.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 52.13 111.786 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 63' ' ' TYR . 6.4 mp -71.89 -55.94 6.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.207 -0.451 . . . . 73.15 111.216 -177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.117 -0.944 . . . . 63.32 111.015 -177.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 120.906 0.17 . . . . 63.04 112.852 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.91 149.74 22.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.928 0.394 . . . . 71.42 110.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.34 109.91 1.77 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.661 -0.976 . . . . 25.13 110.661 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 HD12 ' A' ' 36' ' ' ILE . 16.7 m -101.35 134.55 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.095 0.474 . . . . 63.5 111.801 -173.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 37' ' ' VAL . 12.5 t70 -71.85 148.44 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.527 -0.76 . . . . 73.23 110.504 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.22 -20.4 44.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.444 0.535 . . . . 73.43 112.444 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -60.89 -31.91 71.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 53.14 110.711 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.1 m -61.44 -47.95 83.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 71.0 110.277 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.603 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 42.0 t -63.58 -40.85 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.51 -0.768 . . . . 65.23 110.769 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 70.35 111.05 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.683 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 25.2 mmt180 -63.97 -40.78 97.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 72.02 111.223 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 14.4 m-85 -58.62 -33.34 69.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.135 0.493 . . . . 65.14 110.476 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -42.47 73.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 71.02 110.566 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.16 -41.83 99.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 62.43 110.353 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 14' ' ' ARG . 83.1 mt -50.22 -57.14 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.302 -0.863 . . . . 50.33 111.264 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -83.04 -51.92 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 64.03 112.083 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.05 -55.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.845 0.313 . . . . 63.41 111.845 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -71.95 -14.92 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.234 -0.186 . . . . 62.45 110.831 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 60.27 24.08 13.51 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.882 0.739 . . . . 72.3 110.98 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.1 p -105.15 100.47 10.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.867 -0.606 . . . . 54.2 109.478 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.82 133.62 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.466 0.65 . . . . 71.13 110.458 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.6 mppt? -137.66 146.29 43.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 73.21 108.687 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.726 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.5 t90 -91.41 122.73 34.26 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.571 -1.27 . . . . 71.22 107.571 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.784 HG22 ' HB3' ' A' ' 41' ' ' ASP . 40.1 pt -107.12 131.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.143 0.497 . . . . 72.43 110.561 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 53' ' ' LEU . 88.2 t -112.64 116.02 51.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.551 -0.75 . . . . 62.32 109.397 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 37.4 p90 -116.79 163.37 16.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.694 -0.684 . . . . 74.23 110.393 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -112.27 124.79 53.24 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.412 -0.588 . . . . 75.25 109.412 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 36' ' ' ILE . 25.9 mt -99.12 102.71 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.262 -1.014 . . . . 74.42 108.262 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.11 137.49 32.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.466 -0.334 . . . . 73.24 110.678 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.3 t30 49.21 46.39 22.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.733 -0.667 . . . . 74.13 111.328 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p 56.64 22.58 6.89 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.999 0.919 . . . . 72.41 113.135 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -132.65 126.84 33.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.315 -0.624 . . . . 72.41 109.315 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 31' ' ' ILE . 58.1 mt -112.94 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.6 . . . . 73.51 111.436 -171.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 8' ' ' ASP . 14.0 m -129.38 141.45 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 72.21 110.992 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 4.6 p -86.46 133.99 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 41.52 110.522 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -100.49 -36.29 9.25 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.155 0.503 . . . . 74.31 109.912 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -138.69 141.06 38.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 75.34 111.428 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HB3' HG22 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -133.0 131.62 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 168.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.45 14.73 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.344 -1.408 . . . . 31.11 113.74 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -103.17 160.6 14.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.379 -0.971 . . . . 71.14 108.379 172.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.53 42.95 98.74 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.393 -1.883 . . . . 32.21 108.393 -163.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -44.7 -51.39 9.3 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.129 1.372 . . . . 64.31 113.041 -166.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.32 64.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.089 -0.505 . . . . 54.32 111.914 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.76 -52.19 5.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.72 0.295 . . . . 74.43 110.962 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.21 -33.62 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 64.02 111.492 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.677 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 20.5 m-85 -84.39 -0.08 51.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.932 0.715 . . . . 75.24 112.932 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 50.7 mtm180 -68.12 -25.27 65.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.158 0.504 . . . . 75.3 110.199 174.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.64 28.68 3.72 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.766 -0.731 . . . . 61.52 112.147 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -129.07 -19.65 3.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.513 0.19 . . . . 63.2 111.513 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 66.1 mt -98.88 121.88 54.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.938 0.399 . . . . 63.11 111.086 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 38.3 Cg_endo -96.57 102.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.275 2.65 . . . . 32.41 111.975 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -13.27 6.91 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.986 0.422 . . . . 74.31 112.109 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -57.49 -31.09 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 52.44 111.83 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.651 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 3.2 p30 -139.52 158.02 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.812 -0.44 . . . . 63.24 109.812 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.843 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 14.3 p -97.07 141.77 29.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.492 0.553 . . . . 71.03 112.492 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -150.76 154.24 36.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.062 -1.088 . . . . 63.14 108.062 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.556 ' HD2' ' HD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -95.98 123.41 39.56 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.512 -0.475 . . . . 73.35 110.642 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.726 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.94 133.76 9.85 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.213 -0.755 . . . . 72.13 111.213 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.42 121.53 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.54 0.686 . . . . 51.34 110.818 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 3.2 t80 -122.71 143.62 49.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.241 -0.891 . . . . 72.45 108.966 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.7 t70 -115.22 140.71 48.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.11 0.481 . . . . 74.2 110.075 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.75 168.92 16.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.73 -0.668 . . . . 74.55 109.475 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.57 -25.98 61.64 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 114.791 0.676 . . . . 65.14 114.791 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.47 -5.1 13.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.158 0.799 . . . . 72.22 113.158 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -171.37 161.84 6.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.602 0.593 . . . . 74.05 112.602 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.1 mm -93.08 134.35 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 72.43 108.932 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -115.01 106.65 14.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.842 0.354 . . . . 74.14 111.307 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.517 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . 43.3 m-85 -83.51 109.9 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.922 -0.77 . . . . 72.43 108.922 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.32 124.76 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.048 0.452 . . . . 71.3 111.441 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 65.9 tp -128.2 105.36 8.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.71 -0.677 . . . . 64.05 110.301 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -86.2 109.64 19.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 74.52 109.283 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.2 p -79.83 150.61 72.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.228 -0.442 . . . . 71.41 110.564 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 72.0 Cg_endo -82.75 97.92 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.458 2.105 . . . . 74.15 112.405 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 109' ' ' HIS . 34.5 t70 -76.63 -14.99 59.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.494 0.664 . . . . 71.35 109.765 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.52 8.47 21.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 51.01 109.552 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' A' ' 80' ' ' PRO . . . -144.36 175.23 2.91 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.711 -0.677 . . . . 51.53 109.661 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 21.8 Cg_endo -62.83 154.71 64.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.973 1.782 . . . . 62.43 111.643 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.33 12.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.028 0.381 . . . . 75.42 112.028 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.618 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 59.4 tttm -69.69 -50.98 16.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.496 -0.32 . . . . 73.33 111.814 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 51.3 Cg_exo -55.77 -24.26 45.65 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.471 2.114 . . . . 71.34 112.943 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.499 ' HD3' ' OE1' ' A' ' 107' ' ' GLU . 11.0 ttm180 -60.45 -33.91 73.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.147 0.499 . . . . 55.21 110.133 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.8 mtt -71.57 -33.6 69.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 71.05 110.692 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -63.77 -47.5 80.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 62.22 110.529 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HD2' ' HD2' ' A' ' 60' ' ' PHE . 41.5 m-85 -67.77 -37.24 81.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 72.03 111.05 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.47 65.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.169 0.509 . . . . 74.24 111.086 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -86.46 -54.58 4.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.85 -0.614 . . . . 75.01 110.91 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -77.48 -9.23 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.588 0.588 . . . . 43.22 112.588 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.703 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -58.24 -24.53 59.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.703 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 4.8 t70 -81.8 -25.7 35.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.818 0.342 . . . . 71.31 110.876 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.01 62.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 71.3 110.448 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 48.6 mt -92.14 -56.97 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.263 -0.881 . . . . 50.22 109.87 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 103' ' ' ALA . 43.8 tp -53.64 -58.94 5.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.61 -1.177 . . . . 72.11 113.079 -170.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 3.7 tmmm? -65.38 -20.34 66.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.053 -0.521 . . . . 75.42 111.523 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.66 -22.94 12.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.981 0.734 . . . . 75.45 112.981 -172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 99' ' ' ASP . 4.3 pp -87.08 -39.6 15.44 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 118.914 -1.114 . . . . 74.13 112.166 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 98' ' ' LEU . 17.0 t70 -154.07 177.05 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.17 -0.612 . . . . 74.54 111.637 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 13.44 42.63 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.899 -0.88 . . . . 43.42 110.899 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.077 0.951 . . . . 74.2 112.695 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 104' ' ' VAL . 2.5 m -84.32 136.22 33.99 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.477 -0.783 . . . . 71.24 110.403 -171.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -77.29 4.52 10.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.81 -0.632 . . . . 44.0 112.029 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 102' ' ' THR . 46.8 t -82.75 147.41 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.202 0.525 . . . . 74.12 110.428 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.26 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.772 -0.649 . . . . 70.42 109.715 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 tp -108.76 117.23 33.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.34 -0.391 . . . . 73.23 110.265 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.7 117.16 29.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.526 -0.546 . . . . 72.34 109.526 175.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.4 35.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.136 -0.484 . . . . 50.15 111.041 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p-80 -119.25 2.16 11.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.409 -0.589 . . . . 72.53 109.409 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 153.56 42.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.108 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 68.3 mtt -77.63 47.31 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 74.13 111.702 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.69 -17.07 64.49 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.213 -0.755 . . . . 73.14 111.213 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -64.0 -45.8 87.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.963 0.505 . . . . 73.01 111.197 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 3.5 pp -86.21 10.24 15.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.696 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 159.04 49.57 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.268 -0.424 . . . . 74.44 110.121 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.98 107.53 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.121 1.881 . . . . 45.35 111.351 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.3 mp -72.12 -71.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 73.33 111.033 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.607 -0.711 . . . . 65.42 110.483 -178.769 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.229 0 CA-C-O 120.685 0.047 . . . . 70.35 113.023 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.46 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -88.27 162.96 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.96 0.41 . . . . 75.22 110.39 178.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.65 108.89 1.65 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.55 -1.02 . . . . 65.34 110.55 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.39 138.67 28.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.481 0.658 . . . . 72.01 111.72 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 10' ' ' ASN . 10.2 t70 -75.62 136.28 40.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.783 -1.099 . . . . 71.12 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.28 -20.05 35.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 72.43 111.639 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 48.2 t30 -63.4 -34.98 78.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.92 -0.77 . . . . 73.53 108.92 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 38' ' ' VAL . 33.1 m -53.69 -52.05 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.142 -0.936 . . . . 73.44 109.859 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 48.3 t -59.07 -43.39 89.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.555 -0.748 . . . . 74.33 110.957 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.93 86.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 44.01 110.818 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -68.48 -30.76 69.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 70.33 111.311 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 22.1 m-85 -62.52 -35.65 80.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.109 0.481 . . . . 75.55 109.904 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.9 OUTLIER -67.75 -46.87 70.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 73.44 109.638 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 44.6 mt-10 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 75.35 112.374 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 19' ' ' LYS . 4.3 pp -65.21 -29.41 70.22 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.996 -0.681 . . . . 52.02 110.775 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.4 tmtp? -84.26 -58.68 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.488 . . . . 65.03 110.726 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.87 -29.83 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.775 0.658 . . . . 74.34 112.775 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 77.7 mtp180 -91.31 -21.04 21.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.943 -0.473 . . . . 71.02 111.347 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.13 27.75 0.34 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.314 1.046 . . . . 73.33 113.546 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.81 170.58 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.999 -1.111 . . . . 73.12 107.999 166.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 45' ' ' ASN . 8.8 p -92.1 131.19 39.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 55.52 110.668 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.653 ' HZ3' ' HB2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -140.57 170.6 15.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 63.15 111.32 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.857 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.0 t90 -152.0 129.44 11.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.083 -1.08 . . . . 70.22 108.083 172.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 41' ' ' ASP . 17.3 pt -124.94 122.72 64.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.998 0.428 . . . . 63.2 109.945 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -106.6 111.24 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.97 0.414 . . . . 74.2 110.973 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.301 0.572 . . . . 73.15 109.991 177.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -114.26 125.06 53.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.241 -0.89 . . . . 72.24 109.234 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.505 HG23 HG12 ' A' ' 36' ' ' ILE . 22.2 mt -97.0 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.254 -1.017 . . . . 71.21 108.254 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.68 137.51 25.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.724 . . . . 75.43 110.204 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 54.63 29.63 11.85 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.578 0.549 . . . . 53.21 111.389 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m 69.93 15.63 7.79 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.932 0.872 . . . . 73.01 110.721 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -107.64 156.64 18.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.71 -0.848 . . . . 64.44 108.71 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.804 HG21 HD11 ' A' ' 94' ' ' LEU . 45.5 mt -132.68 107.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.828 -0.434 . . . . 64.31 109.828 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 8' ' ' ASP . 55.7 t -133.11 134.45 57.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.39 . . . . 54.22 110.457 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.031 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -79.12 128.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 73.43 111.257 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -84.86 -38.1 19.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 75.31 111.441 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -143.24 142.84 31.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 73.14 110.592 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' A' ' 27' ' ' ILE . 2.0 p-10 -141.54 128.83 21.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.766 -0.652 . . . . 73.41 109.288 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.78 161.77 27.45 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.631 -0.795 . . . . 55.43 113.522 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -108.59 158.44 17.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.923 -1.14 . . . . 73.3 107.923 169.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.22 34.44 89.97 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.643 -1.383 . . . . 61.32 109.643 -170.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.81 HD21 HG22 ' A' ' 24' ' ' VAL . 6.6 p30 -70.89 -42.42 70.02 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.756 -1.222 . . . . 71.42 112.79 -165.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.65 36.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.927 0.394 . . . . 74.21 110.705 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.624 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 19.7 t70 -89.55 -58.36 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 64.4 111.374 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.15 -38.45 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.78 0.659 . . . . 71.52 112.78 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 6.1 m-30 -79.52 -2.68 43.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.544 . . . . 72.2 112.47 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 47' ' ' ASP . 45.8 mtm180 -81.04 -12.9 59.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.56 0.695 . . . . 75.43 109.31 173.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.69 13.24 11.84 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.266 -0.879 . . . . 62.51 111.081 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -130.94 20.38 4.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.477 0.656 . . . . 62.01 110.133 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.5 pt? -68.66 163.52 54.0 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.986 -1.006 . . . . 74.12 111.016 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.56 163.89 33.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.657 2.238 . . . . 71.23 111.203 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.29 -37.19 61.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.879 0.371 . . . . 75.0 111.022 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.53 14.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.42 0.629 . . . . 71.41 109.451 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.76 151.79 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.917 -1.038 . . . . 70.33 110.423 -172.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -90.38 141.79 28.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.603 -0.271 . . . . 65.04 110.538 175.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 58' ' ' CYS . 43.2 mmt-85 -144.77 157.07 44.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 75.03 110.528 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HE2' ' HD1' ' A' ' 87' ' ' TYR . 1.8 m-85 -112.31 117.27 32.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.519 -0.548 . . . . 75.22 109.519 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.857 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.99 130.68 8.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.388 -0.91 . . . . 51.21 113.178 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 42.5 t -98.98 121.01 49.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.881 -0.785 . . . . 74.34 108.881 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -131.83 135.7 46.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.205 0.526 . . . . 75.21 109.86 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 24' ' ' VAL . 5.1 p-10 -99.86 153.72 18.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.266 -0.879 . . . . 71.44 110.861 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 8.1 t -142.6 169.53 17.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.203 -1.036 . . . . 75.52 108.203 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.23 -27.65 63.15 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.477 0.551 . . . . 74.23 114.477 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.93 -3.38 8.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.538 0.669 . . . . 72.51 111.84 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 15.5 ptmt -149.2 158.31 44.07 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.182 0.808 . . . . 71.13 113.182 -168.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.3 mm -126.22 115.41 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 114.801 -1.09 . . . . 63.34 108.136 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 32.4 mt-30 -115.17 124.31 51.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.153 -0.619 . . . . 75.02 112.197 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.25 109.49 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.98 -0.748 . . . . 54.44 108.98 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.27 125.22 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.054 0.454 . . . . 74.42 110.701 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 87' ' ' TYR . 40.8 tp -108.05 116.2 31.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.638 -0.71 . . . . 71.12 110.392 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 113' ' ' ASP . 45.7 m95 -85.49 111.82 20.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.019 -1.104 . . . . 73.32 108.019 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 95.1 m -85.87 149.4 50.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.585 -0.446 . . . . 74.03 110.908 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 73.7 Cg_endo -88.32 110.05 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.674 2.249 . . . . 72.03 112.907 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.63 -28.15 33.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.735 -0.666 . . . . 63.13 109.608 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -94.25 9.78 36.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.395 -0.821 . . . . 71.52 110.788 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -136.66 147.12 58.27 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.312 -0.404 . . . . 75.13 110.796 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 14.8 Cg_exo -70.71 -176.78 1.88 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.152 2.568 . . . . 71.42 113.062 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.19 -19.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.66 -0.7 . . . . 73.4 112.128 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 14.6 mptt -67.62 -56.13 12.86 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 111.632 0.234 . . . . 62.13 111.632 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' PRO . 37.3 Cg_exo -59.21 -30.52 93.23 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.712 1.608 . . . . 72.43 111.747 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 61.1 ttt180 -68.25 -44.81 74.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 64.14 111.001 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.0 mtt -70.78 -22.22 62.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.616 0.246 . . . . 73.3 111.212 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -60.55 -48.83 80.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 65.13 111.312 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 27.0 p90 -81.72 -28.42 33.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.764 -0.374 . . . . 70.11 110.979 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -68.89 -18.55 64.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.596 0.712 . . . . 73.25 110.923 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -88.19 -17.13 31.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.17 -0.923 . . . . 62.21 110.682 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 31' ' ' ILE . 6.7 m -111.77 10.53 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 64.03 110.895 -173.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -73.08 -20.16 61.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.923 0.712 . . . . 75.54 112.923 -172.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.558 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 41.8 m-20 -79.26 -22.26 44.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.606 0.241 . . . . 70.11 111.345 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 5' ' ' MET . . . -61.47 -17.74 55.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.03 111.703 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.804 HD11 HG21 ' A' ' 36' ' ' ILE . 90.7 mt -104.57 -51.87 3.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.403 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.27 -44.1 75.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 61.32 111.269 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.71 -10.24 59.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 73.04 111.063 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -104.88 -39.8 6.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 62.12 112.618 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 99' ' ' ASP . 3.3 pp -89.73 -43.14 10.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.135 1.531 . . . . 75.41 115.135 -161.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.623 ' N ' HD12 ' A' ' 98' ' ' LEU . 20.8 t70 -155.03 -177.13 6.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.033 0.833 . . . . 71.33 111.983 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.61 12.87 64.52 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.26 -0.882 . . . . 73.52 111.194 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.57 178.48 0.04 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.553 0.741 . . . . 43.42 111.98 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 104' ' ' VAL . 5.4 m -84.02 136.85 33.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.909 0.385 . . . . 60.2 110.546 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.49 4.66 7.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.69 -0.686 . . . . 64.23 111.984 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 102' ' ' THR . 85.7 t -73.17 145.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 74.43 109.969 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.51 151.81 45.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.527 . . . . 75.33 109.935 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -124.61 117.91 25.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.787 0.327 . . . . 64.04 110.367 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.518 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 7.4 pt-20 -94.04 145.22 24.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 72.11 110.516 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.88 119.94 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.886 -0.597 . . . . 72.4 109.906 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -129.67 -0.71 4.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 64.12 110.045 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.12 -149.66 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.266 -0.879 . . . . 63.43 108.801 174.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 77.8 mtp -100.45 24.12 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.129 0.49 . . . . 74.31 110.751 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.1 -15.73 78.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.629 -0.714 . . . . 34.01 111.504 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 11.3 p-10 -57.32 -47.74 80.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.548 0.739 . . . . 75.41 111.798 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 3.9 pp -99.92 5.52 45.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.221 0.534 . . . . 72.23 111.008 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -94.52 151.36 39.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.963 -0.562 . . . . 61.14 109.979 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 12.1 Cg_exo -71.42 113.7 3.7 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.5 2.133 . . . . 72.34 111.498 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.23 -98.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 72.15 110.385 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.944 -1.027 . . . . 73.22 109.511 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 111.357 -0.697 . . . . 73.1 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.584 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -71.46 151.2 44.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.198 -0.501 . . . . 74.33 110.667 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.593 ' O ' ' HD2' ' A' ' 35' ' ' LYS . . . -110.18 109.38 2.65 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.566 -0.826 . . . . 40.44 111.584 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.4 t -79.23 149.51 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 3.7 p-10 -82.9 165.46 19.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.161 0.505 . . . . 54.34 110.542 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 9' ' ' GLU . 1.3 pm0 -84.47 -17.57 38.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.617 -0.72 . . . . 75.21 112.027 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.69 -32.94 35.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 73.31 110.226 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.0 t -54.34 -55.49 27.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 71.34 110.548 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.16 -34.67 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 71.32 110.812 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.08 -39.03 79.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 44.34 111.693 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -60.55 -25.5 66.2 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.22 0.452 . . . . 52.44 112.22 -173.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m-85 -60.27 -20.94 61.11 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.855 0.317 . . . . 61.21 111.855 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 2.0 p30 -64.3 -39.51 94.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.109 0.48 . . . . 65.33 110.005 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 23' ' ' THR . 41.8 mt-10 -82.53 -43.91 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.263 -0.643 . . . . 50.23 109.263 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 26.3 tp -53.76 -61.19 2.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.179 -1.373 . . . . 63.34 111.284 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -85.86 -65.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.243 0.544 . . . . 74.42 112.371 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 50.1 mm -59.65 -51.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.224 -0.898 . . . . 72.43 113.068 -165.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.677 ' HB2' HG22 ' A' ' 23' ' ' THR . 68.2 mtp180 -83.96 -4.82 59.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.861 0.363 . . . . 74.12 110.869 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 27.8 mtpt 55.9 24.34 7.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.624 -0.716 . . . . 74.31 111.79 -176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 21' ' ' ARG . 4.4 t -107.14 93.51 4.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.318 -0.993 . . . . 75.41 108.318 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.38 138.16 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.552 -0.749 . . . . 65.2 111.684 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.09 138.65 46.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 72.34 108.669 174.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.9 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -86.08 123.56 31.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.039 -1.097 . . . . 75.43 108.039 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.74 HG21 ' HG2' ' A' ' 14' ' ' ARG . 23.3 pt -115.87 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.918 -0.583 . . . . 75.54 110.89 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' LYS . 23.3 m -106.35 127.78 61.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.961 -0.563 . . . . 64.23 110.538 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -102.7 162.96 12.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.443 0.639 . . . . 64.53 110.253 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 28.3 ttpt -113.14 123.02 49.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.715 -1.13 . . . . 71.43 108.457 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 36' ' ' ILE . 31.1 mt -99.71 104.05 15.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.713 -0.847 . . . . 63.34 108.713 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.2 139.85 14.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.475 -0.33 . . . . 70.4 110.364 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 t30 61.01 32.17 19.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.493 . . . . 64.5 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 5' ' ' MET . 9.7 m 68.18 6.45 5.27 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.649 -0.705 . . . . 71.31 110.975 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 55.2 tptt -110.95 132.19 54.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.55 109.813 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 31' ' ' ILE . 54.8 mt -113.11 110.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.166 -0.679 . . . . 72.44 109.166 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 35' ' ' LYS . 5.1 t -126.27 136.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 123.053 0.22 . . . . 63.3 111.181 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 29' ' ' PHE . 56.2 t -59.48 121.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 O-C-N 123.286 0.366 . . . . 64.52 110.027 172.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 8.5 mm-40 -96.8 -26.04 15.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.424 -0.353 . . . . 61.11 110.47 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 28' ' ' VAL . 16.3 tppt? -146.98 141.54 26.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 71.31 112.212 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.68 131.06 47.97 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.695 -1.224 . . . . 75.02 107.695 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.36 157.39 24.47 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.036 -1.078 . . . . 55.22 111.899 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -123.1 143.66 49.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.234 -0.654 . . . . 63.31 109.234 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.41 41.22 37.86 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.395 -1.882 . . . . 74.4 108.395 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 1.7 m-20 -44.42 -51.39 8.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 113.443 -1.378 . . . . 74.13 113.155 -166.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -65.38 -28.81 69.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.927 -0.579 . . . . 43.52 112.121 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -89.35 -44.83 9.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.815 0.341 . . . . 73.33 110.631 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.02 -49.82 74.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.724 -0.671 . . . . 73.53 110.661 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HE1' ' HG2' ' A' ' 40' ' ' LYS . 12.9 m-85 -75.35 8.33 2.84 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.118 0.784 . . . . 74.43 113.118 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 78.4 mtp180 -78.32 -11.95 59.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.604 -0.517 . . . . 62.32 109.604 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.32 11.82 0.57 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.651 -0.704 . . . . 65.42 112.593 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.91 8.7 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.961 0.38 . . . . 61.13 111.638 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.57 68.89 74.82 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 61.34 112.011 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.14 27.66 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.633 2.222 . . . . 61.45 111.824 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -60.76 -35.03 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.671 . . . . 53.34 111.634 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 13.8 t30 76.33 -25.67 0.2 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.711 0.632 . . . . 60.2 110.987 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 55' ' ' ALA . 54.6 m-20 -95.84 171.81 8.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.326 -0.62 . . . . 72.51 109.326 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.1 p -77.79 142.12 38.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 44.11 111.14 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -140.87 160.15 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 72.34 109.712 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.23 120.39 40.31 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.029 -0.359 . . . . 63.54 110.029 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.9 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.4 136.96 11.44 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.911 -0.661 . . . . 64.12 113.6 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 88.5 t -97.99 120.78 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.913 -0.403 . . . . 75.1 109.913 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.437 ' HD2' HD22 ' A' ' 117' ' ' LEU . 10.4 t80 -142.18 126.55 17.67 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.879 -0.415 . . . . 73.33 109.879 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.24 146.09 30.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.179 0.514 . . . . 71.32 110.342 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.8 t -130.52 162.12 29.95 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.173 -0.677 . . . . 74.44 109.173 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.61 -24.93 71.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 74.14 111.342 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -73.61 -48.26 33.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.36 . . . . 73.05 110.346 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.15 164.82 20.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 72.4 111.518 -174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.52 127.6 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.833 -0.803 . . . . 72.2 108.833 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.43 106.24 10.88 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.776 -0.37 . . . . 74.51 111.363 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 62' ' ' VAL . 32.8 m-85 -78.77 109.16 12.77 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.828 -0.804 . . . . 74.3 108.828 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.57 137.59 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.433 . . . . 63.43 111.038 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 87' ' ' TYR . 64.4 tp -144.19 124.9 14.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.0 110.872 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.425 ' HE3' ' N ' ' A' ' 75' ' ' CYS . 0.0 OUTLIER -86.49 141.91 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.969 -0.752 . . . . 63.15 108.969 176.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 27.2 p -88.23 151.27 48.65 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 63.41 110.682 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 4.3 Cg_exo -76.93 92.05 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.516 2.144 . . . . 71.55 111.983 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.59 -32.94 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 74.21 110.545 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -88.91 9.34 25.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.744 0.783 . . . . 73.34 110.066 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.14 159.4 52.77 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 60.32 109.469 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 25.4 Cg_exo -64.15 176.01 2.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.347 2.031 . . . . 65.41 112.158 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.19 4.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.998 0.37 . . . . 75.45 111.998 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.767 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 26.4 ttpp -68.66 -54.94 12.33 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 74.03 111.137 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 42.0 Cg_exo -59.78 -23.63 72.76 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.222 1.948 . . . . 60.34 112.979 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 47.4 ttt-85 -63.98 -39.17 93.53 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.825 0.345 . . . . 72.31 110.378 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.1 mtm -66.36 -33.22 75.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 75.15 110.426 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.6 m -60.57 -56.86 16.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.574 -0.739 . . . . 74.04 111.561 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.755 ' CE1' HD21 ' A' ' 73' ' ' LEU . 3.4 p90 -75.7 -23.59 56.17 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.472 -0.491 . . . . 74.13 111.399 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.04 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 74.15 110.385 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.1 t -86.55 -8.24 57.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.344 -0.844 . . . . 72.33 110.453 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -123.45 4.23 9.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.007 0.432 . . . . 63.31 111.127 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -71.91 -21.38 61.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 72.4 111.651 -171.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.64 -21.77 32.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 73.31 111.431 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.95 78.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 71.3 111.767 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.2 mm? -65.71 -44.79 85.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.345 0.593 . . . . 52.41 110.388 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.986 HD23 ' HA ' ' A' ' 103' ' ' ALA . 7.6 mp -64.22 -24.69 67.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.324 -0.853 . . . . 73.1 110.92 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -81.18 -28.72 34.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 62.45 111.681 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -106.39 -26.46 11.46 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.389 0.885 . . . . 73.34 113.389 -169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 36.2 mt -86.1 -42.99 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 118.806 -1.158 . . . . 74.25 111.566 -170.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.24 -166.33 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 73.0 111.103 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.92 14.0 63.15 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.802 -0.919 . . . . 55.32 110.802 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.22 177.66 0.08 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.675 0.79 . . . . 75.33 111.977 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 104' ' ' VAL . 7.0 m -85.28 140.53 30.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.321 -170.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.986 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -72.13 4.86 3.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.507 -0.769 . . . . 61.34 112.256 -175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.569 HG23 HG22 ' A' ' 102' ' ' THR . 47.8 t -83.9 147.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.461 0.648 . . . . 62.43 110.436 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.69 155.09 47.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.549 -0.75 . . . . 51.04 109.26 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.6 tp -110.34 116.99 32.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.013 -0.366 . . . . 64.23 110.013 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.9 pt-20 -97.87 128.71 44.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.654 -0.499 . . . . 73.22 109.654 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.23 119.07 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.58 . . . . 52.45 110.18 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 23.5 t-80 -104.6 -45.25 4.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.569 -0.741 . . . . 63.14 110.237 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.03 101.58 4.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.49 -0.323 . . . . 70.13 111.421 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.525 ' HG3' HD11 ' A' ' 114' ' ' LEU . 56.8 ttm 71.18 -4.29 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.705 0.632 . . . . 74.45 112.705 170.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.9 -18.18 61.74 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.899 -0.667 . . . . 61.31 112.901 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.53 -46.88 13.84 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.719 0.408 . . . . 72.24 111.595 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.525 HD11 ' HG3' ' A' ' 111' ' ' MET . 3.9 pp -98.06 14.77 26.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.903 0.382 . . . . 62.0 111.841 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.59 154.26 46.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.106 -0.497 . . . . 74.43 109.969 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.6 123.95 10.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.053 2.502 . . . . 73.24 112.489 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.437 HD22 ' HD2' ' A' ' 63' ' ' TYR . 5.6 mp -83.17 -2.45 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 73.13 111.496 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.88 -1.057 . . . . 63.24 111.077 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.313 0 N-CA-C 113.471 0.148 . . . . 51.12 113.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.1 ptt? -109.79 166.49 10.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.941 0.401 . . . . 73.42 110.275 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 132.17 10.69 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.416 -1.074 . . . . 63.25 110.416 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.33 124.87 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 117.129 0.464 . . . . 64.4 110.851 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.62 115.5 4.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.679 . . . . 63.21 111.417 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -84.99 -13.44 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 73.53 111.178 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.3 -35.4 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 74.24 110.604 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 42.2 t -53.35 -40.78 65.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 74.2 111.235 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.74 -47.3 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 72.5 110.751 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -68.46 -28.02 66.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 73.41 110.54 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.836 ' HG3' HG21 ' A' ' 27' ' ' ILE . 1.8 tmm_? -66.6 -38.33 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 74.44 110.095 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -60.71 -21.12 62.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.648 0.261 . . . . 63.25 111.133 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -75.98 -30.65 58.66 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.863 -0.421 . . . . 74.13 109.863 176.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.19 -38.98 89.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.073 -0.714 . . . . 73.53 109.073 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.76 -43.51 97.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.022 . . . . 74.42 110.909 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.11 -64.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 75.01 111.917 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.49 -54.38 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 70.41 111.917 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -75.46 -16.84 60.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.453 -0.34 . . . . 71.22 110.993 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? 58.49 24.48 11.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.662 0.744 . . . . 75.13 109.965 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.4 p -104.18 116.36 32.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.452 -0.794 . . . . 73.24 109.552 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 7.1 p -88.07 134.3 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.838 -0.745 . . . . 73.43 109.996 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 19.1 ptpt -138.45 150.38 46.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.587 -0.733 . . . . 72.11 110.102 177.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -97.31 123.2 41.04 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.95 -1.13 . . . . 72.43 107.95 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.836 HG21 ' HG3' ' A' ' 14' ' ' ARG . 43.1 pt -117.51 144.77 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.482 -0.326 . . . . 75.23 110.219 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.45 114.4 42.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.032 0.444 . . . . 62.22 111.163 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -94.7 145.75 24.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.494 -0.928 . . . . 73.03 108.494 168.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -112.11 125.14 53.79 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.045 -0.525 . . . . 65.24 109.979 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 36' ' ' ILE . 20.6 mt -91.24 102.02 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.37 -0.974 . . . . 74.45 108.37 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.07 147.03 20.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.393 -0.595 . . . . 73.32 109.393 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.48 26.22 15.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.276 0.56 . . . . 63.2 110.179 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' MET . 1.6 m 65.13 28.02 12.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.03 -0.987 . . . . 65.22 111.64 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE2' HG21 ' A' ' 37' ' ' VAL . 18.8 ptmt -136.94 148.87 47.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.984 -0.376 . . . . 64.31 109.984 171.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG23 ' A' ' 31' ' ' ILE . 23.0 mt -113.42 109.94 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.632 -0.507 . . . . 73.4 109.632 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 35' ' ' LYS . 3.2 t -138.48 136.77 43.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.868 -0.419 . . . . 73.53 109.868 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.022 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 86.3 t -62.4 131.27 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.137 0.494 . . . . 53.42 110.49 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG3' ' HD2' ' A' ' 40' ' ' LYS . 16.8 pt-20 -104.99 -31.09 9.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.522 -0.763 . . . . 61.42 111.316 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 3.0 mptp? -147.65 156.01 42.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.919 0.39 . . . . 62.35 111.123 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' HG22 ' A' ' 27' ' ' ILE . 7.1 p-10 -140.31 132.03 27.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.964 -1.125 . . . . 75.32 107.964 170.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.09 13.11 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.059 -1.067 . . . . 44.25 114.366 -168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 3.0 ptpp? -128.6 130.54 47.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.113 -1.069 . . . . 61.32 108.113 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 52.19 8.48 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.991 -2.044 . . . . 72.32 107.991 -163.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.486 HD22 ' HE1' ' A' ' 63' ' ' TYR . 46.6 m-20 -44.91 -51.93 9.19 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.75 -1.225 . . . . 72.4 113.542 -162.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -49.41 70.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 44.42 111.06 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.531 ' HA ' HH11 ' A' ' 50' ' ' ARG . 19.8 t70 -68.8 -42.64 77.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.079 -0.509 . . . . 73.44 111.595 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 43' ' ' LYS . 10.0 tt0 -65.31 -47.23 77.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 64.43 111.135 -174.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 27.2 m-85 -71.73 -22.18 61.66 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.057 0.391 . . . . 75.33 112.057 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 18.0 mtp180 -61.61 -22.94 65.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.813 0.34 . . . . 73.43 111.111 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.28 18.13 6.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.717 -0.754 . . . . 62.34 112.055 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -96.22 -73.99 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.873 -0.192 . . . . 71.35 111.278 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 mp -126.65 90.22 50.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.239 0.459 . . . . 75.25 112.239 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.21 48.31 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.906 2.404 . . . . 74.21 109.584 170.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.42 -12.71 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.006 -0.997 . . . . 74.51 112.837 -169.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.603 ' HA ' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 p30 51.6 26.43 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.757 0.823 . . . . 60.12 111.38 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.07 170.72 8.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.756 -1.111 . . . . 65.43 109.14 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.955 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 3.3 p -86.5 134.2 33.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.709 -1.196 . . . . 73.32 110.05 174.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 39' ' ' GLU . 17.6 mmt85 -143.41 152.06 41.12 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.502 -1.226 . . . . 71.0 108.173 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.692 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -103.53 113.54 27.12 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.721 -0.474 . . . . 64.51 109.721 -178.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.65 131.73 8.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.985 -0.626 . . . . 72.31 113.114 -175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 3.0 t -102.74 120.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 75.41 109.309 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 5.0 t80 -134.69 124.97 26.12 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.409 -0.589 . . . . 64.22 109.409 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 11.3 t70 -92.31 140.93 29.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.741 -0.466 . . . . 70.13 109.741 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.6 t -122.12 171.12 9.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.49 -23.9 55.23 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.236 -0.507 . . . . 75.02 113.829 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -102.25 -26.26 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 73.12 112.873 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -170.27 169.05 7.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.306 0.484 . . . . 73.22 112.306 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.22 129.8 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 170.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -118.29 115.27 24.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.078 0.466 . . . . 54.11 111.635 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.731 ' HZ ' HD22 ' A' ' 98' ' ' LEU . 48.4 m-85 -76.17 110.68 10.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.639 -0.71 . . . . 71.45 109.532 166.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.04 112.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.569 -0.53 . . . . 61.42 109.569 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 87' ' ' TYR . 36.4 tp -115.97 89.32 3.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.658 -0.701 . . . . 65.53 110.304 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.674 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 0.8 OUTLIER -85.59 121.06 27.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.633 -0.876 . . . . 71.45 108.633 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.3 p -96.48 149.98 36.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.857 -0.337 . . . . 61.42 110.856 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.955 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 59.1 Cg_endo -71.8 130.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.42 2.08 . . . . 75.22 113.052 -170.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.68 -40.29 16.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 61.14 110.814 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.89 20.57 5.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 72.0 110.613 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -132.32 157.81 77.27 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.233 -0.44 . . . . 62.0 110.534 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 50.7 Cg_endo -69.21 -170.99 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.928 2.419 . . . . 44.25 113.227 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.15 -10.84 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 42.42 112.1 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 39.5 ttmt -68.08 -47.53 40.27 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.189 0.44 . . . . 71.13 112.189 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 15.6 Cg_endo -58.62 -16.78 31.92 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.116 1.877 . . . . 74.34 112.824 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.552 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 19.4 mtp-105 -73.93 -32.68 63.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.598 -0.519 . . . . 72.32 109.598 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 24.7 mmt -78.14 -13.59 59.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.776 -0.647 . . . . 73.13 110.301 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -65.2 -55.78 16.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 53.23 110.779 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 73' ' ' LEU . 11.0 p90 -77.33 -19.34 56.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 74.42 110.89 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 85' ' ' MET . . . -75.02 -18.52 60.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.208 0.528 . . . . 73.34 110.316 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 t -82.71 -34.35 27.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.769 -0.651 . . . . 64.11 110.463 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 p -104.76 20.89 17.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.52 110.909 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 19.7 pttp -56.71 -55.22 36.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.423 -0.808 . . . . 73.42 112.454 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.631 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 8.7 p-10 -85.88 -20.09 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 72.0 111.35 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.18 67.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.644 -0.253 . . . . 74.11 111.349 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 4.2 mm? -66.96 -40.43 87.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.958 -0.386 . . . . 72.01 109.958 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 33.7 tp -67.85 -18.53 64.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.535 -0.757 . . . . 61.54 111.582 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.534 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -111.57 16.45 20.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.564 1.173 . . . . 71.22 108.656 177.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.731 HD22 ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -111.35 10.36 21.56 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.929 -1.487 . . . . 54.44 111.101 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' ALA . 21.8 m-20 -34.69 -145.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.845 2.458 . . . . 62.31 116.491 -151.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.24 15.7 0.02 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 118.013 1.965 . . . . 62.44 118.013 -150.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -56.97 -177.14 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.702 -0.851 . . . . 52.32 108.702 154.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 m -80.47 117.33 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.696 -1.252 . . . . 61.23 109.356 -168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -87.49 -0.77 57.3 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.944 -1.026 . . . . 51.14 111.486 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.94 146.33 10.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.638 . . . . 64.32 109.276 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -129.79 146.76 51.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.326 -0.397 . . . . 73.2 110.444 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 tt -119.84 117.39 28.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.117 -0.698 . . . . 62.43 109.117 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 13.4 pt-20 -97.47 141.05 31.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 74.31 110.275 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.68 54.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 73.14 111.062 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -126.07 4.3 7.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.478 -0.783 . . . . 73.23 109.931 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.94 163.55 14.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 73.13 109.119 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 67.5 mtt -78.31 57.87 1.98 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.444 0.64 . . . . 65.02 110.853 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.42 -15.51 68.62 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.95 -1.023 . . . . 50.43 111.598 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.08 -38.83 73.89 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 122.974 0.51 . . . . 75.51 111.165 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.9 pp -98.2 18.95 15.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.117 0.484 . . . . 73.21 110.819 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.02 156.3 54.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 64.11 110.412 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.01 91.24 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.333 2.022 . . . . 74.32 112.043 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.08 -7.54 59.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.43 111.064 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.457 -0.783 . . . . 74.34 109.906 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.836 -0.105 . . . . 61.12 112.836 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.44 172.22 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.112 0.482 . . . . 54.1 111.588 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.58 110.1 0.62 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.696 -0.962 . . . . 61.23 110.696 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.85 122.97 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.998 0.399 . . . . 64.1 111.829 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.13 120.84 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.182 -0.673 . . . . 71.44 109.182 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.76 -13.4 61.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.392 0.886 . . . . 72.35 113.392 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.552 HD22 HG11 ' A' ' 38' ' ' VAL . 9.9 t30 -58.9 -30.65 67.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.063 0.459 . . . . 53.41 110.213 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 m -66.95 -41.86 86.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.85 -0.614 . . . . 74.34 110.088 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.85 -43.92 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 70.24 110.893 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.58 63.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 73.32 111.592 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.773 ' HG3' HG21 ' A' ' 27' ' ' ILE . 20.9 mmt180 -64.54 -26.83 68.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.361 . . . . 74.22 111.706 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 82.2 m-85 -82.5 -26.25 32.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 64.4 110.325 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -75.84 -36.85 59.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.26 -0.644 . . . . 74.14 109.26 177.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.83 -19.03 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.551 -0.75 . . . . 65.42 110.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 11.8 mt -63.27 -50.79 68.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.147 -0.479 . . . . 53.42 111.15 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -70.91 -40.37 72.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.859 0.361 . . . . 73.21 111.3 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.22 -63.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.128 -0.487 . . . . 63.24 111.786 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -79.49 -24.02 42.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.491 -0.322 . . . . 75.3 110.725 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 53.6 mttp 59.32 24.79 13.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.797 -0.638 . . . . 73.21 111.222 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -93.2 122.44 35.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.123 -0.695 . . . . 62.35 109.123 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.67 134.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 120.131 -0.628 . . . . 73.14 110.476 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -141.12 172.14 13.1 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.34 -0.845 . . . . 64.34 109.718 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB2' ' HB3' ' A' ' 45' ' ' ASN . 4.1 t90 -125.97 127.56 46.13 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 74.12 107.482 173.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.773 HG21 ' HG3' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -117.79 128.83 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.065 0.46 . . . . 64.22 110.46 177.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 77.1 t -110.29 120.01 60.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.028 0.442 . . . . 71.23 110.26 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 p90 -116.73 160.98 19.95 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.832 -0.622 . . . . 74.25 110.844 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 39' ' ' GLU . 38.3 ttmt -115.39 125.11 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.419 -0.809 . . . . 62.21 109.267 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 90' ' ' SER . 16.3 mt -88.05 102.44 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.693 -1.225 . . . . 70.33 107.693 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.1 138.95 39.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.479 -0.328 . . . . 73.34 110.379 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 34' ' ' THR . 15.8 m120 60.22 22.06 11.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 64.35 110.725 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 33' ' ' ASN . 46.9 m 79.48 -10.13 1.36 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.86 -0.609 . . . . 62.01 111.138 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE3' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -102.16 138.3 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.587 -0.523 . . . . 71.4 109.587 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.657 HD13 HD21 ' A' ' 94' ' ' LEU . 57.4 mt -99.34 114.12 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.392 -0.367 . . . . 62.21 111.188 -172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HE3' ' A' ' 35' ' ' LYS . 6.8 m -125.71 135.41 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 71.51 111.155 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -88.67 125.42 41.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.96 0.409 . . . . 70.52 110.077 176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 27.4 mt-10 -79.65 -37.76 35.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.908 -0.587 . . . . 73.32 111.151 -173.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' HB2' ' A' ' 39' ' ' GLU . 19.3 pttm -171.52 159.59 5.59 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.321 0.581 . . . . 70.43 112.191 -167.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.711 ' CB ' HG22 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -154.29 146.55 23.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.591 -1.186 . . . . 73.21 108.383 173.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.32 161.41 26.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.016 -1.088 . . . . 64.31 112.71 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -93.66 120.52 34.04 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.335 -1.358 . . . . 61.42 107.335 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.52 53.96 0.58 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 107.191 -2.363 . . . . 62.24 107.191 -161.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 38.8 m-20 -61.35 -53.01 62.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.026 -1.087 . . . . 54.4 112.471 -160.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.44 -32.7 42.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.726 -0.472 . . . . 75.21 109.726 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.97 -58.31 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 70.33 111.582 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.66 -46.51 78.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 71.52 111.542 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 27.9 m-85 -73.82 -14.83 61.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.899 0.703 . . . . 72.23 112.899 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.7 -13.19 60.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.962 0.411 . . . . 63.14 110.703 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.98 11.78 6.18 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.617 -0.593 . . . . 55.24 111.617 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -118.61 -0.15 11.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 72.21 111.099 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 87.2 mt -101.53 123.29 44.87 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.239 -0.437 . . . . 53.03 110.092 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 12.8 Cg_exo -70.06 134.1 26.55 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.86 2.373 . . . . 74.22 112.101 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.18 -14.88 57.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 72.43 110.877 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -86.15 -33.11 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 61.21 111.531 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' C ' ' HG3' ' A' ' 76' ' ' PRO . 35.6 t0 -123.34 163.49 20.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.769 0.319 . . . . 73.21 110.965 -172.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.885 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 4.2 p -98.61 138.72 35.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.446 0.641 . . . . 73.44 109.818 173.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 30' ' ' LYS . 18.8 mmt85 -130.07 152.32 49.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.073 -0.967 . . . . 74.21 109.023 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.403 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t80 -107.52 112.05 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.455 -0.572 . . . . 74.11 109.455 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 28' ' ' VAL . . . -120.02 125.9 6.48 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.903 -0.665 . . . . 63.2 111.701 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.17 121.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.559 0.695 . . . . 64.31 109.617 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 2.1 t80 -113.48 125.67 54.48 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.001 -0.999 . . . . 73.15 109.678 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.588 ' CG ' HD21 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -103.62 140.66 37.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.587 0.708 . . . . 73.1 110.582 175.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.0 t -131.02 170.44 14.49 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.776 -0.824 . . . . 64.23 108.776 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.28 -34.16 89.18 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.983 -0.627 . . . . 34.13 112.757 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -81.68 -39.78 23.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.535 0.207 . . . . 54.44 111.502 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -164.59 171.67 14.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.732 0.301 . . . . 74.42 110.773 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.51 140.84 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.458 -0.571 . . . . 74.24 109.458 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -122.04 116.36 24.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.554 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.69 109.18 12.68 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.977 -0.749 . . . . 55.53 108.977 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 115.37 32.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.402 0.62 . . . . 60.11 110.825 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 60.6 tp -119.41 81.93 1.79 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.185 -0.916 . . . . 72.23 109.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -89.6 118.22 29.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.985 -0.552 . . . . 74.11 109.77 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 13.9 p -102.34 147.95 34.73 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.865 -0.42 . . . . 63.04 109.865 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 54.1 Cg_endo -99.52 169.99 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.155 2.57 . . . . 71.53 113.291 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.64 -28.46 66.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.1 -0.954 . . . . 63.25 110.814 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -88.46 9.84 22.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.664 -0.698 . . . . 73.33 111.624 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . . . -107.28 111.25 63.31 Favored Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 122.061 -0.399 . . . . 74.4 111.247 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 7.0 Cg_exo -74.06 -166.76 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 65.34 112.238 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 31.0 m -75.56 -13.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 63.2 112.033 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 25.5 mtpp -69.27 -58.22 6.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.44 -0.345 . . . . 71.12 111.178 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.86 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 7.3 Cg_exo -74.28 -13.93 23.08 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.027 1.818 . . . . 51.44 111.32 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 2.7 tpt180 -60.92 -47.25 87.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 75.41 110.349 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -76.18 -14.51 60.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.581 . . . . 72.14 110.567 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.4 m -69.75 -43.97 71.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.048 -0.523 . . . . 71.2 110.952 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CE1' HD21 ' A' ' 73' ' ' LEU . 8.9 p90 -79.5 -30.1 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.558 -0.457 . . . . 73.22 111.272 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.85 -19.95 64.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.139 0.495 . . . . 64.34 111.247 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -86.87 -53.15 5.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.653 -0.703 . . . . 70.3 110.649 178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' HD13 ' A' ' 31' ' ' ILE . 4.1 m -68.39 -25.98 65.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.414 -0.812 . . . . 71.53 111.84 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -57.5 -27.63 62.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.462 0.541 . . . . 60.34 112.462 -175.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.64 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 27.6 t70 -76.68 -40.11 49.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.833 0.349 . . . . 73.42 110.934 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.66 91.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.826 -0.625 . . . . 64.54 111.267 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.657 HD21 HD13 ' A' ' 36' ' ' ILE . 3.9 mm? -63.8 -50.69 67.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 63.32 110.446 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 103' ' ' ALA . 36.5 tp -57.63 -30.17 65.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 74.24 110.958 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -76.74 -32.09 57.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.601 -0.727 . . . . 74.3 112.535 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -112.07 -14.61 13.41 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.37 1.248 . . . . 75.43 114.37 -166.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 68.5 mt -86.96 -45.38 10.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 118.111 -1.436 . . . . 73.11 112.903 -167.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 20.6 t70 -157.64 -167.07 2.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.438 -0.505 . . . . 65.25 111.124 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -90.33 15.36 60.11 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.385 -1.086 . . . . 74.11 110.385 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.35 179.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.42 1.088 . . . . 45.24 113.272 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -82.97 136.77 34.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.565 -0.743 . . . . 74.24 110.456 -169.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -79.16 5.39 12.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 61.15 112.466 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.7 148.36 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.947 0.404 . . . . 74.33 110.307 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.99 45.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.342 -0.614 . . . . 62.53 109.342 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 tp -122.64 118.41 28.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.817 0.341 . . . . 62.23 110.694 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 pt-20 -98.37 121.07 39.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.966 -0.561 . . . . 73.45 109.669 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.65 150.94 29.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.077 -0.51 . . . . 74.14 111.021 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -136.34 10.03 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 72.33 110.218 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 111' ' ' MET . 47.0 tt0 -131.34 167.18 19.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 73.53 110.095 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.419 ' N ' ' HG2' ' A' ' 110' ' ' GLU . 86.3 mtp -79.41 6.92 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.608 0.242 . . . . 64.03 111.52 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.91 -20.1 74.18 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.739 -0.743 . . . . 43.22 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.59 -37.29 73.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.296 0.569 . . . . 72.23 110.384 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 pp -89.62 14.46 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 74.14 110.829 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -87.81 162.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.223 -0.658 . . . . 71.32 109.223 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 34.2 Cg_endo -66.65 88.45 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 121.936 1.757 . . . . 72.5 113.026 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -77.66 -71.02 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.421 -0.585 . . . . 61.13 109.421 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.538 -0.744 . . . . 72.42 109.968 178.849 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . . . . . . 0 N--CA 1.449 -0.47 0 CA-C-O 120.495 -0.058 . . . . 70.24 113.099 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.4 ptt? -84.9 159.04 20.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 65.31 110.704 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.46 119.99 4.03 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.811 -0.631 . . . . 70.04 111.778 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 36' ' ' ILE . 62.0 t -73.64 104.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.828 -0.804 . . . . 73.25 108.828 174.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -71.68 142.25 49.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.16 -0.473 . . . . 61.24 110.868 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 12' ' ' VAL . 20.9 pt-20 -64.83 -15.62 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.721 -0.672 . . . . 75.11 111.337 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -55.23 -40.55 71.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.849 -0.614 . . . . 55.54 110.23 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.1 t -73.89 -44.23 55.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 53.4 111.438 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 9' ' ' GLU . 34.5 m -72.81 -24.31 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 63.53 111.527 -175.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.54 70.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 64.11 110.876 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 33.2 mmt180 -75.33 -23.51 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 70.22 111.226 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 43.4 m-85 -82.82 -23.31 33.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.399 . . . . 73.32 109.99 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.77 84.93 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.381 -0.6 . . . . 70.04 109.381 171.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -71.73 -49.57 38.07 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.473 0.654 . . . . 71.25 109.505 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 16.5 tp -58.59 -47.72 83.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.695 -1.139 . . . . 73.02 112.179 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -73.3 -51.86 16.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.938 0.348 . . . . 74.25 111.938 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.61 -56.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.062 0.393 . . . . 75.33 112.062 -171.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -68.6 -26.3 65.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.711 0.291 . . . . 65.14 110.479 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 58.58 24.42 11.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.552 -0.749 . . . . 63.0 111.491 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 p -92.83 106.37 18.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.05 -1.463 . . . . 74.42 107.05 164.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 64' ' ' ASP . 7.6 p -87.46 136.63 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.656 0.741 . . . . 75.14 111.184 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 41' ' ' ASP . 19.0 ptpt -137.35 140.18 41.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.692 -1.14 . . . . 62.15 109.408 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 1.014 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.2 t90 -89.04 136.37 33.05 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.152 -1.425 . . . . 74.52 107.152 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.49 132.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.162 0.506 . . . . 73.51 110.642 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -106.52 110.5 31.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.45 -0.795 . . . . 73.11 109.278 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.624 ' HB3' HG22 ' A' ' 38' ' ' VAL . 2.6 p90 -115.58 159.5 21.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.645 0.736 . . . . 74.11 111.623 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 34.5 ttmt -123.25 125.36 44.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.775 -1.102 . . . . 73.21 109.242 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.854 HG12 HG23 ' A' ' 36' ' ' ILE . 56.4 mt -112.3 101.6 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.872 0.368 . . . . 71.55 111.167 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -159.6 170.28 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 73.31 110.383 175.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m120 53.0 39.38 29.35 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.743 0.652 . . . . 53.24 110.942 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' MET . 58.0 p 58.22 20.43 7.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.783 -1.099 . . . . 71.05 113.274 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.2 mmmm -129.88 137.81 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.111 0.481 . . . . 72.44 110.997 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.854 HG23 HG12 ' A' ' 31' ' ' ILE . 56.7 mt -103.15 108.77 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.77 -0.826 . . . . 72.42 108.77 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.96 135.87 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 71.35 111.498 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 29' ' ' PHE . 17.3 t -88.21 133.51 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 75.32 109.181 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' ' HG3' ' A' ' 40' ' ' LYS . 10.4 pt-20 -106.9 -18.47 13.91 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.806 -0.758 . . . . 73.13 110.854 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -145.06 140.88 28.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.221 -0.591 . . . . 72.21 111.803 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.613 ' HB3' HG22 ' A' ' 27' ' ' ILE . 10.6 p-10 -132.54 132.98 43.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.583 -1.265 . . . . 64.42 107.583 166.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.767 ' HA3' ' HG2' ' A' ' 48' ' ' GLU . . . -116.8 161.86 12.9 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.045 -1.074 . . . . 43.34 114.033 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.4 ptpp? -108.15 124.43 50.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.814 -0.81 . . . . 64.4 108.814 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.3 56.98 3.27 Favored Glycine 0 C--N 1.313 -0.72 0 N-CA-C 108.658 -1.777 . . . . 71.04 108.658 -169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.014 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 28.4 p-10 -41.99 -52.31 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.236 1.569 . . . . 72.54 115.236 -158.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.16 69.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.165 0.432 . . . . 65.23 112.165 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.65 -41.09 18.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.267 0.556 . . . . 70.44 110.327 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HG2' ' HA3' ' A' ' 42' ' ' GLY . 6.0 tp10 -48.11 -55.6 9.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.386 -1.279 . . . . 74.5 111.479 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 21.1 m-85 -74.61 -25.01 58.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.997 0.74 . . . . 75.14 112.997 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.721 ' HE ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 ttm105 -65.28 -21.0 66.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.222 0.534 . . . . 71.23 109.721 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.28 12.16 10.5 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.055 -0.593 . . . . 73.31 111.959 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -108.75 -25.21 10.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.444 0.164 . . . . 64.34 111.083 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 3.6 mm? -120.9 100.27 46.3 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-O 121.057 0.456 . . . . 74.1 111.992 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HB3' HD13 ' A' ' 114' ' ' LEU . 91.3 Cg_endo -101.2 37.35 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.777 2.985 . . . . 34.51 109.957 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.34 -35.44 30.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.083 -0.962 . . . . 74.4 112.732 -165.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 37.0 m-80 65.23 19.98 11.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.567 0.699 . . . . 61.44 109.65 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.43 151.73 23.17 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.958 -1.019 . . . . 60.44 109.667 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 6.6 p -87.47 133.54 33.74 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.916 -1.114 . . . . 75.51 108.907 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -151.47 169.14 22.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.147 -0.933 . . . . 70.03 109.18 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' HE1' ' HD2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -114.55 115.08 26.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.109 0.481 . . . . 62.5 109.921 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.752 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -123.63 136.44 10.36 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.876 -0.678 . . . . 75.0 112.401 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 15' ' ' PHE . 33.6 m -117.96 131.68 70.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.983 0.391 . . . . 64.32 110.519 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.786 ' HB2' HD22 ' A' ' 45' ' ' ASN . 0.5 OUTLIER -141.07 149.09 41.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.033 0.444 . . . . 73.41 111.334 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.588 ' HA ' HG12 ' A' ' 69' ' ' ILE . 19.0 t70 -92.03 144.32 25.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.524 -0.762 . . . . 72.04 110.176 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.622 ' SG ' ' HG2' ' A' ' 68' ' ' LYS . 12.1 p -135.44 175.15 9.85 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.001 -1.0 . . . . 61.51 108.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.33 -24.39 45.07 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 114.899 0.72 . . . . 42.34 114.899 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 67' ' ' ASN . 7.2 m120 -121.54 -15.93 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.416 1.108 . . . . 62.15 113.032 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HG2' ' SG ' ' A' ' 65' ' ' CYS . 9.7 ptpt -163.3 168.35 20.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.162 -0.615 . . . . 72.01 112.052 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 64' ' ' ASP . 23.6 mt -113.27 123.77 69.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.028 -0.73 . . . . 74.43 109.028 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.02 133.82 43.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.358 -0.383 . . . . 71.0 111.434 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' HD2' ' HE1' ' A' ' 60' ' ' PHE . 10.8 m-85 -89.84 108.79 19.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 60.41 109.208 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.9 t -104.78 131.35 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.987 0.422 . . . . 61.41 111.602 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.3 tp -127.28 130.12 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.609 -0.723 . . . . 70.53 110.283 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 58' ' ' CYS . 19.1 m95 -90.17 159.36 16.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 74.2 109.936 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 31.0 p -86.14 151.87 54.91 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 44.23 109.557 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -74.7 79.4 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.293 1.995 . . . . 54.22 111.375 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.96 -38.96 64.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.633 -0.712 . . . . 54.43 110.233 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.11 9.22 28.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 70.31 110.253 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -126.68 165.54 27.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.633 . . . . 50.21 111.009 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.534 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 17.2 Cg_exo -68.92 175.69 7.08 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.939 2.426 . . . . 73.25 112.846 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.84 -8.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.067 -0.515 . . . . 74.33 111.852 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 67.2 tttt -67.71 -56.03 12.85 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 112.657 0.614 . . . . 74.32 112.657 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 52.5 Cg_exo -53.33 -40.2 78.74 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.285 1.99 . . . . 73.22 113.562 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 76' ' ' PRO . 57.8 ttp85 -60.47 -45.85 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 60.21 111.025 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.77 -26.95 66.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.151 0.5 . . . . 65.12 109.94 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.1 m -71.87 -48.2 47.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.271 -0.877 . . . . 74.13 111.652 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -61.37 -31.53 71.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.837 0.351 . . . . 74.42 111.408 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.33 69.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 70.34 111.719 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -71.29 -30.15 65.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 63.45 111.228 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 94' ' ' LEU . 3.2 p -97.63 12.48 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.275 -0.421 . . . . 62.21 111.825 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -57.24 -52.47 65.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.376 . . . . 71.21 111.694 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -76.56 -31.36 57.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 72.3 111.548 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.27 67.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.987 0.366 . . . . 53.01 111.987 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 36' ' ' ILE . 4.1 mm? -96.15 -42.22 8.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 72.11 109.997 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 103' ' ' ALA . 55.0 tp -55.47 -39.34 70.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 63.53 110.994 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -81.46 -21.59 38.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.435 -0.802 . . . . 65.53 112.191 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -32.5 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.818 0.673 . . . . 74.04 112.818 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.687 HD11 HD12 ' A' ' 94' ' ' LEU . 65.5 mt -88.13 -40.65 13.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.746 -0.782 . . . . 63.44 112.762 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -151.82 -174.23 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.455 -0.498 . . . . 74.54 111.038 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.75 13.6 66.05 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.338 -1.105 . . . . 74.24 110.338 172.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.48 177.28 0.05 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.111 0.964 . . . . 74.21 113.13 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 104' ' ' VAL . 4.9 m -85.45 140.38 30.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.417 -0.81 . . . . 73.24 111.106 -167.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -69.3 5.91 1.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.286 -0.87 . . . . 32.45 113.056 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 102' ' ' THR . 46.0 t -85.56 149.32 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.922 -0.399 . . . . 75.21 109.922 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -125.61 165.17 19.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.023 -0.362 . . . . 72.33 110.023 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 tt -133.21 117.77 17.82 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.7 -0.482 . . . . 72.42 109.7 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.96 132.92 53.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.48 -0.563 . . . . 73.22 109.48 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . . . -131.43 162.67 29.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.312 -0.404 . . . . 74.01 110.127 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.557 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 1.9 p80 -112.19 -158.6 0.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.119 -0.491 . . . . 74.32 111.145 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.478 ' H ' ' HB2' ' A' ' 109' ' ' HIS . 0.8 OUTLIER -51.15 157.23 0.93 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.161 0.8 . . . . 64.31 113.161 -170.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 64.4 mtm 79.61 -45.31 0.32 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.597 -1.183 . . . . 70.34 111.789 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.0 -19.1 21.33 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.862 0.705 . . . . 65.1 114.862 -171.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.15 -51.57 69.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.619 0.368 . . . . 63.33 111.263 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 114' ' ' LEU . 2.4 pt? -120.32 20.23 11.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 63.11 111.485 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -101.77 155.97 35.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.786 -0.449 . . . . 72.24 109.786 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.721 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 18.9 Cg_endo -59.61 100.18 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.492 2.128 . . . . 71.21 113.316 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 117' ' ' LEU . 4.8 mp -64.47 -54.11 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.808 -0.812 . . . . 75.03 108.808 171.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-N 114.69 -1.141 . . . . 74.23 108.985 176.664 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.4 tpt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.943 0.401 . . . . 65.44 110.583 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.22 -19.19 28.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.88 -0.6 . . . . 73.22 111.937 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 m -67.57 134.73 51.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.266 -0.425 . . . . 61.12 111.756 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 61.49 50.57 65.16 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.902 -0.59 . . . . 54.13 112.99 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 152.55 25.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.116 0.484 . . . . 73.24 111.37 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.96 132.77 7.75 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.716 -0.954 . . . . 63.44 110.716 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 7.5 p -107.26 132.83 53.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.947 0.403 . . . . 63.32 111.247 -174.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.19 139.25 33.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.757 -0.46 . . . . 62.02 109.757 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -13.83 62.67 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.2 0.444 . . . . 72.14 112.2 -173.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -64.8 -32.99 74.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.933 0.397 . . . . 65.14 110.504 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.6 m -64.41 -35.32 80.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.901 -0.59 . . . . 61.31 110.453 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.1 t -85.25 -31.55 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.847 -0.615 . . . . 73.51 110.23 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.55 -26.61 68.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.66 -0.7 . . . . 71.22 111.948 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -64.15 -20.11 65.76 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.945 -0.302 . . . . 64.21 111.525 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.682 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 40.7 m-85 -75.5 -18.24 59.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.29 0.478 . . . . 74.32 112.29 -177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -82.0 -23.41 36.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.017 -0.673 . . . . 64.04 110.35 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HG2' HH11 ' A' ' 21' ' ' ARG . 1.1 tm-20 -84.1 -21.09 31.59 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.27 -1.011 . . . . 72.12 108.27 171.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 27.4 tp -84.17 -59.79 2.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.683 -1.144 . . . . 73.3 111.594 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -76.25 -43.94 39.64 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.375 -0.375 . . . . 73.5 111.82 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.1 mm -66.51 -44.21 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.006 0.431 . . . . 74.31 111.662 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 17' ' ' GLU . 58.5 mtp180 -80.51 -10.36 59.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.282 -0.417 . . . . 73.51 110.515 -177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 82.2 tttt 56.57 24.3 8.59 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.46 -0.791 . . . . 73.03 111.14 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.9 p -99.82 125.61 45.79 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.807 -0.812 . . . . 73.51 108.807 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.9 m -83.83 138.24 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.113 0.482 . . . . 75.1 110.051 -169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.477 0.656 . . . . 74.14 112.115 -172.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.762 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.9 t90 -142.54 123.76 14.64 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.427 -1.323 . . . . 54.14 107.427 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 41' ' ' ASP . 27.1 pt -119.22 138.98 48.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.427 -0.583 . . . . 65.21 109.427 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 5.9 p -115.83 120.29 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.839 0.828 . . . . 73.31 111.237 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -114.94 163.38 15.66 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.908 -1.042 . . . . 63.45 110.672 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -112.09 127.55 55.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.72 -0.673 . . . . 75.13 109.653 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.756 HG22 HG22 ' A' ' 86' ' ' THR . 68.8 mt -113.04 100.29 10.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.203 -0.453 . . . . 71.42 110.214 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.592 ' HA ' HG21 ' A' ' 86' ' ' THR . 8.8 tp10 -162.55 165.48 25.96 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.95 -1.13 . . . . 72.54 107.95 171.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.9 t30 60.6 29.38 18.97 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.739 0.781 . . . . 71.34 109.936 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 4' ' ' GLY . 50.0 p 57.52 26.97 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.446 -1.252 . . . . 55.4 112.9 177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -125.55 136.75 53.65 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.213 -0.304 . . . . 72.24 110.613 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.609 HG21 HD11 ' A' ' 94' ' ' LEU . 9.8 mm -106.34 107.14 21.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.353 -0.61 . . . . 53.44 109.353 172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -141.56 142.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 -0.275 . . . . 74.23 110.467 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.837 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 1.8 m -79.91 146.39 7.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.794 0.331 . . . . 75.41 110.478 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.543 ' OE1' ' HD2' ' A' ' 59' ' ' ARG . 50.2 mt-10 -107.03 -18.54 13.88 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.327 -0.62 . . . . 75.53 109.327 176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . 18.3 tppt? -160.54 145.62 14.56 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.531 -0.758 . . . . 70.22 110.812 -177.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 27' ' ' ILE . 3.4 p30 -152.08 133.35 14.44 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.807 -0.812 . . . . 71.21 108.807 174.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.38 159.27 25.69 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.038 -1.077 . . . . 75.21 113.344 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -114.31 121.54 43.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.513 0.673 . . . . 74.04 109.71 175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 29.44 1.4 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 108.238 -1.945 . . . . 64.25 108.238 -168.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -44.42 -53.4 6.91 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 115.492 1.664 . . . . 74.44 115.492 -160.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -69.5 -34.75 74.76 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 111.91 0.337 . . . . 74.51 111.91 -171.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.35 -43.81 11.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.583 0.706 . . . . 54.02 109.932 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.11 -53.52 56.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.485 -1.234 . . . . 63.11 111.518 -176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.7 ' HD1' ' HG ' ' A' ' 53' ' ' LEU . 13.8 m-85 -68.06 -19.05 64.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.35 0.871 . . . . 61.03 113.35 -172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.661 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 55.8 mtm-85 -66.33 -30.9 71.4 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.412 -0.515 . . . . 74.32 110.8 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.0 -20.13 9.02 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.575 -0.821 . . . . 73.42 112.498 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -84.84 -16.45 41.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.86 0.319 . . . . 43.11 111.86 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HG ' ' HD1' ' A' ' 49' ' ' PHE . 35.8 mt -111.99 92.12 17.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 112.978 0.732 . . . . 71.35 112.978 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 52' ' ' ALA . 73.9 Cg_endo -101.04 44.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.875 3.05 . . . . 64.3 108.902 162.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -51.47 -37.95 51.41 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 114.456 1.28 . . . . 75.01 114.456 -163.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 16.6 t-20 68.82 -46.36 0.55 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.473 0.483 . . . . 53.41 111.448 -176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.74 172.33 7.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.128 -0.487 . . . . 64.44 109.754 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 9.5 p -84.11 136.08 34.14 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 120.093 -0.643 . . . . 64.02 109.99 174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HD2' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mmt85 -135.75 170.5 15.89 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.059 -1.089 . . . . 73.25 108.059 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 71' ' ' PHE . 2.2 t80 -117.3 119.07 34.01 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.335 -0.546 . . . . 71.3 110.996 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.762 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.07 135.3 10.62 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.71 -0.757 . . . . 73.2 112.488 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 2.8 p -106.02 123.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 72.24 110.385 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 2.4 t80 -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.232 -0.895 . . . . 73.24 109.323 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.53 141.79 31.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 75.4 111.505 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 60.7 m -131.08 169.55 15.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.421 -0.809 . . . . 63.2 109.44 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.9 66.92 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.697 -0.763 . . . . 33.52 112.478 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -72.45 -34.27 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 44.41 111.374 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -170.53 168.48 7.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.191 -0.459 . . . . 73.31 110.35 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.413 ' HB ' ' HB1' ' A' ' 101' ' ' ALA . 13.2 mt -122.33 118.16 54.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.271 -0.64 . . . . 63.12 109.271 170.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -112.92 129.14 56.58 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.321 0.581 . . . . 75.32 110.509 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.737 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 7.8 m-85 -78.57 114.06 17.15 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.314 -0.857 . . . . 74.53 109.471 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.36 127.04 43.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.315 0.578 . . . . 62.25 111.511 -168.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 58.4 tp -131.14 107.1 8.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.094 -0.957 . . . . 73.11 110.029 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 38.0 t90 -85.62 130.29 34.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.871 -0.789 . . . . 72.34 108.871 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -78.14 148.27 74.48 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-O 120.82 0.343 . . . . 62.11 110.624 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.833 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 96.7 Cg_endo -89.43 115.54 0.67 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.584 2.189 . . . . 70.13 111.88 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.71 -19.34 41.69 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.48 0.657 . . . . 74.22 109.662 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -102.41 9.88 39.42 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.379 -0.828 . . . . 74.44 110.639 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.833 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -139.14 152.48 69.88 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 121.962 -0.461 . . . . 72.42 111.013 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 16.7 Cg_exo -68.7 -178.86 2.12 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 123.177 2.584 . . . . 70.5 113.232 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' HG2' ' A' ' 85' ' ' MET . 9.1 p -84.64 -8.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 71.03 111.515 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 48.6 mtpt -68.25 -49.73 32.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.393 0.516 . . . . 74.34 112.393 -175.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 26.9 Cg_endo -65.18 -31.54 53.79 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 121.4 1.4 . . . . 74.51 111.1 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.56 -39.09 92.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.158 -0.928 . . . . 75.11 110.698 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 22.1 mmt -61.34 -39.17 89.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.778 -0.647 . . . . 71.23 111.487 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.756 HG22 HG22 ' A' ' 31' ' ' ILE . 8.2 m -58.08 -43.85 87.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.811 0.339 . . . . 73.32 111.286 -176.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.721 ' HD2' ' HB2' ' A' ' 60' ' ' PHE . 90.4 m-85 -66.43 -54.11 27.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 73.51 111.783 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.62 67.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.451 . . . . 61.14 111.808 -174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 m -86.48 -45.16 11.38 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.358 -0.383 . . . . 71.21 111.382 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB2' HG21 ' A' ' 31' ' ' ILE . 8.1 m -79.94 -11.18 59.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.41 -0.359 . . . . 70.05 111.691 -173.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.09 -21.76 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.827 0.346 . . . . 74.45 111.363 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.73 -37.01 81.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.348 -0.387 . . . . 54.54 110.55 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.77 -30.74 71.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 72.32 110.683 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.0 mm? -73.54 -57.6 3.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 53.53 109.389 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.797 HD21 ' HA ' ' A' ' 103' ' ' ALA . 25.1 tp -54.63 -43.51 72.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.676 -1.147 . . . . 71.42 112.282 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -64.66 -25.17 67.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.979 -0.555 . . . . 74.11 111.585 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -104.27 -36.8 7.5 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.379 0.881 . . . . 64.31 113.379 -168.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 1.6 pp -87.11 -37.59 17.25 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.906 1.076 . . . . 75.1 113.906 -164.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.6 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.1 t70 -151.38 168.47 24.71 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.779 -0.769 . . . . 72.04 111.421 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.39 14.11 30.65 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.572 -0.74 . . . . 23.21 111.435 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.52 179.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.005 0.922 . . . . 71.5 112.645 -178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -83.4 140.28 32.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.594 -0.73 . . . . 74.24 110.333 -169.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.797 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -78.23 -0.29 27.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 64.13 111.521 -174.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -82.82 147.96 5.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.12 0.486 . . . . 64.02 109.728 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.97 157.77 30.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.99 -0.55 . . . . 74.01 109.581 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.1 tp -104.82 116.54 32.19 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.675 -0.491 . . . . 73.12 109.675 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.67 127.58 49.73 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.971 -0.381 . . . . 74.02 109.971 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.21 119.04 32.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.96 0.409 . . . . 65.11 110.851 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -111.87 -11.23 13.93 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.139 -0.689 . . . . 73.21 109.139 172.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -93.14 -161.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.171 -0.922 . . . . 72.11 108.73 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.6 mtp -86.56 18.36 3.37 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.389 -0.194 . . . . 63.1 110.842 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -59.18 -33.36 74.67 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 114.416 0.526 . . . . 71.02 114.416 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.65 -51.66 68.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.099 0.476 . . . . 71.45 111.356 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 114' ' ' LEU . 2.9 pp -96.49 12.42 31.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.939 -0.573 . . . . 65.34 111.397 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -87.73 165.35 30.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.119 -0.491 . . . . 71.23 109.98 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.661 ' HA ' ' HD3' ' A' ' 50' ' ' ARG . 37.0 Cg_endo -67.38 89.56 0.33 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 121.937 1.758 . . . . 73.12 112.793 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 115' ' ' ALA . 5.6 mp -68.53 -39.7 81.03 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.219 -0.66 . . . . 74.03 109.219 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.419 -0.809 . . . . 53.04 109.186 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 120.684 0.278 . . . . 71.05 110.445 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 90' ' ' SER . . . -90.2 -19.7 23.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.703 0.631 . . . . 50.23 112.703 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 t -64.42 144.93 56.82 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.152 -0.219 . . . . 51.35 110.843 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.92 39.47 97.58 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.381 -0.437 . . . . 65.11 112.726 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -92.17 174.28 7.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.256 0.55 . . . . 73.32 111.213 -178.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.35 118.59 3.57 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.749 -0.941 . . . . 64.41 110.749 171.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.5 t -79.06 124.59 37.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.668 -0.493 . . . . 74.31 109.668 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -88.9 147.18 24.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.901 0.382 . . . . 73.01 110.378 -178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 9' ' ' GLU . 6.2 pt-20 -74.81 -13.06 60.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.85 -0.614 . . . . 61.42 112.431 -174.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -54.9 -27.75 45.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.935 0.398 . . . . 75.14 111.024 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.96 -56.21 14.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 65.24 110.797 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.96 -27.31 29.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.517 -0.31 . . . . 74.42 111.558 -175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.35 -30.82 71.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.259 0.552 . . . . 73.04 110.434 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.437 ' HG3' ' CD ' ' A' ' 25' ' ' LYS . 0.8 OUTLIER -72.32 -38.56 68.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.808 -0.633 . . . . 73.22 110.652 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 82.5 m-85 -60.75 -28.84 69.0 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.572 -0.285 . . . . 74.24 111.252 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -62.63 -47.22 84.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 65.42 110.375 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 31.8 mt-10 -67.25 -37.19 83.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 63.25 110.035 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.664 HD13 ' H ' ' A' ' 25' ' ' LYS . 21.5 tp -57.61 -47.93 80.81 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.996 -1.002 . . . . 72.33 111.052 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -83.43 -58.9 2.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.347 0.499 . . . . 72.54 112.347 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.81 -47.55 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.452 0.538 . . . . 63.45 112.452 -169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 82.7 mtp180 -72.53 -11.52 60.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.507 0.194 . . . . 75.54 111.193 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 39.7 ttmt 58.95 24.15 12.27 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.093 0.949 . . . . 72.41 110.136 -174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 p -105.76 122.44 46.08 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.104 -0.953 . . . . 72.14 108.544 173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.3 m -86.39 135.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.758 -0.777 . . . . 54.12 110.608 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' H ' HD13 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -137.94 147.44 44.33 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 75.51 110.314 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.978 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 4.0 t90 -109.5 124.99 52.0 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.75 -1.574 . . . . 71.35 106.75 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.495 ' O ' ' HA2' ' A' ' 61' ' ' GLY . 29.3 pt -108.43 122.16 62.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 C-N-CA 119.614 -0.834 . . . . 73.42 110.668 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 83.7 t -105.87 114.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 109.265 -0.643 . . . . 72.34 109.265 177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.581 ' CE1' ' HB3' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -112.99 160.2 18.35 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.544 -0.753 . . . . 72.01 111.038 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 3.2 tppp? -113.46 124.47 52.49 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.092 -0.958 . . . . 63.13 108.518 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 94' ' ' LEU . 70.3 mt -109.12 101.53 12.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.027 0.442 . . . . 71.23 110.576 -175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -161.21 162.09 31.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.554 -0.748 . . . . 61.1 109.323 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.88 40.06 23.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.038 0.447 . . . . 71.13 111.282 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.6 p 56.54 19.31 4.1 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.802 0.841 . . . . 74.55 113.168 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -127.98 128.54 45.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 73.41 111.07 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mm -93.42 107.99 19.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.685 -0.857 . . . . 72.21 108.685 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.1 t -127.13 134.37 66.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.709 -0.223 . . . . 63.33 110.477 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 29' ' ' PHE . 21.3 t -91.56 134.14 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.139 -0.689 . . . . 75.14 109.139 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.08 -18.02 12.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.184 -0.672 . . . . 74.42 109.184 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -144.64 142.78 30.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 121.565 0.698 . . . . 72.45 112.723 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 27' ' ' ILE . 3.2 p-10 -131.78 131.69 43.15 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.515 -1.661 . . . . 74.02 106.515 161.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' LYS . . . -107.37 144.68 16.0 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 119.747 -1.216 . . . . 73.22 113.524 -167.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 43' ' ' LYS . 3.7 ptpp? -109.21 121.37 45.02 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.328 -0.989 . . . . 72.21 108.328 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.48 49.67 7.15 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 107.596 -2.202 . . . . 43.03 107.596 -158.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.978 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 26.8 p-10 -45.09 -51.48 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 114.469 1.285 . . . . 71.4 114.469 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.13 -23.51 51.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.701 0.286 . . . . 34.21 111.768 -174.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -89.35 -43.08 11.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.57 -0.286 . . . . 65.23 111.189 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -56.83 -53.92 52.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.249 -0.432 . . . . 72.04 110.867 -175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 33.3 m-85 -68.56 -10.36 55.3 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.974 0.731 . . . . 73.34 112.974 -172.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -68.02 -15.81 63.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.178 0.513 . . . . 74.23 109.838 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.18 9.19 1.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.929 -0.653 . . . . 34.23 112.339 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -76.85 -54.43 6.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.742 0.306 . . . . 74.21 111.073 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.1 tp -145.03 78.37 12.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 120.859 -0.336 . . . . 73.0 111.802 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -86.69 77.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.165 2.577 . . . . 65.12 110.387 170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.49 -14.11 57.37 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.99 0.737 . . . . 64.22 112.99 -170.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 14.4 m120 68.25 8.92 6.9 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.278 0.561 . . . . 54.14 110.737 -175.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -117.26 163.52 16.2 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.034 -0.728 . . . . 72.13 109.034 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 4.9 p -79.37 135.43 36.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 122.295 1.045 . . . . 72.53 110.414 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 151.91 32.85 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.873 -1.512 . . . . 73.51 108.938 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.0 t80 -102.24 122.22 43.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.927 0.394 . . . . 64.12 110.644 -173.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -122.31 135.95 10.55 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.16 -0.543 . . . . 75.15 112.161 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.98 131.44 71.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.272 0.536 . . . . 52.23 110.74 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.629 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -146.24 148.74 32.8 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.275 -0.42 . . . . 75.55 111.388 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.805 ' HA ' HG12 ' A' ' 69' ' ' ILE . 26.7 t70 -69.4 144.87 53.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 73.04 109.85 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LYS . 12.9 t -133.45 173.18 11.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.172 -0.677 . . . . 74.55 109.172 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -40.29 92.48 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 121.164 -0.541 . . . . 65.35 113.824 -171.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -99.75 -46.36 5.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.376 0.588 . . . . 61.32 110.93 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' CYS . 0.3 OUTLIER -141.75 177.34 8.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.764 -0.653 . . . . 73.32 110.116 -171.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.805 HG12 ' HA ' ' A' ' 64' ' ' ASP . 11.4 mt -100.45 123.22 53.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.978 -0.749 . . . . 62.25 108.978 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -101.49 121.82 42.67 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.623 -0.431 . . . . 62.45 111.222 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.429 ' CE2' HD12 ' A' ' 98' ' ' LEU . 15.1 m-85 -78.01 109.01 11.71 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.774 -0.825 . . . . 73.24 108.774 168.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.94 113.85 40.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.504 0.669 . . . . 61.14 111.203 -173.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 45.7 tp -113.94 112.16 22.86 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.354 -0.839 . . . . 73.24 109.51 175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.698 ' HZ2' ' HG2' ' A' ' 111' ' ' MET . 37.4 t90 -85.19 123.22 30.44 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.617 -0.882 . . . . 73.42 108.617 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 60.8 m -70.8 149.06 95.09 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.011 -0.54 . . . . 62.45 110.834 -173.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.808 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 17.1 Cg_exo -67.28 101.21 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.548 2.166 . . . . 64.14 111.559 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -86.03 -34.38 20.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.029 -0.532 . . . . 61.02 109.805 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -98.44 9.74 42.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.559 -0.746 . . . . 72.53 109.903 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -139.98 155.08 71.01 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.042 -0.527 . . . . 55.53 110.07 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.71 -151.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.973 2.449 . . . . 73.41 113.603 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.31 -25.59 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 113.897 1.073 . . . . 65.55 113.897 -166.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 68.2 mttm -68.59 -48.93 31.64 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 112.573 0.582 . . . . 73.33 112.573 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.584 ' HB2' ' SG ' ' A' ' 58' ' ' CYS . 14.2 Cg_endo -57.74 -27.53 78.17 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.727 1.618 . . . . 44.22 111.758 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -69.8 -40.43 75.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 74.52 109.726 177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.8 mtt -72.04 -26.79 62.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 75.41 111.297 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.4 m -57.08 -52.76 64.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.076 0.465 . . . . 74.41 110.518 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' OH ' ' HD3' ' A' ' 30' ' ' LYS . 96.7 m-85 -76.18 -37.94 57.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 73.22 111.192 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.5 -19.24 65.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.905 0.383 . . . . 74.32 111.595 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.2 t -88.08 -50.25 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.247 0.546 . . . . 72.53 110.458 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 8.6 p -75.86 -11.99 60.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.606 -0.725 . . . . 72.14 112.43 -171.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -61.47 -24.31 66.48 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.035 0.383 . . . . 72.3 112.035 -178.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 51.0 m-20 -83.76 -31.74 25.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.042 0.449 . . . . 73.1 110.347 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.3 -38.37 63.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.927 -0.578 . . . . 70.15 110.394 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.611 HD11 HD11 ' A' ' 31' ' ' ILE . 64.9 mt -56.9 -47.35 80.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.488 -0.56 . . . . 65.54 109.488 173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 37.9 tp -62.17 -21.74 65.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.968 -1.015 . . . . 75.12 112.17 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -76.59 -15.08 59.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.52 0.676 . . . . 74.42 110.411 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER -111.65 -4.58 14.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.044 0.926 . . . . 61.3 108.921 176.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HB2' ' HA ' ' A' ' 95' ' ' LEU . 6.5 mt -111.96 13.18 20.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.666 -1.606 . . . . 70.32 112.608 -169.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 101' ' ' ALA . 5.7 m-20 -33.61 -145.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 128.041 2.536 . . . . 70.13 116.741 -152.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.2 16.13 0.02 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 117.729 1.852 . . . . 61.31 117.729 -151.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -55.73 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.161 -1.051 . . . . 61.55 108.161 152.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.564 ' HB ' ' O ' ' A' ' 69' ' ' ILE . 5.4 m -77.84 117.81 19.56 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.301 -1.499 . . . . 74.52 109.834 -167.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -85.42 4.37 35.81 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.273 -1.33 . . . . 54.12 111.963 -169.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 31.4 t -85.55 146.92 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.775 -0.454 . . . . 73.54 109.775 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -126.18 146.1 50.1 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 116.027 -0.533 . . . . 50.22 109.688 176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 58.3 tp -125.13 118.28 25.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.202 -0.454 . . . . 52.23 109.916 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 7.2 pt-20 -96.5 117.47 30.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.462 0.649 . . . . 72.23 110.635 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.6 119.9 32.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.592 -0.731 . . . . 62.13 109.621 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -99.37 -13.54 19.55 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.01 0.433 . . . . 74.05 110.892 -176.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -105.4 166.57 10.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.588 -0.893 . . . . 72.33 108.588 169.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.698 ' HG2' ' HZ2' ' A' ' 74' ' ' TRP . 38.7 mtp -78.28 70.52 4.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.553 0.692 . . . . 53.52 111.262 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.46 -16.0 74.79 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.072 -0.967 . . . . 42.44 110.938 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -62.13 -31.94 72.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.228 -0.486 . . . . 71.33 111.615 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.13 19.23 20.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.387 0.613 . . . . 61.2 110.788 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.17 154.84 44.21 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.731 -0.668 . . . . 43.21 109.865 177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.51 104.28 0.52 Allowed 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.28 1.986 . . . . 52.44 112.294 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -99.23 -31.97 11.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.501 0.667 . . . . 73.23 109.68 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.267 -0.879 . . . . 73.12 109.313 177.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG2' ' H ' ' A' ' 3' ' ' SER . 52.6 ttm . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 110.247 -0.279 . . . . 74.44 110.247 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 5' ' ' MET . . . -90.92 -19.63 23.1 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 111.797 0.295 . . . . 72.2 111.797 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.519 ' H ' ' HG2' ' A' ' 1' ' ' MET . 20.5 m -60.02 141.84 54.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 64.12 111.312 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.94 48.77 81.41 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.685 -0.566 . . . . 62.33 111.685 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.571 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -85.99 152.1 23.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.434 0.635 . . . . 73.03 112.009 -176.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.94 125.27 5.08 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.998 -1.001 . . . . 72.42 110.682 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.546 ' HA ' ' HB ' ' A' ' 36' ' ' ILE . 44.8 t -89.78 132.59 34.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.731 0.266 . . . . 63.44 110.479 -177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.84 140.37 45.72 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.101 -0.333 . . . . 71.2 110.101 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -62.81 -28.97 70.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.981 0.419 . . . . 74.13 111.039 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.23 -28.7 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.041 -0.527 . . . . 71.42 111.01 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.027 0.442 . . . . 74.11 110.453 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG22 HD22 ' A' ' 98' ' ' LEU . 14.1 t -78.65 -34.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 71.5 110.757 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -25.66 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.807 -0.633 . . . . 53.32 112.219 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.707 ' HG2' HG21 ' A' ' 27' ' ' ILE . 15.6 tpt180 -66.56 -17.35 64.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.819 0.342 . . . . 73.43 111.468 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.589 ' HA ' HD12 ' A' ' 18' ' ' LEU . 58.7 m-85 -74.42 -19.26 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.046 0.387 . . . . 74.14 112.046 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -77.25 -26.33 52.41 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.882 -0.727 . . . . 55.45 110.054 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -69.2 -33.39 73.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.666 0.746 . . . . 65.33 109.541 171.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 HD12 ' HA ' ' A' ' 15' ' ' PHE . 65.2 mt -70.08 -48.33 58.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.803 -1.089 . . . . 71.33 111.105 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -82.08 -55.07 4.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.454 -0.794 . . . . 71.52 112.609 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.96 -48.0 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.151 0.426 . . . . 74.4 112.151 -171.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt-85 -81.32 -11.09 59.43 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.172 -0.211 . . . . 71.15 111.076 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 59.13 23.6 11.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.143 -0.481 . . . . 72.13 110.348 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.8 p -101.76 117.63 35.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.068 -0.514 . . . . 74.21 109.708 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.22 135.92 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.443 0.639 . . . . 71.32 110.654 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -138.48 161.13 37.8 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.58 -0.896 . . . . 71.41 108.58 177.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.6 t90 -112.78 123.49 50.42 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.786 -0.82 . . . . 73.45 108.786 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 14' ' ' ARG . 43.4 pt -110.75 131.29 62.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.642 -0.503 . . . . 74.11 109.642 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.82 HG21 HD21 ' A' ' 53' ' ' LEU . 93.4 t -113.18 113.93 45.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.38 -0.373 . . . . 75.31 110.304 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.935 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 44.1 p90 -102.06 151.51 22.07 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.473 0.654 . . . . 63.34 110.508 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 32' ' ' GLU . 3.8 tmmm? -114.58 124.11 51.04 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.057 -0.974 . . . . 75.32 108.641 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 87' ' ' TYR . 48.3 mt -88.88 103.84 14.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.719 -0.673 . . . . 52.01 109.665 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 30' ' ' LYS . 25.0 tt0 -139.64 139.3 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 73.14 111.019 -168.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 t30 49.93 46.4 24.32 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.872 0.733 . . . . 70.31 111.581 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' MET . 70.3 p 55.61 25.46 8.1 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.497 0.719 . . . . 73.41 112.666 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HG2' HG13 ' A' ' 37' ' ' VAL . 7.1 ttpm? -133.71 137.39 45.23 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.013 -0.43 . . . . 75.4 110.414 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.546 ' HB ' ' HA ' ' A' ' 7' ' ' VAL . 43.9 mm -95.09 109.37 22.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.951 -0.568 . . . . 54.34 110.1 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG13 ' HG2' ' A' ' 35' ' ' LYS . 16.3 m -133.8 135.47 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.026 0.441 . . . . 75.12 110.887 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.935 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.2 p -89.17 140.24 16.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.014 -0.539 . . . . 71.43 110.038 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -91.98 -35.43 13.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.922 0.392 . . . . 74.31 110.31 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HE2' ' CZ ' ' A' ' 49' ' ' PHE . 8.9 ptmt -171.75 165.45 6.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.924 -0.58 . . . . 64.24 111.686 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG22 ' A' ' 27' ' ' ILE . 4.9 p-10 -142.98 158.62 43.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.197 -0.911 . . . . 65.45 108.726 177.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.77 148.67 20.23 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.259 -1.448 . . . . 61.02 114.951 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -93.71 129.35 40.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.556 -1.275 . . . . 75.12 107.556 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.99 35.86 7.99 Favored Glycine 0 C--O 1.208 -1.489 0 N-CA-C 108.294 -1.922 . . . . 54.51 108.294 -161.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.909 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 7.4 p30 -44.41 -53.11 7.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.996 1.11 . . . . 75.4 113.996 -173.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.02 -14.35 58.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.439 0.638 . . . . 61.21 110.68 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -88.98 -49.16 6.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.14 -0.936 . . . . 71.2 110.885 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 49' ' ' PHE . 1.1 pt-20 -81.2 -36.04 30.6 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.895 -1.048 . . . . 73.22 111.185 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 26' ' ' TRP . 9.3 m-85 -72.46 -4.47 30.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.108 0.41 . . . . 73.21 112.108 -175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -72.83 -13.98 61.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.063 0.459 . . . . 75.54 110.102 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.65 11.96 2.68 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.0 -0.619 . . . . 61.1 112.424 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -111.51 12.58 21.37 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 64.52 111.389 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 28' ' ' VAL . 75.0 mt -117.83 140.78 28.14 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.351 -0.386 . . . . 72.21 111.172 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 14.5 Cg_exo -69.14 105.17 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.773 2.315 . . . . 64.41 111.278 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.22 -12.53 61.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.967 -0.561 . . . . 63.15 111.858 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -90.43 -19.08 24.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.378 -0.373 . . . . 70.3 111.214 -177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -120.73 173.41 7.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.257 -0.429 . . . . 63.34 110.257 -174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 6.9 p -97.99 139.09 34.33 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.302 -0.629 . . . . 73.25 109.302 171.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 61.9 mmt-85 -134.09 151.83 51.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.957 -0.565 . . . . 71.53 110.043 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -111.18 105.18 13.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.128 0.489 . . . . 75.25 109.746 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.578 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -113.3 135.03 12.28 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.818 -0.628 . . . . 52.1 111.743 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 71' ' ' PHE . 27.1 m -125.85 129.09 72.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.255 0.55 . . . . 44.23 110.224 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' HB3' ' CG ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -140.36 147.18 39.41 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.015 -0.538 . . . . 62.24 110.216 177.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.36 143.3 27.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.904 -0.589 . . . . 71.44 110.414 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.499 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 34.0 t -122.73 169.56 10.95 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.518 -0.919 . . . . 71.3 108.518 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.64 -24.18 59.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.105 -0.569 . . . . 70.42 114.084 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -126.94 4.91 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.463 0.631 . . . . 73.52 112.577 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 13.0 ptmt -169.6 151.8 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.222 0.823 . . . . 74.33 113.222 -169.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 26.8 mm -100.13 125.58 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.277 -0.874 . . . . 71.43 108.802 167.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 68' ' ' LYS . 26.5 mt-30 -116.25 114.95 25.09 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.471 -0.492 . . . . 74.0 111.975 -176.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.653 ' HA ' HG12 ' A' ' 62' ' ' VAL . 29.9 m-85 -85.14 109.54 18.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 73.21 109.197 170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.67 126.07 64.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.008 0.432 . . . . 75.13 110.949 -174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 62.9 tp -133.3 108.02 8.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 60.24 110.521 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.408 ' HD1' ' HB3' ' A' ' 108' ' ' ALA . 63.2 t90 -85.47 119.96 26.4 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.712 -0.847 . . . . 63.21 108.712 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 23.9 p -74.52 148.22 85.45 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 121.018 -0.273 . . . . 65.3 110.296 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.799 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 71.6 Cg_endo -78.77 121.25 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.321 2.014 . . . . 74.05 113.47 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.06 -20.12 30.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.55 -0.75 . . . . 54.33 110.246 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.69 16.11 21.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.538 0.685 . . . . 71.3 110.31 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -140.66 155.68 69.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 74.44 109.85 177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -76.43 -165.97 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.396 2.731 . . . . 63.31 113.622 -175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.67 -24.23 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 112.768 0.655 . . . . 54.44 112.768 -171.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 61.8 mttp -67.05 -48.74 48.94 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 119.281 -0.39 . . . . 61.04 111.936 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 51.0 Cg_exo -55.82 -41.01 81.66 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.416 1.41 . . . . 74.22 111.468 173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -62.86 -51.16 68.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.481 -0.781 . . . . 73.4 111.221 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 82' ' ' LYS . 26.0 ptt? -68.78 -24.35 64.41 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 53.44 110.925 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.1 m -62.93 -56.17 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.404 -0.362 . . . . 64.44 110.42 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.5 m-85 -60.97 -37.0 80.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 75.24 111.033 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.27 -31.25 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 63.33 111.777 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.5 t -66.36 -33.41 75.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.957 0.408 . . . . 64.21 110.901 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.536 ' OG ' HD13 ' A' ' 31' ' ' ILE . 2.0 p -87.19 7.4 28.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.167 -0.47 . . . . 52.02 112.078 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.615 ' O ' HD13 ' A' ' 95' ' ' LEU . 15.9 tttm -57.45 -55.55 33.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 75.53 111.338 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.443 ' HA ' HD22 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -76.75 -21.64 54.95 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.17 -0.468 . . . . 51.51 110.332 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.43 92.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.447 -0.797 . . . . 70.34 110.889 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.75 HD12 HD11 ' A' ' 98' ' ' LEU . 4.6 mm? -77.64 -37.25 50.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 70.03 110.276 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 91' ' ' LYS . 4.8 mp -57.04 -43.04 81.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.584 0.706 . . . . 72.25 110.366 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -77.55 -10.48 59.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.907 -1.042 . . . . 73.23 111.956 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HG2' HG21 ' A' ' 7' ' ' VAL . 52.9 tptt -106.24 -48.58 3.55 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.271 0.841 . . . . 74.44 113.271 -169.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 94' ' ' LEU . 17.8 mt -89.0 -45.05 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.765 1.024 . . . . 70.23 113.765 -162.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 4.8 t70 -156.54 -166.53 2.16 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.467 -0.493 . . . . 74.1 111.254 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -88.09 16.18 52.86 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 110.722 -0.951 . . . . 75.31 110.722 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.81 179.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.268 1.027 . . . . 75.01 113.034 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.588 HG22 HG23 ' A' ' 104' ' ' VAL . 2.1 m -83.36 139.95 32.71 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.838 -0.619 . . . . 72.54 110.764 -167.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HA ' ' CD2' ' A' ' 95' ' ' LEU . . . -81.16 2.01 29.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.576 -0.738 . . . . 45.22 112.048 -174.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' THR . 40.6 t -76.69 147.08 7.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.906 0.384 . . . . 64.1 110.279 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.16 144.36 34.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.302 -0.629 . . . . 54.34 109.302 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -118.93 118.64 32.07 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.179 -0.209 . . . . 62.12 110.482 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.0 pt-20 -104.04 118.56 36.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.364 0.602 . . . . 74.31 110.129 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 74' ' ' TRP . . . -97.51 143.08 28.58 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.924 -0.58 . . . . 65.44 110.678 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -6.09 6.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 65.13 109.473 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.75 -162.03 1.18 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.77 -1.105 . . . . 70.43 109.691 -175.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 84.9 mtp -85.57 28.2 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.746 0.308 . . . . 71.12 111.259 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.36 -23.02 59.44 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.838 -0.696 . . . . 72.41 111.871 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.39 -51.81 53.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.221 0.534 . . . . 44.25 110.478 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.845 ' H ' HD23 ' A' ' 114' ' ' LEU . 1.3 pt? -84.25 23.89 1.02 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.703 -0.681 . . . . 65.25 111.051 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -117.56 160.57 37.58 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 109.339 -0.615 . . . . 75.53 109.339 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 13.2 Cg_endo -56.28 107.89 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.41 2.073 . . . . 71.23 112.403 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.1 mp -76.12 -32.6 59.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 75.1 110.097 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 CA-C-N 115.669 -0.696 . . . . 60.02 109.787 177.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.572 0.225 . . . . 73.35 110.437 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.52 -20.56 21.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.091 0.472 . . . . 65.21 111.06 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -80.02 151.11 30.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.906 -0.588 . . . . 55.31 111.064 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.05 29.69 75.16 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.307 -0.861 . . . . 72.13 113.959 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -106.39 144.07 33.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.106 0.453 . . . . 73.11 109.878 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.49 116.49 5.59 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.081 -0.808 . . . . 74.12 111.081 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.44 130.66 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.754 0.311 . . . . 72.54 111.05 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.61 131.03 44.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.885 -0.598 . . . . 34.11 111.362 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.2 -18.02 37.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.915 -0.584 . . . . 44.23 111.641 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -68.1 -25.44 65.32 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.631 0.253 . . . . 44.33 110.642 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.7 m -53.12 -45.2 68.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.887 -0.597 . . . . 75.1 110.867 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 45.9 t -61.72 -39.68 84.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.208 -0.451 . . . . 63.01 111.092 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.97 -25.99 68.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 54.54 111.183 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 14' ' ' ARG . 22.0 mmt180 -75.65 -18.73 59.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 71.21 111.364 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.597 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 88.1 m-85 -84.0 -21.91 31.53 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.355 0.598 . . . . 73.1 109.444 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -45.27 44.59 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.365 -0.834 . . . . 74.01 109.267 172.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.666 ' HA ' ' CG ' ' A' ' 21' ' ' ARG . 11.0 mm-40 -65.16 -15.63 62.64 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.193 0.521 . . . . 74.13 110.696 171.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 23.7 tp -86.58 -61.59 1.7 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.761 -0.654 . . . . 34.15 111.002 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -82.51 -50.6 8.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.379 0.511 . . . . 63.23 112.379 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.5 mm -68.41 -28.51 40.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 74.11 110.777 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.666 ' CG ' ' HA ' ' A' ' 17' ' ' GLU . 39.5 mmt180 -85.91 -10.54 55.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.884 -0.598 . . . . 74.54 110.691 178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 59.37 45.25 14.1 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.974 -0.557 . . . . 73.43 111.798 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 18' ' ' LEU . 13.8 t -143.59 151.98 40.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.385 -0.598 . . . . 74.45 109.385 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG12 ' OD2' ' A' ' 64' ' ' ASP . 33.1 m -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.596 -0.442 . . . . 71.22 110.677 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -140.69 164.23 30.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.379 0.609 . . . . 72.24 111.424 173.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.713 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 5.8 t90 -129.57 123.58 31.71 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.218 -1.03 . . . . 75.51 108.218 177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.925 HG22 ' HB2' ' A' ' 41' ' ' ASP . 15.0 pt -116.15 134.56 59.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.697 -0.483 . . . . 72.13 109.697 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.1 109.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.138 0.494 . . . . 62.43 110.913 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.849 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -101.91 147.84 26.05 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.684 -0.689 . . . . 73.42 109.638 175.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -113.99 125.29 53.84 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.103 0.478 . . . . 72.23 110.802 -174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.75 HG12 HD12 ' A' ' 36' ' ' ILE . 62.2 mt -83.07 103.43 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.587 -0.894 . . . . 72.34 108.587 175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -146.35 139.89 25.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.182 -0.463 . . . . 71.51 110.541 -173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.69 31.15 20.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.285 0.564 . . . . 74.5 110.118 175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m 65.97 20.13 11.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.593 -0.73 . . . . 54.21 110.655 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -130.02 143.61 50.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.593 -0.73 . . . . 64.13 110.098 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.75 HD12 HG12 ' A' ' 31' ' ' ILE . 10.7 mm -111.91 111.22 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.381 -0.372 . . . . 64.41 110.58 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.7 154.27 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.736 0.303 . . . . 75.43 110.412 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.849 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 11.4 t -83.49 132.44 31.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.082 -0.508 . . . . 63.23 110.396 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -80.23 -37.74 32.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.92 -0.77 . . . . 62.13 108.92 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 40' ' ' LYS . 10.9 ptmm? -173.56 164.66 4.53 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.041 -0.982 . . . . 72.53 110.039 177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.925 ' HB2' HG22 ' A' ' 27' ' ' ILE . 2.3 p-10 -126.19 148.07 49.51 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.801 -1.185 . . . . 64.4 107.801 171.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.0 161.52 12.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.92 -1.133 . . . . 51.15 113.977 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -137.49 129.27 28.69 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.782 -1.562 . . . . 52.41 106.782 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.8 36.99 35.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.016 -2.033 . . . . 70.22 108.016 -159.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 2.5 m-20 -44.56 -52.77 7.73 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.398 -1.401 . . . . 71.42 113.933 -163.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -66.02 -34.85 79.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.13 -0.486 . . . . 73.12 111.208 -172.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -89.57 -34.95 16.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.882 0.372 . . . . 65.21 111.108 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.613 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 7.8 tt0 -62.17 -50.22 72.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 71.05 110.611 -177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.65 -0.6 7.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.166 0.432 . . . . 73.32 112.166 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 48.5 mtp180 -81.27 -15.35 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 75.42 110.832 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.05 -19.85 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.106 -1.045 . . . . 72.13 113.63 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -58.51 -59.52 5.24 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 70.13 110.807 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.27 85.94 4.5 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.836 -0.62 . . . . 74.42 110.223 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.28 117.92 4.75 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.047 1.831 . . . . 75.24 109.594 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.61 78.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.006 0.373 . . . . 72.03 112.006 -169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.5 t30 67.12 -47.28 0.48 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.622 0.769 . . . . 71.11 111.144 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -100.41 172.04 7.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.63 -0.878 . . . . 72.34 108.63 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 76' ' ' PRO . 5.4 p -78.8 139.55 38.37 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.535 -0.466 . . . . 73.44 110.478 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -151.1 163.79 37.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.989 -0.745 . . . . 74.23 108.989 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.734 ' HD2' ' HE1' ' A' ' 29' ' ' PHE . 6.9 t80 -109.73 116.05 30.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.503 0.668 . . . . 52.13 110.419 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.713 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.29 135.23 10.5 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 115.377 -0.829 . . . . 64.54 111.829 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 27' ' ' ILE . 34.0 m -105.34 122.45 58.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 117.465 0.633 . . . . 64.21 110.362 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.638 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 6.2 t80 -135.59 132.26 36.92 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.523 -0.762 . . . . 63.33 109.684 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' OD2' HG12 ' A' ' 24' ' ' VAL . 10.0 p-10 -102.91 143.32 32.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.686 0.755 . . . . 74.23 111.023 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 44.7 t -112.38 169.62 8.75 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.401 -0.963 . . . . 73.51 108.401 173.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.53 -24.75 68.08 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.755 -0.736 . . . . 44.23 112.511 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.99 -46.51 6.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.782 0.29 . . . . 74.4 111.782 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.94 167.81 27.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.541 0.21 . . . . 73.13 110.688 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.407 HG12 ' CB ' ' A' ' 64' ' ' ASP . 7.6 mt -100.7 139.3 22.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.551 -0.537 . . . . 70.32 109.551 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -117.65 118.3 31.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.942 0.401 . . . . 72.55 110.71 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.42 ' HD2' ' CE2' ' A' ' 60' ' ' PHE . 61.4 m-85 -79.44 110.04 14.37 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.844 -0.798 . . . . 71.41 108.844 171.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -93.51 117.65 37.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.198 -0.455 . . . . 65.32 111.385 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 63.7 tp -141.18 82.77 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.526 -0.761 . . . . 61.14 109.489 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -85.71 149.36 25.35 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.647 -0.501 . . . . 75.41 109.647 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 57.8 m -97.8 147.28 32.81 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.832 -0.433 . . . . 72.5 109.832 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.723 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 7.7 Cg_endo -91.78 144.11 2.94 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.146 2.564 . . . . 52.14 112.798 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -80.36 -7.03 58.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.608 0.718 . . . . 65.23 109.583 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -107.46 15.64 24.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.052 -0.976 . . . . 74.45 110.334 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.723 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . . . -141.65 154.39 66.15 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 121.866 -0.521 . . . . 53.41 111.028 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 19.0 Cg_endo -91.59 -178.33 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.135 2.557 . . . . 65.23 112.801 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.4 m -79.33 3.3 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.853 -0.612 . . . . 65.44 112.077 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 39.9 ttmt -68.32 -58.1 7.87 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 121.195 -0.202 . . . . 73.01 110.954 -177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' O ' ' HD1' ' A' ' 87' ' ' TYR . 60.0 Cg_endo -74.05 -26.93 12.45 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.222 1.281 . . . . 34.22 111.579 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -32.49 67.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 65.23 111.104 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 25.0 mmt -76.9 -29.57 55.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.12 110.746 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -66.66 -44.85 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 74.32 110.634 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.547 ' CD2' HD12 ' A' ' 31' ' ' ILE . 77.1 m-85 -64.35 -30.22 71.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 74.43 110.266 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -18.18 62.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.972 -0.558 . . . . 74.13 110.908 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.8 m -84.72 -53.94 5.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.09 0.472 . . . . 72.14 110.711 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.9 m -72.53 -17.07 61.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 75.14 112.012 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -33.21 74.96 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.731 0.271 . . . . 64.53 111.731 -176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.74 -45.47 43.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 70.31 110.22 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.638 -0.71 . . . . 71.42 110.948 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.594 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 3.7 mm? -64.15 -48.81 74.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 53.41 110.848 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 103' ' ' ALA . 7.8 tt -56.66 -43.95 80.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 74.21 110.578 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -67.76 -27.7 66.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.217 0.532 . . . . 24.42 110.733 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.15 -43.14 12.48 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.839 0.681 . . . . 75.22 112.839 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 3.5 pp -88.72 -36.74 15.99 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.471 1.286 . . . . 74.41 114.471 -162.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.591 ' N ' HD12 ' A' ' 98' ' ' LEU . 38.7 t0 -150.3 170.81 18.12 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.348 -0.941 . . . . 72.11 112.501 -174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.1 14.12 61.53 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 114.93 -1.032 . . . . 72.32 110.657 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -179.35 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.315 1.046 . . . . 63.04 112.749 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.417 HG22 HG23 ' A' ' 104' ' ' VAL . 5.6 m -82.85 139.62 33.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.612 -0.722 . . . . 74.3 109.991 -172.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.614 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -75.14 4.49 6.78 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.361 0.504 . . . . 63.41 112.361 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 102' ' ' THR . 43.5 t -82.29 147.55 5.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.841 -0.429 . . . . 75.04 109.841 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.4 130.99 35.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.684 -0.488 . . . . 74.1 109.684 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.49 117.08 29.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.055 -0.52 . . . . 54.43 110.541 -176.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.3 pt-20 -123.58 121.63 36.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.128 0.49 . . . . 73.34 109.721 175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.84 148.58 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.868 -0.606 . . . . 72.12 110.471 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.45 11.64 27.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 73.44 110.328 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -131.12 168.48 17.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 74.5 109.991 -175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 65.3 mtt -74.48 73.11 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.253 0.464 . . . . 75.0 112.253 -172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.27 -17.59 64.35 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.683 -0.967 . . . . 54.41 110.683 170.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.19 -46.78 75.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.455 -0.872 . . . . 75.23 111.835 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.1 pp -105.19 23.18 14.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.017 0.437 . . . . 74.24 111.166 -179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.34 54.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 71.1 110.827 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.98 116.88 3.84 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 52.13 111.786 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.504 HD22 ' HD2' ' A' ' 63' ' ' TYR . 6.4 mp -71.89 -55.94 6.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.207 -0.451 . . . . 73.15 111.216 -177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.117 -0.944 . . . . 63.32 111.015 -177.876 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.989 -0.374 . . . . 60.04 109.989 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.74 -22.02 21.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.296 -0.411 . . . . 74.42 111.346 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -105.31 160.14 15.34 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.385 -0.37 . . . . 65.24 110.846 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.4 43.56 98.88 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.925 -0.58 . . . . 63.04 112.852 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.91 149.74 22.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.928 0.394 . . . . 71.42 110.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.34 109.91 1.77 Allowed Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.661 -0.976 . . . . 25.13 110.661 175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 HD12 ' A' ' 36' ' ' ILE . 16.7 m -101.35 134.55 41.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.095 0.474 . . . . 63.5 111.801 -173.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 37' ' ' VAL . 12.5 t70 -71.85 148.44 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.527 -0.76 . . . . 73.23 110.504 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.22 -20.4 44.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.444 0.535 . . . . 73.43 112.444 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -60.89 -31.91 71.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.873 0.368 . . . . 53.14 110.711 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.1 m -61.44 -47.95 83.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.94 -0.573 . . . . 71.0 110.277 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.603 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 42.0 t -63.58 -40.85 90.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.51 -0.768 . . . . 65.23 110.769 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 70.35 111.05 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.683 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 25.2 mmt180 -63.97 -40.78 97.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 72.02 111.223 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 14.4 m-85 -58.62 -33.34 69.92 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.135 0.493 . . . . 65.14 110.476 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.71 -42.47 73.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.779 -0.646 . . . . 71.02 110.566 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -63.16 -41.83 99.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 62.43 110.353 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 14' ' ' ARG . 83.1 mt -50.22 -57.14 8.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.302 -0.863 . . . . 50.33 111.264 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -83.04 -51.92 7.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 64.03 112.083 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.05 -55.95 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 111.845 0.313 . . . . 63.41 111.845 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -71.95 -14.92 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.234 -0.186 . . . . 62.45 110.831 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 60.27 24.08 13.51 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.882 0.739 . . . . 72.3 110.98 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 36.1 p -105.15 100.47 10.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.867 -0.606 . . . . 54.2 109.478 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.82 133.62 30.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.466 0.65 . . . . 71.13 110.458 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 3.6 mppt? -137.66 146.29 43.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 73.21 108.687 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.726 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 3.5 t90 -91.41 122.73 34.26 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.571 -1.27 . . . . 71.22 107.571 176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.784 HG22 ' HB3' ' A' ' 41' ' ' ASP . 40.1 pt -107.12 131.31 57.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.143 0.497 . . . . 72.43 110.561 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.778 HG21 HD21 ' A' ' 53' ' ' LEU . 88.2 t -112.64 116.02 51.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.551 -0.75 . . . . 62.32 109.397 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 37.4 p90 -116.79 163.37 16.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.694 -0.684 . . . . 74.23 110.393 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -112.27 124.79 53.24 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.412 -0.588 . . . . 75.25 109.412 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 36' ' ' ILE . 25.9 mt -99.12 102.71 13.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.262 -1.014 . . . . 74.42 108.262 176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.11 137.49 32.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.466 -0.334 . . . . 73.24 110.678 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.3 t30 49.21 46.39 22.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.733 -0.667 . . . . 74.13 111.328 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p 56.64 22.58 6.89 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.999 0.919 . . . . 72.41 113.135 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -132.65 126.84 33.56 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.315 -0.624 . . . . 72.41 109.315 175.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 31' ' ' ILE . 58.1 mt -112.94 113.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.881 -0.6 . . . . 73.51 111.436 -171.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 8' ' ' ASP . 14.0 m -129.38 141.45 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 72.21 110.992 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 4.6 p -86.46 133.99 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.391 -0.368 . . . . 41.52 110.522 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -100.49 -36.29 9.25 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.155 0.503 . . . . 74.31 109.912 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -138.69 141.06 38.99 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.57 -0.741 . . . . 75.34 111.428 -173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HB3' HG22 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -133.0 131.62 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.093 -1.077 . . . . 73.34 108.093 168.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.06 143.45 14.73 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.344 -1.408 . . . . 31.11 113.74 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -103.17 160.6 14.51 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.379 -0.971 . . . . 71.14 108.379 172.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.53 42.95 98.74 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.393 -1.883 . . . . 32.21 108.393 -163.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.489 HD22 ' HB2' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -44.7 -51.39 9.3 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.129 1.372 . . . . 64.31 113.041 -166.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.77 -24.32 64.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.089 -0.505 . . . . 54.32 111.914 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.76 -52.19 5.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.72 0.295 . . . . 74.43 110.962 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.21 -33.62 72.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 64.02 111.492 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.677 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 20.5 m-85 -84.39 -0.08 51.37 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.932 0.715 . . . . 75.24 112.932 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 50.7 mtm180 -68.12 -25.27 65.21 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.158 0.504 . . . . 75.3 110.199 174.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.64 28.68 3.72 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.766 -0.731 . . . . 61.52 112.147 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -129.07 -19.65 3.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.513 0.19 . . . . 63.2 111.513 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.778 HD21 HG21 ' A' ' 28' ' ' VAL . 66.1 mt -98.88 121.88 54.54 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.938 0.399 . . . . 63.11 111.086 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 38.3 Cg_endo -96.57 102.36 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.275 2.65 . . . . 32.41 111.975 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.19 -13.27 6.91 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.986 0.422 . . . . 74.31 112.109 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -57.49 -31.09 65.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 52.44 111.83 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.651 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 3.2 p30 -139.52 158.02 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.812 -0.44 . . . . 63.24 109.812 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.843 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 14.3 p -97.07 141.77 29.81 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.492 0.553 . . . . 71.03 112.492 -172.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -150.76 154.24 36.98 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.062 -1.088 . . . . 63.14 108.062 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.556 ' HD2' ' HD2' ' A' ' 87' ' ' TYR . 0.2 OUTLIER -95.98 123.41 39.56 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.512 -0.475 . . . . 73.35 110.642 -177.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.726 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.94 133.76 9.85 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.213 -0.755 . . . . 72.13 111.213 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.42 121.53 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.54 0.686 . . . . 51.34 110.818 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.589 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 3.2 t80 -122.71 143.62 49.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.241 -0.891 . . . . 72.45 108.966 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 63' ' ' TYR . 6.7 t70 -115.22 140.71 48.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.11 0.481 . . . . 74.2 110.075 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.75 168.92 16.41 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.73 -0.668 . . . . 74.55 109.475 173.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.57 -25.98 61.64 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 114.791 0.676 . . . . 65.14 114.791 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.47 -5.1 13.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.158 0.799 . . . . 72.22 113.158 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' NZ ' ' HB3' ' A' ' 68' ' ' LYS . 0.4 OUTLIER -171.37 161.84 6.55 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.602 0.593 . . . . 74.05 112.602 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 35.1 mm -93.08 134.35 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.27 -0.877 . . . . 72.43 108.932 172.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -115.01 106.65 14.39 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.842 0.354 . . . . 74.14 111.307 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.517 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . 43.3 m-85 -83.51 109.9 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.922 -0.77 . . . . 72.43 108.922 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.32 124.76 63.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.048 0.452 . . . . 71.3 111.441 -172.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 65.9 tp -128.2 105.36 8.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.71 -0.677 . . . . 64.05 110.301 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -86.2 109.64 19.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 74.52 109.283 174.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.2 p -79.83 150.61 72.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.228 -0.442 . . . . 71.41 110.564 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.843 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 72.0 Cg_endo -82.75 97.92 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.458 2.105 . . . . 74.15 112.405 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 109' ' ' HIS . 34.5 t70 -76.63 -14.99 59.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.494 0.664 . . . . 71.35 109.765 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.52 8.47 21.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.601 -0.727 . . . . 51.01 109.552 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HB1' ' HD2' ' A' ' 80' ' ' PRO . . . -144.36 175.23 2.91 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.711 -0.677 . . . . 51.53 109.661 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.713 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 21.8 Cg_endo -62.83 154.71 64.4 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.973 1.782 . . . . 62.43 111.643 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.3 m -84.33 12.67 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.028 0.381 . . . . 75.42 112.028 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.618 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 59.4 tttm -69.69 -50.98 16.71 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.496 -0.32 . . . . 73.33 111.814 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 51.3 Cg_exo -55.77 -24.26 45.65 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.471 2.114 . . . . 71.34 112.943 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.499 ' HD3' ' OE1' ' A' ' 107' ' ' GLU . 11.0 ttm180 -60.45 -33.91 73.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.147 0.499 . . . . 55.21 110.133 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.8 mtt -71.57 -33.6 69.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 71.05 110.692 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.2 m -63.77 -47.5 80.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.079 -0.51 . . . . 62.22 110.529 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' HD2' ' HD2' ' A' ' 60' ' ' PHE . 41.5 m-85 -67.77 -37.24 81.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 72.03 111.05 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.15 -18.47 65.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.169 0.509 . . . . 74.24 111.086 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -86.46 -54.58 4.34 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.85 -0.614 . . . . 75.01 110.91 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.6 m -77.48 -9.23 58.77 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.588 0.588 . . . . 43.22 112.588 -171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.703 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -58.24 -24.53 59.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.703 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 4.8 t70 -81.8 -25.7 35.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.818 0.342 . . . . 71.31 110.876 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.01 62.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.857 -0.611 . . . . 71.3 110.448 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 48.6 mt -92.14 -56.97 2.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.263 -0.881 . . . . 50.22 109.87 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 103' ' ' ALA . 43.8 tp -53.64 -58.94 5.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.61 -1.177 . . . . 72.11 113.079 -170.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 3.7 tmmm? -65.38 -20.34 66.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.053 -0.521 . . . . 75.42 111.523 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -105.66 -22.94 12.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.981 0.734 . . . . 75.45 112.981 -172.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 99' ' ' ASP . 4.3 pp -87.08 -39.6 15.44 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 118.914 -1.114 . . . . 74.13 112.166 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.465 ' HB2' HD12 ' A' ' 98' ' ' LEU . 17.0 t70 -154.07 177.05 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.17 -0.612 . . . . 74.54 111.637 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.75 13.44 42.63 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.899 -0.88 . . . . 43.42 110.899 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.84 177.99 0.05 OUTLIER 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.077 0.951 . . . . 74.2 112.695 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.465 HG22 HG23 ' A' ' 104' ' ' VAL . 2.5 m -84.32 136.22 33.99 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.477 -0.783 . . . . 71.24 110.403 -171.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.425 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -77.29 4.52 10.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.81 -0.632 . . . . 44.0 112.029 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 102' ' ' THR . 46.8 t -82.75 147.41 5.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.202 0.525 . . . . 74.12 110.428 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.19 142.26 35.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.772 -0.649 . . . . 70.42 109.715 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 tp -108.76 117.23 33.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.34 -0.391 . . . . 73.23 110.265 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -115.7 117.16 29.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.526 -0.546 . . . . 72.34 109.526 175.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.07 162.4 35.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.136 -0.484 . . . . 50.15 111.041 -175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p-80 -119.25 2.16 11.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.409 -0.589 . . . . 72.53 109.409 174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -70.86 153.56 42.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.108 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 68.3 mtt -77.63 47.31 0.6 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.039 0.447 . . . . 74.13 111.702 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.69 -17.07 64.49 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.213 -0.755 . . . . 73.14 111.213 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -64.0 -45.8 87.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.963 0.505 . . . . 73.01 111.197 -176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 3.5 pp -86.21 10.24 15.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.696 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 159.04 49.57 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.268 -0.424 . . . . 74.44 110.121 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.98 107.53 0.46 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.121 1.881 . . . . 45.35 111.351 175.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 117' ' ' LEU . 5.3 mp -72.12 -71.57 0.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.093 -0.503 . . . . 73.33 111.033 -176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.607 -0.711 . . . . 65.42 110.483 -178.769 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 3' ' ' SER . 28.4 ttt . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.647 -0.501 . . . . 64.11 109.647 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.83 -19.12 41.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.89 -0.595 . . . . 70.44 111.66 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 1' ' ' MET . 7.7 t -101.39 152.7 20.41 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.991 -0.374 . . . . 74.23 109.991 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.91 33.7 86.34 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 121.41 -0.424 . . . . 70.35 113.023 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.46 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -88.27 162.96 16.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.96 0.41 . . . . 75.22 110.39 178.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.65 108.89 1.65 Allowed Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.55 -1.02 . . . . 65.34 110.55 172.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.39 138.67 28.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.481 0.658 . . . . 72.01 111.72 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 10' ' ' ASN . 10.2 t70 -75.62 136.28 40.47 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.783 -1.099 . . . . 71.12 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.28 -20.05 35.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 72.43 111.639 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.487 ' HB3' ' OD2' ' A' ' 8' ' ' ASP . 48.2 t30 -63.4 -34.98 78.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.92 -0.77 . . . . 73.53 108.92 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 38' ' ' VAL . 33.1 m -53.69 -52.05 61.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.142 -0.936 . . . . 73.44 109.859 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.736 ' HA ' ' CD2' ' A' ' 15' ' ' PHE . 48.3 t -59.07 -43.39 89.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.555 -0.748 . . . . 74.33 110.957 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.96 -42.93 86.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 44.01 110.818 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -68.48 -30.76 69.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 70.33 111.311 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 12' ' ' VAL . 22.1 m-85 -62.52 -35.65 80.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.109 0.481 . . . . 75.55 109.904 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.9 OUTLIER -67.75 -46.87 70.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.805 -0.634 . . . . 73.44 109.638 176.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' HB3' ' HD3' ' A' ' 21' ' ' ARG . 44.6 mt-10 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.316 -0.856 . . . . 75.35 112.374 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 19' ' ' LYS . 4.3 pp -65.21 -29.41 70.22 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.996 -0.681 . . . . 52.02 110.775 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.4 tmtp? -84.26 -58.68 2.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.488 . . . . 65.03 110.726 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.87 -29.83 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.775 0.658 . . . . 74.34 112.775 -170.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' HD3' ' HB3' ' A' ' 17' ' ' GLU . 77.7 mtp180 -91.31 -21.04 21.25 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 121.943 -0.473 . . . . 71.02 111.347 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.13 27.75 0.34 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.314 1.046 . . . . 73.33 113.546 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.81 170.58 10.63 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.999 -1.111 . . . . 73.12 107.999 166.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.81 HG22 HD21 ' A' ' 45' ' ' ASN . 8.8 p -92.1 131.19 39.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 119.177 -1.009 . . . . 55.52 110.668 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.653 ' HZ3' ' HB2' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -140.57 170.6 15.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 63.15 111.32 -179.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.857 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.0 t90 -152.0 129.44 11.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.083 -1.08 . . . . 70.22 108.083 172.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 41' ' ' ASP . 17.3 pt -124.94 122.72 64.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.998 0.428 . . . . 63.2 109.945 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 11.0 m -106.6 111.24 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.97 0.414 . . . . 74.2 110.973 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.031 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -95.57 160.92 14.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.301 0.572 . . . . 73.15 109.991 177.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -114.26 125.06 53.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 115.241 -0.89 . . . . 72.24 109.234 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.505 HG23 HG12 ' A' ' 36' ' ' ILE . 22.2 mt -97.0 103.76 15.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.254 -1.017 . . . . 71.21 108.254 177.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.68 137.51 25.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.606 -0.724 . . . . 75.43 110.204 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.2 m120 54.63 29.63 11.85 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.578 0.549 . . . . 53.21 111.389 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.0 m 69.93 15.63 7.79 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.932 0.872 . . . . 73.01 110.721 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -107.64 156.64 18.83 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.71 -0.848 . . . . 64.44 108.71 172.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.804 HG21 HD11 ' A' ' 94' ' ' LEU . 45.5 mt -132.68 107.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 109.828 -0.434 . . . . 64.31 109.828 177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 8' ' ' ASP . 55.7 t -133.11 134.45 57.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.39 . . . . 54.22 110.457 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.031 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -79.12 128.96 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.055 0.455 . . . . 73.43 111.257 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -84.86 -38.1 19.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 75.31 111.441 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -143.24 142.84 31.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.727 -0.389 . . . . 73.14 110.592 -168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' A' ' 27' ' ' ILE . 2.0 p-10 -141.54 128.83 21.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.766 -0.652 . . . . 73.41 109.288 173.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.78 161.77 27.45 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.631 -0.795 . . . . 55.43 113.522 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HD2' ' C ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -108.59 158.44 17.57 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.923 -1.14 . . . . 73.3 107.923 169.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.22 34.44 89.97 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 109.643 -1.383 . . . . 61.32 109.643 -170.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.81 HD21 HG22 ' A' ' 24' ' ' VAL . 6.6 p30 -70.89 -42.42 70.02 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.756 -1.222 . . . . 71.42 112.79 -165.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.65 36.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.927 0.394 . . . . 74.21 110.705 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.624 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 19.7 t70 -89.55 -58.36 2.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 64.4 111.374 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.15 -38.45 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.78 0.659 . . . . 71.52 112.78 -172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.629 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 6.1 m-30 -79.52 -2.68 43.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.47 0.544 . . . . 72.2 112.47 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.624 ' HE ' ' HA ' ' A' ' 47' ' ' ASP . 45.8 mtm180 -81.04 -12.9 59.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.56 0.695 . . . . 75.43 109.31 173.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.69 13.24 11.84 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.266 -0.879 . . . . 62.51 111.081 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -130.94 20.38 4.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.477 0.656 . . . . 62.01 110.133 -177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.5 pt? -68.66 163.52 54.0 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 114.986 -1.006 . . . . 74.12 111.016 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.56 163.89 33.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.657 2.238 . . . . 71.23 111.203 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.29 -37.19 61.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.879 0.371 . . . . 75.0 111.022 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -168.53 14.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.42 0.629 . . . . 71.41 109.451 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.76 151.79 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.917 -1.038 . . . . 70.33 110.423 -172.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -90.38 141.79 28.38 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.603 -0.271 . . . . 65.04 110.538 175.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 58' ' ' CYS . 43.2 mmt-85 -144.77 157.07 44.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 75.03 110.528 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HE2' ' HD1' ' A' ' 87' ' ' TYR . 1.8 m-85 -112.31 117.27 32.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.519 -0.548 . . . . 75.22 109.519 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.857 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.99 130.68 8.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.388 -0.91 . . . . 51.21 113.178 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 42.5 t -98.98 121.01 49.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.881 -0.785 . . . . 74.34 108.881 172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 0.3 OUTLIER -131.83 135.7 46.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.205 0.526 . . . . 75.21 109.86 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD2' ' HA ' ' A' ' 24' ' ' VAL . 5.1 p-10 -99.86 153.72 18.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.266 -0.879 . . . . 71.44 110.861 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 68' ' ' LYS . 8.1 t -142.6 169.53 17.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.203 -1.036 . . . . 75.52 108.203 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.23 -27.65 63.15 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 114.477 0.551 . . . . 74.23 114.477 -171.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.93 -3.38 8.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.538 0.669 . . . . 72.51 111.84 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 65' ' ' CYS . 15.5 ptmt -149.2 158.31 44.07 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.182 0.808 . . . . 71.13 113.182 -168.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.3 mm -126.22 115.41 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 114.801 -1.09 . . . . 63.34 108.136 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 63' ' ' TYR . 32.4 mt-30 -115.17 124.31 51.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.153 -0.619 . . . . 75.02 112.197 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.25 109.49 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.98 -0.748 . . . . 54.44 108.98 167.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.1 t -96.27 125.22 49.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.054 0.454 . . . . 74.42 110.701 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 87' ' ' TYR . 40.8 tp -108.05 116.2 31.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.638 -0.71 . . . . 71.12 110.392 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 113' ' ' ASP . 45.7 m95 -85.49 111.82 20.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.019 -1.104 . . . . 73.32 108.019 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 107' ' ' GLU . 95.1 m -85.87 149.4 50.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 120.585 -0.446 . . . . 74.03 110.908 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 79' ' ' ALA . 73.7 Cg_endo -88.32 110.05 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.674 2.249 . . . . 72.03 112.907 -177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -81.63 -28.15 33.82 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.735 -0.666 . . . . 63.13 109.608 173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -94.25 9.78 36.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.395 -0.821 . . . . 71.52 110.788 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.786 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -136.66 147.12 58.27 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.312 -0.404 . . . . 75.13 110.796 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 14.8 Cg_exo -70.71 -176.78 1.88 Allowed 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.152 2.568 . . . . 71.42 113.062 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.19 -19.82 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.66 -0.7 . . . . 73.4 112.128 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 14.6 mptt -67.62 -56.13 12.86 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 111.632 0.234 . . . . 62.13 111.632 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' PRO . 37.3 Cg_exo -59.21 -30.52 93.23 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 121.712 1.608 . . . . 72.43 111.747 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 61.1 ttt180 -68.25 -44.81 74.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.772 -0.649 . . . . 64.14 111.001 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.0 mtt -70.78 -22.22 62.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.616 0.246 . . . . 73.3 111.212 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.5 m -60.55 -48.83 80.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 65.13 111.312 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 84' ' ' ARG . 27.0 p90 -81.72 -28.42 33.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.764 -0.374 . . . . 70.11 110.979 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' LYS . . . -68.89 -18.55 64.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.596 0.712 . . . . 73.25 110.923 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -88.19 -17.13 31.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.17 -0.923 . . . . 62.21 110.682 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.417 ' HB2' HG21 ' A' ' 31' ' ' ILE . 6.7 m -111.77 10.53 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.178 0.513 . . . . 64.03 110.895 -173.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -73.08 -20.16 61.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.923 0.712 . . . . 75.54 112.923 -172.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.558 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 41.8 m-20 -79.26 -22.26 44.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.606 0.241 . . . . 70.11 111.345 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 5' ' ' MET . . . -61.47 -17.74 55.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.191 -0.459 . . . . 73.03 111.703 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.804 HD11 HG21 ' A' ' 36' ' ' ILE . 90.7 mt -104.57 -51.87 3.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.403 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.6 tp -55.27 -44.1 75.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 61.32 111.269 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.71 -10.24 59.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.57 -0.741 . . . . 73.04 111.063 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -104.88 -39.8 6.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.852 -0.613 . . . . 62.12 112.618 -172.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 99' ' ' ASP . 3.3 pp -89.73 -43.14 10.9 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.135 1.531 . . . . 75.41 115.135 -161.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.623 ' N ' HD12 ' A' ' 98' ' ' LEU . 20.8 t70 -155.03 -177.13 6.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.033 0.833 . . . . 71.33 111.983 -176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.61 12.87 64.52 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.26 -0.882 . . . . 73.52 111.194 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.57 178.48 0.04 OUTLIER 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.553 0.741 . . . . 43.42 111.98 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 104' ' ' VAL . 5.4 m -84.02 136.85 33.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 120.909 0.385 . . . . 60.2 110.546 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.49 4.66 7.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.69 -0.686 . . . . 64.23 111.984 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 102' ' ' THR . 85.7 t -73.17 145.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 74.43 109.969 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.51 151.81 45.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.527 . . . . 75.33 109.935 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -124.61 117.91 25.34 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.787 0.327 . . . . 64.04 110.367 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.518 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 7.4 pt-20 -94.04 145.22 24.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 72.11 110.516 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.88 119.94 35.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.886 -0.597 . . . . 72.4 109.906 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -129.67 -0.71 4.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.286 0.565 . . . . 64.12 110.045 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -98.12 -149.66 0.34 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.266 -0.879 . . . . 63.43 108.801 174.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 77.8 mtp -100.45 24.12 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.129 0.49 . . . . 74.31 110.751 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.1 -15.73 78.59 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.629 -0.714 . . . . 34.01 111.504 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 11.3 p-10 -57.32 -47.74 80.74 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.548 0.739 . . . . 75.41 111.798 -176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 3.9 pp -99.92 5.52 45.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.221 0.534 . . . . 72.23 111.008 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -94.52 151.36 39.22 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.963 -0.562 . . . . 61.14 109.979 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 12.1 Cg_exo -71.42 113.7 3.7 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.5 2.133 . . . . 72.34 111.498 177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.23 -98.26 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.156 -0.475 . . . . 72.15 110.385 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.944 -1.027 . . . . 73.22 109.511 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 tmm? . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 108.857 -0.794 . . . . 54.32 108.857 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.18 -23.59 21.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.596 -0.891 . . . . 43.21 108.596 170.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 p -67.1 150.8 48.68 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.836 -1.075 . . . . 60.53 109.978 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.4 41.77 99.74 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.739 -0.743 . . . . 73.1 111.357 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.584 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -71.46 151.2 44.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.198 -0.501 . . . . 74.33 110.667 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.593 ' O ' ' HD2' ' A' ' 35' ' ' LYS . . . -110.18 109.38 2.65 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.566 -0.826 . . . . 40.44 111.584 177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.4 t -79.23 149.51 5.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 37' ' ' VAL . 3.7 p-10 -82.9 165.46 19.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.161 0.505 . . . . 54.34 110.542 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 9' ' ' GLU . 1.3 pm0 -84.47 -17.57 38.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.617 -0.72 . . . . 75.21 112.027 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -80.69 -32.94 35.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 73.31 110.226 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.0 t -54.34 -55.49 27.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.062 -0.517 . . . . 71.34 110.548 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.16 -34.67 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 71.32 110.812 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.08 -39.03 79.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.808 -0.633 . . . . 44.34 111.693 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -60.55 -25.5 66.2 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.22 0.452 . . . . 52.44 112.22 -173.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 61.4 m-85 -60.27 -20.94 61.11 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 111.855 0.317 . . . . 61.21 111.855 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 2.0 p30 -64.3 -39.51 94.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.109 0.48 . . . . 65.33 110.005 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HB3' HG23 ' A' ' 23' ' ' THR . 41.8 mt-10 -82.53 -43.91 16.55 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.263 -0.643 . . . . 50.23 109.263 176.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 26.3 tp -53.76 -61.19 2.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.179 -1.373 . . . . 63.34 111.284 -175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -85.86 -65.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.243 0.544 . . . . 74.42 112.371 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 16' ' ' ASN . 50.1 mm -59.65 -51.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.224 -0.898 . . . . 72.43 113.068 -165.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.677 ' HB2' HG22 ' A' ' 23' ' ' THR . 68.2 mtp180 -83.96 -4.82 59.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.861 0.363 . . . . 74.12 110.869 -175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 27.8 mtpt 55.9 24.34 7.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.624 -0.716 . . . . 74.31 111.79 -176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 21' ' ' ARG . 4.4 t -107.14 93.51 4.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.318 -0.993 . . . . 75.41 108.318 172.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.4 m -87.38 138.16 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.552 -0.749 . . . . 65.2 111.684 -167.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -133.09 138.65 46.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 72.34 108.669 174.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.9 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -86.08 123.56 31.52 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.039 -1.097 . . . . 75.43 108.039 177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.74 HG21 ' HG2' ' A' ' 14' ' ' ARG . 23.3 pt -115.87 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.918 -0.583 . . . . 75.54 110.89 -177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' A' ' 40' ' ' LYS . 23.3 m -106.35 127.78 61.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.961 -0.563 . . . . 64.23 110.538 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -102.7 162.96 12.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.443 0.639 . . . . 64.53 110.253 179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 28.3 ttpt -113.14 123.02 49.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.715 -1.13 . . . . 71.43 108.457 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.637 HG23 HG12 ' A' ' 36' ' ' ILE . 31.1 mt -99.71 104.05 15.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.713 -0.847 . . . . 63.34 108.713 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -157.2 139.85 14.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.475 -0.33 . . . . 70.4 110.364 -173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 t30 61.01 32.17 19.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.493 . . . . 64.5 110.076 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 5' ' ' MET . 9.7 m 68.18 6.45 5.27 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.649 -0.705 . . . . 71.31 110.975 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' O ' ' A' ' 6' ' ' GLY . 55.2 tptt -110.95 132.19 54.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.196 -0.456 . . . . 75.55 109.813 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.637 HG12 HG23 ' A' ' 31' ' ' ILE . 54.8 mt -113.11 110.69 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.166 -0.679 . . . . 72.44 109.166 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 35' ' ' LYS . 5.1 t -126.27 136.23 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 123.053 0.22 . . . . 63.3 111.181 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 29' ' ' PHE . 56.2 t -59.48 121.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 O-C-N 123.286 0.366 . . . . 64.52 110.027 172.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 30' ' ' LYS . 8.5 mm-40 -96.8 -26.04 15.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.424 -0.353 . . . . 61.11 110.47 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HB3' HG22 ' A' ' 28' ' ' VAL . 16.3 tppt? -146.98 141.54 26.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.143 0.497 . . . . 71.31 112.212 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.68 131.06 47.97 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.695 -1.224 . . . . 75.02 107.695 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.36 157.39 24.47 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.036 -1.078 . . . . 55.22 111.899 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -123.1 143.66 49.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.234 -0.654 . . . . 63.31 109.234 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.41 41.22 37.86 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 108.395 -1.882 . . . . 74.4 108.395 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 26' ' ' TRP . 1.7 m-20 -44.42 -51.39 8.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 113.443 -1.378 . . . . 74.13 113.155 -166.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' ARG . . . -65.38 -28.81 69.53 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.927 -0.579 . . . . 43.52 112.121 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -89.35 -44.83 9.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.815 0.341 . . . . 73.33 110.631 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.02 -49.82 74.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.724 -0.671 . . . . 73.53 110.661 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HE1' ' HG2' ' A' ' 40' ' ' LYS . 12.9 m-85 -75.35 8.33 2.84 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 113.118 0.784 . . . . 74.43 113.118 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' ALA . 78.4 mtp180 -78.32 -11.95 59.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.604 -0.517 . . . . 62.32 109.604 172.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.32 11.82 0.57 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.651 -0.704 . . . . 65.42 112.593 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.91 8.7 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.961 0.38 . . . . 61.13 111.638 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.57 68.89 74.82 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.305 0.574 . . . . 61.34 112.011 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.14 27.66 0.53 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.633 2.222 . . . . 61.45 111.824 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . -60.76 -35.03 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.725 -0.671 . . . . 53.34 111.634 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 55' ' ' ALA . 13.8 t30 76.33 -25.67 0.2 Allowed 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.711 0.632 . . . . 60.2 110.987 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 55' ' ' ALA . 54.6 m-20 -95.84 171.81 8.41 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.326 -0.62 . . . . 72.51 109.326 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 4.1 p -77.79 142.12 38.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.97 0.414 . . . . 44.11 111.14 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -140.87 160.15 40.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 72.34 109.712 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.23 120.39 40.31 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.029 -0.359 . . . . 63.54 110.029 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.9 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -121.4 136.96 11.44 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.911 -0.661 . . . . 64.12 113.6 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 88.5 t -97.99 120.78 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.913 -0.403 . . . . 75.1 109.913 171.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.437 ' HD2' HD22 ' A' ' 117' ' ' LEU . 10.4 t80 -142.18 126.55 17.67 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.879 -0.415 . . . . 73.33 109.879 174.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.24 146.09 30.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.179 0.514 . . . . 71.32 110.342 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.8 t -130.52 162.12 29.95 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.173 -0.677 . . . . 74.44 109.173 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.61 -24.93 71.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 74.14 111.342 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -73.61 -48.26 33.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.36 . . . . 73.05 110.346 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.15 164.82 20.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 72.4 111.518 -174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.9 mm -88.52 127.6 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.833 -0.803 . . . . 72.2 108.833 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.43 106.24 10.88 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.776 -0.37 . . . . 74.51 111.363 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.455 ' CE1' HG22 ' A' ' 62' ' ' VAL . 32.8 m-85 -78.77 109.16 12.77 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.828 -0.804 . . . . 74.3 108.828 166.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -93.57 137.59 22.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.01 0.433 . . . . 63.43 111.038 -171.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 87' ' ' TYR . 64.4 tp -144.19 124.9 14.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 72.0 110.872 -176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.425 ' HE3' ' N ' ' A' ' 75' ' ' CYS . 0.0 OUTLIER -86.49 141.91 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.969 -0.752 . . . . 63.15 108.969 176.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 27.2 p -88.23 151.27 48.65 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 63.41 110.682 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD3' ' OH ' ' A' ' 87' ' ' TYR . 4.3 Cg_exo -76.93 92.05 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.516 2.144 . . . . 71.55 111.983 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.59 -32.94 21.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 74.21 110.545 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -88.91 9.34 25.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.744 0.783 . . . . 73.34 110.066 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -144.14 159.4 52.77 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 60.32 109.469 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.587 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 25.4 Cg_exo -64.15 176.01 2.85 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.347 2.031 . . . . 65.41 112.158 177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.19 4.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.998 0.37 . . . . 75.45 111.998 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.767 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 26.4 ttpp -68.66 -54.94 12.33 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.348 -0.387 . . . . 74.03 111.137 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 42.0 Cg_exo -59.78 -23.63 72.76 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.222 1.948 . . . . 60.34 112.979 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 87' ' ' TYR . 47.4 ttt-85 -63.98 -39.17 93.53 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 120.825 0.345 . . . . 72.31 110.378 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 55.1 mtm -66.36 -33.22 75.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.162 -0.472 . . . . 75.15 110.426 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 21.6 m -60.57 -56.86 16.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.574 -0.739 . . . . 74.04 111.561 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.755 ' CE1' HD21 ' A' ' 73' ' ' LEU . 3.4 p90 -75.7 -23.59 56.17 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.472 -0.491 . . . . 74.13 111.399 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.6 -24.04 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.439 0.638 . . . . 74.15 110.385 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.1 t -86.55 -8.24 57.7 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.344 -0.844 . . . . 72.33 110.453 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 m -123.45 4.23 9.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.007 0.432 . . . . 63.31 111.127 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -71.91 -21.38 61.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 72.4 111.651 -171.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.64 -21.77 32.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 73.31 111.431 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.06 -48.95 78.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.801 0.334 . . . . 71.3 111.767 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 4.2 mm? -65.71 -44.79 85.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.345 0.593 . . . . 52.41 110.388 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.986 HD23 ' HA ' ' A' ' 103' ' ' ALA . 7.6 mp -64.22 -24.69 67.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.324 -0.853 . . . . 73.1 110.92 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -81.18 -28.72 34.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 62.45 111.681 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -106.39 -26.46 11.46 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.389 0.885 . . . . 73.34 113.389 -169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 36.2 mt -86.1 -42.99 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 118.806 -1.158 . . . . 74.25 111.566 -170.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.24 -166.33 2.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 73.0 111.103 177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.92 14.0 63.15 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.802 -0.919 . . . . 55.32 110.802 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.22 177.66 0.08 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.675 0.79 . . . . 75.33 111.977 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 104' ' ' VAL . 7.0 m -85.28 140.53 30.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.158 -0.474 . . . . 72.32 110.321 -170.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.986 ' HA ' HD23 ' A' ' 95' ' ' LEU . . . -72.13 4.86 3.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.507 -0.769 . . . . 61.34 112.256 -175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.569 HG23 HG22 ' A' ' 102' ' ' THR . 47.8 t -83.9 147.87 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.461 0.648 . . . . 62.43 110.436 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -139.69 155.09 47.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.549 -0.75 . . . . 51.04 109.26 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 62.6 tp -110.34 116.99 32.43 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 110.013 -0.366 . . . . 64.23 110.013 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 16.9 pt-20 -97.87 128.71 44.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.654 -0.499 . . . . 73.22 109.654 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.23 119.07 31.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.925 -0.58 . . . . 52.45 110.18 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 23.5 t-80 -104.6 -45.25 4.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.569 -0.741 . . . . 63.14 110.237 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -141.03 101.58 4.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.49 -0.323 . . . . 70.13 111.421 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.525 ' HG3' HD11 ' A' ' 114' ' ' LEU . 56.8 ttm 71.18 -4.29 1.84 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.705 0.632 . . . . 74.45 112.705 170.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.9 -18.18 61.74 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.899 -0.667 . . . . 61.31 112.901 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -81.53 -46.88 13.84 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.719 0.408 . . . . 72.24 111.595 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.525 HD11 ' HG3' ' A' ' 111' ' ' MET . 3.9 pp -98.06 14.77 26.29 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.903 0.382 . . . . 62.0 111.841 -173.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -114.59 154.26 46.67 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.106 -0.497 . . . . 74.43 109.969 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.6 123.95 10.18 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.053 2.502 . . . . 73.24 112.489 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.437 HD22 ' HD2' ' A' ' 63' ' ' TYR . 5.6 mp -83.17 -2.45 55.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 73.13 111.496 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.88 -1.057 . . . . 63.24 111.077 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.673 0.273 . . . . 70.44 110.561 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.29 -18.95 51.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.962 0.411 . . . . 64.44 110.887 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 p -101.64 153.37 19.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.345 -0.389 . . . . 74.1 110.756 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 63.46 27.32 70.64 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.89 -0.596 . . . . 51.12 113.471 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' THR . 25.1 ptt? -109.79 166.49 10.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.941 0.401 . . . . 73.42 110.275 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -111.73 132.17 10.69 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.416 -1.074 . . . . 63.25 110.416 173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.33 124.87 51.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 117.129 0.464 . . . . 64.4 110.851 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.62 115.5 4.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.679 . . . . 63.21 111.417 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -84.99 -13.44 50.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.514 . . . . 73.53 111.178 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -66.3 -35.4 80.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 74.24 110.604 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 29' ' ' PHE . 42.2 t -53.35 -40.78 65.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 74.2 111.235 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.74 -47.3 93.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 72.5 110.751 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -68.46 -28.02 66.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.939 -0.573 . . . . 73.41 110.54 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.836 ' HG3' HG21 ' A' ' 27' ' ' ILE . 1.8 tmm_? -66.6 -38.33 86.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.882 -0.599 . . . . 74.44 110.095 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -60.71 -21.12 62.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.648 0.261 . . . . 63.25 111.133 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -75.98 -30.65 58.66 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.863 -0.421 . . . . 74.13 109.863 176.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.19 -38.98 89.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.073 -0.714 . . . . 73.53 109.073 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.0 mt -60.76 -43.51 97.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.953 -1.022 . . . . 74.42 110.909 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -82.11 -64.54 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 75.01 111.917 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.5 mt -67.49 -54.38 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.371 -0.377 . . . . 70.41 111.917 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -75.46 -16.84 60.28 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.453 -0.34 . . . . 71.22 110.993 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? 58.49 24.48 11.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.662 0.744 . . . . 75.13 109.965 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.4 p -104.18 116.36 32.04 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.452 -0.794 . . . . 73.24 109.552 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 7.1 p -88.07 134.3 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.838 -0.745 . . . . 73.43 109.996 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 19.1 ptpt -138.45 150.38 46.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.587 -0.733 . . . . 72.11 110.102 177.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.73 ' HE1' ' HA3' ' A' ' 61' ' ' GLY . 4.4 t90 -97.31 123.2 41.04 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.95 -1.13 . . . . 72.43 107.95 173.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.836 HG21 ' HG3' ' A' ' 14' ' ' ARG . 43.1 pt -117.51 144.77 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.482 -0.326 . . . . 75.23 110.219 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.45 114.4 42.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.032 0.444 . . . . 62.22 111.163 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -94.7 145.75 24.64 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.494 -0.928 . . . . 73.03 108.494 168.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -112.11 125.14 53.79 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.045 -0.525 . . . . 65.24 109.979 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 36' ' ' ILE . 20.6 mt -91.24 102.02 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.37 -0.974 . . . . 74.45 108.37 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.07 147.03 20.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.393 -0.595 . . . . 73.32 109.393 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 60.48 26.22 15.84 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.276 0.56 . . . . 63.2 110.179 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' MET . 1.6 m 65.13 28.02 12.3 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.03 -0.987 . . . . 65.22 111.64 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE2' HG21 ' A' ' 37' ' ' VAL . 18.8 ptmt -136.94 148.87 47.22 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.984 -0.376 . . . . 64.31 109.984 171.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.598 HG12 HG23 ' A' ' 31' ' ' ILE . 23.0 mt -113.42 109.94 30.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.632 -0.507 . . . . 73.4 109.632 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG21 ' HE2' ' A' ' 35' ' ' LYS . 3.2 t -138.48 136.77 43.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.868 -0.419 . . . . 73.53 109.868 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.022 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 86.3 t -62.4 131.27 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-O 121.137 0.494 . . . . 53.42 110.49 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.806 ' HG3' ' HD2' ' A' ' 40' ' ' LYS . 16.8 pt-20 -104.99 -31.09 9.38 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.522 -0.763 . . . . 61.42 111.316 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 3.0 mptp? -147.65 156.01 42.36 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.919 0.39 . . . . 62.35 111.123 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' HG22 ' A' ' 27' ' ' ILE . 7.1 p-10 -140.31 132.03 27.35 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.964 -1.125 . . . . 75.32 107.964 170.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.09 13.11 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.059 -1.067 . . . . 44.25 114.366 -168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.43 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 3.0 ptpp? -128.6 130.54 47.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.113 -1.069 . . . . 61.32 108.113 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 52.19 8.48 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 107.991 -2.044 . . . . 72.32 107.991 -163.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.486 HD22 ' HE1' ' A' ' 63' ' ' TYR . 46.6 m-20 -44.91 -51.93 9.19 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 113.75 -1.225 . . . . 72.4 113.542 -162.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -49.41 70.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 44.42 111.06 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.531 ' HA ' HH11 ' A' ' 50' ' ' ARG . 19.8 t70 -68.8 -42.64 77.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.079 -0.509 . . . . 73.44 111.595 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 43' ' ' LYS . 10.0 tt0 -65.31 -47.23 77.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 64.43 111.135 -174.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 26' ' ' TRP . 27.2 m-85 -71.73 -22.18 61.66 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.057 0.391 . . . . 75.33 112.057 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 114' ' ' LEU . 18.0 mtp180 -61.61 -22.94 65.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.813 0.34 . . . . 73.43 111.111 175.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -127.28 18.13 6.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.717 -0.754 . . . . 62.34 112.055 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -96.22 -73.99 0.58 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.873 -0.192 . . . . 71.35 111.278 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.2 mp -126.65 90.22 50.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.239 0.459 . . . . 75.25 112.239 -175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.21 48.31 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.906 2.404 . . . . 74.21 109.584 170.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.42 -12.71 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.006 -0.997 . . . . 74.51 112.837 -169.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.603 ' HA ' ' CZ3' ' A' ' 74' ' ' TRP . 10.2 p30 51.6 26.43 3.33 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.757 0.823 . . . . 60.12 111.38 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -116.07 170.72 8.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 114.756 -1.111 . . . . 65.43 109.14 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.955 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 3.3 p -86.5 134.2 33.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.709 -1.196 . . . . 73.32 110.05 174.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HD2' ' OE2' ' A' ' 39' ' ' GLU . 17.6 mmt85 -143.41 152.06 41.12 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.502 -1.226 . . . . 71.0 108.173 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.692 ' HB3' ' CD1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -103.53 113.54 27.12 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.721 -0.474 . . . . 64.51 109.721 -178.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.73 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -120.65 131.73 8.9 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.985 -0.626 . . . . 72.31 113.114 -175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 26' ' ' TRP . 3.0 t -102.74 120.14 52.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 75.41 109.309 172.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' TRP . 5.0 t80 -134.69 124.97 26.12 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.409 -0.589 . . . . 64.22 109.409 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 11.3 t70 -92.31 140.93 29.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.741 -0.466 . . . . 70.13 109.741 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 5.6 t -122.12 171.12 9.22 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.772 -0.825 . . . . 74.52 108.772 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.49 -23.9 55.23 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 121.236 -0.507 . . . . 75.02 113.829 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -102.25 -26.26 13.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.873 0.694 . . . . 73.12 112.873 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -170.27 169.05 7.88 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.306 0.484 . . . . 73.22 112.306 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.5 mm -79.22 129.8 37.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 170.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -118.29 115.27 24.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.078 0.466 . . . . 54.11 111.635 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.731 ' HZ ' HD22 ' A' ' 98' ' ' LEU . 48.4 m-85 -76.17 110.68 10.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.639 -0.71 . . . . 71.45 109.532 166.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.04 112.27 27.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.569 -0.53 . . . . 61.42 109.569 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 87' ' ' TYR . 36.4 tp -115.97 89.32 3.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.658 -0.701 . . . . 65.53 110.304 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.674 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 0.8 OUTLIER -85.59 121.06 27.74 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.633 -0.876 . . . . 71.45 108.633 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.3 p -96.48 149.98 36.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.857 -0.337 . . . . 61.42 110.856 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.955 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 59.1 Cg_endo -71.8 130.26 16.63 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.42 2.08 . . . . 75.22 113.052 -170.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.68 -40.29 16.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 61.14 110.814 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.89 20.57 5.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 72.0 110.613 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . . . -132.32 157.81 77.27 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.233 -0.44 . . . . 62.0 110.534 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 79' ' ' ALA . 50.7 Cg_endo -69.21 -170.99 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.928 2.419 . . . . 44.25 113.227 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.15 -10.84 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 42.42 112.1 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 39.5 ttmt -68.08 -47.53 40.27 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.189 0.44 . . . . 71.13 112.189 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 15.6 Cg_endo -58.62 -16.78 31.92 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.116 1.877 . . . . 74.34 112.824 177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.552 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 19.4 mtp-105 -73.93 -32.68 63.62 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.598 -0.519 . . . . 72.32 109.598 176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.415 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . 24.7 mmt -78.14 -13.59 59.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.776 -0.647 . . . . 73.13 110.301 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -65.2 -55.78 16.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 53.23 110.779 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 73' ' ' LEU . 11.0 p90 -77.33 -19.34 56.48 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 74.42 110.89 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 85' ' ' MET . . . -75.02 -18.52 60.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.208 0.528 . . . . 73.34 110.316 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.2 t -82.71 -34.35 27.32 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.769 -0.651 . . . . 64.11 110.463 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.2 p -104.76 20.89 17.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.081 -0.509 . . . . 73.52 110.909 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 19.7 pttp -56.71 -55.22 36.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.423 -0.808 . . . . 73.42 112.454 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.631 ' H ' ' HG3' ' A' ' 91' ' ' LYS . 8.7 p-10 -85.88 -20.09 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.327 -0.397 . . . . 72.0 111.35 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.33 -51.18 67.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.644 -0.253 . . . . 74.11 111.349 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 4.2 mm? -66.96 -40.43 87.48 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.958 -0.386 . . . . 72.01 109.958 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 33.7 tp -67.85 -18.53 64.84 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.535 -0.757 . . . . 61.54 111.582 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -29.23 63.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.212 -0.449 . . . . 74.13 110.534 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -111.57 16.45 20.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.564 1.173 . . . . 71.22 108.656 177.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.731 HD22 ' HZ ' ' A' ' 71' ' ' PHE . 0.3 OUTLIER -111.35 10.36 21.56 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.929 -1.487 . . . . 54.44 111.101 -175.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 101' ' ' ALA . 21.8 m-20 -34.69 -145.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.845 2.458 . . . . 62.31 116.491 -151.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -58.24 15.7 0.02 OUTLIER Glycine 0 CA--C 1.538 1.5 0 N-CA-C 118.013 1.965 . . . . 62.44 118.013 -150.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . -56.97 -177.14 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.702 -0.851 . . . . 52.32 108.702 154.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.8 m -80.47 117.33 21.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.696 -1.252 . . . . 61.23 109.356 -168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB1' HD21 ' A' ' 95' ' ' LEU . . . -87.49 -0.77 57.3 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.944 -1.026 . . . . 51.14 111.486 -173.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.94 146.33 10.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.638 . . . . 64.32 109.276 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.633 ' HA ' ' HB2' ' A' ' 71' ' ' PHE . . . -129.79 146.76 51.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.326 -0.397 . . . . 73.2 110.444 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 tt -119.84 117.39 28.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.117 -0.698 . . . . 62.43 109.117 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 13.4 pt-20 -97.47 141.05 31.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 74.31 110.275 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.35 138.68 54.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 73.14 111.062 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -126.07 4.3 7.19 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.478 -0.783 . . . . 73.23 109.931 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.94 163.55 14.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.389 -0.823 . . . . 73.13 109.119 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 67.5 mtt -78.31 57.87 1.98 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.444 0.64 . . . . 65.02 110.853 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.42 -15.51 68.62 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 114.95 -1.023 . . . . 50.43 111.598 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -57.08 -38.83 73.89 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 122.974 0.51 . . . . 75.51 111.165 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 2.9 pp -98.2 18.95 15.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.117 0.484 . . . . 73.21 110.819 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.02 156.3 54.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.974 -0.557 . . . . 64.11 110.412 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.01 91.24 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.333 2.022 . . . . 74.32 112.043 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.08 -7.54 59.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 73.43 111.064 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.457 -0.783 . . . . 74.34 109.906 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 65.5 mtm . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.372 -0.603 . . . . 74.01 109.372 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.03 -29.05 69.92 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.963 0.411 . . . . 74.42 110.664 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 p -69.31 119.06 13.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.872 -0.604 . . . . 73.14 110.56 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.77 40.39 98.07 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.153 -0.476 . . . . 61.12 112.836 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.44 172.22 12.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.112 0.482 . . . . 54.1 111.588 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.58 110.1 0.62 Allowed Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.696 -0.962 . . . . 61.23 110.696 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.85 122.97 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.998 0.399 . . . . 64.1 111.829 -173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.13 120.84 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.182 -0.673 . . . . 71.44 109.182 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.76 -13.4 61.37 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.392 0.886 . . . . 72.35 113.392 -169.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.552 HD22 HG11 ' A' ' 38' ' ' VAL . 9.9 t30 -58.9 -30.65 67.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.063 0.459 . . . . 53.41 110.213 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.0 m -66.95 -41.86 86.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.85 -0.614 . . . . 74.34 110.088 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.85 -43.92 79.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.792 -0.64 . . . . 70.24 110.893 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.58 63.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.881 -0.599 . . . . 73.32 111.592 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.773 ' HG3' HG21 ' A' ' 27' ' ' ILE . 20.9 mmt180 -64.54 -26.83 68.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.405 -0.361 . . . . 74.22 111.706 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 82.2 m-85 -82.5 -26.25 32.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.156 0.503 . . . . 64.4 110.325 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -75.84 -36.85 59.5 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.26 -0.644 . . . . 74.14 109.26 177.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.83 -19.03 64.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.551 -0.75 . . . . 65.42 110.555 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 15' ' ' PHE . 11.8 mt -63.27 -50.79 68.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.147 -0.479 . . . . 53.42 111.15 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -70.91 -40.37 72.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.859 0.361 . . . . 73.21 111.3 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.22 -63.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.128 -0.487 . . . . 63.24 111.786 -174.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -79.49 -24.02 42.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.491 -0.322 . . . . 75.3 110.725 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' LEU . 53.6 mttp 59.32 24.79 13.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.797 -0.638 . . . . 73.21 111.222 178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -93.2 122.44 35.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.123 -0.695 . . . . 62.35 109.123 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -88.67 134.56 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 120.131 -0.628 . . . . 73.14 110.476 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -141.12 172.14 13.1 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.34 -0.845 . . . . 64.34 109.718 -179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.683 ' HB2' ' HB3' ' A' ' 45' ' ' ASN . 4.1 t90 -125.97 127.56 46.13 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.482 -1.303 . . . . 74.12 107.482 173.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.773 HG21 ' HG3' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -117.79 128.83 74.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.065 0.46 . . . . 64.22 110.46 177.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 77.1 t -110.29 120.01 60.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.028 0.442 . . . . 71.23 110.26 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 p90 -116.73 160.98 19.95 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.832 -0.622 . . . . 74.25 110.844 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 39' ' ' GLU . 38.3 ttmt -115.39 125.11 52.76 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.419 -0.809 . . . . 62.21 109.267 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 90' ' ' SER . 16.3 mt -88.05 102.44 12.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 107.693 -1.225 . . . . 70.33 107.693 174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.1 138.95 39.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.479 -0.328 . . . . 73.34 110.379 -169.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 34' ' ' THR . 15.8 m120 60.22 22.06 11.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 64.35 110.725 -177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 33' ' ' ASN . 46.9 m 79.48 -10.13 1.36 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.86 -0.609 . . . . 62.01 111.138 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HE3' HG13 ' A' ' 37' ' ' VAL . 0.8 OUTLIER -102.16 138.3 39.28 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.587 -0.523 . . . . 71.4 109.587 -178.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.657 HD13 HD21 ' A' ' 94' ' ' LEU . 57.4 mt -99.34 114.12 36.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.392 -0.367 . . . . 62.21 111.188 -172.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG13 ' HE3' ' A' ' 35' ' ' LYS . 6.8 m -125.71 135.41 64.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 71.51 111.155 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 29' ' ' PHE . 2.5 p -88.67 125.42 41.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.96 0.409 . . . . 70.52 110.077 176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 30' ' ' LYS . 27.4 mt-10 -79.65 -37.76 35.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.908 -0.587 . . . . 73.32 111.151 -173.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HG2' ' HB2' ' A' ' 39' ' ' GLU . 19.3 pttm -171.52 159.59 5.59 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.321 0.581 . . . . 70.43 112.191 -167.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.711 ' CB ' HG22 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -154.29 146.55 23.82 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.591 -1.186 . . . . 73.21 108.383 173.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.32 161.41 26.05 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.016 -1.088 . . . . 64.31 112.71 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -93.66 120.52 34.04 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.335 -1.358 . . . . 61.42 107.335 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.52 53.96 0.58 Allowed Glycine 0 CA--C 1.5 -0.878 0 N-CA-C 107.191 -2.363 . . . . 62.24 107.191 -161.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' TRP . 38.8 m-20 -61.35 -53.01 62.18 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.026 -1.087 . . . . 54.4 112.471 -160.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.44 -32.7 42.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.726 -0.472 . . . . 75.21 109.726 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.97 -58.31 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.598 -0.728 . . . . 70.33 111.582 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.66 -46.51 78.88 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 71.52 111.542 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.74 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 27.9 m-85 -73.82 -14.83 61.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.899 0.703 . . . . 72.23 112.899 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -66.7 -13.19 60.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.962 0.411 . . . . 63.14 110.703 172.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.98 11.78 6.18 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.617 -0.593 . . . . 55.24 111.617 174.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -118.61 -0.15 11.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 72.21 111.099 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 87.2 mt -101.53 123.29 44.87 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.239 -0.437 . . . . 53.03 110.092 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 53' ' ' LEU . 12.8 Cg_exo -70.06 134.1 26.55 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.86 2.373 . . . . 74.22 112.101 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.18 -14.88 57.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 72.43 110.877 177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -86.15 -33.11 20.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.014 -0.539 . . . . 61.21 111.531 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' C ' ' HG3' ' A' ' 76' ' ' PRO . 35.6 t0 -123.34 163.49 20.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 120.769 0.319 . . . . 73.21 110.965 -172.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.885 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 4.2 p -98.61 138.72 35.38 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.446 0.641 . . . . 73.44 109.818 173.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 30' ' ' LYS . 18.8 mmt85 -130.07 152.32 49.64 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.073 -0.967 . . . . 74.21 109.023 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.403 ' HB3' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t80 -107.52 112.05 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.455 -0.572 . . . . 74.11 109.455 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 28' ' ' VAL . . . -120.02 125.9 6.48 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.903 -0.665 . . . . 63.2 111.701 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.17 121.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.559 0.695 . . . . 64.31 109.617 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' HB2' ' CD2' ' A' ' 26' ' ' TRP . 2.1 t80 -113.48 125.67 54.48 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.001 -0.999 . . . . 73.15 109.678 -177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.588 ' CG ' HD21 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -103.62 140.66 37.26 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.587 0.708 . . . . 73.1 110.582 175.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 25.0 t -131.02 170.44 14.49 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.776 -0.824 . . . . 64.23 108.776 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.28 -34.16 89.18 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.983 -0.627 . . . . 34.13 112.757 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -81.68 -39.78 23.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.535 0.207 . . . . 54.44 111.502 -177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -164.59 171.67 14.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.732 0.301 . . . . 74.42 110.773 -175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.51 140.84 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.458 -0.571 . . . . 74.24 109.458 173.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -122.04 116.36 24.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.157 -0.474 . . . . 74.44 110.554 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -78.69 109.18 12.68 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.977 -0.749 . . . . 55.53 108.977 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.23 115.37 32.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.402 0.62 . . . . 60.11 110.825 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 107' ' ' GLU . 60.6 tp -119.41 81.93 1.79 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.185 -0.916 . . . . 72.23 109.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -89.6 118.22 29.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.985 -0.552 . . . . 74.11 109.77 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 13.9 p -102.34 147.95 34.73 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.865 -0.42 . . . . 63.04 109.865 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.885 ' HD3' ' HB3' ' A' ' 58' ' ' CYS . 54.1 Cg_endo -99.52 169.99 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.155 2.57 . . . . 71.53 113.291 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.64 -28.46 66.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.1 -0.954 . . . . 63.25 110.814 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -88.46 9.84 22.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.664 -0.698 . . . . 73.33 111.624 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . . . -107.28 111.25 63.31 Favored Pre-proline 0 C--N 1.327 -0.388 0 O-C-N 122.061 -0.399 . . . . 74.4 111.247 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 79' ' ' ALA . 7.0 Cg_exo -74.06 -166.76 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.17 2.58 . . . . 65.34 112.238 178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.442 ' HA ' ' HB2' ' A' ' 84' ' ' ARG . 31.0 m -75.56 -13.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.499 . . . . 63.2 112.033 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 83' ' ' PRO . 25.5 mtpp -69.27 -58.22 6.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.44 -0.345 . . . . 71.12 111.178 -176.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.86 ' HD3' ' HB2' ' A' ' 82' ' ' LYS . 7.3 Cg_exo -74.28 -13.93 23.08 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.027 1.818 . . . . 51.44 111.32 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HA ' ' CE2' ' A' ' 87' ' ' TYR . 2.7 tpt180 -60.92 -47.25 87.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.409 -0.814 . . . . 75.41 110.349 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -76.18 -14.51 60.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.581 . . . . 72.14 110.567 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.496 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 32.4 m -69.75 -43.97 71.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.048 -0.523 . . . . 71.2 110.952 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.53 ' CE1' HD21 ' A' ' 73' ' ' LEU . 8.9 p90 -79.5 -30.1 41.83 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.558 -0.457 . . . . 73.22 111.272 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.85 -19.95 64.27 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.139 0.495 . . . . 64.34 111.247 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 1' ' ' MET . 6.2 t -86.87 -53.15 5.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.653 -0.703 . . . . 70.3 110.649 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HB2' HD13 ' A' ' 31' ' ' ILE . 4.1 m -68.39 -25.98 65.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.414 -0.812 . . . . 71.53 111.84 -171.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.64 ' HD3' ' N ' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -57.5 -27.63 62.72 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.462 0.541 . . . . 60.34 112.462 -175.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.64 ' N ' ' HD3' ' A' ' 91' ' ' LYS . 27.6 t70 -76.68 -40.11 49.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.833 0.349 . . . . 73.42 110.934 -175.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.66 91.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.826 -0.625 . . . . 64.54 111.267 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.657 HD21 HD13 ' A' ' 36' ' ' ILE . 3.9 mm? -63.8 -50.69 67.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.014 -0.539 . . . . 63.32 110.446 177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 103' ' ' ALA . 36.5 tp -57.63 -30.17 65.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.668 -0.696 . . . . 74.24 110.958 -179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -76.74 -32.09 57.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.601 -0.727 . . . . 74.3 112.535 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -112.07 -14.61 13.41 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.37 1.248 . . . . 75.43 114.37 -166.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 94' ' ' LEU . 68.5 mt -86.96 -45.38 10.85 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 118.111 -1.436 . . . . 73.11 112.903 -167.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 100' ' ' GLY . 20.6 t70 -157.64 -167.07 2.16 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.438 -0.505 . . . . 65.25 111.124 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.459 ' H ' ' CG ' ' A' ' 99' ' ' ASP . . . -90.33 15.36 60.11 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.385 -1.086 . . . . 74.11 110.385 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.35 179.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.42 1.088 . . . . 45.24 113.272 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 m -82.97 136.77 34.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.565 -0.743 . . . . 74.24 110.456 -169.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.606 ' HA ' HD11 ' A' ' 95' ' ' LEU . . . -79.16 5.39 12.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.594 -0.73 . . . . 61.15 112.466 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.7 148.36 4.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.947 0.404 . . . . 74.33 110.307 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.55 152.99 45.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.342 -0.614 . . . . 62.53 109.342 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.7 tp -122.64 118.41 28.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.817 0.341 . . . . 62.23 110.694 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 pt-20 -98.37 121.07 39.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.966 -0.561 . . . . 73.45 109.669 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.65 150.94 29.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.077 -0.51 . . . . 74.14 111.021 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -136.34 10.03 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 72.33 110.218 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 111' ' ' MET . 47.0 tt0 -131.34 167.18 19.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.917 -0.583 . . . . 73.53 110.095 -175.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.419 ' N ' ' HG2' ' A' ' 110' ' ' GLU . 86.3 mtp -79.41 6.92 8.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.608 0.242 . . . . 64.03 111.52 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.91 -20.1 74.18 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.739 -0.743 . . . . 43.22 112.082 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.59 -37.29 73.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.296 0.569 . . . . 72.23 110.384 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 pp -89.62 14.46 11.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 74.14 110.829 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 116' ' ' PRO . . . -87.81 162.68 40.78 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.223 -0.658 . . . . 71.32 109.223 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 115' ' ' ALA . 34.2 Cg_endo -66.65 88.45 0.28 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 121.936 1.757 . . . . 72.5 113.026 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mp -77.66 -71.02 0.44 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.421 -0.585 . . . . 61.13 109.421 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.538 -0.744 . . . . 72.42 109.968 178.849 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB3' ' A' ' 5' ' ' MET . 52.9 ttm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.452 -0.573 . . . . 74.44 109.452 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.643 ' HA ' ' SD ' ' A' ' 5' ' ' MET . . . -81.58 -30.07 33.15 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.608 0.596 . . . . 64.31 112.608 -173.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -67.08 117.94 9.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 73.44 111.245 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 61.37 33.76 85.76 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.742 -0.663 . . . . 70.24 113.099 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 2' ' ' ALA . 25.4 ptt? -84.9 159.04 20.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.995 0.426 . . . . 65.31 110.704 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.46 119.99 4.03 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-N 115.811 -0.631 . . . . 70.04 111.778 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 36' ' ' ILE . 62.0 t -73.64 104.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.828 -0.804 . . . . 73.25 108.828 174.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -71.68 142.25 49.86 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.16 -0.473 . . . . 61.24 110.868 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' A' ' 12' ' ' VAL . 20.9 pt-20 -64.83 -15.62 62.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.721 -0.672 . . . . 75.11 111.337 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -55.23 -40.55 71.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.849 -0.614 . . . . 55.54 110.23 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.1 t -73.89 -44.23 55.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 53.4 111.438 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' A' ' 9' ' ' GLU . 34.5 m -72.81 -24.31 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 63.53 111.527 -175.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.44 -29.54 70.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 64.11 110.876 178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.489 ' HD2' ' HD2' ' A' ' 25' ' ' LYS . 33.2 mmt180 -75.33 -23.51 57.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 70.22 111.226 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.634 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 43.4 m-85 -82.82 -23.31 33.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.939 0.399 . . . . 73.32 109.99 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -36.77 84.93 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.381 -0.6 . . . . 70.04 109.381 171.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -71.73 -49.57 38.07 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.473 0.654 . . . . 71.25 109.505 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB3' ' HA ' ' A' ' 15' ' ' PHE . 16.5 tp -58.59 -47.72 83.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.695 -1.139 . . . . 73.02 112.179 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -73.3 -51.86 16.03 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.938 0.348 . . . . 74.25 111.938 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.61 -56.68 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.062 0.393 . . . . 75.33 112.062 -171.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -68.6 -26.3 65.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.711 0.291 . . . . 65.14 110.479 -175.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 58.58 24.42 11.97 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.552 -0.749 . . . . 63.0 111.491 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.0 p -92.83 106.37 18.35 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.05 -1.463 . . . . 74.42 107.05 164.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 64' ' ' ASP . 7.6 p -87.46 136.63 22.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.656 0.741 . . . . 75.14 111.184 -165.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.524 ' HD3' ' HB2' ' A' ' 41' ' ' ASP . 19.0 ptpt -137.35 140.18 41.27 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 114.692 -1.14 . . . . 62.15 109.408 176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 1.014 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 3.2 t90 -89.04 136.37 33.05 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.152 -1.425 . . . . 74.52 107.152 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.613 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -116.49 132.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.162 0.506 . . . . 73.51 110.642 176.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -106.52 110.5 31.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.45 -0.795 . . . . 73.11 109.278 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.624 ' HB3' HG22 ' A' ' 38' ' ' VAL . 2.6 p90 -115.58 159.5 21.19 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.645 0.736 . . . . 74.11 111.623 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HB2' ' HE3' ' A' ' 30' ' ' LYS . 34.5 ttmt -123.25 125.36 44.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.775 -1.102 . . . . 73.21 109.242 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.854 HG12 HG23 ' A' ' 36' ' ' ILE . 56.4 mt -112.3 101.6 12.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.872 0.368 . . . . 71.55 111.167 -173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.472 ' HA ' ' OE1' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -159.6 170.28 21.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.003 -0.544 . . . . 73.31 110.383 175.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.8 m120 53.0 39.38 29.35 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.743 0.652 . . . . 53.24 110.942 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' MET . 58.0 p 58.22 20.43 7.11 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.783 -1.099 . . . . 71.05 113.274 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . 9.2 mmmm -129.88 137.81 50.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.111 0.481 . . . . 72.44 110.997 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.854 HG23 HG12 ' A' ' 31' ' ' ILE . 56.7 mt -103.15 108.77 25.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.77 -0.826 . . . . 72.42 108.77 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.96 135.87 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.125 0.488 . . . . 71.35 111.498 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 29' ' ' PHE . 17.3 t -88.21 133.51 30.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 75.32 109.181 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' HG3' ' HG3' ' A' ' 40' ' ' LYS . 10.4 pt-20 -106.9 -18.47 13.91 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.806 -0.758 . . . . 73.13 110.854 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.594 ' HG3' ' HG3' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -145.06 140.88 28.4 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 120.221 -0.591 . . . . 72.21 111.803 -178.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.613 ' HB3' HG22 ' A' ' 27' ' ' ILE . 10.6 p-10 -132.54 132.98 43.18 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.583 -1.265 . . . . 64.42 107.583 166.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.767 ' HA3' ' HG2' ' A' ' 48' ' ' GLU . . . -116.8 161.86 12.9 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.045 -1.074 . . . . 43.34 114.033 -168.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 4.4 ptpp? -108.15 124.43 50.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.814 -0.81 . . . . 64.4 108.814 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.3 56.98 3.27 Favored Glycine 0 C--N 1.313 -0.72 0 N-CA-C 108.658 -1.777 . . . . 71.04 108.658 -169.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.014 ' HB2' ' HB2' ' A' ' 26' ' ' TRP . 28.4 p-10 -41.99 -52.31 4.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.236 1.569 . . . . 72.54 115.236 -158.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.2 -37.16 69.31 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.165 0.432 . . . . 65.23 112.165 -175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.65 -41.09 18.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.267 0.556 . . . . 70.44 110.327 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.767 ' HG2' ' HA3' ' A' ' 42' ' ' GLY . 6.0 tp10 -48.11 -55.6 9.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.386 -1.279 . . . . 74.5 111.479 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 21.1 m-85 -74.61 -25.01 58.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.997 0.74 . . . . 75.14 112.997 -172.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.721 ' HE ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 ttm105 -65.28 -21.0 66.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.222 0.534 . . . . 71.23 109.721 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.28 12.16 10.5 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.055 -0.593 . . . . 73.31 111.959 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.563 ' HB3' ' HA ' ' A' ' 49' ' ' PHE . . . -108.75 -25.21 10.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.444 0.164 . . . . 64.34 111.083 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.586 ' O ' ' HB3' ' A' ' 114' ' ' LEU . 3.6 mm? -120.9 100.27 46.3 Favored Pre-proline 0 C--O 1.223 -0.341 0 CA-C-O 121.057 0.456 . . . . 74.1 111.992 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HB3' HD13 ' A' ' 114' ' ' LEU . 91.3 Cg_endo -101.2 37.35 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.777 2.985 . . . . 34.51 109.957 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . -81.34 -35.44 30.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.083 -0.962 . . . . 74.4 112.732 -165.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 37.0 m-80 65.23 19.98 11.82 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.567 0.699 . . . . 61.44 109.65 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -104.43 151.73 23.17 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.958 -1.019 . . . . 60.44 109.667 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 83' ' ' PRO . 6.6 p -87.47 133.54 33.74 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 118.916 -1.114 . . . . 75.51 108.907 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -151.47 169.14 22.77 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.147 -0.933 . . . . 70.03 109.18 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' HE1' ' HD2' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -114.55 115.08 26.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.109 0.481 . . . . 62.5 109.921 -178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.752 ' HA3' ' HE1' ' A' ' 26' ' ' TRP . . . -123.63 136.44 10.36 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.876 -0.678 . . . . 75.0 112.401 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.613 HG21 ' HZ ' ' A' ' 15' ' ' PHE . 33.6 m -117.96 131.68 70.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.983 0.391 . . . . 64.32 110.519 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.786 ' HB2' HD22 ' A' ' 45' ' ' ASN . 0.5 OUTLIER -141.07 149.09 41.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.033 0.444 . . . . 73.41 111.334 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.588 ' HA ' HG12 ' A' ' 69' ' ' ILE . 19.0 t70 -92.03 144.32 25.57 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.524 -0.762 . . . . 72.04 110.176 -176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.622 ' SG ' ' HG2' ' A' ' 68' ' ' LYS . 12.1 p -135.44 175.15 9.85 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.001 -1.0 . . . . 61.51 108.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.33 -24.39 45.07 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 114.899 0.72 . . . . 42.34 114.899 -166.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 67' ' ' ASN . 7.2 m120 -121.54 -15.93 7.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.416 1.108 . . . . 62.15 113.032 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HG2' ' SG ' ' A' ' 65' ' ' CYS . 9.7 ptpt -163.3 168.35 20.65 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.162 -0.615 . . . . 72.01 112.052 -168.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' A' ' 64' ' ' ASP . 23.6 mt -113.27 123.77 69.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.028 -0.73 . . . . 74.43 109.028 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -100.02 133.82 43.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.358 -0.383 . . . . 71.0 111.434 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' HD2' ' HE1' ' A' ' 60' ' ' PHE . 10.8 m-85 -89.84 108.79 19.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.689 -0.687 . . . . 60.41 109.208 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 53.9 t -104.78 131.35 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.987 0.422 . . . . 61.41 111.602 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.3 tp -127.28 130.12 48.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.609 -0.723 . . . . 70.53 110.283 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 58' ' ' CYS . 19.1 m95 -90.17 159.36 16.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 74.2 109.936 175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 109' ' ' HIS . 31.0 p -86.14 151.87 54.91 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.557 -0.535 . . . . 44.23 109.557 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 3.2 Cg_exo -74.7 79.4 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.293 1.995 . . . . 54.22 111.375 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -73.96 -38.96 64.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.633 -0.712 . . . . 54.43 110.233 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.11 9.22 28.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 70.31 110.253 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' PRO . . . -126.68 165.54 27.74 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.806 -0.633 . . . . 50.21 111.009 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.534 ' O ' ' HD2' ' A' ' 83' ' ' PRO . 17.2 Cg_exo -68.92 175.69 7.08 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.939 2.426 . . . . 73.25 112.846 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.0 t -78.84 -8.55 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.067 -0.515 . . . . 74.33 111.852 -174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 83' ' ' PRO . 67.2 tttt -67.71 -56.03 12.85 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 112.657 0.614 . . . . 74.32 112.657 -176.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 82' ' ' LYS . 52.5 Cg_exo -53.33 -40.2 78.74 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.285 1.99 . . . . 73.22 113.562 -173.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 76' ' ' PRO . 57.8 ttp85 -60.47 -45.85 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.798 0.332 . . . . 60.21 111.025 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 95.9 mmm -67.77 -26.95 66.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.151 0.5 . . . . 65.12 109.94 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.1 m -71.87 -48.2 47.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.271 -0.877 . . . . 74.13 111.652 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -61.37 -31.53 71.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.837 0.351 . . . . 74.42 111.408 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.92 -27.33 69.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 70.34 111.719 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.5 m -71.29 -30.15 65.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.039 0.447 . . . . 63.45 111.228 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.416 ' O ' HD23 ' A' ' 94' ' ' LEU . 3.2 p -97.63 12.48 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.275 -0.421 . . . . 62.21 111.825 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -57.24 -52.47 65.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.376 . . . . 71.21 111.694 -176.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -76.56 -31.36 57.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 72.3 111.548 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.8 -23.27 67.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.987 0.366 . . . . 53.01 111.987 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 36' ' ' ILE . 4.1 mm? -96.15 -42.22 8.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.076 0.465 . . . . 72.11 109.997 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 103' ' ' ALA . 55.0 tp -55.47 -39.34 70.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.525 -0.761 . . . . 63.53 110.994 178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -81.46 -21.59 38.67 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.435 -0.802 . . . . 65.53 112.191 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -32.5 9.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.818 0.673 . . . . 74.04 112.818 -168.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.687 HD11 HD12 ' A' ' 94' ' ' LEU . 65.5 mt -88.13 -40.65 13.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.746 -0.782 . . . . 63.44 112.762 -167.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -151.82 -174.23 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.455 -0.498 . . . . 74.54 111.038 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.75 13.6 66.05 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.338 -1.105 . . . . 74.24 110.338 172.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 69' ' ' ILE . . . -55.48 177.28 0.05 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.111 0.964 . . . . 74.21 113.13 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 104' ' ' VAL . 4.9 m -85.45 140.38 30.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.417 -0.81 . . . . 73.24 111.106 -167.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 95' ' ' LEU . . . -69.3 5.91 1.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.286 -0.87 . . . . 32.45 113.056 -175.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 102' ' ' THR . 46.0 t -85.56 149.32 4.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.922 -0.399 . . . . 75.21 109.922 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -125.61 165.17 19.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.023 -0.362 . . . . 72.33 110.023 176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 tt -133.21 117.77 17.82 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.7 -0.482 . . . . 72.42 109.7 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.96 132.92 53.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.48 -0.563 . . . . 73.22 109.48 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' CZ3' ' A' ' 74' ' ' TRP . . . -131.43 162.67 29.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.312 -0.404 . . . . 74.01 110.127 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.557 ' HA ' ' SG ' ' A' ' 75' ' ' CYS . 1.9 p80 -112.19 -158.6 0.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.119 -0.491 . . . . 74.32 111.145 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.478 ' H ' ' HB2' ' A' ' 109' ' ' HIS . 0.8 OUTLIER -51.15 157.23 0.93 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.161 0.8 . . . . 64.31 113.161 -170.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 110' ' ' GLU . 64.4 mtm 79.61 -45.31 0.32 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 114.597 -1.183 . . . . 70.34 111.789 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.0 -19.1 21.33 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.862 0.705 . . . . 65.1 114.862 -171.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.15 -51.57 69.15 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.619 0.368 . . . . 63.33 111.263 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 114' ' ' LEU . 2.4 pt? -120.32 20.23 11.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 63.11 111.485 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 117' ' ' LEU . . . -101.77 155.97 35.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.786 -0.449 . . . . 72.24 109.786 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.721 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 18.9 Cg_endo -59.61 100.18 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.492 2.128 . . . . 71.21 113.316 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 117' ' ' LEU . 4.8 mp -64.47 -54.11 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.808 -0.812 . . . . 75.03 108.808 171.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 CA-C-N 114.69 -1.141 . . . . 74.23 108.985 176.664 . . . . . . . . 0 0 . 1 stop_ save_